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Summary
The production of biodiesel has been steadily increasing during the last
decade, and with it crude glycerol as a byproduct. Despite being rich in
glycerol, the increased supply has saturated the demand for glycerol, making
purification a non-viable option. The background for this project was to
investigate the suitability of lactic acid bacteria as production organisms for
the production of biofuels and biochemicals. Specifically, the goal was to
adapt the model organism Lactococcus lactis to convert crude glycerol, to
value-added fuels or chemicals. Work was divided between four main areas:
life cycle assessment of the GLYFINERY project, screening of L. lactis spp.
for glycerol utilization, engineering of glycerol metabolism in L. lactis and
finally an investigation into perturbation of energy metabolism in L. lactis.
The work from the life cycle assessment resulted in two reports, detailing
the technological requirements for the GLYFINERY processes. These have
been included in the appendix (section A).
The screening did not reveal any L. lactis strains capable of assimilating
glycerol nor did it reveal any conditions favorable to glycerol dissimilation in
L. lactis. The conditions evaluated were: anaerobic, aerobic and respiration
permissive growth in combination with either glycerol as a sole substrate or
with co-metabolization of glycerol with common sugar substrates. Although
no growth on glycerol was seen, both positive and detrimental effects were
observed from cultures with glycerol supplementation.
The positive effects were observed from cultivation of L. lactis IL1403
with trehalose as a substrate under aerated conditions. Under these condi-
tions, the supplementation of glycerol would cause an increase in biomass
production of over night cultures. The growth rate of the cultures with
glycerol supplementation were determined to be 84% of the reference cul-
tures without glycerol. The detrimental effects of glycerol were observed
as reduced growth rate and decreased biomass formation. The effects were
observed when cultivating plant isolates of L. lactis on xylose. The effect
manifested itself under both anaerobic and respiration permissive condi-
tions, but was not found to have the same profound effect on other sugar
substrates such as galactose or ribose.
Supplementation of nucleosides to the growth medium or increased sub-
strate concentration were found to counteract the inhibitory effects and im-
prove the growth rate, though not completely to the level of the reference
strain. The fact that this effect was predominantly observed while utilizing
xylose implicates the involvement of the pentose phosphate pathway. A pos-
sible mechanism underlying the observed growth characteristics under anae-
robic conditions could be a rise in triosephosphate levels (the entry point of
glycerol in glycolysis) regulating pyruvate formate-lyase. Under aerobic and
respiration permissive conditions, the rise in the redox level from channel-
ing glycerol into metabolism could possibly regulate both glyceraldehyde-3-
phophate dehydrogenase and the pyruvate dehydrogenase complex, disrupt-
ing flow through the central metabolism and ATP production.
If this is the case, the question remains, as to why the excess redox is
not simply removed by respiration. The results from this investigation have
provided an initial characterization of the inhibitory effects and some pos-
sible directions for future investigations, but more work is needed to fully
elucidate the mechanism and target of inhibition.
The engineering of glycerol metabolism in L. lactis was initiated from
three different perspectives: overexpression of glycerol kinase from L. lactis,
introduction of a heterologous glycerol assimilation pathway and construc-
tion of a library of NADH oxidase activity. Based on a preliminary analysis
of transcription level data, an attempt was made to stimulate glycerol as-
similation by overexpressing the glycerol kinase already present in L. lactis.
The construction and verification of a strain with increased glycerol kinase
activity was not fully completed and is still ongoing.
Similarly the construction of mutants expressing a heterologous pathway
for glycerol dissimilation is also an ongoing task. An artificial glycerol as-
similation operon was designed based on components from known glycerol
metabolizers. Three genetic elements were placed in the operon: the gly-
cerol facilitator glpF from E. coli, the glycerol dehydrogenase dhaD from
Citrobacter freundii and the dihydroxyacetone kinase dhaK also from Cit-
robacter freundii. These were arranged in an operon structure where glpF
was placed in front of dhaD and dhaK. Ribosomal binding sites from glyco-
lytic promoters in L. lactis were placed in front of each gene. The operon was
introduced into L. lactis with expression modulated by a synthetic promoter
library.
Lastly, to prevent possible issues with redox accumulation during growth
on glycerol, a library of mutants with NADH oxidase activity was construc-
ted and verified by enzymatic assays. Despite the NADH oxidase activity,
no growth could be detected in defined medium supplemented with glycerol
as sole carbon and energy source. This could possibly be connected to the
expression levels of the library, which were in the lower range.
Investigations were also made into the response of L. lactis mutants to
perturbations in energy metabolism. The motivation was to apply, tran-
scriptomic and metabolomic techniques that were not available at the time
of the previous characterization by Koebmann et al., in 2002. To minimize
noise and pleiotropic effects, strains with mild perturbations were selected
for transcriptomic analysis. For the purpose of investigating the changes in
internal metabolite concentrations, a mutant with very high ATPase activ-
ity was included with the mildly perturbed strains. The data obtained from
the metabolomic study of internal metabolites, did not provide any novel
observations and did not substantiate the results from the transcriptomic
investigation.
Although significance of the transcriptomic analysis was affected by tech-
nical issues, the overall impression gathered from the response to perturba-
tion of ATP levels, was that the genes were generally downregulated. Glyco-
lysis along with most of the anabolic pathways were downregulated in what
resembled a starvation response. During hydrolysis of ATP two signals were
generated, lowered energy state and increased inorganic phosphate levels
(Pi). The exact contribution of each signal along with many other interest-
ing observations will need to be confirmed by additional experiments and
further investigation in future studies.
The task of making Lactococcus lactis grow on glycerol as a sole carbon
and energy source still remains to be accomplished. It will require continued
efforts in the three areas investigated in this work and others, to fulfill this
task. Hopefully, future investigations can successfully bridge the integration
of the complex challenges encountered, when engineering central carbon
metabolism, to complete the goal.
Resume
Produktionen af biodiesel har været støt stigende gennem det sidste a˚rti og
ligeledes biproduktet r˚aglycerin. Selvom r˚aglycerin er rig p˚a glycerol, har
den stigende produktion mættet markedet og oprensning er ikke længere
en rentabel m˚ade at h˚andtere r˚aglycerin p˚a. Baggrunden for dette projekt
var at afklare hvorvidt mælkesyrebakterier kunne anvendes som produk-
tionsorganismer til produktion af biobrændsler og biokemikalier. Specifikt
var m˚alet at tilpasse model organismen Lactococcus lactis til at omdanne
r˚aglycerin til biobrændsler eller biokemikalier. Arbejdet i denne afhandling
er inddelt i fire hovedomr˚ader: Livscyklusanalyse af GLYFINERY projek-
tet, screening af L. lactis stammer for naturlig anvendelse af glycerol, modi-
fikation af glycerolmetabolismen i L. lactis og undersøgelse af effekten ved
perturbation af energimetabolismen i L. lactis.
Arbejdet med livscyklusanalyse af GLYFINERY projektet udmundede i
to rapporter, der beskriver de tekniske krav til processerne der udvikles i
GLYFINERY projektet. Disse er inkluderet i appendiks A.
Screeningen af L. lactis stammer for glycerol afslørede ikke nogen kan-
didater. Ej heller var det muligt at finde betingelser der kunne stimulere
vækst p˚a glycerol. De betingelser der blev undersøgt var: anaerob, aerob
og respiratorisk vækst kombineret med enten glycerol eller kombinationer af
glycerol og sukkersubstrater. Selvom det ikke var muligt at stimulere vækst
p˚a glycerol alene, blev b˚ade gavnlige og skadelige effekter observeret.
En positiv effekt kunne observeres ved øget biomasse udbytte i overnat-
skulturer med trehalose som substrat. Væksthastigheden af kulturer med
glyceroltilsætning blev m˚alt til 84% af værdien for kulturer uden glycer-
oltilsætning. De skadelige virkninger af glyceroltilsætning blev konstateret
som værende sænket væksthastighed og et fald i biomasseudbytte. In-
dledende blev fænomenet opdaget ved vækst af planteisolater p˚a xylose.
Glycerol inhibering gør sig gældende under b˚ade anaerobe og respirator-
iske forhold, men har ikke samme hæmmende effekt med andre substrater,
s˚asom galaktose eller ribose. Tilførsel af nukleosider til vækstmediet eller en
forøgelse af xylose koncentrationen, viste sig at modvirke glycerol inhiberin-
gen øgede væksthastigheden, dog ikke helt p˚a niveau med referencen. Siden
dette fænomen først og fremmest kunne observeres med xylose som substrat
perger p˚a pentose phosphat vejen. En mulig virkningsmekanisme kunne un-
der anaerobe forhold være en stigning i triosephophatniveauet (indgangen
for glycerol til glykolysen), hvilket regulerer pyruvate formate-lyase. Under
aerobe or respiratoriske betingelser, kunne en mulig effekt være en stigning
i redox niveauet, fra glycerols vej ind i glykolysen, hvilket regulerer b˚ade
glyceraldehyd-3-phosphat dehydrogenase og pyruvate dehydrogenase kom-
plekset. Dette ville forstyrre flowet gennem den centrale metabolisme, samt
ATP produktionen.
Skulle dette være tilfældet er spørgsm˚alet s˚a, hvorfor den overskydende
redox energi ikke blot fjernes gennem respiration. Denne undersøgelse har
givet en basal undersøgelse af glycerolinhibering og leveret et udgangspunkt
for fremtidige undersøgelser, selvom en større indsats er p˚akrævet for til
fulde at karakterisere dette fænomen.
Tilpasningen af glycerol metabolismen i L. lactis foregik ud fra tre in-
dgangsvinkler: overudtryk af glycerol kinase fra L. lactis, introduktionen
af det komplette enzymatiske maskineri p˚akrævet til vækst p˚a glycerol og
konstruktionen af et bibliotek af NADH oxidase aktivitet. Baseret p˚a den in-
dledende analyse af transkriptionsdata, blev et forsøg p˚a at stimulere vækst
p˚a glycerol ved glycerol kinase overudtryk igangsat. Konstruktion of veri-
fikation af en s˚adan stamme er stadig undervejs og endnu ikke afsluttet.
Stammer med en komplet pathway til vækst p˚a glycerol er ligeledes heller
ikke færdige. Til at indsætte en komplet pathway, blev der designet en syn-
tetisk operon. Komponenterne blev baseret p˚a stammer der allerede var
kendt for at vokse p˚a glycerol. Sammenlagt er der tre genetiske elementer
i operonstrukturen: glycerol facilitatoren glpF fra E. coli, glycerol dehyd-
rogenasen dhaD fra Citrobacter freundii og dihydroxyacetone kinasen dhaK
ligeledes fra Citrobacter freundii. Generne blev arrangeret i en operonstruk-
tur med glpF placeret foran dhaD og dhaK. Ribosomale bindingsteder fra
glykolystiske promotorer fra L. lactis, blev indsat foran hvert gen. Denne op-
eron blev introduceret i L. lactis med et syntetisk promoterbibliotek indsat
foran.
Til at forhindre problemer med redox niveauet under vækst p˚a glycerol,
blev der fremstillet et bibliotek af stammer med NADH oxidase aktivitet.
Disse blev verificeret med et enzymatisk assay og testet for vækst p˚a gly-
cerol. Ingen vækst kunne konstateres i defineret medium med glycerol som
eneste kulstof- og energikilde. Dette skyldes muligvis at NADH oxidase en-
zymaktiviteterne ikke var høje nok.
Det blev yderligere undersøgt, hvorledes L. lactis reagerede p˚a pertuba-
tioner i energimetabolismen. Motivationen bag dette studie var at genoptage
analysen af stammerne fra tidligere, men denne gang anvende transkrip-
tionelle og metabolske analyseværktøjer der ikke var tilgængelige ved den
tidligere analyse fra Koebmann et al. i 2002. For at minimere støjen og
pleiotropiske effekter, blev stammer med milde perturberinger udvalgt til
transkriptionsanalysen. Til analyse af interne metabolitniveauer inkluderes
en stamme med kraftig pertubering, sammen med stammerne med de milde
perturberinger. Data fra metabolitstudiet gav ikke anledning til nogle nye
opdagelser. Transkriptionsanalysen viste en generel tendens til nedreguler-
ing af glykolysen og anabolske reaktionsveje, hvilket kunne minde om en
sultrespons. N˚ar man hydrolyserer ATP p˚avirkes b˚ade cellens energiniveau,
samt niveauet af fri phosphat Pi. Den præcise virking og kontrol af hver af
disse signaler er ukendt og skal afklares i fremtidige undersøgelser.
Ma˚let med at f˚a Lactococcus lactis til at vokse p˚a glycerol som ene-
ste kulstof- og energikilde, er endnu ikke n˚aet. Det vil kræve betydelig
indsats indefor omr˚aderne beskrevet her, samt muligvis andre, at opfylde
dette. Forh˚abentligt vil fremtidige undersøgelser kunne løfte denne opgave
og fuldføre m˚alet.
Contents
List of Figures IX
List of Tables X
Preface 1
I General introduction 2
1 Outline of the thesis 3
1.1 Organization of the thesis . . . . . . . . . . . . . . . . . . . . 3
1.1.1 Thesis layout . . . . . . . . . . . . . . . . . . . . . . . 4
1.1.2 Work package 7 - GLYFINERY integrated assessment 4
2 The origins of the glycerol refinery 5
2.1 7th Framework programme . . . . . . . . . . . . . . . . . . . 5
2.1.1 Organization of the GLYFINERY consortium . . . . . 5
2.1.2 Life cycle assessment . . . . . . . . . . . . . . . . . . . 6
2.2 Biodiesel production . . . . . . . . . . . . . . . . . . . . . . . 6
2.2.1 Waste glycerol . . . . . . . . . . . . . . . . . . . . . . 7
3 Selecting a suitable microorganism 9
3.1 Lactic acid bacteria . . . . . . . . . . . . . . . . . . . . . . . . 10
3.1.1 From lab to industry . . . . . . . . . . . . . . . . . . . 10
3.1.2 Lactococcus lactis - a model lactic acid bacterium . . . 11
4 Glycerol and metabolism 13
4.1 Glycerol assimilation . . . . . . . . . . . . . . . . . . . . . . . 13
4.2 Fermentative glycerol metabolism . . . . . . . . . . . . . . . . 14
4.2.1 Genetic framework of glycerol assimilation . . . . . . . 15
4.2.2 Regulation of glycerol metabolism . . . . . . . . . . . 15
I
5 Central metabolism of Lactococus lactis 17
5.1 Anaerobic metabolism of Lactococcus lactis . . . . . . . . . . 17
5.2 Central carbon metabolism . . . . . . . . . . . . . . . . . . . 19
5.2.1 Regulation of carbon metabolism by HPr and CcpA . 19
5.3 Aerobic metabolism of Lactococcus lactis . . . . . . . . . . . . 21
5.3.1 Oxygen tolerance in Lactococcus lactis . . . . . . . . . 21
5.3.2 Respiration in Lactococcus lactis . . . . . . . . . . . . 22
5.4 Redox and energy metabolism is highly connected to central
metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
5.5 Integration of information from the transcriptomic and the
metabolic level . . . . . . . . . . . . . . . . . . . . . . . . . . 25
6 Potential challenges to glycerol assimilation by Lactococcus
lactis 27
6.0.1 Genetic components . . . . . . . . . . . . . . . . . . . 28
6.1 Approaches to overcome the problems faced by Lactococcus
lactis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
References 32
II Screening of Lactococcus spp. for glycerol utilization 40
7 Introduction 41
7.1 Glycerol has become an abundant molecule suitable as an
industrial substrate . . . . . . . . . . . . . . . . . . . . . . . . 41
7.1.1 Prototrophic plant isolates of Lactococcus lactis might
have retained the ability to grow on glycerol . . . . . . 41
7.2 Xylose metabolism in Lactococcus lactis . . . . . . . . . . . . 44
7.2.1 The ability to utilize xylose among Lactococcus spp.
depends on the origin . . . . . . . . . . . . . . . . . . 44
8 Materials and Methods 46
8.1 Bacterial strains and growth conditions . . . . . . . . . . . . 46
8.1.1 Growth conditions . . . . . . . . . . . . . . . . . . . . 46
8.2 Sampling for metabolite analysis . . . . . . . . . . . . . . . . 47
8.3 Correlation of cell density to cell mass . . . . . . . . . . . . . 47
8.4 Calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
9 Results 48
9.1 Preliminary serial cultivation does not induce glycerol utiliz-
ation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
9.2 Dairy isolates of Lactococcus lactis show improved adaptation
to growth under nutrient rich conditions compared to plant
isolates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
II
9.3 The selected Lactococcus lactis spp. were unable to utilize
glycerol under all of the conditions tested . . . . . . . . . . . 51
9.3.1 Variation of carbon source is not sufficient to stimulate
glycerol utilization . . . . . . . . . . . . . . . . . . . . 51
9.3.2 Prolonged incubation in medium supplemented with
glycerol does not stimulate utilization . . . . . . . . . 51
9.3.3 Overexpression of ATPase activity does not stimulate
glycerol utilization . . . . . . . . . . . . . . . . . . . . 56
9.3.4 Growth experiments do not reveal any glycerol utiliz-
ation under respiration permissive conditions . . . . . 56
9.4 Glycerol supplementation to the growth medium has a great
effect on growth rate but only for certain substrates . . . . . 59
9.4.1 Supplementation of glycerol to the growth medium
shows indications of increased biomass formation for
strains grown under aerobic conditions with trehalose
as a substrate . . . . . . . . . . . . . . . . . . . . . . . 59
9.4.2 Glycerol supplementation to growth medium has a
detrimental effect on growth rate of cultivated strains 60
9.4.3 Growth experiments show glycerol inhibition of growth
rate in most types of growth media . . . . . . . . . . . 60
9.4.4 Internal metabolite measurements do not reveal sig-
nificant differences between cultures grown with or
without glycerol supplementation . . . . . . . . . . . . 68
10 Discussion 70
10.1 A serial transfer regime was not sufficient to stimulate glycerol
assimilation in Lactococcus lactis NCDO2118 . . . . . . . . . 70
10.1.1 How can you enrich for something that does not grow? 70
10.2 None of the tested conditions could stimulate the selected
Lactococcus lactis strains to utilize glycerol . . . . . . . . . . 71
10.2.1 The role of glycerol transport . . . . . . . . . . . . . . 72
10.2.2 Measurements of internal metabolites did not provide
new insights . . . . . . . . . . . . . . . . . . . . . . . . 72
10.2.3 Glycerol supplementation affects growth rate in me-
dium with xylose and is counteracted by addition of
nucleosides, sodium acetate and trehalose . . . . . . . 73
References 76




11.1 Metabolic engineering of glycerol utilization . . . . . . . . . . 81
11.2 Engineering recombinant glycerol utilization in Lactococcus
lactis MG1363 . . . . . . . . . . . . . . . . . . . . . . . . . . 82
11.2.1 Both overexpression of endogenous genes and an artifi-
cial operon containing a complete pathway for glycerol
dissimilation is employed to allow anaerobic growth on
glycerol by L. lactis . . . . . . . . . . . . . . . . . . . 83
12 Materials and Methods 84
12.1 Bacterial strains, plasmids and growth conditions . . . . . . . 84
12.2 Primers and PCR protocols . . . . . . . . . . . . . . . . . . . 84
12.2.1 PCR using Taq polymerase . . . . . . . . . . . . . . . 88
12.2.2 PCR using Phusion polymerase . . . . . . . . . . . . . 88
12.2.3 DNA techniques . . . . . . . . . . . . . . . . . . . . . 90
12.2.4 Preparation of crude enzyme extract . . . . . . . . . . 93
12.2.5 Enzyme assays . . . . . . . . . . . . . . . . . . . . . . 93
12.2.6 Transformation . . . . . . . . . . . . . . . . . . . . . . 94
12.3 Construction of strains overexpressing Glycerol kinase . . . . 97
12.3.1 pAH184: An artificial operon with the machinery re-
quired to metabolize glycerol . . . . . . . . . . . . . . 97
12.3.2 Construction of strains with NADH oxidase activity . 99
13 Results 101
13.1 Overexpression of endogenous glycerol kinase from a synthetic
promoter library as way to stimulate glycerol assimilation . . 101
13.2 Introduction of an artificial operon for glycerol dissimilation
into Lactococcus lactis . . . . . . . . . . . . . . . . . . . . . . 103
13.3 Overexpression of NADH oxidase is not sufficient to enable
growth on glycerol . . . . . . . . . . . . . . . . . . . . . . . . 107
14 Discussion 109
14.1 Design and introduction of a complete recombinant pathway
for glycerol assimilation into Lactococcus lactis . . . . . . . . 109
14.2 Overexpression of NADH oxidase activity is not enough to
allow growth of Lactococcus lactis on glycerol as sole carbon
and energy source . . . . . . . . . . . . . . . . . . . . . . . . 110
References 111
IV Investigation of Lactococcus lactis strains with per-
turbed ATP levels 116
15 Introduction 117
15.1 Investigations into glycolytic flux control in Lactococcus lactis 117
IV
15.1.1 The effect of ATP demand on glycolytic flux . . . . . 118
15.2 Experimental setup . . . . . . . . . . . . . . . . . . . . . . . . 118
16 Materials and Methods 120
16.1 Bacterial strains, plasmids and growth conditions . . . . . . . 120
16.2 High-pressure liquid chromatography analysis . . . . . . . . . 121
16.3 RNA purification . . . . . . . . . . . . . . . . . . . . . . . . . 121
16.4 DNA microarray analysis . . . . . . . . . . . . . . . . . . . . 122
16.5 Carbon labeling experiments . . . . . . . . . . . . . . . . . . 122
16.6 Sampling for metabolite analysis . . . . . . . . . . . . . . . . 122
16.7 Correlation of cell density to cell mass . . . . . . . . . . . . . 122
16.8 Calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
17 Results 123
17.1 Physiological characterization of strains with varying degrees
of ATPase activity . . . . . . . . . . . . . . . . . . . . . . . . 123
17.2 Metabolomic profiling of strains expressing various degrees of
ATPase activity . . . . . . . . . . . . . . . . . . . . . . . . . . 124
17.3 Analysis of transcriptome levels in strains expressing ATPase
activity reveals starvation like response to pertubation of ATP
level . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
17.3.1 Data quality check and normalization . . . . . . . . . 126
17.3.2 Normalization and averaging of probe data using ro-
bust multi-array averaging . . . . . . . . . . . . . . . . 130
17.3.3 Transcriptome level analysis of Lactococcus lactis strains
displaying varying degrees of ATPase activity . . . . . 131
17.3.4 Mapping the response of strains expressing varying
degrees of ATPase activity to metabolic pathways re-
veals a global picture of the transcriptomic response . 136
18 Discussion 144
18.1 Metabolomic profiling of strains expressing ATPase activity
confirms the ATPase system as working but reveals the need
for further optimization . . . . . . . . . . . . . . . . . . . . . 144
18.2 Transcriptome profiling of strains expressing varying degrees
of ATPase activity indicates a starvation like response to per-
turbations in energy level . . . . . . . . . . . . . . . . . . . . 145
18.2.1 Proper handling and processing of microarrays plays
a vital role in further data analysis . . . . . . . . . . . 145
18.2.2 Implications of the observations made in the transcrip-
tome level analysis of strains expressing varying de-







2.1 Biodiesel production in Europe from 2002–2010. Data from
the European Biodiesel Board [4]. . . . . . . . . . . . . . . . . 7
4.1 The structure of glycerol . . . . . . . . . . . . . . . . . . . . . 13
4.2 Overview of the pathways for glycerol dissimilation in bacteria 14
4.3 Overview of glycerol metabolism in Klebsiella spp. . . . . . . 16
5.1 Central carbon metabolism of Lactococcus lactis . . . . . . . 18
5.2 Regulation of central carbon metabolism . . . . . . . . . . . . 20
5.3 Respiration in lactic acid bacteria . . . . . . . . . . . . . . . . 22
5.4 Metabolic map of central metabolism in Lactococcus lactis
MG1363 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
5.5 Figure depicting the effects of pertubating ATP and NADH
levels on the metabolism of Escherichia coli . . . . . . . . . . 26
6.1 Problems associated with growth on glycerol . . . . . . . . . 28
6.2 Overview of transcriptomic data for Lactococcus lactis MG1363 29
6.3 Illustration of the transcriptional level of genes connected
with glycolysis and glycerol assimilation in Lactococcus lactis
MG1363 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
6.4 Ways to solve the problems associated with glycerol dissimil-
ation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
7.1 Central carbon metabolism of Lactococcus lactis . . . . . . . 42
7.2 Proposed map of xylose metabolism in selected Lactococcus
spp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
9.1 Growth of Lactococcus lactis MG1363 in SAL medium sup-
plemented with increasing amounts of glucose . . . . . . . . . 49
9.2 Growth of Lactococcus lactis NCDO2118 in SAL medium sup-
plemented with increasing amounts of glucose . . . . . . . . . 50
9.3 Growth of Lactococcus lactis KF147 in SAL medium supple-
mented with increasing amounts of glucose . . . . . . . . . . 50
9.4 Growth of Lactococcus lactis IL1403 in SAL medium supple-
mented with different concentrations of glycerol . . . . . . . . 54
VII
9.5 Growth of Lactococcus lactis NCDO2118 and MG1363 in SAL
medium supplemented with glucose and glycerol . . . . . . . 54
9.6 Product formation and substrate consumption - SAL + gluc-
ose + glycerol . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
9.7 Product formation and substrate consumption - SAL + maltose
+ glycerol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
9.8 Inhibitory effect of glycerol addition on Lactococcus lactis
NCDO2118 in SAL medium . . . . . . . . . . . . . . . . . . . 61
9.9 Inhibitory effect of glycerol addition on Lactococcus lactis
NCDO2118 in SAL and BLL medium . . . . . . . . . . . . . 61
9.10 NCDO2118 internal metabolite concentration plot . . . . . . 69
11.1 Overview of the components involved in glycerol metabolism 82
12.1 Synthetic Promoter Library . . . . . . . . . . . . . . . . . . . 89
12.2 Size distribution of Fermentas ladders: SM0333 and SM1333 90
12.3 Illustration of site specific recombination of plasmid DNA into
the chromosome of L. lactis . . . . . . . . . . . . . . . . . . . 97
12.4 Illustration of pAH184 plasmid carrying an artificial operon
for glycerol dissimilation . . . . . . . . . . . . . . . . . . . . . 98
13.1 Results from promoter strength assay using β-glucuronidase
as a reporter gene in strains overexpressing glpK from Lacto-
coccus lactis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
13.2 Plot of the results from a glycerol kinase assay using selected
strains overexpressing glpK from Lactococcus lactis . . . . . . 103
13.3 Results from promoter strength assay using β-glucuronidase
as a reporter gene on strains expressing the synthetic glycerol
assimilation operon . . . . . . . . . . . . . . . . . . . . . . . . 104
13.4 Results from glycerol dehydrogenase assay on strains express-
ing the synthetic glycerol assimilation operon . . . . . . . . . 105
13.5 Results from dihydroxyacetone kinase assay on strains ex-
pressing the synthetic glycerol assimilation operon . . . . . . 105
13.6 Results from promoter strength assay using β-glucuronidase
as a reporter gene on strains expressing NADH oxidase activity107
13.7 Results from NADH oxidase assay on strains expressing NADH
oxidase activity . . . . . . . . . . . . . . . . . . . . . . . . . . 108
17.1 Plot of internal metabolite concentrations in strains overex-
pressing ATPase activity . . . . . . . . . . . . . . . . . . . . . 125
17.2 Overview of microarray analysis workflow . . . . . . . . . . . 127
17.3 A heatmap of SVD analysis of all samples . . . . . . . . . . . 128
17.4 Plot of intensity distribution data from chip 1 . . . . . . . . . 129
17.5 Regulatory effects by ATP/ADP level of central metabolism
in Lactococcus lactis . . . . . . . . . . . . . . . . . . . . . . . 143
VIII
List of Tables
6.1 Overview of the presence of genes required for glycerol assim-
ilation in sequenced Lactococcus lactis strains . . . . . . . . . 29
7.1 Overview of the presence of genes required for glycerol assim-
ilation in sequenced Lactococcus lactis strains . . . . . . . . . 43
8.1 Bacterial strains used in the screening. . . . . . . . . . . . . . 46
9.1 Conditions tested in glycerol utilization screening . . . . . . . 52
9.2 Examples of test results from glucose and glycerol screening
of Lactococcus lactis . . . . . . . . . . . . . . . . . . . . . . . 53
9.3 Example of test result from prolonged glycerol incubation of
Lactococcus lactis . . . . . . . . . . . . . . . . . . . . . . . . . 55
9.4 Test results from glucose and glycerol screening of Lactococcus
lactis strains with ATPase overexpression . . . . . . . . . . . 56
9.5 Results from growth experiment in SAL supplemented with
glucose or maltose with or without glycerol . . . . . . . . . . 57
9.6 Test results from trehalose and glycerol screening of L. lactis
IL1403 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
9.7 Results from a growth experiment with L. lactis IL1403 in
SAL medium supplemented with 0.1% trehalose and 0.2%
glycerol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
9.8 Results from growth experiment in BLL supplemented with
xylose with or without glycerol . . . . . . . . . . . . . . . . . 62
9.9 Product formation from cultures in a growth experiment in
BLL supplemented with xylose with or without glycerol . . . 63
9.10 Results from growth experiment in BLL medium supplemen-
ted with galactose with or without glycerol . . . . . . . . . . 64
9.11 Product formation from cultures in a growth experiment in
BLL supplemented with galactose with or without glycerol . . 64
9.12 Results from growth experiment in defined SAL medium sup-
plemented with xylose . . . . . . . . . . . . . . . . . . . . . . 65
9.13 Results from growth experiments in various defined and com-
plex media with Lactococcus lactis NCDO2118 and IL1403 . . 66
IX
9.14 Summary of results from growth experiments in various media
defined and complex with Lactococcus lactis NCDO2118 and
IL1403 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
9.15 NCDO2118 internal metabolite concentrations . . . . . . . . 68
12.1 Plasmids and bacterial strains used in the engineering of L.
lactis glycerol metabolism. . . . . . . . . . . . . . . . . . . . . 85
12.2 Primers used in the project. . . . . . . . . . . . . . . . . . . . 87
12.3 PCR with Taq polymerase . . . . . . . . . . . . . . . . . . . . 88
12.4 Standard PCR with Phusion polymerase . . . . . . . . . . . . 88
12.5 Touchdown PCR with Phusion polymerase . . . . . . . . . . 89
12.6 Protocol for digestion of DNA with standard restriction en-
zymes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
12.7 Protocol for digestion of DNA with FastDigestr restriction
enzymes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
12.8 Ligation protocol . . . . . . . . . . . . . . . . . . . . . . . . . 92
12.9 USER cloning ligation protocol . . . . . . . . . . . . . . . . . 93
12.10Composition of solutions 1 and 2 used for preparation of com-
petent cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
13.1 Results from glycerol kinase assay . . . . . . . . . . . . . . . 102
13.2 Results from screening strains with a synthetic glycerol assim-
ilation pathway for growth in defined medium supplemented
with glycerol . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
16.1 Plasmids and bacterial strains used in part IV of the project. 120
17.1 Growth rates for experiments used to remake the study by
Koebmann et al. . . . . . . . . . . . . . . . . . . . . . . . . . 123
17.2 Internal metabolite concentrations of strains with overexpres-
sion of ATPase activity . . . . . . . . . . . . . . . . . . . . . 124
17.3 50 most differentially upregulated genes in BK1506 . . . . . . 132
17.4 50 most differentially downregulated genes in BK1506 . . . . 133
17.5 50 most differentially upregulated genes in BK1503 . . . . . . 134
17.6 50 most differentially downregulated genes in BK1503 . . . . 135
17.7 Results of expression analysis for glycolysis . . . . . . . . . . 137
17.8 Results of expression analysis for the PTS system . . . . . . . 138
17.9 Results of expression analysis for the ABC transporters . . . 140
17.10Results of expression analysis for genes regulated by CodY . 141
17.11Results of expression analysis for genes regulated by CcpA . . 142
X
Preface
When this project started some years ago the outset seemed simple. But
as things progressed a certain feeling began to rise. Were I to describe the
sensation it was not unlike trying to master the art of flying:
There is an art, it says, or rather, a knack to flying. The knack
lies in learning how to throw yourself at the ground and miss.
Pick a nice day it suggests, and try it.
The first part is easy. All it requires is simply the ability to
throw yourself forward with all your weight, and the willingness
not to mind that it’s going to hurt.
That is, it’s going to hurt if you fail to miss the ground. Most
people fail to miss the ground, and if they are really trying prop-
erly, the likelihood is that they will fail to miss it fairly hard.
Clearly, it is the second part, the missing, which presents the
difficulties.
-The Hitchhiker’s Guide to the Galaxy, Douglas Adams
I find that this description of putting theory to practice fairly accurately
describes my own progression. What seems straightforward (like a freshly
started PhD. project) usually turns out to be a more complex affair upon
contact with reality. Especially if it seems like you spend more time hitting
the ground than you do flying. But even though failing to miss the ground
does invoke a certain feeling of discomfort, especially during those particu-
larly determined attempts, it is the innate possibility of missing that propels
us forward time and again. When reflecting on the course of the project it
has overall been a great and extremely educational experience. I have been
fortunate to get the chance to expand my abilities on both a scientific and a
personal level. Looking back there are of course things that today I would
do differently. Not just because hindsight reveals that the result did not
materialize as expected, but also because my entire point of reference has







Outline of the thesis
As stated in the frontmatter, the project was financed by the European
Community’s 7th Framework Research Programme under Grant Agreement
Number 213506 (Project GLYFINERY).
Project GLYFINERY deals with the production of biofuels and biochem-
icals from waste glycerol derived form biodiesel production, so called crude
glycerol. To that aim we set out to investigate the hypothesis that a well
established model organism at the center, Lactococcus lactis, could in fact
be used as a production organism. Although Lactococcus lactis had at the
time mostly been studied as a dairy isolate of starter cultures for cheese pro-
duction, isolates can be found in most ecological niches. Even though the
model organisms isolated from dairy sources did not appear to possess the
ability to grow on glycerol as sole carbon and energy source, it was our hy-
pothesis that a plant isolate, generally being more prototrophic, could have
retained the ability to utilize glycerol as sole carbon and energy source. The
metabolic flexibility of Lactococcus lactis i.e. the ability to grow very well
under anaerobic conditions while still being aerotolerant to a large extent
and even being able to respire in the presence of hemin, held the promise
that perhaps it was possible to coax Lactococcus into utilizing glycerol.
1.1 Organization of the thesis
Although there is a single matter at heart of the investigation, the thesis
has been divided into 4 parts:
I A general introduction
II Screening of Lactococcus spp. for glycerol utilization
III Engineering glycerol metabolism and cofactor levels in Lactococcus lac-
tis MG1363
IV Investigation of Lactococcus lactis strains with perturbed ATP levels
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The division reflects mostly my assessment and interpretation of which issues
were key in relation to the project. It is more a framework to convey the
results of the project rather than a strict chronological account. Work in
all parts have mostly been ongoing in parallel throughout the project. Each
section is treated as a self contained unit while still being a part of the whole.
1.1.1 Thesis layout
The layout of the thesis was chosen to represent the format of peer reviewed
articles as closely as possible. Currently additional experimental support is
underway for part IV and in the future that may be the case for the other
parts as well hence this layout might be beneficial for future manuscript
preparations. Thus in addition to the general introduction each part has
been given a separate introduction which, although short, is intended to be
combined with material from the general introduction in any future work.
1.1.2 Work package 7 - GLYFINERY integrated assessment
In addition to the work outlined in the four parts described above there was
an additional aspect to my work in the GLYFINERY project. I was also in-
volved in work package 7 (WP7) which was an integrated assessment of the
processes defined by the GLYFINERY consortium. It contained multiple
work tasks: WT 7.1 - Technological assessment, WT 7.2 - Environmental
assessment, WT 7.3 - Economical assessment, WT 7.4 - Optimization of
product chains and WT 7.5 - Integrated assessment. The goal for the work
package was to integrate performance from both environmental and eco-
nomical aspects to evaluate each process.
My involvement in WP7
My role in WP7 was the work task (WT) 7.1 - Technological assessment.
More specifically I was involved in the preparation of deliverables 7.1 and
7.4 - both are reports dealing with the technological aspects of the processes
being developed in the GLYFINERY project. The initial report - D7.1
contains the preliminary introduction to the GLYFINERY projects processes
and technological definitions. As such it is an excellent introduction to the
entire GLYFINERY project itself. The second report - D7.4 is an updated
version of the initial report to reflect the experimental results obtained in
each process. Since the preparation of these reports did not directly tie in
with the other parts, the reports have not been included in the thesis, but
both reports can be found in appendix A.
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Chapter 2
The origins of the glycerol
refinery (GLYFINERY)
2.1 7th Framework programme
The project name “GLYFINERY” is an acronym playing on the words gly-
cerol and refinery. As mentioned previously the project is funded by the 7 th
Framework Programme for Research and Technological Development (FP7
for short), and aims at developing processes to handle the increased avail-
ability of crude glycerol as a byproduct of biodiesel production. The FP7
programme is scheduled to run for seven years from 2007–2013. The total
budget of FP7 is over 50 billion euro. This money will mostly be spent on
grants to players within the field of research all over Europe and beyond, in
order to co-finance research, technological development and demonstration
projects [15]. The GLYFINERY project proposal was approved in November
2007 under theme 5 - Energy. The timeline for the project was four years
running from March 2008 until March 2012. The focus of the GLYFINERY
project was to develop novel processes for the production of next generation
biofuels and biochemicals from glycerol. The target products were the bio-
fuels ethanol and butanol, the biochemical 1,3-propanediol and biomethane
as an energy carrier.
2.1.1 Organization of the GLYFINERY consortium
The project is divided into several work packages each with one or more
partners responsible for various stages. The entire project was designed to
run from initial strain discovery through strain development and process
optimization to a final implementation of pilot scale testing for the most
promising processes. The GLYFINERY consortium consists of six partners:
• Technical University of Denmark (DTU), Denmark
• BioGasol ApS., Denmark
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• A&A Biotechnology s.c. - Poland
• The Institute for Energy and Environmental Research (IFEU), Ger-
many
• MEROCO A.S., Slovakia
• Prochimia Surfaces Sp. z.o.o., Poland
Initially MEROCO supplied the crude glycerol to be used as a substrate for
the bioconversion processes, DTU together with BioGasol and A&A Bio-
technology were responsible for strain isolation and development, Prochimia
was responsible for product recovery and IFEU performed a life cycle and
integrated assessment for the processes.
2.1.2 Life cycle assessment
As described above, part of the project contained a life cycle assessment.
This work was delegated to work package 7 (WP7). Part of the work package
was to perform a technological assessment of the GLYFINERY processes. I
participated together with IFEU in the preparation of these reports which
can be found in appendix A.
2.2 Biodiesel production
Biodiesel is a fuel produced from oleaginous materials. It is yellowish in
color and has similar properties to petroleum derived diesel. Emissions from
biodiesel compared to petrol diesel display lowered amounts of particulate
matter, CO and soot but increased levels of NOx (15-20%). The idea of
using vegetable oils as fuel is not novel. Rudolf Diesel ran his diesel engine on
peanut oil, but vegetable oils as fuels do have performance issues and were
eventually replaced by the easy access to inexpensive petroleum derived
fuels [8]. Realizing that petroleum reserves are finite, attention has once
again been directed to the renewable oil based fuels as an alternative to
fossil diesel.
There are several ways to adapt the density of oils to better suit their use
as a fuel in combustion engines. These include: dilution with solvents such
as ethanol to lower viscosity, thermal based approaches such as pyrolysis or
cracking and transesterification [16]. Currently the most common method
of producing biodiesel is by transesterification. Transesterification is a fairly
simple chemical process where an alcohol (typically methanol) is used to
cleave off the fatty acid sidechains of triglycerides in presence of a catalyst,
leaving the glycerol backbone and fatty acid esters. As a result of this process
the byproduct glycerol represents approx. 10% [wt.] of the production [33].
Many types of oleaginous materials can be used to produce biodiesel: Virgin
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oils (non-used), waste oils such as waste cooking oil or animal fats, non-
edible oils such as palm oil (jatropha) or even oil from algae. There is also
the matter of which alcohol and catalyst to use. The most prevalent process
in europe is using mainly virgin oils such as rape seed or soy bean oil with an
alkali based catalyst and methanol as the alcohol. This process is efficient,
cheap, and robust [70, 62, 61]. The choice of alcohol is mainly determined
by price, since the type of alcohol does not severely affect the quality of
biodiesel. The choice of feedstock on the other hand has a greater influence
on the quality of biodiesel [8, 30]. The production of biodiesel has been
increasing at an incredible rate since 1992 [16]. An overview of the biodiesel
































































Figure 2.1: Biodiesel production in Europe from 2002–2010. Data from the
European Biodiesel Board [4].
2.2.1 Waste glycerol
As seen in figure 2.1 the production of biodiesel has been steadily increas-
ing since the beginning of the century. When the project began in 2008,
production of biodiesel in Europe was 7,800,000 tonnes and expected to in-
crease. This represents a supply of 780,000 tonnes of crude glycerol. The
increasing production of biodiesel has been saturating the existing markets
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for glycerol [52]. The cost of purification is relatively expensive and with
prices for refined and crude glycerol decreasing, it is not an obvious choice
for handling the increased amounts of crude glycerol [19]. Although the
expected increase in biodiesel production had leveled off, there was still an
increase in production of biodiesel in 2010 to 2,861,000 tonnes. With the
traditional glycerol markets saturated, alternative solutions are needed to
handle the increased production of biodiesel and with it crude glycerol. This
is where the GLYFINERY project comes in.
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Chapter 3
Selection of a suitable
production organism
When investigating the biological production of biofuels and biochemicals,
an important parameter is obviously the choice of production organism.
Although there is a huge variety in microbial species, one is often faced with
the needle in a haystack scenario when screening for novel production strains.
This is further complicated by the fact, that the act of cultivating strains
from a sample already represents a selection based on the environmental
conditions that can be simulated in an efficient manner in the laboratory.
Since this is a time consuming and laborious process, often the tactic is to fall
back to the well established laboratory strains of microbial workhorses, since
these are well described, easily amendable and well known to researchers [24].
The optimal production host is a combination of certain key traits such
as flexible substrate utilization, high product yield and titer, high productiv-
ity, high product tolerance, the ability to grow in extreme temperature or
pH and preferably anaerobic growth [24, 72]. Since no known microor-
ganism exists at the moment which possesses all these traits, the selection
of production organism becomes a choice of selecting an appropriate com-
promise. The advent of modern recombinant DNA technologies allows for
the improvement or adaptation of missing traits, but there are limits to
the problems which can be solved within the scope of a limited number of
manipulations. Introduction of a new product pathway is achievable within
a fairly small number of genetic manipulations, while engineering of tem-
perature or osmotolerance involves complex systems operating throughout
a given cell. These challenges provide a basis for the selection of traits more
or less amendable to improvement in a given host.
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3.1 Lactic acid bacteria
Lactic acid bacteria (LAB) are a diverse group which have had industrial
relevance for many years. They have been a topic of scientific study and
interest at the Center for Systems Microbiology (formerly the Bacterial Sys-
tems Biology group) for several decades. They comprise a range of gen-
era such as Lactobacillus, Leuconostoc, Pediococcus, Aerococcus, Carnobac-
terium, Enterococcus, Lactobacillus, Lactococcus, Oenococcus, Pediococcus
and Streptococcus. They have traditionally been associated with food and
feed fermentation, and have been named from a common defining trait: the
production of lactic acid as a principal end product of sugar fermentation.
Lactic acid bacteria in general are typically found in habitats which
are fairly rich in nutrients. This includes milk, meat and beverages, but
also on plant material and leaves in nature as well as the mouth, intest-
ine, and vagina of mammals [2, 71]. As a group LAB exhibit very broad
substrate utilization and a high degree of tolerance towards environmental
stress. They readily metabolize both hexoses such as glucose, mannose,
galactose and fructose, pentoses such as arabinose, ribose and xylose and
various disaccharides such as maltose, lactose and sucrose. Their toler-
ance ranges from low pH (pH 3.0, L. suebicus, L. acetotolerans, L. acido-
philus) to high salt concentrations (above 20%, Tetragenococcus muriaticus,
Carnobacterium viridans) and high ethanol tolerance (13%–15%, L. fruct-
ivorans, Oenococcus oeni) [69, 2]. Recently LAB have even been adapted
to grow in 3–4% butanol, an ability which is top ranked among microbial
species [44, 37].
3.1.1 From lab to industry
When looking at industrial production there are several barriers to intro-
ducing improvements from commonly used research strains into organisms
with an industrial background. Often the laboratory strains are cured of
plasmids and phages, leaving them unable to utilize certain substrates such
as milk and vulnerable to infection by bacteriophages. This often requires
that advances pioneered in common laboratory strains, have to be recreated
in industrial strains, which can present further problems, since the introduc-
tion of DNA into industrial strains can be challenging [32]. Furthermore,
there are often regulatory issues associated with production at an industrial
scale, often not encountered in the research laboratories at the university.
This is especially important when considering the use of genetically mod-
ified microorganisms in food grade systems. This has been a challenge fa-
cing the research with model organisms such as Lactococcus lactis IL1403 or
MG1363, which are commonly used in the production of dairy starter cul-
tures. To answer that problem, several methods have been developed that
facilitate the food-grade manipulation of genetic material [32, 53].
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3.1.2 Lactococcus lactis - a model lactic acid bacterium
Not only is the general class of lactic acid bacteria a broad and diverse group
of microorganisms - this also holds true for the individual species. The spe-
cies Lactococcus lactis can be be divided into three subspecies: Lactococcus
lactis subsp. lactis, Lactococcus lactis subsp. cremoris and Lactococcus lac-
tis subsp. hordniae. Furthermore, to add to the complexity of this picture,
Lactococcus lactis subsp. lactis includes species formerly designated: Strep-
tococcus lactis subsp. lactis, Streptococcus lactis subsp. diacetylactis and
Lactobacillus xylosus [59].
Traditional investigations into the metabolism of Lactococcus lactis have
typically been associated with the dairy industry and their use in starter
cultures for fermented dairy products [21, 71]. As mentioned earlier LAB can
be found in many other habitats. Two intensely studied model organisms:
Lactococcus lactis MG1363 (subsp. cremoris) and Lactococcus lactis IL1403
(subsp. lactis) both have a dairy background and are typically referred to as
dairy strains. But Lactococcus lactis strains have been isolated from many
habitats and the strains Lactococcus lactis NCDO2118 and KF147 (both
subsp. lactis) were isolated from vegetables (frozen peas and mung bean
sprouts respectively) and are considered to be representatives of the so called
plant isolates [23, 36]. The plant isolates show evidence of being adapted to
grow on substrates from plant materials (eg. arabinose and xylose) [63] and
are generally more prototrophic than their dairy counterparts [13].
The choice of organism for the project
At the onset of the project a choice had to be made with respect to an
interesting production organism. As mentioned, the aim of the GLYFINERY
project was to produce ethanol, butanol and 1,3-PDO from glycerol. The
list of natural candidates with these qualifications is rather short. The field
was further narrowed by looking only at anaerobic organisms. The list of
microbial producers of the target products are limited to mainly Clostridium,
Citrobacter, Enterobacter and Klebsiella species. These produce butanol and
1,3-PDO from glycerol naturally, but they are somewhat difficult to work
with, since there is a lack of tools and a requirements for strict anaerobic
conditions [73]. All except Citrobacter (although it is still considered an
opportunistic pathogen) are considered class 2 organisms which leads to
pathogenicity issues. For Clostridium, the main product formation is a mix
of the products, butanol, ethanol and acetone (ABE-fermentation) which
further complicates product optimization [27, 76, 35].
Production of ethanol has traditionally been the domain of yeasts, nor-
mally baker’s yeast, also known as Saccharomyces cerevisiae. This is carried
out as a standard aerobic batch or fed-batch fermentation, exploiting the
innate capability of the Crabtree effect in S. cerevisiae. When looking at an-
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aerobic growth, neither S. cerevisiae nor E. coli [12] grow on glycerol without
an external electron acceptor and even when grown aerobically S. cerevisiae
grows very slowly [45, 50]. Reports of anaerobic fermentation of glycerol has
been reported for E. coli both naturally and through engineering [48, 60].
As a part of the GLYFINERY project, other PhD. students are working
on characterizing non-saccharomyces yeasts such as Pachisolen tannophilus
or Yarrowia lipolytica and their use in bioconversion of glycerol. Also the
two other partners engaged in strain isolation and development have both
chosen biocatalysts from Clostridium spp. as their choice for production of
butanol and 1,3-PDO respectively.
Limited availability of candidates both fermenting glycerol and
producing target products imposes a choice
In this setting, with the list of potential candidates severely limited, the
option of using a species which could both ferment glycerol and produce
the target products seemed unattainable. Therefore the choice came down
to either engineering product formation or engineering substrate utilization.
In this process an alternative idea came up - to investigate the use of lactic
acid bacteria as cell factories for the microbial conversion of glycerol. This
approach obviously has two major flaws: the model organisms Lactococcus
lactis MG1363, IL1403 and NCDO2118 do not natively utilize glycerol as
sole carbon and energy source and they do not produce butanol or 1,3-PDO.
Despite their shortcomings, they do possess several other traits that would
make them very suited for use as industrial production organisms.
Lactococci do have the capability to produce many other interesting com-
pounds including lactic acid, ethanol, acetate, acetoin and 2,3-butanediol.
Furthermore they are aerotolerant and grow exceedingly well under anaero-
bic conditions with very high glycolytic flux. They are generally regarded
as safe (GRAS) and have a high level of tolerance against alcohols and or-
ganic acids in particular. Finally the Center For Systems Microbiology have
been investigating Lactococcus lactis for many years, producing an array of
tools including several patented technologies and a huge catalog of interest-
ing mutants to assist the development of novel production strains. So we
set out to investigate the use of Lactococcus lactis as a potential production




Glycerol (1,2,3-propanetriol) also known as glycerin, is a simple molecule
which can be found in all living organisms (figure 4.1). It was discovered in
1779 from saponification of olive oil with lead oxide but was first named in
1813 by French chemist Michel Euge`ne Chevreul after the Greek word for
sweet: γλυκρoσ (glukeros). The most famous use of glycerol, and prob-
ably also the first industrial use, was in 1866 when Alfred Nobel produced
dynamite from the trinitrate of glycerol (nitroglycerin). Today glycerol has
several thousand applications ranging from pharmaceutical applications to
use in food and and cosmetics [11]. Today the primary source of glycerol is
the increasing production of biodiesel as outlined in section 2.2.
Figure 4.1: An illustration of the molecular structure of glycerol
4.1 Glycerol assimilation
In the world of bacteria, there exist only two different ways of metabolizing
glycerol [43]. One starts with a dehydrogenation followed by a phosphoryla-
tion, the other proceeds in the reverse order. A schematic overview can be
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Figure 4.2: Overview of the two pathways for glycerol assimilation. The aero-
bic pathway (glp regulon) is activated by glycerol kinase trapping the glycerol as
glycerol-3-phosphate followed by by the action of glycerol-3-P dehydrogenase. The
anaerobic pathway (dha regulon) proceeds in the reverse order (glycerol dehydro-
genase followed by DHA kinase). Both pathways convert glycerol to dihydroxy-
acetone phosphate (DHAP) a key intermediary in glycolysis.
As is often the case in biology, this seemingly simple system of course has
a rich variation in the actual enzymatic machinery that performs the task.
The ability and extent of glycerol assimilation is highly species and strain
dependent. Among the Enterobacteriaceae only 8 species of 126 tested have
been shown to grow fermentatively on glycerol. This ability was intimately
tied to the existence of both glycerol dehydrogenase and 1,3-PDO dehydro-
genase [5, 6].
4.2 Fermentative glycerol metabolism
Although not a lactic acid bacterium, one of the most studied organisms with
respect to fermentative glycerol assimilation is the species Klebsiella. The
reason for this interest has been partly the ability to grow fermentatively on
glycerol and partly because while doing so, one of the main end products is
1,3-PDO, a chemical that has seen renewed interest recently. Several strains
retain the ability to ferment glycerol among others Klebsiella aerogenes,
Klebsiella pneumoniae and Klebsiella oxytoca [6].
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4.2.1 Genetic framework of glycerol assimilation
The Klebsiella species mentioned are capable of metabolizing glycerol both
aerobically and anaerobically. Even if molecular oxygen is not available
species that are unable to metabolize glycerol fermentatively (eg. Klebsiella
planticola) can usually do so if an alternative electronacceptor is present
such as fumarate or nitrate.
When oxygen is present glycerol is metabolized via the glp regulon. This
regulon is similar to the one present in E. coli. Glycerol is phosphorylated to
glycerol-3-phosphate via glycerol kinase and further oxidized to dihydroxy-
acetonephosphate through the action of a flavin-linked glycerol-3-phosphate
dehydrogenase. When no oxygen or other electron acceptors are present the
glycerol is metabolized via the so called dha regulon, which allows for the
use of glycerol itself as electron acceptor. The dha regulon consists of four
enzymatic steps typically divided into an oxidative pathway and a reductive
pathway. In the oxidative pathway a NAD-linked dehydrogenase converts
glycerol to dihydroxyacetone (DHA). Then an ATP dependent kinase phos-
phorylates DHA into DHAP which connects to glycolysis. In parallel the
reductive pathway serves as a redox sink for the redox equivalents produced
in the oxidative branch. First a B12-dependent dehydratase converts gly-
cerol into 3-hydroxypropionaldehyde which is further reduced to 1,3-PDO
by an NADH-linked oxidoreductase [5, 57, 34]. An overview of the process
can be seen in figure 4.3
4.2.2 Regulation of glycerol metabolism
Dihydroxyacetone has been identified as the inducer of the dha regulon [34].
The oxidative branch of glycerol assimilation is regulated at a metabolic
level while the reductive branch is governed by synthesis of the enzymes [1].
Overexpression of glycerol dehydratase and 1,3-pd oxidoreductase did not
improve 1,3-PDO production [74]. Glycerol kinase is inhibited allosteric-
ally by 1,6-FBP (like E. coli). Dihydroxyacetone kinase is highly specific



























Figure 4.3: Overview of the pathways for glycerol dissimilation in Klebsiella spp.
When oxygen is present glycerol is metabolized via the glp regulon encoding gly-
cerol kinase and glycerol-3-P dehydrogenase. If oxygen is not present glycerol is
metabolized vi the dha regulon, encoding the enzymatic activity for a parallel sys-
tem consisting of an oxidative branch (glycerol dehydrogenase, DHA kinase) and a
reductive branch (glycerol dehydratase, 1,3-PDO oxidoreductase). The end result
for both the aerobic glp regulon and the oxidative branch of the dha regulon is the






5.1 Anaerobic metabolism of Lactococcus lactis
Lactococcus lactis is traditionally described as a facultative anaerobe grow-
ing fermentatively with lactic acid as a major fermentation end product. The
lack of a complete citric acid cycle and complete respiratory chain means
that L. lactis relies on substrate level phosphorylation for energy production.
When grown in the presence of a preferred carbon source such as glucose,
more than 90% of the sugar ends up in the main fermentation product, lactic
acid. When a less favorable carbon source such as maltose is available, the
fermentation pattern shifts and becomes a mix of lactate, formate, acetate
and ethanol. These two modes of growth are generally referred to as ho-
molactic and mixed acid fermentation [22, 14]. An overview of the central
carbon metabolism can be seen in figure 5.1 and a detailed overview can be
seen in figure 5.4.
Sugars are can be taken up by the phosphoenolpyruvate-dependent phos-
photransferase system (PTS) or via permease systems. Glucose is mainly
transported by the mannose/glucose specific PTS (PTSMan) but can also be
transported by the cellobiose specific PTS (PTSCel) or a glucose permease
(glcU ) requiring subsequent phosphorylation by glucokinase [10]. PTS trans-
port have been described for the transport of galactose, lactose, trehalose,
sucrose and fructose. Additional permease systems are present for transport
of galactose and lactose. Permease systems are also used to transport sugars
such as ribose, xylose and maltose [49, 14]. An overview of the metabolic
connections between various sugar substrates and central metabolism can

































Figure 5.1: Overview of the central carbon metabolism of Lactoccus lactis. This
is a simplified overview of the metabolites in central metabolism, without enzymes
and cofactors. This illustrates the connection between different (mono) sugar sub-
strates and central carbon metabolism. PPP - Pentose phosphate pathway, Phos-
phoketolase - The phosphoketolase pathway, DHAP - dihydroxyacetone phosphate,
GAP - glyceraldehyde-3-phoshate, PEP - phosphoenolpyruvate. The ability to
metabolize certain sugars is strain dependent ie. xylose can be metabolized by
Lactococcus lactis NCDO2118 but not by L. lactis MG1363 or IL1403.
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5.2 Central carbon metabolism
Several factors regulate the utilization of sugars and the shift from ho-
molactic to mixed acid fermentation in Lactococcus lactis. A simplified
schematic overview of central metabolism with metabolic regulation can
be seen in figure 5.4.
5.2.1 Regulation of carbon metabolism by HPr and CcpA
The major regulator of carbon metabolism in L. lactis (and other gram pos-
itive organisms such as Bacillus subtilis, Staphylococcus xylosus and Lacto-
bacillus reuteri) is the protein HPr (ptsH ). HPr is involved in both the PTS
system as a phosporyl donor and in transcriptional regulation while inter-
acting with catabolite control protein A (CcpA) as either a transcriptional
repressor (carbon catabolite repression - CCR) or a transcriptional activ-
ator (carbon catabolite activation - CCA). The active role of the protein
is determined by the phosphorylation state. HPr has two different sites
where it can be phosphorylated: At His-15 (utilizing PEP) and at Ser-
46 (utilizing ATP). This provides four different states in which HPr can
exist; HPr (unphosphorylated), HPr-His-15-P (phosphorylated on histidine
15), HPr-Ser-46-P (phosphorylated on serine 46) and HPr-His-Ser-P (doubly
phosphorylated on both His-15 and on Ser-46) [47, 18].
The role of HPr is determined by the phosphorylation state
The transport and phosphorylation of sugars through the PTS system con-
sists of a cascade involving several components. The process was initially
described as comprising of two steps catalyzed by enzyme I (EI) and enzyme
II (EII) with HPr as an intermediary phosphoryl donor. All three compon-
ents can both accept and transfer a phosphoryl group thus causing them to
cycle through a state of either being phosphorylated or not [18].
Phosphorylation of HPr at His-15 is mediated by EI (ptsI ) utilizing
PEP and in this state HPr-His-P interacts with the EIIA and EIIB compon-
ents of the PTS allowing the transfer of a phosphoryl group to the incoming
sugar. HPr-His-P can also interact with histidyl residues in other proteins
such as glycerol kinase and non PTS transporters to exert regulatory effects.
Phosphorylation of HPr at Ser-46 is carried out by the HPr kinase/phos-
phorylase (HPrK/P, hprK or ptsK ) utilizing either ATP or pyrophosphate
(PPi). This enzyme also catalyzes the opposite reaction, i.e. dephosphoryla-
tion of HPr-Ser-P to HPr by generating PPi. The two opposing reactions
are regulated by the metabolites: FBP, ATP and Pi, but the effects may
vary depending on the species [68]. A high level of FBP together with a
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low level of Pi stimulates the kinase reaction with the opposite effect on the
phosphorylase reaction. When growing on a rapidly metabolizable carbon
source, the levels of these metabolites result in HPr kinase activity rather
than HPr-Ser-P phosphorylase activity.
Initial findings showed that phosphorylation of HPr on Ser-46 almost
completely eliminated phosphorylation on His-15 in Enterococcus faecalis,
Bacillus subtilis and Streptococcus salivarius [9, 17, 54]. Further study indic-
ates that this may not be the case for all species as large amounts of doubly
phosphorylated HPr was observed for Lactococcus lactis with the majority of
HPr present as HPr-Ser-P and HPr-His-Ser-P. In Lactococcus lactis MG1363
almost 75% of HPr was detected as being doubly phosphorylated (HPr-His-
Ser-P) during growth on glucose. There was also evidence that the doubly
phosphorylated form could still transfer a phosphoryl group to proteins of


































Figure 5.2: Overview of the regulation of central carbon metabolism in Lactococ-
cus lactis by HPr and CcpA. HPr: HPr protein, CcpA: Catabolite control protein
A, HPrK/P: HPr kinase/phosphatase, CRE: catabolite responsive element, CCR:
carbon catabolite repression, CCA: carbon catabolite activation. Based on [18, 68]
HPr-Ser-P is involved in carbon catabolite repression and activa-
tion HPr-Ser-P is involved in CCR/CCA through the interaction with
CcpA. Together the two proteins can bind so called catabolite respons-
ive elements (cre) which results in either repression or activation of af-
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fected genes depending on if the cre site is upstream or downstream of
the promoter[47, 14, 18]. The binding of CcpA is strongly stimulated by
interaction with HPr-Ser-P, although there are indications that CcpA might
exhibit some degree of unspecific binding in L. lactis which is not observed
in Bacillus [40]. A schematic overview of the regulatory system can be seen
in figure 5.2.
CcpA targets cre sites located adjacent to genes involved in regulation
and central metabolism which are often glycolytic genes but there are many
cre sites throughout the chromosome of Lactococcus lactis. Known targets
are the gal operon (galactose utilization), fru operon (fructose utilization),
las operon (encoding phosphofructokinase, pyruvate kinase and lactate de-
hydrogenase) and NoxE (noxE) encoding the primary NADH oxidase in
Lactococcus lactis. The las operon is activated by CcpA and is an example
of CCA. This involvement places CcpA in direct contact key parts of both
central carbon metabolism and redox metabolism via control of the las op-
eron and NoxE [26, 75]. There are also indications of a link between CcpA
and the proteolytic system through activation of pepQ which affects the
pleitropic regulator CodY (codY ).
5.3 Aerobic metabolism of Lactococcus lactis
5.3.1 Oxygen tolerance in Lactococcus lactis
When growing under aerobic conditions a cell is subjected to oxidative stress.
This does not arise from oxygen itself, but rather as a side product of cellular
processes in which partially reduced oxygen can generate reactive oxygen
species such as O2- (superoxide anion), OH• (hydroxyl radical) and H2O2
(hydrogen peroxide) [46]. Lactococcus lactis has several systems to combat
oxidative stress [46, 31]:
• Superoxide dismutase (sodA), 2 O2- + 2 H+ −→ H2O2 + O2
• Water forming NADH oxidase (noxE), 2 NADH + 2 H+ + O2 −→
2 NAD+ + 2 H2O
• Coupled NADH oxidase/NADH peroxidase (ahpR - ahpF + ahpC),
NADH + O2 + H+ −→ NAD+ + H2O2 and H2O2 + NADH + H+ −→
NAD+ + 2 H2O (overall reaction is the same as in the water forming NADH
oxidase above)
The water forming NADH oxidase (noxE) is believed to be the main provider
of NADH oxidase activity (NOX) in Lactococcus lactis (noxE provided 95%
of the NOX activity in Lactococcus lactis TIL46). Though very important for
oxygen consumption and NOX activity, noxE is not essential for protection
from oxidative stress nor for growth or NAD+ regeneration under aerobic
conditions and natural strains have been isolated without any NADH oxidase
activity [67].
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5.3.2 Respiration in Lactococcus lactis
The observation that lactic acid bacteria, and Lactococcus lactis (Strepto-
coccus lactis) in particular, can respire when hemin is added to the growth
medium was made more that 40 years ago [64] (heme or hemin reflects the
redox state of iron atom). This added another capability to the already di-
verse capabilities of lactic acid bacteria. When looking into this phenomenon
many years later, it was discovered that not only the two previously tested
species but many lactic acid bacteria exhibit increased growth-efficiency in
the presence of heme and aeration: Lactococcus lactis, Enterococcus faecalis,
Leuconostoc mesenteriodes and Streptococcus spp. [7]. To enable respiration
a minimal respiratory chain must exist. In LAB this consists of an electron
donor, an electron shuttle and a heme-dependant terminal electron acceptor.
None of the LAB synthesize heme naturally and therefore scavenge it from
the surrounding environment. The degree to which the various components
in the electron transport chain are synthesized varies in different species but







Figure 5.3: Overview of respiration in lactic acid bacteria. Genes present in
Lactoccus lactis are indicated below each component. Adapted from [41]
Components and regulation of respiratory metabolism in Lacto-
coccus lactis
The best studied model of respiration in a lactic acid bacterium is Lactococ-
cus lactis. Since L. lactis was among the first, in which the latent ability to
respire was discovered, it has received the attention of several studies over
the years to elucidate the effect of respiration on the metabolism. The main
benefit to respiring cells are improved long term survival and improved bio-
mass formation [20, 25, 55] both of which has proven useful in the production
of starter cultures for the dairy industry.
Initial investigations indicated that when a heme source is added to
an aerated culture the growth is biphasic. First the culture grows under
normal fermentative conditions only to begin respiration in late exponential
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phase [20, 25]. This was later questioned by Koebmann et al. by their finding
that ATPase deficient mutants required respiration permissive conditions for
exponential growth [38].
The mechanism behind the beneficial effects on biomass formation is
believed to be a combination of acetate production (yielding extra ATP
compared to lactate production) and the fact that respiration-coupled ex-
pulsion of protons, spares the energy required for the ATPase complex to
perform a similar task, amounting to a saving of energy rather than a pro-
duction of energy through oxidative phosphorylation. Similarly any effects
from amino acid catabolism or lower maintenance were also ruled out [38].
The reasons behind the increased survival rates of cultures grown under
respiratory conditions stems from a lower oxygen concentration inside the
cells leading to reduced oxidative stress in respiring cultures, with lower
DNA damage, lower protein damage and a reduced mutational frequency,
when compared to aerated cultures without heme. Another factor is reduced
acid production under respiratory conditions, which in turn leads to an
increase in pH, positively impacting the survival of respiring cultures [25, 55].
Regulatory mechanisms of respiration in Lactococcus lactis
As with many other aspects of metabolism, the control of respiration in
Lactococcus lactis has been linked to CcpA. The regulation by CcpA on
heme uptake is believed to be negative regulation [26].
Intracellular heme homeostasis is managed by HrtR, an intracellular
heme sensor that regulates transcription of hrtBA which constitutes a heme
eﬄux pump. HrtR acts as a transcriptional repressor of hrtBA which is
alleviated upon binding of heme [42].
Anaerobic respiration and alternative electron acceptors
The use of alternative electron acceptors has not been extensively studied.
A literature review has only revealed a single paper on the use of alternative
electron acceptors in Lactococcus lactis. The conclusion is that even though
Lactococcus lactis C10 (Streptococcus lactis C10) posseses a fumarate re-
ductase it is not able to allow fermentative growth on glycerol [28]. This
is contrary to the finding of Tachon et al. [66] and a genome search which
only reveals the presence of a single gene frdC, encoding a FRD flavopro-
tein subunit in Lactococcus lactis MG1363, KF147 and IL1403 and no other
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LEGEND: GLUC - glucose, GLU6P – glucose-6-phosphate, FRU6P - fructose-6-phosphate, F16BP - fructose-1,6-
biphosphate, DHAP - dihydroxyacetonephosphate, GAP - glyceraldehyde-3-phosphate, 13BPG - 1,3-
bisphosphoglycerate, 3PHOS - 3-phosphoglycerate, 2PHOS - 2-phosphoglycerate, PEP - phosphoenolpyruvate, 
PYR - pyruvate, LACTA - lactate, FORMA - formate, GLYCE - glycerol, DIHYD - dihydroxyacetonephosphate, 
GLY3P - glycerol-3-phosphate, ACCOA - Acetyl-Coa, ACETAL - acetaldehyde, ETOH - ethanol, ACETP - 
acetylphosphate, ACETA - acetate, α-ACET – α-acetolactate, DIACET - diacetyl, ACETOI - acetoin, 23BUT - 2,3,-
butanediol, RIBU5P - ribulose-5-phosphate, XYLU5P - xylulose-5-phosphate, RIBO5P - ribose-5-phosphate, PRPP 
- 5-Phosphoribosyl diphosphate, SED7P - sedoheptulose-7-phosphate and ERY4P - erythrose-4-phosphate. 
Pi 
glpD 
Figure 5.4: A simplified schematic overview of central metabolism in Lactococcus
lactis MG1363. Coloured dashed lines indicates regulation (based on [49]).
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5.4 Redox and energy metabolism is highly con-
nected to central metabolism
Traditional metabolic engineering has often focused on the engineering of
enzyme levels as well as inserting or deleting entire pathways to improve
production of a given compound [3]. Initial attempts at investigating the
control of flux through glycolysis by overexpressing various enzymes in the
pathway have not been successful [39]. This implies that flux control must lie
somewhere else. At the core of any metabolic network are only 12 metabolic
precursors and the cofactors ATP, NADH and NADPH [65, 58]. The energy
and redox cofactors are some of the most frequently used metabolites in the
central metabolism of E. coli [51] and as such they have a large potential
as regulators of metabolism. The effect of redox metabolism on the central
metabolism of Lactococcus lactis has been well studied.
5.5 Integration of information from the transcrip-
tomic and the metabolic level
The characterization of strains with increased expression of ATPase activity,
presented later in this thesis, was intended to combine the information from
several levels. The idea of combining several layers of information is similar
to the work previously done for Escherichia coli where both transcriptional
and metabolomic analysis were combined [29]. For that investigation, strains
which overexpressed NADH oxidase and the soluble F1 part of ATPase in
Escherichia coli were constructed to lower the level of NADH and ATP, re-
spectively. A global interaction network, comprising of protein interactions,
transcriptional regulation, and metabolic networks, was used to integrate
data from transcription profiles, metabolic fluxes, and the metabolite levels.
High-scoring networks for the two strains were identified.
The results revealed a smaller, but denser network for perturbations of
ATP level, compared with that of NADH level. The action of many global
transcription factors such as ArcA, Fnr, CRP, and IHF commonly involved
both NADH and ATP, whereas others responded to either ATP or NADH.
Overexpressing NADH oxidase invokes response in widespread aspects of
metabolism involving the redox cofactors (NADH and NADPH), whereas
ATPase has a more focused response to restore ATP level by enhancing
proton translocation mechanisms and repressing biosynthesis. Interestingly,
NADPH played a key role in restoring redox homeostasis through the con-
certed activity of isocitrate dehydrogenase and UdhA transhydrogenase. A
figure showing the regulatory effects of these perturbations can be seen in
figure 5.5.
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Figure 5.5: A figure showing the regulatory roles of ATP and NADH on the
metabolism of Escherichia coli. Green lines - activation, red lines - repression.
Reproduced from [29].
This research was originally published in Journal of Biological Chemistry. Holm, Anders K. · Blank,
Lars M. · Oldiges, Marco · Schmid, Andreas · Solem, Christian · Jensen, Peter R. · Vemuri, Goutham N.,
Metabolic and Transcriptional Response to Cofactor Perturbations in Escherichia coli, Journal of Biological
Chemistry, 2010; Vol. 285:pp. 17498-17506 ©the American Society for Biochemistry and Molecular Biology.
Manipulation of redox and energy metabolism as a potential tool
to redirect cellular metabolism into producing desirable products
The redox and energy cofactors have a great influence on the metabolism
in E. coli. This control could potentially be applied to the investigation
into glycerol metabolism in Lactotoccus lactis. Cells overexpressing ATPase
activity have a lowered energy state which might simulate growth on a poor
substrate. This could lead to alleviation of catabolite repression and stim-
ulate a metabolic response to allow L. lactis to use glycerol either as sole
carbon and energy source or in co-metabolization. Furthermore the applic-
ation of glycerol as a substrate in itself presents a challenge with respect to
maintaining redox balance in the cell.
The further investigation into the response of L. lactis to perturbations
in energy metabolism as presented in part IV, not only has implications for
the utilization of glycerol as carbon and energy source but also for design-
ing efficient cell factories for the production of essential chemical building
blocks in the future. Any insights into the complex interplay between central
carbon metabolism and control imposed by the redox and energy cofactors
could prove valuable for engineering competitive bioconversion platforms,
not only for glycerol conversion but also for other substrates such as ligno-






An initial analysis of the challenges facing Lactococcus lactis when utiliz-
ing glycerol as a substrate, revealed three areas that were deemed likely to
present difficulties. These were: 1) when growing on glycerol the glucon-
eogenic flux needs to be high enough to sustain growth, 2) the biochemical
pathway for glycerol dissimilation may not be entirely functional, and 3) the
growth on glycerol generates a greater amount of redox energy per pyruvate
than equivalent growth on glucose, which the cell needs to regenerate. An
overview of the analysis and the three areas can be seen in figure 6.1.
The challenge facing gluconeogenic flux is evident in figure 6.1 when
looking at the connection between glycerol and central metabolism. Be-
sides generating energy for growth there is also a need for certain build-
ing blocks such as glucose-6-phosphate and fructose-6-phosphate in growing
cells. When growing on glucose these would be generated in the normal
course of glycolysis but growth on glycerol requires a flux to be channeled
back up from DHAP via gluconeogenesis. A complete biochemical pathway
obviously needs to be present for glycerol to be channeled into glycolysis.
Even though many genetic components appear to be present there could
still be structural or regulatory issues that prevents the functionality of the
pathway. Unbalanced growth with a surplus of redox energy will be prob-
lematic for the cell since this would deplete the supply of cofactors. If this




































Redox balance [PYR normalized] 
Glucose Glycerol 
1 ATP 1 ATP 
1 NADH 2 NADH 
Gluconeogenesis: fbp 
Figure 6.1: Overview of the possible problems associated with glycerol dissimil-
ation in Lactococcus lactis. TOP - gluconeogenic flux, substrates and conditions,
LEFT - functional pathway for glycerol uptake and dissimilation and RIGHT -
redox levels needs to be balanced in growing cells.
6.0.1 Genetic components
As previously outlined (figure 4.2, page 14) the pathway from glycerol to
glycolysis is made up of two routes each with their own set of enzymes.
• Aerobic: Glycerol kinase/Glycerol-3P dehydrogenase
• Anaerobic: Glycerol dehydrogenase/Dihydroxyacetone kinase
A quick scan of the genomes from the sequenced Lactococcus lactis strains
reveals the presence of most of the components. An overview can be seen
in table 6.1. Even though the presence of most of the components required
for glycerol assimilation can be found in the genomes of various strains of
Lactococcus lactis, many of them are uncharacterized or putative annota-
tions. This opens up questions to whether they are active and functional.
A very rough idea of the activity was gained from a simple look into
intensity data from microarray analysis of Lactococcus lactis MG1363 cul-
tivated on glucose, maltose and galactose (manuscript in preparation) cour-
tesy of Associate professor Christian Solem (Center for Systems Microbi-
ology, Department of Systems Biology, Technical University of Denmark).
The results can be seen in figure 6.2 and figure 6.3. This indicated that
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Component MG1363 IL1403 SK11 KF147
Transport
glpF (llmg 0870) glpF1 (L47650) (LACR 0255) glpF (LLKF 0248)
glpF2 (llmg 1097) glpF2 (L0015) (LACR 1487) glpF (LLKF 1309)
glpF3 (llmg 2327) (LACR 1732)
Glycerol kinase glpK (llmg 1099) glpK (L014) glpK (LACR 1485) glpK (LLKF 1311)
G3P dehydrogenase glpD (llmg 1098) glpD (L0013) (LACR 1486) gpsA (LLKF 1429)gpsA (llmg 1114) gpsA (L0016) gpsA (LACR 1461)
Glycerol dehydrogenase Putative (llmg 0945) - (LACR 1650) gldA (LLKF 1680)
DHA kinase
dhaK (dhaQ, llmg 0255) dhaK (dhaQ, L44063) dhaK (dhaQ, LACR 0250) dhaK (LLKF 0245)
dhaL (llmg pseudo 05) dhaL (L45677) dhaL (LLKF 0246)
dhaM (llmg 0257) dhaM (L46694) dhaM (LLKF 0247)
dhaQ (LLKF 0243)
Table 6.1: An overview of the genetic components required for glycerol assimila-
tion and their presence on the genomes of sequenced Lactococcus lactis strains. G3P
dehydrogenase - Glycerol-3-phosphate dehydrogenase, DHA kinase - Dihydroxy-
acetone kinase.
at least for Lactococcus lactis MG1363 most of the components seem to be
transcribed to some extent and some almost on par with glycolytic enzymes,
even on a PTS sugar such as glucose.
Glykolytic genes: Glucose Maltose Galactose 
glk llmg_2299 11.05 10.80 10.52 Glucokinase 
pgi llmg_2448 13.41 13.17 13.27 Glucose-6-P isomerase 
fbp llmg_0264 7.38 9.06 8.19   Fructosebisphosphatase   Gluconeogenesis 
pfk llmg_1118 16.36 15.34 15.66 6-Phosphofructokinase 
fbaA llmg_2167 14.51 13.78 14.26   Fructosebisphosphat aldolase   
tpiA llmg_1424 10.63 9.89 10.07 Triosephophat isomerase 
gapA llmg_0530 8.67 9.13 9.50 Glyceraldehyd-3-P dehydrogenase 
gapB llmg_2539 14.52 14.05 14.41 Glyceraldehyd-3-P dehydrogenase 
pgk llmg_0253 15.14 14.75 14.96 Phosphoglycerate kinase 
pmg llmg_0355 14.21 13.51 13.80 Phosphoglycerate mutase 
gpmB llmg_1579 14.77 15.07 14.90 Phosphoglycerate mutase 
gpmC llmg_1894 5.79 5.76 5.63 Phosphoglycerate mutase 
eno llmg_0617 12.91 13.07 12.50 Phosphopyruvate hydratase (Enolase) 
pyk llmg_1119 15.16 14.29 14.88 Pyruvate kinase 
Glycerol genes: 
glpF llmg_0870 12.00 12.04 11.76 Glycerol uptake facilitator 
glpF2 llmg_1097 6.70 8.12 6.93 Glycerol uptake facilitator 
glpF3 llmg_2327 11.88 10.42 10.34 Glycerol uptake facilitator 
glpK llmg_1099 6.94 8.14 6.93   Glycerol kinase     Route 1 
dhaK llmg_0255 7.68 7.73 7.91   Dihydroxyacetone kinase   Route 2 
dhaM llmg_0257 6.02 6.28 6.39   Dihydroxyacetone kinase   Route 2 
glpT llmg_0523 4.91 5.15 6.00 Glycerol-3-P transporter 
Putative llmg_0945 12.84 12.34 11.70   Putative glycerol dehydrogenase Route 2 
gpsA llmg_1114 13.82 13.20 13.27   Glycerol-3-P dehydrogenase   Route 1 
glpD llmg_1098 6.99 8.17 7.00 Glycerol-3-P-dehydrogenase 
Figure 6.2: Overview of transcriptomic data from Lactococcus lactis MG1363
cultivated on the sugars glucose, maltose and galactose. The intensity data has
been averaged for each of the five different probes representing each gene. The
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glpF – Trans. 
GLC MAL GAL 
12,0 12,0 11,8 
6,70 8,12 6,93 
11,9 10,4 10,3 
glpK 
GLC MAL GAL 
6,94 8,14 6,93 
gpsA 
GLC MAL GAL 
13,8 13,2 13,3 
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GLC MAL GAL 
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6,02 6,28 6,39 
Put. Gly-dehy. 
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12,8 12,3 11,7 
Figure 6.3: Overview of the simple averages of transcriptional data for glycolytic
and glycerol assimilation genes for Lactococcus lactis MG1363 cultivated on glucose,
maltose and galactose.
6.1 Approaches to overcome the problems faced
by Lactococcus lactis
To investigate these possible problems a strategy was devised for each area.
For the investigation into the extent of gluconeogenic flux and presence of
the required enzymatic machinery, screening of growth with different sub-
strates was used to ascertain whether gluconeogenic flux is sufficiently active
and whether all the components for glycerol assimilation are functional. If
this were not to be the case, the solution to the biochemical problem is a
complete pathway with all necessary genes introduced into Lactococcus lac-
tis. For that purpose a novel artificial operon was designed which contained
all the necessary components to assimilate glycerol, these being a glycerol
fascilitator from Escherichia coli, a glycerol dehydrogenase from Citrobacter
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freundii and a dihydroxyacetone kinase also from Citrobacter freundii. To
solve a potential redox problem, a library of NADH oxidase activity will be
introduced into Lactococcus lactis to efficiently tune the level of oxidation































Growth on fructose 
means sufficient 
gluconeogenic flux? 
Construction of plasmids 
carrying a NADH oxidase 
library: 
Integration on the chromosome of an artificial 
operon carrying the genes needed for glycerol 
metabolization. 
Glycerol facilitator from E. coli 
Glycerol dehydrogenase from 
Citrobacter freundii 
Dihydroxyacetone kinase from 
Citrobacter freundii 
Screening of various 
sugars and conditions 
with or without glycerol 
addition 
Figure 6.4: Approaches to investigate and overcome the problems associated with
glycerol dissimilation in Lactococcus lactis. TOP - screening of growth under various
conditions, LEFT - construction of an artificial operon containing all necessary
genes for glycerol dissimilation and RIGHT - construction of synthetic promoter
libraries with varied levels of NADH oxidsase activity.
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7.1 Glycerol has become an abundant molecule
suitable as an industrial substrate
The potential use of glycerol as a substrate for industrial fermentation has
emerged through increased production of biodiesel. Biodiesel production
results in a byproduct of waste (or crude) glycerol which contains salts,
methanol, free fatty acids and glycerol. Refinement of crude glycerol is
expensive and bioconversion of crude glycerol could present a better way of
handling the increased amounts of waste [19, 124, 60, 73, 48].
While many microorganisms can metabolize glycerol with an external
electron acceptor such as oxygen, few are able to do so anaerobically. Mi-
croorganisms that can metabolize glycerol anaerobically have been reported
for the species Citrobacter, Clostridium, Klebsiella, Enterobacter, Lactoba-
cillus, Bacillus, Propionibacterium and Anaerobiospirillum [73, 48]. It has
even been reported that by manipulating the right fermentation conditions
it is possible for E. coli to grow fermentatively on glycerol [118, 48].
There are many advantages to anaerobic bioconversion for production
of fuels and chemicals such as less biomass formation resulting in higher
yields and easier production in large scale since oxygen limitation no longer
presents a problem [72]. Since Lactococcus lactis is adept at growing an-
aerobically and already produces several interesting biochemicals it seemed
a promising place to start. Furthermore strains that are easily amendable
and well characterized are good starting points for developing a production
organism [24].
7.1.1 Prototrophic plant isolates of Lactococcus lactis might
have retained the ability to grow on glycerol
Glycerol is metabolized through glycolysis as shown in figure 7.1. There are











































Figure 7.1: Overview of the central carbon metabolism of Lactococcus lactis. This
is a simplified overview of the metabolites in central metabolism, without enzymes
and cofactors. This illustrates the connection between glycerol and glycolysis.
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and dihydroxyacetone kinase or via glycerol kinase and glycerol-3-phosphate
dehydrogenase. The aim of this investigation was to determine whether any
of the commonly used L. lactis strains have retained the ability to grow on
glycerol as a sole energy and carbon source. The main sources of L. lactis
strains which have been isolated to date have either a dairy or a plant origin.
As presented in the general introduction, many of the required components
for glycerol metabolization has been annotated for the sequenced strains of
L. lactis. These are so far mostly of dairy origin. An overview of these genes
can be seen in table 7.1.
Component MG1363 IL1403 SK11 KF147
Transport
glpF (llmg 0870) glpF1 (L47650) (LACR 0255) glpF (LLKF 0248)
glpF2 (llmg 1097) glpF2 (L0015) (LACR 1487) glpF (LLKF 1309)
glpF3 (llmg 2327) (LACR 1732)
Glycerol kinase glpK (llmg 1099) glpK (L014) glpK (LACR 1485) glpK (LLKF 1311)
G3P dehydrogenase glpD (llmg 1098) glpD (L0013) (LACR 1486) gpsA (LLKF 1429)gpsA (llmg 1114) gpsA (L0016) gpsA (LACR 1461)
Glycerol dehydrogenase Putative (llmg 0945) - (LACR 1650) gldA (LLKF 1680)
DHA kinase
dhaK (dhaQ, llmg 0255) dhaK (dhaQ, L44063) dhaK (dhaQ, LACR 0250) dhaK (LLKF 0245)
dhaL (llmg pseudo 05) dhaL (L45677) dhaL (LLKF 0246)
dhaM (llmg 0257) dhaM (L46694) dhaM (LLKF 0247)
dhaQ (LLKF 0243)
Table 7.1: An overview of the genetic components required for glycerol assimila-
tion and their presence on the genomes of sequenced Lactococcus lactis strains. G3P
dehydrogenase - Glycerol-3-phosphate dehydrogenase, DHA kinase - Dihydroxy-
acetone kinase.
Many components of glycerol assimilation can be found in the gen-
omes of sequenced L. lactis strains As shown in table 7.1 most com-
ponents are present on the chromosomes of the sequenced L. lactis strains.
In particular L. lactis MG1363 and L. lactis KF147 contain components
for both pathways. In L. lactis MG1363 glycerol dehydrogenase has only a
putative status, but as can be viewed in the transcriptome analysis in part
IV still undergoes regulation in strains overexpressing ATPase activity.
To ascertain whether any of the strains have retained the ability to
use glycerol various conditions under which glycerol assimilation might be
stimulated were tested. These included different carbon sources (for co-
metabolization) and environmental conditions such as aeration in combina-
tion with hemin for respiration permissive settings. Ideally a combination
of these parameters will alleviate any potential problems such as regulatory
issues or problems with the redox balance. The goal was to find a suitable
candidate which grows on glycerol for the production of value-added fuels
and chemicals such as ethanol or butanol from waste glycerol.
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7.2 Xylose metabolism in Lactococcus lactis
The utilization of xylose as a substrate has been reported for several bac-
terial species such as E. coli, Lactobacillus and Bacillus spp. After transport
of xylose into the cell by either low-affinity symport systems or other (high-
affinity) systems, xylose isomerase (xylA) converts xylose to xylulose which
is further phosphorylated by xylulokinase (xylB) to xylulose-5-phosphate
(xylu5P) [83, 96]. Further assimilation can then proceed via two different
routes depending on the capabilities of the given strain. If assimilation pro-
ceeds along the phosphoketolase pathway xylu5P is converted (cleaved) to
equimolar amounts of glyceraldehyde-3-phosphate (GAP) and acetylphos-
phate (acetylP). These are further metabolized to lactic acid and acetate,
providing a theoretical yield of 1 mol of lactic acid (and acetate) per mole
of xylose. If xylose on the other hand is shuttled into the pentose phosphate
pathway the final result is 5 mol of lactate from 3 mol of xylose equal to a
theoretical yield of 1.67 mol lactic acid per mol of xylose [103, 89, 100].
7.2.1 The ability to utilize xylose among Lactococcus spp.
depends on the origin
The ability to utilize xylose among Lactococcus spp. is strain dependant.
Among the two major groups of Lactococcus dairy isolates (subsp. cremoris)
such as L. lactis MG1363 and IL1403 are unable to utilize xylose while some
plant isolates (subsp. lactis) such as L. lactis IO-1, KF147 and NCDO2118
have retained the ability [83]. Known manipulations of xylose metabolism
include transferring the genes required for xylose assimilation (xylRAB)
from L. lactis IO-1 to L. lactis IL1403 allowing growth on xylose as sole
carbon and energy source [100] and the production of xylitol from xylose
by expressing a xylose reductase (Pichia stipitis) in L. lactis NZ9800 [95].





































Figure 7.2: Overview of the proposed xylose metabolism in Lactoccus lactis IO-
1 [103]. This is a simplified schematic overview of the metabolic routes for xylose
assimilation in L. lactis strains capable of growing on xylose. Xylose is either
metabolized via the phosphoketolase pathway, the pentose phosphate pathway or
a combination of these. GAP - glyceraldehyde-3-phosphate, DHAP - dihydroxy-




8.1 Bacterial strains and growth conditions
The bacterial strains used in the project are listed in table 8.1.
Strain Alias Description Source
AH64 MG1363 Lactococcus lactis subsp. cremoris, plasmid-free derivative of L. lactis
NCDO712, dairy isolate (cheese starter culture)
[123]
AH186 IL1403 Lactococcus lactis subsp. cremoris, plasmid-free derivative of the strain
IL594, dairy isolate (cheese starter culture)
[78, 77]
AH63 NCDO2118 Lactococcus lactis subsp. lactis, plant isolate (frozen peas) [23]
AH83 KF147 Lactococcus lactis subsp. lactis, plant isolate (mung bean) [36, 63]
AH66 NCDO1867 Lactococcus lactis subsp. lactis, plant isolate (frozen peas 1966) NCIMB 701867, [23]
AH67 NCDO2091 Lactococcus lactis subsp. lactis, plant isolate (fermenting radishes) NCIMB 702091, [23]
AH68 NCDO2108 Lactococcus lactis subsp. lactis, plant isolate (frozen beans, lac-) NCIMB 702108, [23]
AH69 NCDO2110 Lactococcus lactis subsp. lactis, plant isolate (frozen peas) NCIMB 702110, [23]
AH70 NCDO2111 Lactococcus lactis subsp. lactis, plant isolate (frozen peas) NCIMB 702111, [23]
AH71 NCDO2125 Lactococcus lactis subsp. lactis, isolated from termite gut NCIMB 702125, [23]
AH72 NCDO2146 Lactococcus lactis subsp. lactis, isolated from mastitis NCIMB 702146, [23]
AH73 NCDO2633 Lactococcus lactis subsp. lactis, isolated from the rectum of cow 330 NCIMB 702633
AH74 NCDO2727 Lactococcus lactis subsp. lactis, plant isolate (mung bean) NCIMB 702727
AH75 NCDO2738 Lactococcus lactis subsp. lactis, plant isolate (”Anchu” mash) NCIMB 702738
AH76 NCDO2181 Lactococcus lactis subsp. hordniae, isolated from leafhopper NCIMB 702181, [93]
AH77 NCDO2112 Lactococcus raffinolactis, isolated from garden carrots NCIMB 702112
BK1010 L. lactis MG1363 transformed with pAK80, Ermr [164]
BK1503 L. lactis MG1363 transformed with pCPC4::atpAGD, Ermr [164]
BK1506 L. lactis MG1363 transformed with pCPC7::atpAGD, Ermr [164]
BK1502 L. lactis MG1363 transformed with pCPC3::atpAGD, Ermr [164]
Table 8.1: An overview of the bacterial strains used in the screening part of
the project. All strains are wild type strains. NCIMB - NCIMB Ltd, Aberdeen,
Scotland, UK.
8.1.1 Growth conditions
Strains were routinely cultivated under three different conditions: 1) anaer-
obically, 2) aerobically and 3) respiratory (aerobic incubation with addition
of hemin). Temperature for strain cultivation was maintained at 30°C in
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either rich or defined media with either no antibiotic or containing 5 µg/mL
Erythromycin or 5 µg/mL Tetracycline, depending on the selection require-
ments. Other temperatures such as at 28°C or room temperature (22°C)
were used when appropriate. Rich medium consisted of GM17 broth [149]
and defined medium was either BL or SA [143]. The defined media were
modified as follows: 1) SAL/BLL: SA or BL medium without sodium acetate
but supplemented with 2 µg/mL lipoic acid, 2) SALN: SA medium without
sodium acetate but supplemented with 2 µg/mL lipoic acid and 20 µg/mL
of adenosine, guanosine, cytidine, thymidine, inosine and uridine. Growth
was monitored by optical density and was measured at 600 nm (OD600) on
a Shimadzu UV mini 1240 spectrophotometer.
8.2 Sampling for metabolite analysis
Sampling for metabolite analysis was carried out as follows: 5 mL of culture
was quenched in 5 mL of hot phenol (80°C) and subsequently frozen at -20°C
for further processing. After completing the entire set of measurements, all
samples were treated with 2 times chloroform extraction and the finished
samples were shipped to professor Marco Oldiges, Forschungszentrum Ju¨lich,
Biotechnologie 2, Germany, for further analysis.
8.3 Correlation of cell density to cell mass
To convert OD into dry weight a correlation from Jensen et al. [88] is utilized.
They determined that the correlation between dry weight and optical density
was (on average) 0.19 g DWL OD450 1 . This was based on measurements done at
450 nm. This can be converted to 600 nm:
0.19 g DWL OD450 of 1 · 1.8 = 0.342
g DW
L OD600 of 1
8.4 Calculations
Growth rates were calculated from plots of OD vs. time on a logarithmic
scale. The growth rates were then estimated from the slope of a logarithmic
regression on the data points under exponential growth. Each experiment
gave rise to a set of growth parameters for each strain, and from these three
separate values a mean and standard deviation was calculated.
The specific glycolytic fluxes were calculated from slopes of glucose con-
sumption, lactate production, formate production and acetate production,
which, were plotted against OD, and multiplied by the specific growth rates.
Biomass yield was calculated as the inverse of the slope generated by linear




This section describes the work conducted to screen various Lactococcus
spp. candidates for the ability to utilize glycerol as a carbon and energy
source. The idea behind these experiments is that perhaps some of the
problems associated with growth on glycerol can be mediated by changing
the substrate and environmental conditions i.e. a redox imbalance could be
remedied by the addition of heme and aeration or perhaps glycerol could be
utilized in co-metabolization with another substrate. The general approach
was:
• Utilization of glycerol as sole carbon and energy source
• Co-metabolization of glycerol in combination with other substrates
The results represented in the following section are representative data sets,
often from different strains. Not all the data, from all the strains has been
presented here. Additional information can be seen in the appendix.
9.1 Preliminary serial cultivation does not induce
glycerol utilization
As an early attempt at activating glycerol utilization, the strain Lactococ-
cus lactis NCDO2118 was subjected to a serial transfer regiment in order
to stimulate this activation by directed evolution. The medium and condi-
tions chosen were SALN + 1% glycerol incubated anaerobically at 30°C to
represent the ideal production conditions. A total of 15 transfers (of one
mL into 10mL of fresh medium) were completed without any sign of addi-
tional biomass formation above OD600 ≈ 0.100. Since SALN medium con-
tains amino acids and nucleosides, limited growth can be observed (around
OD600 ≈ 0.100) in this medium without any carbon and energy source ad-
ded. After this period the experiment was discontinued.
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9.2 Dairy isolates of Lactococcus lactis show im-
proved adaptation to growth under nutrient
rich conditions compared to plant isolates
When screening strains for substrate utilization in liquid cultures, it is im-
portant to ensure that the culture is only limited by the carbon and energy
source. In any other case the effect of adding a supplemental carbon source
such as glycerol to the growth medium might not be detected. Therefore
an initial screening was performed to establish growth patterns on standard
sugar substrates (glucose, fructose, galactose, maltose and for the plant isol-
ates also xylose) for three selected model organisms. Growth characteristics
of these strains when grown in SAL medium supplemented with glucose can
be seen in figure 9.1 (L. lactis MG1363), figure 9.2 (L. lactis NCDO2118)







































Glucose concentration in %
Figure 9.1: Overview of growth by Lactococcus lactis MG1363 in SAL medium
supplemented with increasing amounts of glucose. Blue (square) - respiratory
growth, Green (triangle) - anaerobic growth.
Comparing the three plots, the dairy isolate (MG1363) seems to grow 50%
better under anaerobic conditions and almost twice as good under respirat-
ory conditions as the plant isolates (NCDO2118 and KF147). This could be
indicative of the specialization by the dairy strains to better utilize the nu-
trients found in the (fairly) rich environment with plenty of available amino
acids. The full range of data for all tested sugars can be seen in appendix









































Glucose concentration in %
Figure 9.2: Overview of growth by Lactococcus lactis NCDO2118 in SAL me-
dium supplemented with increasing amounts of glucose. Blue (square) - respiratory








































Glucose concentration in %
Figure 9.3: Overview of growth by Lactococcus lactis KF147 in SAL medium sup-
plemented with increasing amounts of glucose. Blue (square) - respiratory growth,
Green (triangle) - anaerobic growth.
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linear range of growth in SAL medium, were selected as a basis for screening
co-metabolism of glycerol utilization.
9.3 The selected Lactococcus lactis spp. were un-
able to utilize glycerol under all of the condi-
tions tested
As detailed earlier to test for glycerol utilization, comparisons are made
between cultures with and without glycerol addition for indications of an
increase in OD600. This has been done in medium containing only glycerol
or in medium with a sugar substrate supplemented with glycerol. An over-
view of the core experimental conditions tested for the most common model
organisms can be seen in table 9.1.
9.3.1 Variation of carbon source is not sufficient to stimulate
glycerol utilization
One of the screening variables was to investigate the effect of cultivating
Lactococcus lactis on different carbon sources. A change in carbon source
might alleviate the effects of CCR induced by glucose and perhaps allow
utilization or co-metabolization of glycerol.
The results from cultivation of L. lactis MG1363, IL1403, NCDO2118
and KF147 in defined medium with supplementation of different carbon
sources can be seen in table 9.2. Further information can be found in ap-
pendix C. The different carbon sources were combined with either anaerobic,
aerobic or respiratory conditions.
As can be seen in the table a change in carbon source to slower metabol-
izable substrate such as maltose did not induce glycerol utilization. Likewise
neither a switch to a poorer growth medium (such as BLL) nor an increased
concentration of glycerol (to 1%) appears to have any effect in stimulating
the utilization of glycerol.
To investigate whether glycerol utilization actually took place but at
such a slow rate that it might not immediately be evident from over night
cultures a series of extended cultivations were undertaken.
9.3.2 Prolonged incubation in medium supplemented with
glycerol does not stimulate utilization
Several different approaches were tested out to stimulate glycerol assimila-
tion. These included various sugar and glycerol combinations. Since these
did not indicate any glycerol utilization, experiments with prolonged incub-


















































































































































































































































































































































































































































































































































































































































































































































The results of these experiments can be found in table 9.3. Plots of ad-
ditional experiments can be seen in figure 9.4 and figure 9.5. The individual
strain data can be seen in appendix B.2.
Medium Anaerobic Aerobic Respiratory
IL1403
SAL + 0.1% glucose 0.25± 0.05 0.37± 0.006 0.44± 0.006
SAL + 0.1% glucose + 0.2% glycerol 0.27± 0.03 0.38± 0.003 0.44± 0.004
SAL + 0.1% maltose 0.15± 0.01 0.32± 0.03 0.36± 0.19
SAL + 0.1% maltose + 0.2% glycerol 0.19± 0.01 0.19± 0.01 0.16± 0.08
SAL + 0.1% galactose 0.18± 0.01 0.42± 0.05
SAL + 0.1% galactose + 0.2% glycerol 0.21± 0.02 0.35± 0.03
SAL + 0.1% cellobiose 0.25± 0.01 0.47± 0.01 0.75± 0.22
SAL + 0.1% cellobiose + 0.2% glycerol 0.33± 0.01 0.46± 0.01 0.82± 0.02
SAL + 0.1% sucrose 0.12± 0.01 0.14± 0.01
SAL + 0.1% sucrose + 0.2% glycerol 0.12± 0.02 0.14± 0.01
MG1363
SAL + 0.1% fructose 0.38± 0.02 0.41± 0.08
SAL + 0.1% fructose + 1.0% glycerol 0.32± 0.03 0.32± 0.01
BLL + 0.2% fructose 0.30± 0.02 0.31± 0.06
BLL + 0.2% fructose + 1.0% glycerol 0.27± 0.03 0.18± 0.05
KF147
SAL + 0.1% fructose 0.14± 0.02 0.34± 0.01
SAL + 0.1% fructose + 1.0% glycerol 0.16± 0.02 0.36± 0.01
BLL + 0.2% fructose 0.31± 0.03 0.28± 0.04
BLL + 0.2% fructose + 1.0% glycerol 0.30± 0.01 0.25± 0.14
NCDO2118
BLL + 0.2% fructose 0.23± 0.05 0.37± 0.01
BLL + 0.2% fructose + 1.0% glycerol 0.24± 0.04 0.37± 0.01
Table 9.2: Results from cultivating various Lactococcus lactis strains in defined
medium supplemented with different combinations of sugars with or without gly-
cerol addition. OD600 measurements on over night cultures, averages of three bio-
logical replicates incubated at 30°C. Blank slots indicate that results from that
particular set of conditions are not available. Anaerobic - static cultures, Aerobic -
aerated cultures, Repiratory - aerated cultures with hemin supplementation.
The aim of the experiments was to investigate whether glycerol was at all
metabolized, very slowly, by the strains under investigation. Neither fig-
ure 9.4 nor figure 9.5 show any signs of additional biomass formation after
glucose has been consumed in the first over night culture (0.2% glucose in
the medium would sustain an OD600 of approx. 0.8). Nor does there seem
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Days
Figure 9.4: A plot of growth by Lactococcus lactis IL1403 in SAL medium sup-
plemented with 0.2% glucose and increasing concentrations of glycerol. Cultivated
at 30°C, under anaerobic conditions for a period of 4 days. Similar experiments
were carried out for aerobic and respiratory conditions.
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1 1.5 2 2.5 3 3.5 4 4.5 5
Days
Figure 9.5: A plot of growth by Lactococcus lactis NCDO2118 and MG1363 in
SAL medium supplemented with 0.2% glucose with or without and additional 0.2%
of glycerol. Cultivated at 28°C, under respiratory conditions for a period of 4 days.
Purple (square) - MG1363, glucose + glycerol, Green (diamond) - MG1363, glucose,
Red (triangle) - NCDO2118, glucose + glycerol, Blue (circle), NCDO2118, glucose
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Medium Anaerobic Aerobic Respiratory
MG1363
SAL 0.01± 0.004 0.03± 0.003 0.04± 0.02
SAL + 0.0001% glycerol 0.01± 0.01 0.08± 0.03 0.04± 0.05
SAL + 0.001% glycerol 0.02± 0.01 0.05± 0.01 0.04± 0.02
SAL + 0.01% glycerol 0.01± 0.01 0.06± 0.02 0.07± 0.02
SAL + 0.1% glycerol 0.01± 0.01 0.06± 0.03 0.05± 0.03
SAL + 1.0% glycerol 0.03± 0.01 0.06± 0.002 0.03± 0.01
KF147
SAL 0.018± 0.01
SAL + 0.0001% glycerol 0.02± 0.01
SAL + 0.001% glycerol 0.04± 0.01
SAL + 0.01% glycerol 0.03± 0.002
SAL + 0.1% glycerol 0.11± 0.002
SAL + 1.0% glycerol 0.08± 0.01
NCDO2118
SAL 0.01± 0.002
SAL + 0.0001% glycerol 0.02± 0.002
SAL + 0.001% glycerol 0.03± 0.001
SAL + 0.01% glycerol 0.03± 0.003
SAL + 0.1% glycerol 0.11± 0.01
SAL + 1.0% glycerol 0.08± 0.02
Table 9.3: Results from cultivating various Lactococcus lactis strains in defined
medium supplemented with different concentrations of glycerol. OD600 measure-
ments on cultures were monitored during the period and the values shown are the
values reached from 16 days of incubation. Averages of three biological replicates
incubated at 30°C.
Since glycerol is transported into the cell by facilitated diffusion, a concen-
tration gradient screening (table 9.3) was performed to see if glycerol concen-
tration affected uptake and metabolism. This was done in defined medium
without any additional carbon and energy source. The experiment ran for
16 days during which optical density was regularly monitored. The two
plant isolates NCDO2118 and KF147 showed signs of glycerol utilization,
as they both reached an optical density of approximately 0.1, at a glycerol
concentration of 0.1% (higher than optical density measured in pure SAL
medium), after 16 days of incubation. The lack of a similar response from
MG1363 (dairy strain) could indicate that the more prototrophic plant isol-
ates might not necessarily be metabolizing glycerol, but could perhaps grow
on the remaining components in the medium (19 amino acids are added to
SAL, i.e. all but aspartate).
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9.3.3 Overexpression of ATPase activity does not stimulate
glycerol utilization
The effect of overexpressing ATPase activity was believed to simulate the
growth on a poor substrate and might induce a suitable metabolic response
allowing the utilization of glycerol. Indications that this was indeed the case
can be seen from the transcriptomic analysis in part IV where a starvation
like response is seen to expression of ATPase activity. The strains selected
were BK1010 (reference), BK1506, BK1503 and BK1502 which all expressed
ATPase activity (in increasing order, see table 16.1). The results of over
night screening can be seen in table 9.4.
Strain Medium Anaerobic Aerobic Respiratory
BK1010 SAL + 0.1% glucose 0.36± 0.09 0.39± 0.03 0.61± 0.02SAL + 0.1% glucose + 0.1% glycerol 0.36± 0.02 0.39± 0.03 0.62± 0.04
BK1506 SAL + 0.1% glucose 0.32± 0.03 0.33± 0.02 0.46± 0.04SAL + 0.1% glucose + 0.1% glycerol 0.31± 0.02 0.32± 0.02 0.49± 0.03
BK1503 SAL + 0.1% glucose 0.32± 0.02 0.31± 0.02 0.46± 0.01SAL + 0.1% glucose + 0.1% glycerol 0.27± 0.03 0.30± 0.02 0.45± 0.02
BK1502 SAL + 0.1% glucose 0.31± 0.04 0.31± 0.01 0.44± 0.02SAL + 0.1% glucose + 0.1% glycerol 0.25± 0.02 0.31± 0.03 0.47± 0.05
Table 9.4: Results from cultivating Lactococcus lactis strains overexpressing AT-
Pase activity in defined medium supplemented with 0.1% glucose and 0.1% glucose
with an additional 0.1% glycerol. 5 µg/mL Erythromycin was added to over night
cultures, to stabilize them. OD600 measurements are from over night cultures, and
averages of four biological replicates incubated at 30°C are shown.
These results seem very similar to those previously shown. It is difficult
to distinguish between the strains based on their growth characteristics on
glycerol. When examining the values for BK1503, one might question if there
is sufficient ATPase activity present in the cells. The BK1502 strain would
be expected to have only half the biomass yield of the reference strains,
but here it seems more in the area of 80–85% under anaerobic and aerobic
conditions and around 70% under respiratory conditions. The strains with
the highest expression of ATPase activity are known to be unstable and could
have lost or mutated the plasmid. If one assumes the two other strains are
ok, it would seem that ATPase activity in itself is not enough to stimulate
glycerol assimilation.
9.3.4 Growth experiments do not reveal any glycerol utiliz-
ation under respiration permissive conditions
The initial results from the screening of over night cultures, prompted a
more detailed study via growth experiments. When performing growth ex-
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periments further information can be obtained from the culture, namely
growth rates and product formation. In this case HPLC analysis of samples
taken during the experiment could clarify whether glycerol was being con-
sumed or not. An example of the initial experiments are presented here.
Growth experiments with glucose and maltose supplemented with
glycerol show no indications of glycerol utilization
Growth experiments were performed with the strain Lactococcus lactis
MG1363 with glucose and maltose as substrates under respiratory condi-
tions. This combination of environmental conditions and substrate was be-
lieved to be the best scenario for stimulating either growth on glycerol or
co-metabolization. The choice of respiration permissive conditions meant
that any excess redox produced from glycerol could be channeled to the
respiratory system and thereby not cause problems. Maltose being a slower
metabolizable substrate was hoped to allow induction of a starvation re-
sponse which in turn could stimulate the use of the additional energy source
in the medium. Growth rates, substrate flux and biomass yields can be seen
in table 9.5. Product formation can be seen in figure 9.6 and figure 9.7.
Further information can be viewed in appendix D.
Medium Gen. time Growth rate Average flux Biomass yieldTd [min.] µ [h-1] [mmol / g CDW ·h] [g CDW / mmol]
SAL + 0.1% glucose 53.53± 0.24 0.78± 0.01 18.45± 0.81 0.042± 0.0013
SAL + 0.1% glucose + 1% glycerol 54.16± 0.92 0.77± 0.01 18.35± 0.30 0.042± 0.0001
SAL + 0.1% maltose 84.80± 0.99 0.49± 0.01 20.80± 1.03 0.068± 0.004
SAL + 0.1% maltose + 1% glycerol 78.71± 4.05 0.53± 0.03 19.55± 0.82 0.067± 0.003
Table 9.5: Results from cultivating Lactococcus lactis MG1363 in defined medium
supplemented with 0.1% glucose or maltose and 0.1% glucose or maltose with an
additional 1% glycerol. Experiment performed in quadruplicates incubated at 30°C
under respiratory conditions.
As with the previous investigations no significant difference, on either growth
rate, biomass yield or substrate flux can be observed between cultures grow-
ing with or without glycerol. This is supported by the product formation
plots in which the plot of glycerol concentration remains constant during

















































Figure 9.6: Plot of product formation and substrate consumption in a growth
experiment with Lactococcus lactis MG1363 cultivated in SAL + 0.1% glucose +
1% glycerol at 30°C under respiratory conditions. Samples done in quadruplicates.
Green (triangle) - glycerol concentration (secondary axis), Blue (diamond) - Glucose















































Figure 9.7: Plot of product formation and substrate consumption in a growth
experiment with Lactococcus lactis MG1363 cultivated SAL + 0.1% maltose +
1% glycerol at 30°C under respiratory conditions. Samples done in quadruplicates.
Green (triangle) - glycerol concentration (secondary axis), Blue (diamond) - Maltose
concentration, Turquoise (square) - Lactate concentration.
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9.4 Glycerol supplementation to the growth me-
dium has a great effect on growth rate but
only for certain substrates
Although none of the species exhibited convincing results for glycerol utiliz-
ation there were a few interesting observations to come out of the screening.
Firstly the results from cultivating Lactococcus lactis IL1403 with trehalose
showed of a beneficial effect of glycerol addition to over night cultures.
Secondly the addition of glycerol to cultures growing on xylose or ribose
appears to affect growth rates detrimentally.
9.4.1 Supplementation of glycerol to the growth medium
shows indications of increased biomass formation for
strains grown under aerobic conditions with trehalose
as a substrate
The only example of a beneficial effect of glycerol supplementation was ob-
served when cultivating L. lactis on trehalose under aerobic conditions. The
results can be seen in table 9.6.
Medium Anaerobic Aerobic† Respiratory
SAL + 0.1% trehalose 0.26± 0.06 0.49± 0.01 0.61± 0.004
SAL + 0.1% trehalose + 0.2% glycerol 0.29± 0.01 0.61± 0.07 0.67± 0.01
Table 9.6: Results from cultivating Lactococcus lactis IL1403 in defined medium
supplemented with 0.1% trehalose and 0.1% trehalose with an additional 0.2%
glycerol. OD600 measurements on over night cultures, averages of three biological
replicates incubated at 30°C are shown. †The aerobic experiments were done in six
biological replicates.
It seems that under aerobic conditions, supplementation of glycerol to the
growth medium leads to higher optical density. A follow up growth experi-
ment was performed the results can be seen in table 9.7. From the growth
rates it is clear that the culture with glycerol addition has a growth rate of
84% of the culture with only trehalose. Whether this is sufficient to generate
the difference in optical density observed in over night cultures remains to
be investigated further. The difference though obvious, is small, so it might
be caused by the reduced growth rate or other effects.
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Medium Specific growth rate Average generation time
µ [h-1] Td [min.]
SAL + 0.1% trehalose 0.50± 0.01 83.77± 0.96
SAL + 0.1% trehalose + 0.2% glycerol 0.42± 0.01 99.53± 2.20
Table 9.7: Results from cultivating Lactococcus lactis IL1403 in defined medium
supplemented with 0.1% trehalose and 0.1% trehalose with an additional 0.2%
glycerol. Averages of four biological replicates incubated at 30°C with aeration.
9.4.2 Glycerol supplementation to growth medium has a det-
rimental effect on growth rate of cultivated strains
A second interesting observation was an apparent sign of glycerol toxicity
or glycerol inhibition. This is somewhat opposite to what was hoped when
adding glycerol to the medium and was initially only seen in media with
xylose. In figure 9.8 and 9.9 are two illustrations of the effect. The ini-
tial observation (figure 9.8) pointed to an effect on biomass formation. The
maximum optical density of cultures with glycerol added were significantly
lower than those without. The second screening (figure 9.9) shows an ap-
parent dose effect of glycerol addition in both SAL and BLL medium. The
stronger effect in BLL medium points to an effect in energy metabolism
as BLL compared to SAL has fever amino acids added which increases the
energetic cost of growing.
9.4.3 Growth experiments show glycerol inhibition of growth
rate in most types of growth media
The curious effect of apparent glycerol inhibition or toxicity, first encountered
during screening of Lactococcus lactis NCDO2118 in medium with xylose,
was investigated further by a series of well defined batch experiments with
regular measurements of biomass formation (growth experiments). The aim
was to characterize the effect further in an attempt to elucidate the mech-
anism behind the effect.
Glycerol inhibition effect in BLL medium is evident when supple-
mented with xylose but not when supplemented with galactose
The results from the growth experiment with xylose in BLL medium can
be seen in table 9.8 and an analysis of product formation can be found in
table 9.9. This initial growth experiment focused on BLL medium because
the effect was higher when first encountered, compared to SAL medium (fig-
ure 9.9). Two different concentrations of xylose (high, 5% and low, 0.5%)
were included in the experiment. It had previously been established that
NCDO2118 grows faster at higher xylose concentrations and it would there-









































Figure 9.8: Plot of optical density measurements showing an apparent inhibitory
effect of glycerol addition to defined growth medium supplemented with either
fructose or xylose. The strain tested is Lactococcus lactis NCDO2118 cultivated in









































Figure 9.9: Plot of optical density measurements showing an apparent inhibitory
effect of glycerol addition to two different defined growth media. BLL is essentially
SAL medium with fewer amino acid supplements and greater buffering capacity
but otherwise identical to SAL. The strain tested is Lactococcus lactis NCDO2118
cultivated in different combinations of sugar and glycerol at 30°C under anaerobic
conditions. Samples done in duplicates or triplicates.
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Medium Cond. Growth rate Biomass form.
µ [h-1] [Max. OD600]
BLL + 0.5% xylose resp. 0.18 1.01
BLL + 0.5% xylose + 0.5% glycerol resp. 0.03 0.20
BLL + 5.0% xylose resp. 0.16 1.01
BLL + 5.0% xylose + 0.5% glycerol resp. 0.09 0.51
BLL + 0.5% xylose anaer. 0.096 0.75
BLL + 0.5% xylose + 0.5% glycerol anaer. 0.018 0.069
BLL + 5.0% xylose anaer. 0.17 0.98
BLL + 5.0% xylose + 0.5% glycerol anaer. 0.14 0.87
Table 9.8: Results from cultivating Lactococcus lactis NCDO2118 in defined me-
dium supplemented with 0.5% xylose and 0.5% xylose with an additional 0.5%
glycerol. Incubated at 30°C under respiratory (resp.) and anaerobic (anaer.) con-
ditions.
The results indicated a clear effect on both growth rate and biomass form-
ation, for both high and low concentrations of xylose and under both con-
ditions. The effect seems to be worse under anaerobic conditions, with low
substrate concentration. The cultures with high substrate concentration
seem to be less affected by the toxic effects of glycerol under anaerobic con-
ditions. This could possibly be explained with the higher flux present in
cultures with a high level of substrate generating more energy. No differ-
ence can be seen from substrate concentration on growth rate at respiratory
conditions. These findings indicated the problem was associated with energy
metabolism and since the substrate was xylose, it naturally also pointed to
the pentose phosphate pathway.
Analysis of product formation shows formate is missing in cultures
supplemented with glycerol Samples for analysis of product forma-
tion were taken during the growth experiment. The results can be seen in
table 9.9. The intriguing observation from these samples is the lack of form-
ate formation in the anaerobic cultures with glycerol addition. If glycerol in-
hibited pyruvate formate-lyase (PFL) via elevated levels of triosephosphates
(the endpoint of glycerols assimilation into glycolysis), it could explain the
growth deficiencies under anaerobic conditions, as this severely limits the
capacity for generating acetyl-Coa. Ordinarily, this would not affect the
cultures growing under respiratory conditions, here PDH should supply an
alternative route to acetyl-CoA formation.
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Sample Xylose Glycerol Lactate Formate Acetate Ethanol
mM mM mM mM mM mM
Anaerobic
BLL + 0.5% xylose
1 23.48 n.a. n.a. n.a. n.a. n.a.
2 14.22 n.a. 4.45 6.71 10.99 n.a.
3 0.84 n.a. 10.95 14.00 22.63 n.a.
BLL + 0.5% xylose +
0.5% glycerol
1 39.77 72.12 n.a. n.a. n.a. n.a.
2 37.76 66.25 0.62 n.a. 2.89 n.a.
3 37.26 66.41 1.19 n.a. 3.30 n.a.
4 35.68 67.23 3.36 n.a. 3.64 7.20
BLL + 5% xylose
1 255.87 n.a. n.a. n.a. n.a. n.a.
2 247.00 n.a. 10.03 6.18 8.77 n.a.
3 227.28 n.a. 23.95 9.08 15.19 4.83
BLL + 5% xylose +
0.5% glycerol
1 254.09 74.67 n.a. n.a. n.a. 3.93
2 245.64 76.71 10.37 n.a. 10.96 n.a.
3 240.90 76.28 14.61 n.a. 15.11 8.40
Table 9.9: Product formation in the cultures from cultivating Lactococcus lactis
NCDO2118 in defined medium supplemented with 0.5% xylose and 0.5% xylose
with an additional 0.5% glycerol. Cultures were incubated at 30°C under anaerobic
(static) conditions. Note the absence of formate in the cultures supplemented with
glycerol.
Growth experiments with galactose as a substrate do not show
signs of the glycerol inhibition effect To investigate whether the inhib-
itory effect of glycerol was specific to growth on xylose, growth experiments
were carried out with galactose as main substrate. Galactose was chosen
because it has a very similar profile to xylose with respect to product form-
ation and growth rate [14]. The results from the growth experiment with
galactose in BLL medium can be seen in table 9.10 and an analysis of product
formation can be found in table 9.11.
The results from the growth experiment with galactose showed that the
effect of glycerol on the growth rate is less pronounced, than when the cells
are growing on xylose. There is perhaps evidence of a slight effect for the
cultures grown anaerobically. The addition of glycerol at the mid. exponen-
tial phase did not appear to have much effect. This was done primarily to
show that if an effect was present it would appear from glycerol addition.
The product formation for the anaerobic cultures still show a lack of
formate indicating a possible inactivation of PFL. This observation would
then seem to indicate that the disappearance of formate is not the cause
of the slow down, since cultures with added glycerol grew almost as fast
as those without. Then glycerol inhibition is mainly associated with xylose
metabolism, which again leads to an effect in xylose utilization and the
pentose phosphate pathway.
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Medium Cond. Growth rate Biomass form.
µ [h-1] [Max. OD600]
BLL + 0.5% galactose resp. 0.24 0.74
BLL + 0.5% galactose + 0.5% glycerol resp. 0.23 0.75
BLL + 0.5% galactose + 0.5% glycerol resp. 0.23 0.98
(glycerol added mid. exp.)
BLL + 0.5% galactose anaer. 0.19 1.02
BLL + 0.5% galactose + 0.5% glycerol anaer. 0.16 0.88
BLL + 0.5% galactose + 0.5% glycerol anaer. 0.19 1.01
(glycerol added mid. exp.)
Table 9.10: Results from cultivating Lactococcus lactis NCDO2118 in defined
medium supplemented with 0.5% galactose and 0.5% galactose with an additional
0.5% glycerol. One culture had glycerol added at approx. mid expontial growth
to a final concentration of approx. 0.5% (mid. exp.). Incubated at 30°C under
respiratory (resp.) and anaerobic (anaer.) conditions.
Medium Glycerol Lactate Formate Acetate EthanolmM mM mM mM mM
Respiratory
BLL + 0.5% galactose n.a. 7.48 n.a. 12.95 n.a.
BLL + 0.5% galactose + 0.5% glycerol 69.57 10.93 n.a. 13.14 n.a.
BLL + 0.5% galactose + 0.5% glycerol (mid exp.) 69.72 11.16 n.a. 15.77 n.a.
Anaerobic
BLL + 0.5% galactose n.a. 39.43 7.81 6.67 n.a.
BLL + 0.5% galactose + 0.5% glycerol 70.43 40.12 n.a. 4.92 n.a.
BLL + 0.5% galactose + 0.5% glycerol (mid exp.) 69.56 42.87 n.a. 4.49 n.a.
Table 9.11: Product formation in the cultures from cultivating Lactococcus lac-
tis NCDO2118 in defined medium supplemented with 0.5% galactose and 0.5%
galactose with an additional 0.5% glycerol. Incubated at 30°C under respiratory
and anaerobic (static) conditions. A single sample was taken towards the end of
the experiment.
The inhibitory effects of glycerol supplementation on growth rate
can still be observed in richer defined media and in complex me-
dium
The effect of glycerol supplementation was originally observed in BLL me-
dium. This medium is a reduced version of the more commonly used SAL
medium in which only 8 amino acids are added instead of the 19 added to
SAL. Without these supplements growth in BLL medium is slower than in
SAL, hence if the effect of glycerol was still visible in SAL medium, the
growth experiments duration could be shortened significantly (compared to
using BLL medium).
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The inhibitory effect of glycerol is still present in cultures grown on
SAL medium supplemented with xylose Growth experiments were
performed in SAL medium supplemented with xylose (with or without gly-
cerol supplementation) under anaerobic and respiratory conditions. The
results can be seen in table 9.12.
Medium Spec. growth rate Biomass form.
µ [h-1] [Max. OD600]
Anaerobic
SAL + 0.5% xylose 0.37 0.892
SAL + 0.5% xylose + 0.5% glycerol 0.16 0.564
SAL + 0.5% xylose (addition of 0.5% glycerol mid. exp.) 0.35 0.676
SAL + 5% xylose 0.40 0.896
SAL + 5% xylose + 0.5% glycerol 0.34 0.796
SAL + 5% xylose (addition of 0.5% glycerol mid. exp.) 0.38 0.840
Respiratory
SAL + 0.5% xylose 0.43 0.924
SAL + 0.5% xylose + 0.5% glycerol 0.22 0.401
SAL + 0.5% xylose (addition of 0.5% glycerol mid. exp.) 0.43 0.660
SAL + 5% xylose 0.44 1.29
SAL + 5% xylose + 0.5% glycerol 0.23 0.532
SAL + 5% xylose + (addition of 0.5% glycerol mid. exp.) 0.46 0.904
Table 9.12: Results from cultivating Lactococcus lactis NCDO2118 in SAL me-
dium supplemented with xylose and glycerol. Incubation was at 30°C under respir-
atory or anaerobic (static) conditions.
From these results, it is clear that the same inhibitory effect initially
seen in BLL medium, could also be seen for cultivations in SAL medium. In
SAL medium, the growth rate difference between high and low xylose con-
centration is no longer present, for both conditions. The beneficial effect of
increased substrate concentration is still evident but mostly for the anaero-
bic cultures, where the effect still seems more severe. Future investigations
then focused on utilizing SAL medium instead of BLL medium.
The inhibitory effect of glycerol is still present in cultures grown
on SA, SALN and M17 medium supplemented with xylose but
fades when supplemented with ribose Growth experiments in a series
of other media were performed to narrow down the cause of glycerol inhib-
ition. The results can be seen in table 9.13. A summary of the inhibitory
effect between cultures with and without glycerol addition can be seen in
table 9.14.
From the results in table 9.13 cultivation in SALN medium appears
to reduce the inhibitory effect of glycerol addition on growth rate. The
same applies to cultivation in SA medium compared to SAL medium. The
main difference between SA and SAL medium is the addition (to SAL) of
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lipoic acid required for pyruvate dehydrogenase activity under respiratory
conditions and the removal of sodium acetate.
Medium Spec. growth rate Biomass form.
µ [h-1] [Max. OD600]
Lactococcus lactis NCDO2118
Anaerobic
†SALN + 0.5% xylose 0.35± 0.01 1.06± 0.01
†SALN + 0.5% xylose + 0.5% glycerol 0.25± 0.01 0.76± 0.01
†M17 + 0.5% xylose 0.32± 0.01 2.34± 0.03
†M17 + 0.5% xylose + 0.5% glycerol 0.18± 0.01 2.22± 0.04
‡SAL + 0.5% xylose 0.29± 0.01 0.95± 0.02
‡SAL + 0.5% xylose + 0.5% glycerol 0.14± 0.01 0.59± 0.01
‡SAL + 0.5% xylose + 0.5% glycerol +
10mM formate
0.14± 0.01 0.58± 0.02
‡SAL + 0.5% ribose 0.24± 0.01 0.61± 0.01
‡SAL + 0.5% ribose + 0.5% glycerol 0.22± 0.01 0.55± 0.01
†SA + 0.5% xylose 0.34± 0.01 1.02± 0.01
†SA + 0.5% xylose + 0.5% glycerol 0.22± 0.01 0.64± 0.01
†SA + 0.5% ribose 0.27± 0.01 0.58± 0.01
†SA + 0.5% ribose + 0.5% glycerol 0.26± 0.01 0.52± 0.01
Lactococcus lactis IL1403
Anaerobic
‡SAL + 0.5% ribose 0.21± 0.01 0.59± 0.01
‡SAL + 0.5% ribose + 0.5% glycerol 0.18± 0.01 0.51± 0.01
Table 9.13: Results from cultivating Lactococcus lactis NCDO2118 and IL1403
in defined and complex medium with various sugar substrates supplemented with
or without glycerol. Incubation took place at 30°C under respiratory (heme sup-
plementation) or anaerobic (static) conditions. †Experiments in quadruplicates.
‡Experiments in duplicates.
An experiment was conducted to which 10mM formate was added to the
medium. This was to investigate the absence of formate production, seen
previously (table 9.9) in anaerobic cultures with glycerol supplementation.
If the inclusion of formate could counteract the effects of glycerol supple-
mentation it would point towards C1 metabolism. Since growth in medium
with both glycerol and formate is identical to growth in medium with only
glycerol, it would seem the missing formate is not directly involved in the
inhibitory mechanism.
Interestingly, growth in the rich medium M17 still shows signs of inhib-
ition by glycerol. The effect is worse growth in SALN and SA medium and
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only slightly better than growth in SAL.
Medium µ [% of ref.]
Lactococcus lactis NCDO2118
Anaerobic
BLL + 0.5% xylose + 0.5% glycerol 18.8
SAL + 0.5% xylose + 0.5% glycerol 48.3
SA + 0.5% xylose + 0.5% glycerol 64.7
SALN + 0.5% xylose + 0.5% glycerol 71.4
M17 + 0.5% xylose + 0.5% glycerol 56.3
BLL + 0.5% galactose + 0.5% glycerol 84.2
SAL + 0.5% ribose + 0.5% glycerol 91.7
SA + 0.5% ribose + 0.5% glycerol 96.3
SAL + 5.0% xylose + 0.5% glycerol 85.0
BLL + 5.0% xylose + 0.5% glycerol 82.4
Lactococcus lactis NCDO2118
Respiratory
BLL + 0.5% xylose + 0.5% glycerol 16.7
SAL + 0.5% xylose + 0.5% glycerol 51.2
BLL + 0.5% galactose + 0.5% glycerol 95.8
BLL + 5.0% xylose + 0.5% glycerol 56.3
SAL + 5.0% xylose + 0.5% glycerol 52.3
Lactococcus lactis IL1403
SAL + 0.5% ribose + 0.5% glycerol 85.7
Table 9.14: Summary of results obtained from cultivating Lactococcus lactis
NCDO2118 and IL1403 in defined and complex medium with various sugar sub-
strates supplemented with or without glycerol. The values are percentages of the
respective glycerol cultures compared with a non glycerol culture. Incubation took
place at 30°C under respiratory or anaerobic (static) conditions.
Ribose is also metabolized via xylulose-5-phosphate and PPP like xylose.
Furthermore it would have been very beneficial if ribose could be used as
a substrate since dairy isolates do not grow on xylose. Using ribose would
open up new possibilities to access the already existing mutant collections.
Unfortunately the addition of glycerol to cultivations with ribose as a sub-
strate does not seem to have the same effect as with xylose.
To summarize the effects of glycerol addition an overview of the growth
rate inhibition in the various media was compiled in table 9.14. This con-
firms the interesting observation about SA, SAL and SALN medium earlier
stated. Interestingly cultivation in both SA medium and SALN medium
improves the growth rate of strains cultivated on xylose and glycerol. It
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would seem that the inhibition effect of glycerol is substrate specific and is
counteracted by either supplementation of nucleosides or sodium acetate.
9.4.4 Internal metabolite measurements do not reveal sig-
nificant differences between cultures grown with or
without glycerol supplementation
In order to gain some insight into the internal effects of glycerol inhibition,
samples were prepared from cultures grown in medium with xylose with or
without glycerol supplementation. The results can be seen in table 9.15 and
an illutration of the data can be found in figure 9.10.
Strain G6P F6P F16BP DHAP GAP
NCDO2118 - XYL 0.79± 0.30 0.20± 0.08 14.19± 2.85 3.35± 1.40 3.90± 2.81
NCDO2118 - XYL/GLY -0.21± 0.77 -0.05± 0.10 9.37± 2.14 2.23± 1.45 1.97± 1.34
Strain PEP PYR RIB5P RI/XY5P SEDO7
NCDO2118 - XYL 2.48± 1.30 18.30± 16.34 10.41± 16.23 14.16± 9.58 5.96± 12.34
NCDO2118 - XYL/GLY 1.60± 1.25 11.32± 5.75 -5.62± 13.66 4.66± 2.74 -4.23± 6.57
Strain AMP ADP ATP NAD NADP
NCDO2118 - XYL -0.08± 0.57 1.18± 0.85 0.02± 0.09 1.10± 0.60 0.35± 0.36
NCDO2118 - XYL/GLY 0.47± 0.58 1.90± 0.73 0.08± 0.15 0.74± 0.54 0.41± 0.07
Metabolite concentrations in µM. Samples in triplicate/quadruplicate.
Table 9.15: Overview of the internal metabolite concentrations measured in the
samples taken from mid. exponential growth of Lactococcus lactis NCDO2118.
G6P - Glucose-6-phosphate, F6P - Fructose-6-phosphate, F16BP - Fructose-
1,6-biphosphate, DHAP - Dihydroxyacetonephosphate, GAP - Glyceraldehyde-
3-phosphate, PEP - Phosphoenolpyruvate, PYR - Pyruvate, RIB5P - Ribose-5-
phosphate, RI/XY5P - Ribulose-5-phosphate and xylulose-5-phosphate, SEDO7 -
Sedoheptulose-7-phosphate, AMP - Adenosine monophosphate, ADP - Adenosine
diphosphate, ATP - Adenosine triphosphate, NAD - Nicotineamide adenine dinuc-
leotide, NADP - Nicotineamide adenine dinucleotide phosphate.
From the metabolite data it seems that the only significant difference is the
concentration of F16BP, which is lowered in the culture with glycerol sup-
plementation. Whether this is an effect of glycerol or the slower growth rate
remains to be elucidated. It is difficult to draw any meaningful conclusions

























NCDO2118 - XYL NCDO2118 - XYL/GLY 
Figure 9.10: Plot of internal metabolite concentrations in samples from mid. ex-
ponential growth phase of Lactococcus lactis NCDO2118. GREEN - NCDO2118
cultivated on xylose, LIGHT GREEN - NCDO2118 cultivated on xylose supple-
mented with glycerol. G6P - Glucose-6-phosphate, F6P - Fructose-6-phosphate,
F16BP - Fructose-1,6-biphosphate, DHAP - Dihydroxyacetonephosphate, GAP -
Glyceraldehyde-3-phosphate, PEP - Phosphoenolpyruvate, PYR - Pyruvate, RIB5P
- Ribose-5-phosphate, RI/XY5P - Ribulose-5-phosphate and xylulose-5-phosphate,
SEDO7 - Sedoheptulose-7-phosphate, AMP - Adenosine monophosphate, ADP -
Adenosine diphosphate, ATP - Adenosine triphosphate, NAD - Nicotineamide ad-




10.1 A serial transfer regime was not sufficient to
stimulate glycerol assimilation in Lactococ-
cus lactis NCDO2118
The initial attempt at stimulating glycerol usage by Lactococcus lactis
NCDO2118 was not immediately successful. After a period of around two
weeks and 15 transfers, the experiment was halted. Using SALN medium
(SAL supplemented with nucleosides) allows a certain amount of growth for
the slightly more prototrophic plant isolates such as NCDO2118. It was an-
ticipated that this slight growth in a well buffered medium combined with
a prolonged incubation period in the presence of glycerol, might trigger a
response from latent genes or regulatory systems.
10.1.1 How can you enrich for something that does not grow?
There is of course an inherent problem with using adaptive evolution on
a substrate that does not support growth. The whole foundation of the
concept is to utilize naturally occurring mutations in the population as it
grows and divides, to select for interesting mutants. So the main concern
with the use of directed evolution is the time frame and of course growth.
This approach is founded on the assumption that all genetic machinery is
available, and a fairly simple set of mutational events is enough to react-
ivate glycerol utilization i.e. activation or inactivation of regulatory genes,
sensitizing-desensitizing of regulatory effects etc. Furthermore if the muta-
tions required are deleterious in any way the probability of success decreases
further.
The dilution is approximately 10x per transfer which would allow around
three generations of growth per transfer (growing from 0.010 to 0.100). If the
mutational rate can be compared to that of Escherichia coli (even though
genome size for coli is around 1.5 times that of lactis) which has been estim-
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ated to 1.7 ·10−4 mutations per genome per generation [91], and the density
of lactococcal culture in defined SALN medium is (very) roughly 1 · 106
cells for an OD600 ≈ 0.100, then the culture should have picked up ≈ 275
mutations per transfer. With no change after 15 transfers, it was speculated
that the process of activating glycerol usage requires more drastic changes
to succeed. The main difficulty of the approach is that, the lack of actual
growth on glycerol as an energy and carbon source, made the utilization of
glycerol by any mutant an added bonus, rather than a strict requirement.
This makes enrichment of relevant mutants more difficult since the selection
is based on co-metabolism, and hence exerts less selective pressure.
10.2 None of the tested conditions could stimu-
late the selected Lactococcus lactis strains to
utilize glycerol
None of the strains showed signs of metabolizing glycerol from the screening
done so far. A wide range of substrates and conditions have been tested, and
especially respiration permissive conditions were anticipated to have allowed
the use of glycerol as sole carbon and energy source.
The parameters tested were anaerobic, aerobic and respiration permissive
growth, combined with several substrates such as glucose, fructose, galactose
and xylose with or without glycerol supplementation. Gradients of glycerol
concentration were also tested to find out if this affected usage. There
were slight indications from the prolonged gradient experiment that gly-
cerol might have been metabolized by the two plant isolates NCDO2118
and KF147. These were for the most part difficult to replicate. Both respir-
ation permissive and prolonged incubation was tested with other substrates
and conditions but did not stimulate glycerol utilization.
Only an initial screening was done on the various plant isolates from
NCIMB, none of which showed immediate signs of glycerol usage. There
are still many other isolates, and a repeated screening program could be
interesting for further investigations, perhaps combined with isolation of
strains from environmental samples. One might also consider utilizing a
more sensitive analysis of product formation and substrate utilization to
show whether glycerol is indeed being metabolized or not. A final approach
might be to put environmental samples in a glycerol rich environment and
isolate potential glycerol fermenting candidates for further study.
The results from the screening indicate that the issue of glycerol utiliza-
tion may not only be a question of conditions but perhaps also of machinery
as dicussed below.
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10.2.1 The role of glycerol transport
A pending issue which was never fully addressed in this work is the matter
of glycerol transport into the cell. Since there were no conditions which
seemed to stimulate glycerol utilization, one immediate concern could be
the transport of glycerol into the cell.
The initial screening was performed with an underlying assumption that
glycerol can indeed enter the cell. This was based on the fact that glycerol
can permeate the cell membrane simply by passive diffusion [97]. Most
uptake system concerning glycerol are driven by facilitated diffusion such at
the glpF system in E. coli. These simple uptake systems were annotated in
several Lactococcus lactis species but questions remain as to whether they
are functional or not. The specific model strain used in this work L. lactis
MG1363, has a frameshift in the glpF1 gene which might have rendered
it non-functional [105]. There are two other glycerol transporting genes
annotated but their capacity is yet to be verified.
The initial observations of both beneficial and detrimental effects of gly-
cerol supplementation on growth in defined medium supplemented with xy-
lose would seem to lend support to the fact that glycerol does indeed enter
the cell. If it was only an osmotic effect by the high concentration of glycerol
in the medium a similar effect should have been observed under any condi-
tion with glycerol supplementation. This was not the case as only growth in
defined medium supplemented with xylose was affected by glycerol addition.
10.2.2 Measurements of internal metabolites did not provide
new insights
Samples for internal metabolite analysis were prepared, as the levels of the
various metabolites could have shed some light on the area of effect. The
data obtained in the internal metabolite analysis was not significant enough
to support any conclusions in this regard, although the level of fructose-1,6-
bisphosphate (F16BP) does appear to be lower in the glycerol perturbed
strain. Whether this can be attributed to glycerol or simply the lowered
growth rate remains to be investigated. In general, a trend that appears
(with the exception of AMP and ADP) is a lower level of most metabolites in
the samples from the glycerol perturbed strain. This points in the direction
of a lowered energy state in the cells exposed to glycerol but again this could
also be attributed to the much lower growth rate.
Improvements in the sampling for internal metabolite measure-
ments could increase the reliability of the data
There are several areas where improvements could be made to the current
protocol, such as better extraction or more biomass present in the samples
for analysis. This was a first adaptation of a protocol used successfully on E.
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coli at the relatively same optical density of sampling. Yet the more robust
Lactococcus lactis cells may require extra treatment, such as the use of glass
beads to ensure effective extraction of internal metabolites as used succes-
fully by Solem et al. [176] who sampled at slightly higher optical densities
(0.5–0.8 vs. 0.3–0.6). The cells being perturbed by glycerol (and in energy
metabolism in part V) generate less biomass. The level of biomass is most
likely the most critical parameter to the success of generating interesting
metabolic data. The turn around time of the analysis was long, and another
data set could not be completed within the project time frame. It may be
worthwhile repeating the experiment again in the future but with sampling
at a substantially higher optical density, e.g. OD600 = 1, to improve the sig-
nal. This would ensure that enough biomass is present, and that a proper
baseline from the reference samples cannot interfere with signal from the
main samples.
10.2.3 Glycerol supplementation affects growth rate in me-
dium with xylose and is counteracted by addition of
nucleosides, sodium acetate and trehalose
The only indication of a beneficial effect with glycerol supplementation was
with cultivation in defined medium supplemented with trehalose. When
cultivated under aerobic conditions, over night cultures of Lactococcus lac-
tis IL1403 supplemented with glycerol reached a higher optical density than
cultures without glycerol. A single growth experiment was done under these
conditions which showed that strains supplemented with glycerol grew with
approximately 84% of the growth rate, of cultures without glycerol supple-
mentation.
The beneficial effect of trehalose may be connected to the prop-
erties of the molecule itself
The positive effect in combination with glycerol has so far only been ob-
served with trehalose. Trehalose in itself is an interesting molecule which
is widespread in biology and has been associated with many roles such as
energy and carbon reserve or protection from dehydration, protection from
damage by oxygen radicals, protection from cold and as a sensing compound
and cell wall component [82].
Since it is only during aerobic conditions the effect has materialized, it
could simply be that it is not glycerol consumption which forms the basis of
the difference in optical density, but rather a protective attribute of trehalose
causing increased survival of the cultures with glycerol addition. It would
be very interesting to study this effect further by determining if this is
a strain dependant phenomenon or not. More detailed studies utilizing
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transcriptome analysis or internal metabolite measurements could be used
to investigate the phenomenon further.
Glycerol supplementation has a detrimental effect on growth rate
in cultures grown on xylose
The inhibitory effect of glycerol was initially observed in over night cul-
tures grown in defined medium supplemented with xylose and glycerol. To
investigate this effect, further growth experiments were performed in BLL
medium, initially with xylose and subsequently with galactose. The reason
for choosing galactose as a substrate was that growth rate and product
formation profile was very similar to that of xylose. The effect of glycerol
inhibition was less pronounced on galactose.
This would indicate that the area of effect was involved with xylose meta-
bolism, leading to the pentose phophate pathway. One other curious effect
of glycerol supplementation was the apparent loss of formate production.
A potential mechanism might be a high level of triosephophates regulating
PFL activity (glycerol enters glycolysis as DHAP). When comparing the
effect of glycerol inhibition, the effect is stronger in anaerobic cultures than
in respiring ones. If the problem was shutdown of PFL, cultures respiring
would have an alternative route via PDH to form acetyl-CoA. Furthermore,
cultures under respiration permissive conditions also suffer from decreased
growth rates indicating that there is at least one other cause to the inhibi-
tion. In this case an extraordinarily high redox level caused by the influx of
glycerol to glycolysis, could be the cause. The question still remains as to
why this is not simply re-oxidized through respiration.
Growth experiments with glycerol supplementation reveal its in-
hibitory effect in BLL, SA, SAL and M17 media Several different
growth experiments have been performed with a range of different substrates
and conditions. Even growth in rich medium such as M17 is affected by gly-
cerol supplementation. When cultivated in SA or SALN medium growth
rate is improved when compared to SAL. This would indicate the effect
is localized to xylose metabolism and the PPP. This is further substanti-
ated by an absence of glycerol inhibition for cultures grown on galactose
and on ribose which is metabolized via the same intermediary (xylulose-
5-phosphate) as xylose. Furthermore improvements in the growth rate is
observed when cultivating strains in medium with a high concentration of
xylose (5%).
The difference in growth rates for SA, SALN and SAL medium in con-
nection to anaerobic cultivation on xylose is interesting, and suggests that
pyruvate dehydrogenase complex (PDH) is involved (the main difference
between SA and SAL is addition of lipoic acid, necessary for PDH activity
and removal of sodium acetate). The absence of formate in anaerobic cul-
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tivation points to inactivation of pyruvate formate-lyase (PFL) which would
have a great effect under anaerobic conditions, but less so under respiratory
conditions. Both PFL and PDH share a metabolite namely, acetyl-CoA,
which is the product of both PFL and PDH. If xylose is metabolized via
phosphoketolase the result is GAP and acetyl phosphate [103]. GAP enters
glycolysis while acetyl phosphate can be converted to acetate or acetyl-CoA.
If the level of triose phosphates (GAP and DHAP) is high, PFL is inhibited,
which in combination with a bottleneck at acetyl-CoA would explain the
more severe inhibition of growth in SAL medium compared to SA. An open
question is still the lack of effect with ribose which could be caused by regu-
latory mechanisms governing its route through central carbon metabolism.
So far, the finding that an effect is observed under the diverse conditions
of both anaerobic and respiratory growth could suggest that there may be
more than one area which is affected by glycerol supplementation. One pos-
sible link is xylose uptake and metabolism via the phosphoketolase pathway.
Since ribose might be metabolized via the same pathway this contradicts
this model. Other factors such as redox level might also be influencing the
cellular growth. Further investigations are needed to determine the exact
mechanism by which glycerol interferes with xylose metabolism.
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The availability of glycerol has increased dramatically. An increase in pro-
duction of biodiesel has led to a concomitant rise in the byproduct waste
glycerol (crude glycerol) which consists mainly of glycerol, methanol, salts
and remnants of free fatty acids in varying degrees. As a result of the in-
creased production the price of crude glycerol is low. A saturated market
for pure glycerol and expensive refining costs have made crude glycerol an
attractive substrate for industrial bioconversion [151, 19, 114].
A wide range of different microorganisms and value added products have
been investigated as possible routes to handle excess glycerol. The main
species commonly utilized to convert glycerol are Klebsiella, Clostridium,
Citrobacter, Pichia and Yarrowia. These are natural glycerol fermenters and
have been applied to the production of 1,3-propanediol, citric acid, citrate,
ethanol, 2,3-butanediol and butanol [19, 130, 137, 139, 138, 121].
11.1 Metabolic engineering of glycerol utilization
Other strategies for glycerol valorization includes engineering other species
that do not naturally ferment glycerol. The common work horse Escheri-
chia coli has been widely used for this purpose. Initially E. coli was believed
to only utilize glycerol in the presence of an external electron acceptor but
recent studies have shown that under the right conditions anaerobic ferment-
ation of glycerol is possible [48, 124, 118, 120]. Overexpression of the nat-
ive genes gldA (encoding glycerol dehydrogenase) and dhaKLM (encoding
dihydroxyacetone kinase) involved in glycerol metabolism allowed efficient
production of ethanol from glycerol [60, 113].
Other strategies include the production of 1,3-propanediol by expressing
the dhaB1 (encoding a B12-independent glycerol dehydratase) and dhaB2
(DhaB1 activating factor) genes from Clostridium butyricum together with
the E. coli yqhD gene (encoding a 1,3-propanediol oxidoreductase) [148] and
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the production of serinol (2-amino-1,3-propanediol) by expressing the rtxA






















llmg_0870, glpF2, glpF3 
Figure 11.1: Overview of the possible routes of glycerol dissimilation. The
annotated genes found in Lactococcus lactis are shown next to the enzymatic
steps. After transport into the cell by facilitated diffusion glycerol is either
oxidized to dihydroxyacetone by glycerol dehydrogenase or phosphorylated to
glycerol-3-phosphate by glycerol kinase. Subsequently either dihydroxyacetone is
phosphorylated by dihydroxyactone kinase or glycerol-3-phosphate is oxidized by
glycerol-3-phosphate dehydrogenase to dihydroxyacetone phosphate (DHAP) which
enters glycolysis.
11.2 Engineering recombinant glycerol utilization
in Lactococcus lactis MG1363
In addition to the screening of Lactococcus spp. and conditions which might
induce glycerol utilization a parallel course was undertaken to introduce
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the required enzymatic machinery for anaerobic glycerol fermentation into
Lactococcus lactis MG1363.
A similar approach had already been shown to work in Escherichia coli
and Corynebacterium glutamicum. Rittmann et al. introduced genes encod-
ing glpF, glpK and glpD (encoding a glycerol facilitator, a glycerol kinase
and a glycerol-3-phosphate dehydrogenase respectively) from E. coli into C.
glutamicum allowing production of amino acids from glycerol [141].
Daniel et al. introduced the entire dha regulon (encoding glycerol de-
hydrogenase - dhaD, dihydroxyacetone kinase - dhaK, glycerol dehydratase
- dhaB and 1,3-propanediol dehydrogenase - dhaT) from Citrobacter freun-
dii into E. coli which allowed anaerobic growth on glycerol [116]. Similarly
the dha operon from Clostridium butyricum and Klebsiella pneumonia have
been used to facilitate anerobic growth on glycerol in E. coli while producing
1,3-propanediol [115, 150].
11.2.1 Both overexpression of endogenous genes and an ar-
tificial operon containing a complete pathway for gly-
cerol dissimilation is employed to allow anaerobic growth
on glycerol by L. lactis
In order to allow anaerobic growth on glycerol by L. lactis MG1363 a par-
allel strategy was devised consisting of overexpression of endogenous genes
involved in glycerol metabolism and the introduction of an artificial operon
containing all the required genes for glycerol transport and assimilation.
An overview of the required steps and the annotated genes from L. lactis
MG1363 can be seen in figure 11.1. The operon was based on the glycerol
facilitator from E. coli in combination with glycerol dehydrogenase and di-




12.1 Bacterial strains, plasmids and growth con-
ditions
The bacterial strains and plasmids used in the project are listed in table 12.1.
Escherichia coli strains were cultivated aerobically at 28°C, 30°C or 37°C
either in rich or defined medium. Rich medium consisted of Luria-Bertani
broth [144] and defined medium was either MOPS medium [135] or M9
medium [122] with either no antibiotic or containing any of the following
or both: 200 µg/mL Erythromycin or 100 µg/mL Ampicillin, depending on
the selective requirements. When cultivating E. coli MC1000 in minimal
media 50 µg/mL leucine was added to ensure optimal growth conditions.
Lactococcus lactis strains were cultivated in rich medium which consisted
of GM17 broth [149] (M17 + 1% glucose) or defined media which were
either BL or SA [143] with the appropriate modifications as described in
section 8.1.1. Strains were routinely cultivated at room temperature, 28°C
or 30°C, with or without aeration.
12.2 Primers and PCR protocols
The primers used in the project can be seen in table 12.2.
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Strain Description Source or Reference
E. coli strains
MC1000 (F−, araD139, δ(araA-leu)7679 galU galK lac-174 rpsL
thi-1)
[111]
DH5α (F− ∆(argF-lacZ)U169 phoA glnV44 φ80 ∆(lacZ)M15
gyrA96 recA1 relA1 endA1 endA1 endA1 thi-1 hsdR17)
[133]
AH07 E. coli MG1655 transformed with pTrc99A::nox, indu-




MG1363 Prophage-cured and plasmid-free derivative of Lactococ-
cus lactis subsp. cremoris NCDO 712
[123]
LB436 Lactococcus lactis MG1363 transformed with the plas-
mid pLB65 containing the phage TP901-1 integrase gene,
which is necessary for site specific recombination in the
chromosomal attB region of L. lactis MG1363, Camr
[110]
AH200–216 Lactococcus lactis MG1363 transformed with
pCS574::SPL::glpF::dhaD::dhaK, Tetr
This study
AH220–235 Lactococcus lactis MG1363 transformed with
pLB85::SPL::noxE or pLB85::SPL::nox, Ermr
This study
Plasmids
pAK80 Promoterless vector carrying the lacLM genes encoding
the reporter enzyme β-galactosidase, Ermr
[160]
pLB85 Promoterless vector carrying the gusA gene encoding the
reporter enzyme β-glucuronidase and the integrase from
TP901-1 allowing for integration into the chromosome of
L. lactis at the attB site, Ermr,
[110]
pLB86 Promoterless vector carrying the lacLM genes encoding
the reporter enzyme β-galactosidase, Ermr
[110]
pTD5 Promoterless vector carrying the lacLM genes encoding
the reporter enzyme β-galactosidase, based on pAK80
with around 3kb of sequence removed, Ermr
[117]
pCS574 Promoterless vector carrying the gusA gene encoding the
reporter enzyme β-glucuronidase, based on pLB85 with
Tetr instead of Ermr
[174]
pAH184 Plasmid carrying an artificial operon with the glpF gene
from E. coli and the dhaD and dhaK genes from Cit-
robacter freundii codon optimized for Lactococcus lactis.
pUC57::glpF::dhaD::dhaK::groEL2, Ampr
GenScript
Table 12.1: An overview of the bacterial strains and plasmids used in engineering
L. lactis glycerol metabolism. Ermr - Erythromycin resistance. Ampr - Ampicillin
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12.2.1 PCR using Taq polymerase
The PCR program and the standard reaction mixture for PCR using Taq
polymerase can be seen in table 12.3.
Reaction mixture PCR program
Thermopol buffer 10 µL Initial denaturation 94°C 2 min. 1 cycle
5 mM dNTP mix 4 µL
Primer A 2.5 µL Denaturation 94°C 30 sec.
Primer B 2.5 µL Annealing 50°C 30 sec. 30 cycles
Taq polymerase 1 µL Extension 68°C 1 min. pr. kilobase
H2O 80 µL Hold 4°C -
Total 100 µL
Table 12.3: Reaction mixture and program settings for colony PCR with Taq
polymerase.
12.2.2 PCR using Phusion polymerase
Standard protocol
The PCR program and the standard reaction mixture for PCR with Phusion
polymerase can be seen in table 12.4.
Reaction mixture PCR program
5x Phusion buffer 20 µL Initial denaturation 98°C 30 sec. 1 cycle
5 mM dNTP mix 4 µL
Primer A 5 µL Denaturation 98°C 10 sec.
Primer B 5 µL Annealing 50°C 30 sec. 30 cycles
Template DNA 1 µL Extension 72°C 30 sec. pr. kilobase
DMSO 3 µL
Phusion 1 µL Final extension 72°C 10 min. 1 cycle
H2O 61 µL Hold 4°C -
Total 100 µL
Table 12.4: Reaction mixture and program settings for standard PCR with Phu-
sion polymerase. Reagents: 5x Phusion buffer - Finnzymes F-518, DMSO - Fin-
nzymes F-515, Phusion polymerase - Finnzymes F-530.
Touchdown protocol
The PCR program and the standard reaction mixture for touchdown PCR
using Phusion polymerase can be seen in table 12.5.
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Reaction mixture PCR program
5x Phusion buffer 20 µL Initial denaturation 98°C 30 sec. 1 cycle
5 mM dNTP mix 4 µL
Primer A 5 µL Denaturation 98°C 10 sec.
Primer B 5 µL Annealing first: 65°C 30 sec. 15 cyclesTemplate DNA 1 µL last: 50°C
DMSO 3 µL Extension 72°C 30 sec. pr. kilobase
Phusion 1 µL
H2O 61 µL Denaturation 98°C 10 sec.
Total 100 µL Annealing 50°C 30 sec. 20 cycles
Extension 72°C 30 sec. pr. kilobase
Final extension 72°C 10 min. 1 cycle
Hold 4°C -
Table 12.5: Reaction mixture and program settings for touchdown PCR with
Phusion polymerase. Reagents: 5x Phusion buffer - Finnzymes F-518, DMSO -
Finnzymes F-515, Phusion polymerase - Finnzymes F-530.
USER fragment amplification
The reaction conditions for amplification of fragments with USER based
primers are identical to the mixtures and conditions used in Phusion PCR.
The main difference is the polymerase used was PfuX7 [136] instead of Phu-
sion.
Generating synthetic promoter libraries (SPL)
A promoter library is a collection of promoters with different strengths. The
modulation of promoter strength can be done by modulating the regions
flanking the bacterial promoter concensus sequences -35 (TTGACA) and
-10 (TATAAT) [128, 129]. The construction of such a library has been
made increasingly easy and can in fact be done in a single PCR step using
oligonucleotides with randomized promoter regions [125, 146]. An example






Shine-Dalgarno from atpE gene
Synthetic promoter region
N = all four bases     R = 50% A and 50% G
Figure 12.1: Figure depicting an oligonucleotide with a synthetic promoter region.
The chosen example is an actual primer used to amplify a fragment encoding NADH
kinase (POS5) from Saccharomyces cerevisiae in a previous project.
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Colony PCR on E. coli and L. lactis
To perform colony PCR to verify constructs the reaction conditions for Taq
PCR was used. The polymerase was either Taq (<2kb) or DreamTaq™,
Fermentas (>2kb). A standard reaction of 100 µL was split into 4 seperate
reactions of 25 µL. To the mixture a small amount of a single colony was
added and a standard PCR program was used with one modification: An
initial denaturation time of 15 min. For the L. lactis colony PCR it is
paramount that only a very small amount of cell material is added otherwise
no reaction will occur.
12.2.3 DNA techniques
Agarose gel electrophoresis
To verify DNA fragment sizes, samples were run on 0.7-1% agarose gels
containing 0.3 µg/mL ethidium bromide. Samples were mixed with loading
buffer and loaded next to 10 µL of Fermentas GeneRuler™DNA ladder mix
(#SM0333) or Fermentas GeneRuler™1kb DNA ladder plus (#SM1333)
and subsequently run for 45-90 min. at 100-150V / 200 mA. A size distri-
bution for the ladder mix used can be seen in figure 12.2.
Protocol for Loading 
Step 1:  Mix gently 
Step 2:  Load 1 µl per 1 mm gel lane 
Recommendations 
• Do not heat before loading. 
• Dilute your DNA sample with the 6X DNA Loading Dye 
(#R0611, supplied with the ladder): mix 1 volume of the 
dye solution with 5 volumes of the DNA sample;  
• Load the same volumes of the DNA sample and the DNA 
Ladder; 
• For quantification, adjust the concentration of the sample 
to equalize it approximately with the amount of DNA in the 
nearest band of the Ladder. 
• For DNA band visualization with SYBR
®
 Green, GelRed 
and other intercalating dyes, do not add the dyes into 
the sample, use gel staining after electrophoresis or 
include dyes into agarose gel to avoid aberrant DNA 
migration. 
NOTICE TO PURCHASER: LIMITED LICENSE 
This product or its use is covered by at least one claim of U.S. Patent Nos. 5,834,201, 
6,680,378, and/or 7,132,520 owned by Invitrogen Corporation. The purchase of this product 
conveys to the buyer the non-transferable right to use the purchased amount of the product in 
internal research conducted by the buyer. The buyer cannot use this product or materials made by 
the employment of this product for Commercial Purposes. Commercial Purposes means any 
activity for consideration and may include, but is not limited to: (1) use of the product in 
manufacturing; (2) use of the product to provide a service, information, or data; (3) use of the 
product for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product, whether 
or not the product is resold for use in research. Further information on purchasing licenses under 
the above patents may be obtained by contacting the Business Development Department, 
Invitrogen Corporation, 5791 Van Allen Way, Carlsbad, CA 92008. Email: 
outlicensing@invitrogen.com. 
GeneRuler DNA Ladder Mix, ready-to-use 
 
PRODUCT USE LIMITATION 
This product is developed, designed and sold exclusively for research purposes and in vitro 
use only. The product was not tested for use in diagnostics or for drug development, nor is it 
suitable for administration to humans or animals. Please refer to 
www.thermoscientific.com/fermentas for Material Safety Data Sheet of the product. 
© 2011 Thermo Fisher Scientific Inc. All rights reserved. SYBR is a registered trademark of 
Molecular Probes, Inc. All other trademarks are the property of Thermo Fisher Scientific Inc. 
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Step 1: Mix gently 
Step 2: Load 1 µl per 1 mm gel lane 
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	 Do not heat before loading. 
	 Dilute your DNA sample with the 6X DNA Loading Dye 
(#R0611, supplied with the ladder): mix 1 volume of the dye 
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other intercalating dyes, do not add the dyes into the sample, 
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This product or its use is covered by at least one claim of U.S. Patent Nos. 5,834,201, 6,680,378, 
and/or 7,132,520 owned by Invitrogen Corporation. The purchase of this product conveys to the buyer 
the non-transferable right to use the purchased amount of the product in internal research conducted 
by the buyer. The buyer cannot use this product or materials made by the employment of this product 
for Commercial Purposes. Commercial Purposes means any activity for consideration and may 
include, but is not limited to: (1) use of the product in manufacturing; (2) use of the product to provide 
a service, information, or data; (3) use of the product for therapeutic, diagnostic or prophylactic 
purposes; or (4) resale of the product, whether or not the product is resold for use in research. Further 
information on purchasing licenses under the above patents may be obtained by contacting the 
Business Development Department, Invitrogen Corporation, 5791 Van Allen Way, Carlsbad, CA 
92008. Email: outlicensing@invitrogen.com. 
PRODUCT USE LIMITATION
This product is developed, designed and sold exclusively for research purposes and in vitro use only.
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GeneRuler 1 kb Plus DNA Ladder, ready-to-use 

Note. Formation of diffused bands of small DNA fragments is a feature 
of agarose gel electrophoresis.
(b)
Figure 12.2: (a) Size distribution for Fermentas Generuler™DNA ladder mix




When necessary, DNA was purified from excised gel bands or from solution
by using the GE Healthcare - illustra GFX™PCR, DNA and Gel Band
Purification Kit (product code 28-9034-70). All purification work was done
according to the manufacturers specifications.
Purification of plasmid DNA
The plasmids used in the project were prepared from either Zymo research -
Zyppy™Plasmid Miniprep Kit (catalog no. D4020) or with Macherey-Nagel
- NucleoBondr Xtra Midi Plus kit (ref. 740412.10). The Zyppy Miniprep
kit was mainly used for smaller samples used for analytical purposes and
sequencing while the NucleoBondr kit was used for large quantity plasmid
preparations. The work was carried out according to the specific protocols
supplied by the manufacturer.
Digestions
Two types of digestions were generally employed: Restriction analysis and
preparative digestion. Digestion was performed with either traditional re-
striction enzymes or with the fermentas FastDigestr system. An overview
can be seen in table 12.6 and 12.7. When digesting with traditional en-
zymes buffers were generally selected on the recommendations of Fermentas
and New England Biolabs for both single and double digestions. Reaction
conditions and BSA addition were based upon manufacturer’s specification.
When using the FastDigestr system all reactions took place in fastdigest
buffer.
Standard restriction enzyme digestion
Restriction analysis Peparative digest
DNA 10 µL 40–50 µL
10x reaction buffer 2 µL 10 µL
(10 x BSA) 2 µL 10 µL
Restriction enzyme 1 µL 4 µL
H2O 5–7 µL 26–36 µL
Total 20 µL 100 µL
Table 12.6: Protocol for restriction analysis and preparative digestion of DNA
with standard restriction enzymes.
For standard restriction enzymes digestions were performed for 2–4 hours
at 37°C. For FastDigestr enzymes digestions were performed for 30–60 min
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at 37°C. The effectiveness was gauged by running 1–5 µL samples on a 1%
agarose gel after digestion as described in section 12.2.3.
FastDigestr enzyme digestion
Restriction analysis Peparative digest
DNA 10 µL 40–50 µL
10x fastdigest buffer 2 µL 10 µL
Restriction enzyme 1 µL 4 µL
H2O 7–10 µL 36–46 µL
Total 20 µL 100 µL
Table 12.7: Protocol for restriction analysis and preparative digestion of DNA
with FastDigestr restriction enzymes.
Ligation
Prior to ligation, the molar ratio of vector and insert was determined by gel
electrophoresis. A ratio of at least 1:3 - vector:insert is preferable. Usually a
ratio of 1:5 was utilized. The ligation mix can be seen in table 12.8. Ligation
was performed either at 16°C over night (O/N) or at room temperature for
1–2 hours.
Ligation mix
Vector and insert in a ratio of (at least) 1:3 17µL
T4 ligase Buffer 2µL
T4 DNA ligase 1µL
Total 20µL
Table 12.8: Protocol for ligation used during the project.
Prior to use the ligation mixture was heated to 65°C for 10 min. to inactivate
T4 DNA ligase.
Ligation of USER mix
For assembly of fragments with USER cloning the protocol in table 12.9 was
used.
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USER Ligation mix USER program
Vector and insert 1:1 8 µL 37°C 35 min.
10x BSA 0.5 µL 25°C 25 min.
NEBbuffer 4 0.5 µL 4°C -
USER enzyme mix 1 µL
Total 10µL
Table 12.9: Protocol for ligation used during the project.
12.2.4 Preparation of crude enzyme extract
Culture for enzyme assays was quickly chilled on ice and cells harvested
by centrifugation at 7000 rpm for 10 min. (4°C). The harvested cells were
resuspended in 1mL 0.2 % (w/v) KCl, centrifuged for 2 min. in a cold
microcentrifuge (4 °C) at 7000 rpm, and washed again with 1 mL 0.2% KCl.
The cells were then finally resuspended in 700 µL protein extract buffer: 45
mM Tris, 15 mM tricarballylate, 20% glycerol, 4.5 mM MgCl2 and 1 mM
dithiothreitol. Depending on the enzymatic activity to be measured, glycerol
was sometimes omitted from the extract buffer eg. in the case of glycerol
kinase activity measurements. The cell suspensions were then stored at
-80°C until they were needed. When samples were to be analyzed the cells
suspension was disrupted with glass beads (106 microns acid washed and
finer (G-4649) from Sigma). Approximately 0.5 mL glass beads were added
to each tube and the samples were shaken in a Fastprepr for 45 seconds at
speed rate 4. The disrupted cell suspension was subsequently centrifuged
at maximum speed in a cold centrifuge for 20 min. (0°C). The supernatant
was collected and used to measure relevant enzyme activity.
12.2.5 Enzyme assays
Enzymatic assays were performed in either 1 mL using a Zeiss M500 spec-
trophotometer [162] or in 200 µL using a Tecan infiter 200 pro microplate
reader with a Corningr 96 Well Clear Flat Bottom UV-Transparent Micro-
plate (Product 3635). Enzyme assay activity was measured either by adding
100 µL of sample to 900 µL assaymix or by addition of 20 µL sample in 180
µL assaymix.
All enzyme assays were measured from cell free crude extracts prepared
as described in section 12.2.4 and performed at 30°C. Protein concentration
was quantified using the Bradford assay (reagent B6916 Sigma-Aldrich) with




The assay is based on measuring the decrease of NADH concentration as
a function of time at a wavelength of 340 nm. Cell extract is added to
assaymix containing 100 mM Triethanolamine-HCL buffer, 0.3 mM NADH
and 0.3 mM EDTA at pH 7.2.
Glycerol dehydrogenase assay
The assay is a direct assay based on the linear increase in absorbance at
340nm by (NADH) [57]. Glycerol dehydrogenase activity was measured
by addition of sample to assaymix containing 100mM potassium carbon-
ate/bicarbonate buffer at pH 9.5, 30 mM ammoniumsulfate, 0.6 mM NAD+
and 100 mM glycerol.
Dihydroxyacetone kinase assay
The assay is a coupled assay following the decrease of NADH concentra-
tion which is coupled to the reduction of dihydroxyacetonephosphate to
glycerol-3-phosphate by glycerol dehydrogenase [34]. DHA kinase activity
was measured by addition of sample to assaymix containing 50 mM po-
tassium phosphate buffer at pH 7.2, 1 mM Dihydroxyacetone, 1 mM ATP, 1
mM MgCl2, 0.1 mM NADH, 10U G3P dehydrogenase (rabbit) and 10 mM
α,α-dipyridyl.
Glycerol kinase assay
The assay is a coupled assay based on the action of pyruvate kinase (PK)
and lactate dehydrogenase (LDH) [140]. The ATP consumption of glycerol
kinase is monitored by the conversion of phosphoenolpyruvate (PEP) to pyr-
uvate (PYR) by PK which regenerates ADP to ATP. The following reduction
of PYR to lactate by LDH can then be monitored by a drop in absorbance
at 340nm. Glycerol kinase activity was measured by addition of sample to
assaymix containing 50 mM Triethanolamine-HCL buffer at pH 7.2, 10 mM
MgCl2, 20 mM KCl, 2.5 U Pruvate kinase, 2.5 U Lactate dehydrogenase,
0.2 mM PEP, 0.2 mM NADH, 3 mM ATP and 10 mM glycerol.
12.2.6 Transformation
Competent E. coli cells
Electro competent E. coli cells were prepared by adding exponentially grow-
ing cells from O/N culture to 5 x 250 mL LB medium, resulting in a final OD
of 0.05. When the culture reached an OD600 of 0.4 the cells were quickly
cooled in a slurry of ice and water and harvested by centrifugation at 7000
rpm for 10 min. The pellet was washed with 20 mL 10% glycerol five times
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(until the pellet was slightly runny) and finally resuspended in 2 mL 10%
glycerol, which was aliquoted into 40 µL portions and stored at -80°C.
Competent L. lactis cells
Electro competent L. lactis cells were prepared by adding exponentially
growing inoculum from O/N culture to 100 mL of solution 1, resulting in a
final OD of 0.03. When the culture reached an OD600 of 0.6 the cells were
quickly cooled in a slurry of ice and water and harvested by centrifugation
at 5000 rpm for 10 min. The pellet was washed with 30 mL of solution 2
and finally resuspended in 1 mL solution 2, which was aliquoted into 40-200
µL portions and stored at -80°C. The composition of solution 1 and 2 can be
seen in table 12.10. Glycine concentration in solution 1 is strain dependent.
For MG1363 or IL1403 1.5% is used but other strains usually require lower
concentrations to be added.
Solution 1 Solution 2
Component Final concentration Component Final concentration
15 mL of 10% stock 1.5% glycine 25 mL of 2M stock 0.5M sucrose
12.5 mL of 2M stock 0.25M sucrose 20 mL of 50% stock 10% glycerol
5 mL of 20% stock 1% glucose 55 mL dest. H2O
50 mL of 2x stock 1x M17 Total 100 mL
17.5 mL dest. H2O
Total 100 mL
Table 12.10: Composition of solution 1 and 2 used in the preparation of competent
cells from Lactococcus lactis.
Electroporation and transformation
Escherichia coli Transformation was done by mixing 40 µL of compet-
ent cells with 3.5 µL of plasmid preparation or ligation mix on ice. The
mix was transferred to a pre-chilled Gene Pulser cuvette and electroporated
on a Bio-Rad MicroPulser by a 2.5 kV pulse and resuspended in 2 mL of
transformation mix (LB + 10mM MgCl2 + 10mM CaCl2 + 0.2 % glucose).
The culture was then incubated for two hours at 37°C after which the cells
were plated in dilution on suitable plates.
Lactococcus lactis Transformation was done by mixing 40 µL of compet-
ent cells with 1-5 µL of plasmid preparation or ligation mix on ice. The mix
was transferred to a pre-chilled Gene Pulser cuvette and electroporated on
a Bio-Rad MicroPulser by a 2.0 kV pulse (manual 2.0) and resuspended in
2 mL of transformation mix (SGM17: M17 + 0.2M sucrose + 0.5% glucose
+ 20mM MgCl2 + 2mM CaCl2). The culture was then incubated for two
hours at 30°C after which the cells were plated in dilution on suitable plates.
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USER transformation USER mix was transformed into chemically com-
petent E. coli DH5α by first mixing competent cells and 3–5 µL of DNA
gently. After a 15 min. incubation on ice, the cells were heat shocked at
45°C for 1min. after which they were incubated on ice another 10 min.
Finally, 1 mL of LB was added and the cells incubated for a suitable time
allowing for phenotypic expression before plating on appropriate selective
plates.
Selective plates When screening a synthetic promoter library (SPL) for
transformants with varying promoter strength, the following plates were
used: for E. coli LB plates were prepared containing: Either 150–200 µg/mL
Erythromycin or 100 µg/mL Ampicillin + 1 % glycerol and either 100–
200 µg/mL of X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) or
X-gluc (5-Bromo-4-chloro-3-indolyl-β-D-glucuronic acid) depending on the
reporter gene used. For L. lactis M17 + 1% glucose plates were prepared
containing: either 5 µg/mL Erythromycin or 5 µg/mL Tetracycline + 1 %
glycerol and either 100–200 µg/mL of X-gal (5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside) or X-gluc (5-Bromo-4-chloro-3-indolyl-β-D-glucuronic
acid) depending on the reporter gene used. Glycerol can be omitted if need
be.
Site specific integration onto the chromosome of Lactococcus lac-
tis MG1363 via the TP901-1 phage encoded integrase Site spe-
cific integration of plasmid DNA into the chromosome of Lactococcus lactis
MG1363 can be done utilizing the attachment site (attP) and the enzyme
integrase from the L. lactis phage TP901-1 [110]. By placing the attachment
site on a vector which is unable to replicate in L. lactis integration onto the
chromosome is the only way for the plasmid to remain. This is mediated
by the phage encoded integrase between the attachment site on the vector
(attP) and an attachment site on the chromosome (attB).
Integration is achieved by transforming a non-replicative plasmid such
as pLB85 into a strain carrying the integrase on separate plasmid. This will
allow a high frequency of recombination to occur. An example showcasing
the vector pLB85 is shown in figure 12.3.
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(multiple cloning site) 
Figure 12.3: Illustration of site specific integration of plasmid DNA onto the chro-
mosome of Lactococcus lactis MG1363. pLB85 (shown linearized): ORI - origin of
replication for E. coli, bla - ampicillin resistance gene, erm erythromycin resist-
ance gene, attP - attachment site for site-specific recombination in L. lactis, SPL
- synthetic promoter library in front of a gene of interest inserted in the multiple
cloning site, gusA - β-glucuronidase (reporter gene). Integration is mediated by the
phage encoded integrase between the attachment site on the vector (attP) and the
attachment site on the chromosome (attB).
12.3 Construction of strains overexpressing Gly-
cerol kinase
A glpK (PubMed gene ID: 4798474, llmg1099) fragment was amplified from
chromosomal DNA of Lactococcus lactis MG1363. A corresponding glpK
(PubMed gene ID: 948423, b3926) fragment was amplified from chromo-
somal DNA of E. coli MG1655.
The sequence was amplified using Phusion polymerase together with
primer 28 and 29 for Lactococcus lactis and primer 32 and 33 for E. coli
as described in section 12.2.2. The fragments were digested with XbaI and
PstI and ligated as described in section 12.2.3 and 12.2.3 into the vector
pCS574. The vector had been digested with XbaI and PstI with subsequent
treatment with Shrimp Alkaline Phosphatase (SAP). The constructed plas-
mids were then transformed into competent L. lactis LB436 as described in
section 12.2.6.
12.3.1 pAH184: An artificial operon with the machinery re-
quired to metabolize glycerol
As an alternative to the native enzymes present in Lactococcus lactis an
artificial operon was constructed utilizing genes from E. coli and C. freun-
dii [116]. The operon was designed to be comprised of three genes: glpF
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from E. coli and dhaD plus dhaK from Citrobacter freundii. A leader se-
quence from a glycolytic promoter from Lactococcus lactis was placed in
front of each gene and a terminator placed at the end. An illustration can
be seen in figure 12.4.
Figure 12.4: Illustration of pAH184, a plasmid carrying an artificial operon for
glycerol dissimilation. The operon is constructed from a pUC57 vector with the
glpF gene from E. coli (glycerol facilitator), the dhaD (glycerol dehydrogenase)
gene from Citrobacter freundii and the dhaK (dihydroxyacetone kinase) gene also
from Citrobacter freundii
Construction of L. lactis strains expressing the entire operon
Strains expressing the entire operon were constructed by amplification of a
fragment containing the operon with a synthetic promoter library in front
by using the primers 47 and 48 (table 12.2). The sequence was amplified us-
ing Phusion polymerase with a plasmid preparation of pAH184 as template
as described in section 12.2.2. The fragment was digested with XbaI and
PstI and ligated as described in section 12.2.3 and 12.2.3 into the vector
pCS574. The vector had been digested with XbaI and PstI with subsequent
treatment with Shrimp Alkaline Phosphatase (SAP). The constructed plas-
mids were then transformed into competent L. lactis LB436 as described in
section 12.2.6.
The fragment was also ligated into the vector pLB85 and transformed
into competent L. lactis LB436 using a similar approach as described above.
Finally a fragment without the terminator was amplified using the primers
47 and 54. The fragment was digested with XbaI and SalI and ligated as
described above into the vector pLB85 with subsequent transformation into
competent L. lactis LB436.
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Construction of L. lactis strains expressing dhaD and dhaK
Construction of strains expressing dhaD and dhaK was done by amplify-
ing a fragment from pAH184 with the primers 88 and 91 (table 12.2). The
fragment was digested with XhoI and NotI and ligated as described in sec-
tion 12.2.3 and 12.2.3 into the vector pTD5. The vector had been diges-
ted with XhoI and NotI with subsequent treatment with Shrimp Alkaline
Phosphatase (SAP). The constructed plasmids were then transformed into
competent L. lactis MG1363 as described in section 12.2.6.
Construction of L. lactis strains expressing dhaD
Construction of strains expressing dhaD was done by amplifying a fragment
from pAH184 with the primers 88 and 89 (table 12.2) with Phusion poly-
merase as described in section 12.2.2. The fragment was digested with XhoI
and NotI and ligated as described in section 12.2.3 and 12.2.3 into the vector
pTD5. The vector had been digested with XhoI and NotI with subsequent
treatment with Shrimp Alkaline Phosphatase (SAP). The constructed plas-
mids were then transformed into competent L. lactis MG1363 as described
in section 12.2.6.
Construction of L. lactis strains expressing dhaK
Construction of strains expressing dhaK was done by amplifying a fragment
from pAH184 with the primers 88 and 89 using Phusion polymerase as de-
scribed in section 12.2.2. The fragment was digested with XhoI and NotI
and ligated as described in section 12.2.3 and 12.2.3 into the vector pTD5.
The vector had been digested with XhoI and NotI with subsequent treat-
ment with Shrimp Alkaline Phosphatase (SAP). The constructed plasmids
were then transformed into competent L. lactis MG1363 as described in
section 12.2.6.
12.3.2 Construction of strains with NADH oxidase activity
Strains with NADH oxidase activity were constructed either from the noxE
gene from Lactococcus lactis (Gene ID: 4796799,llmg0408) or with a NADH
oxidase fragment amplified from a template containing the nox gene from
Streptococcus pneumoniae [109] (Genbank entry AF014458). A template
with the nox gene was supplied by Jin Ho, working at CMB, building
223, Technical University of Denmark. This was used to construct the
pTrc99A::nox plasmid which was used as a template for ampification of
the nox fragment.
The noxE sequence was amplified using Phusion polymerase together
with primer 39 and 46 as described in section 12.2.2. The fragment was
digested with XhoI and PstI and ligated as described in section 12.2.3 and
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12.2.3 into the vector pCS574. The vector had been digested with XhoI and
PstI with subsequent treatment with Shrimp Alkaline Phosphatase (SAP).
The constructed plasmids were then transformed into competent L. lactis
LB436 as described in section 12.2.6.
Both the noxE and the nox sequence was amplified using Phusion poly-
merase together with primer 39 and 86 and with primer 17 and 87 respect-
ively as described in section 12.2.2. The fragments were digested with XhoI
and NotI and ligated as described in section 12.2.3 and 12.2.3 into the
vector pTD5. The vector had been digested with XhoI and NotI with sub-
sequent treatment with Shrimp Alkaline Phosphatase (SAP). The construc-
ted plasmids were then transformed into competent L. lactis MG1363 and
NCDO2118 as described in section 12.2.6.
USER cloning
When constructing strains with the USER cloning approach, both the noxE
and the nox sequence was amplified using Pfu-X7 polymerase together with
the primers 73 and 74 and with primers 75 and 76 respectively (table 12.2)
as described in section 12.2.2. The vector pLB85 was amplified from plasmid
preparations using the primers 78 and 79 or 80 and 81 (table 12.2). The
amplified USER fragments were ligated together using the USER enzyme
mix as described in section 12.2.3 and either transformed into competent E.
coli DH5α as described in section 12.2.6 or directly into Lactococcus lactis
LB436 after treatment with T4 DNA ligase. When using plasmid prepar-
ations from verified E. coli constructs, the preparations were transformed




From the initial analysis of challenges with respect to glycerol metabolism in
Lactococcus lactis, several areas were identified as potential problem areas.
Recombinant strategies were devised to investigate and handle the possible
challenges associated with these. The recombinant work included:
• Construction of a strain with glycerol kinase overexpression.
• Design and construction of strains with an artificial operon containing
the necessary enzymes for glycerol assimilation.
• Construction of a NADH oxidase library for tuning redox levels in
connection with glycerol metabolism.
13.1 Overexpression of endogenous glycerol kinase
from a synthetic promoter library as way to
stimulate glycerol assimilation
Initial data indicated that glycerol kinase and dihydroxyacetone kinase were
expressed at a lower level than the rest of the genes in the glycerol pathway.
The solution was to construct a strain overexpressing L. lactis, own glycerol
kinase gene, glpK.
Mutants made with the glycerol kinase gene were constructed with a
synthetic promoter library modulating gene expression. After verification
by colony PCR, the selected clones were subjected to an enzymatic assay
to determine the promoter activity via the reporter gene, typically either β-
galactosidase or β-glucuronidase. The results from a β-glucuronidase assay
can be seen in figure 13.1.
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Figure 13.1: Results from promoter strength assay on strains with increased
glycerol kinase expression using β-glucuronidase as a reporter gene. The strains
have a single copy from an SPL library integrated on the chromosome using the
vector pCS574.
From these results three candidates were selected for further analysis. The
strains AH153, AH159 and AH169 were selected and samples prepared for
a glycerol kinase assay. The results of the glycerol kinse assay can be found
in table 13.1 and a plot of the data can be viewed in figure 13.2.
Strain specific glycerol kinase activity [U/mg]
AH153 0.041 ± 0.001
AH159 0.079 ± 0.04
AH169 0.106 ± 0.09
MG1363 0.036 ± 0.02
MG1363 + glycerol 0.109 ± 0.06
Table 13.1: Results from glycerol kinase assay on selected strains. Strains harves-
ted from anaerobic conditions. The strains have a single copy from an SPL library
integrated on the chromosome using the vector pCS574.
None of the selected strains exhibited increased glycerol kinase activity com-
pared to the reference. The highest activity recorded is from a reference
culture which had been supplemented with glycerol during cultivation and
harvest (substrate was glucose). None of the strains showed any signs of
growth on plates made from defined medium supplemented with glycerol
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(0.1% and 0.5%). It was later realized that the activity of glycerol kinase
is regulated by the phosphotransferase system (PTS) and HPr, causing a
re-evaluation of the whole strategy. After several rounds of unsuccessful

























Figure 13.2: Plot of results from a glycerol kinase assay using selected strains
overexpressing glpK from Lactococcus lactis. The strains have a single copy from an
SPL library integrated on the chromosome using the vector pCS574. AH200 is the
reference strain Lactococcus lactis LB436 with an empty pCS574 vector integrated
on the chromosome.
13.2 Introduction of an artificial operon for gly-
cerol dissimilation into Lactococcus lactis
In order to ensure a complete biochemical pathway for glycerol dissimilation
an artifial operon, comprising all the necessary components, was designed.
The construction was based on the work done by Daniel et al. [116], in which
they characterized the oxidative branch of glycerol metabolism from Citro-
bacter freundii. Citrobacter was selected as a basis for the design because the
species is known to grow fermentatively on glycerol and the genetic makeup
was simple. Not having conclusively determined whether the glycerol trans-
port system was functional in Lactococcus lactis, a decision was made to
also include the glycerol facilitator from E. coli. The operon then consisted
of three elements: the glycerol transport protein glpK from E. coli, the
glycerol dehydrogenase dhaD and the dihydroxyacetone kinase dhaK both
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from Citrobacter freundii. The entire operon was bought as a synthetic gene
from GenScript USA Inc., codon optimized for L. lactis. Futher details on
the operon can be found in materials and methods section 12.3.1.
Multiple rounds of cloning were performed with the artificial operon,
without success. Several different combinations of cloning strategies were
tested. These included integration on the chromosome of L. lactis and con-
struction of plasmids carrying the operon, utilizing either traditional restric-
tion digestion protocols or uracil based excision reagent cloning (USER). So
far multiple series of clones have been generated and characterized, but so
far none have been verified as containing a complete operon. An example
from an initial round of cloning with the integrative vector pCS574 can be
viewed in figure 13.3, figure 13.4 and figure 13.5.
Constructions made from the glycerol operon were made with a synthetic
promoter library modulating gene expression of the operon. After verific-
ation by colony PCR the selected clones were subjected to an enzymatic
assay to determine the promoter activity via the reporter gene, typically
either β-galactosidase or β-glucuronidase. The results from such an assay





































Figure 13.3: Results from promoter strength assay on strains expressing the
synthetic glycerol assimilation operon using β-glucuronidase as a reporter gene.
The strains have a single copy of an SPL fragment integrated on the chromosome
using the vector pCS574. AH200 is the reference strain Lactococcus lactis LB436





















































Figure 13.4: Results from glycerol dehydrogenase assay on strains expressing the
synthetic glycerol assimilation operon. The strains have a single copy of an SPL
fragment integrated on the chromosome using the vector pCS574. AH200 is the






















































Figure 13.5: Results from dihydroxyacetone kinase assay on strains expressing the
synthetic glycerol assimilation operon. The strains have a single copy of an SPL
fragment integrated on the chromosome using the vector pCS574. AH200 is the
reference strain Lactococcus lactis LB436 with an empty pCS574 vector integrated
on the chromosome.
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The glycerol dehydrogenase assay did not reveal significant differences between
the strains and it was therefore difficult to draw conclusions based on the
assay. Standard deviations for the dihydroxyacetone kinase assay, but the
results indicate that the majority of the clones constructed had lower en-
zyme activities than the wild type/reference strain. Despite the inconclusive
results the constructed strains where tested in defined medium supplemen-
ted with glycerol, for the ability to metabolize glycerol. The results can be
seen in table 13.2.

















Table 13.2: Results from screening strains with a synthetic operon for glycerol
assimilation for growth in defined medium supplemented with glycerol. The strains
were inoculated in SAL + 0.1% glycerol + 5 µg/mL tetracycline. Optical density
was measured after 4 days at 30°C.
The strains were tested for glycerol assimilation and from the results, it
is clear that none of tested strains would appear to metabolize glycerol.
This is not surprising given the results from the glycerol dehydrogenase and
dihydroxyacetone kinase assays.
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13.3 Overexpression of NADH oxidase is not suf-
ficient to enable growth on glycerol
When Lactococcus lactis grows on glycerol, more redox is formed in the
form of NADH, than when growing on glucose. In order to re-oxidize the
cofactors, flux must be diverted towards ethanol. This might present a prob-
lem for the cell even though Lactococcus lactis is fairly alcohol tolerant, as
the metabolism is not geared towards producing only ethanol. Furthermore,
when growing under respiration permissive conditions, additional redox is
formed by the action of the pyruvate dehydrogenase complex (PDH). When
the possibility to respire is there, any excess redox would in theory be re-
oxidized by re-routing it to respiration. To make sure that there were no
regulatory effects causing problems, an alternative route is introduced via
NADH oxidase. The water forming NADH oxidase enzyme utilizes excess
NADH to reduce molecular oxygen to water.
As with the previous constructions, strains with NADH oxidase activ-
ity were constructed using a synthetic promoter library to modulate gene
expression. After verification by colony PCR, the selected clones were sub-
jected to an enzymatic assay to determine the promoter activity via the
reporter gene, either β-galactosidase or β-glucuronidase. The results from

































Figure 13.6: Results from promoter strength assay on strains expressing NADH
oxidase activity using beta-glucuronidase as a reporter gene. The strains have a
single copy from an SPL library integrated on the chromosome using the vector
pLB85. AH200 is the reference strain Lactococcus lactis LB436 with an empty















































Figure 13.7: Results from NADH oxidase assay on strains expressing NADH
oxidase activity. The strains have a single copy from an SPL library integrated on
the chromosome using the vector pLB85. AH200 is the reference strain Lactococcus
lactis LB436 with an empty pCS574 vector integrated on the chromosome.
To verify the activity of the constructs they were subjected to a NADH
oxidase assay. The results of this can be seen in figure 13.7. The reason
for lack of correlation between the promoter strength measurements and the
NADH oxidase assay is most likely that two different NADH oxidase genes
were used in the construction of the strains. Both L. lactis own gene, noxE,
and the nox gene from Streptococcus pneumoniae were used. Following the
enzymatic assay the strains were tested for glycerol metabolization. None
of the strains with increased NADH oxidase activity showed signs of growth




Several recombinant cloning strategies were initiated to solve the potential
challenges faced by glycerol dissimilation in Lactococcus lactis. Initially the
construction of a strain overexpressing the glycerol kinase gene glpK from
L. lactis was investigated. This was done on the basis that initial transcrip-
tomic analysis showed that glycerol kinase and dihydroxyacetone kinase were
downregulated during growth on glucose, maltose and galactose.
Although several rounds of cloning and multiple clones were construc-
ted, none were shown to possess increased glycerol kinase activity, when
compared to the reference strain. It was later learned that glycerol kinase
activity is regulated by HPr and the PTS system. The cells used in the
glycerol kinase assay were harvested from static cultures, grown on glucose.
These might not be the best conditions for a glycerol kinase activity assay,
yet the sample with the highest activity was the reference strain, which had
been supplemented with glycerol during cultivation and harvest.
14.1 Design and introduction of a complete re-
combinant pathway for glycerol assimilation
into Lactococcus lactis
The artificial operon created for glycerol assimilation was transformed into
Lactococcus lactis as a synthetic promoter library. Similar to the overexpres-
sion of glycerol kinase, characterization of the constructed clones revealed
few with expression levels of glycerol dehydrogenase activity or dihydroxy-
acetone kinase activity above the level of the reference strain. No assay was
done for the activity of the glpF gene encoding the glycerol facilitator.
From the results so far, there is still much to be done to construct and
verify a fully operational operon. There have been many setbacks under
the construction. It is not possible to entirely rule out that perhaps the
original design of the artificial operon could be flawed in some way or that
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there are other places where errors could have ocured, such as during the
synthesis of the operon or in the codon optimization. An alternative could
be to construct a similar operon or another construct with native genes from
Lactococcus lactis. If this is done, great care has to be taken in order to first
make sure the components are themselves functional.
Overexpression of the transcriptional regulators dhaS (transcriptional
activator) and dhaQ (co-activator) might also provide a route to increased
enzymatic activity for dihydroxyacetone kinase since the system in L. lactis
functions as an activator rather than repressor [112].
14.2 Overexpression of NADH oxidase activity is
not enough to allow growth of Lactococcus
lactis on glycerol as sole carbon and energy
source
The construction of strains overexpressing NADH oxidase was completed
and a selection of clones were characterized by enzymatic assays. They
displayed a range of different NADH oxidase activity levels, albeit to the
lower side.
The strains were not able to grow in defined medium supplemented only
with glycerol, indicating that the redox problem was not the only thing
preventing the strains from metabolizing glycerol. Now that a selection
of strains with NADH oxidase activity have been generated it would be a
logical next step to combine these with the other constructs under way.
Since the additional mutants are still being constructed, initial work
might focus on generating strains with higher levels of NADH oxidase activ-
ity. One might also explore the possibility of utilizing alternative electron
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Working from the assumption that flux control does not necessarily reside
within the metabolic pathways, the focus of metabolic engineering has shif-
ted towards the role played by the redox and energy cofactors. The work
of Koebmann et al. [165] showed that glycolysis in E. coli is mostly con-
trolled by the demand for ATP but also that the degree of control can be
highly specific to both organism and growth conditions [39]. Another study
involving redox and energy cofactors was done by Vemuri et al. [179] where
levels of NADH were reduced, resulting in decreased acetate production and
biomass yield. Furthermore, indications of increased flux through glycolysis
and the TCA cycle suggests that reducing the level of NADH has similar
effects, as those observed by Koebmann et al. [165]. These observations lend
further support to the theory that control of glycolytic flux might lie outside
the pathway itself, perhaps governed by demand for global redox and energy
cofactors. The interesting observation that glycolytic flux in exponentially
growing Lactoccus lactis, an organism that relies solely on glycolysis as a
source of ATP, does not increase as a consequence of ATP hydrolysis still
puzzles today. This was the main reason behind reinvestigating the strains
constructed by Koebmann et al. 2002. The idea was to utilize the advances
in analytics and new high throughput methods, not available at the time
of the original paper, to look a little deeper into the inner workings of the
strains with increased expression of ATPase activity.
15.1 Investigations into glycolytic flux control in
Lactococcus lactis
One way to determinine if a given enzymatic step in a pathway is flux limit-
ing, is to overexpress that given enzymatic activity and record the effect. In
order to determine the control of glycolytic flux in L. lactis the effect of over-
producing most enzymes in glycolysis has been investigated: Phosphofructo
kinase (Koebmann et al. 2005 [162]), Triosephosphate isomerase (Solem et
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al. 2005 [175]), Glyceraldehyde-3-phosphate dehydrogenase (Solem et al.
2003 [174]), Phosophoglycerate mutase (Solem et al. 2010 [177]), Phos-
phoglycerate enolase (Koebmann et al. 2006 [163]), Pyruvate kinase (Koeb-
mann et al. 2005 [162], Ramos et al. 2004 [172]) and Lactate dehydrogenase
(Andersen et al. 2001 [152]). The conclusion was that no one enzyme showed
signs of controlling flux at wild type levels of enzymatic activity and a signi-
ficant reduction in enzymatic activity was required to affect the flux. The re-
maining enzymes showed a similar response [Christian Solem, unpublished].
Even a strain in which the activity of all the enzymes were overproduced to
twice the level of the wild type did not show any increase in flux, indicating
that control was not shared between all the enzymes [Christian Solem, un-
published]. This pointed in the direction of the remaining factors governing
flux control such as energy demand and transport processes such as sugar
uptake or lactic acid export.
15.1.1 The effect of ATP demand on glycolytic flux
In the light that no single enzyme appeared to have control over glycolytic
flux Koebmann et al. set out to investigate the effect of energy demand.
To disrupt the level of ATP in the cell, a system which is based on the
ATP synthase complex, responsible for energy generation in both eukaryotic
and prokaryotic cells was developed. The complex consist of two parts: A
membrane bound part (F0) and a cytoplasmic part (F1). The cytoplasmic
part of the ATP synthase complex is capable both of generating but also
of hydrolyzing ATP in prokaryotic cells [182]. The soluble F1 part of the
ATP synthase complex contains the catalytic sites for ATP synthesis or
hydrolysis and can remain active without the F0 part. Expression of the
genes atpA, atpD and atpG (atpADG), located in the atp operon encoding
the F1 part of the ATP synthase complex therefore represents an easy way of
introducing an ATP hydrolysing process into the cell, which simply removes
ATP without affecting any other parts of metabolism [165, 182].
Overexpressing F1 in L. lactis did not results in any increase in glycolytic
flux, as mentioned previously. When applying the same system in resting
cells the flux increased and approached the level in exponential growing wild
type cells but never surpassed this. Hence energy demand does not seem to
control the glycolytic flux in L. lactis.
15.2 Experimental setup
The main idea behind the reinvestigation was to combine data from both
transcriptional analysis and information on the levels of corresponding in-
ternal metabolites. This combination could hopefully uncover new clues
which might point to why control of the glycolytic flux of L. lactis remains
so elusive. Furthermore, the availability of a library expressing different
118
levels of ATPase activity meant that strains could be selected such that the
pertubation was as minimal as possible but still allowed a significant effect
to be studied. Every time a perturbation is introduced into a system there
is a danger that additional pleiotropic effects are introduced if the perturb-
ation level is too severe. By carefully selecting strains with low but defined
levels of perturbation it would allow the transcriptomic studies to filter out
these effects leading to more robust biological results but would of course
increase the demands on the data analysis.
The experimental setup used in the following study includes four strains
from the previous study by Koebmann et al. [164]: BK1010, BK1506, BK1503
and BK1502. The strains are listed in increasing order of ATPase activity
(BK1010 being the reference strain, REF (containing the empty promotor-
less vector pAK80)).
The selected strains were investigated with respect to two levels of ana-
lysis: transcriptomic profilling and metabolomic profilling. The strain with
the highest degree of perturbation (BK1502) was only used for metabolomic
analysis, as a positive control, since this level of perturbation would most
certainly have a profound effect on the metabolism of the affected cells. No
transcriptional samples were taken from this strain since the goal was to
utilize strains with as little perturbation (but still with a significant effect)




16.1 Bacterial strains, plasmids and growth con-
ditions
The bacterial strains used in this part of the project are listed in table 16.1.
Strain Description Source or Reference
L. lactis strains
BK1010 L. lactis MG1363 transformed with pAK80, Ermr [164]
BK1503 L. lactis MG1363 transformed with pCPC4::atpAGD, Ermr [164]
BK1506 L. lactis MG1363 transformed with pCPC7::atpAGD, Ermr [164]
BK1502 L. lactis MG1363 transformed with pCPC3::atpAGD, Ermr [164]
Plasmids
pAK80 Promoterless vector carrying the lacLM genes encoding the re-
porter enzyme β-galactosidase, Ermr
[160]
Table 16.1: An overview of the bacterial strains and plasmids used in part IV of
the project. Ermr - Erythromycin resistance.
Lactococcus lactis strains were cultivated in the defined medium SAL, as
described in section 8.1.1. Inoculum for growth experiments were incub-
ated over night with selective pressure (5 µg/mL Erythromycin) at 30°C.
Growth experiments were carried out in 100 mL flasks filled with 100 mL
of SAL medium supplemented with 0.2% glucose. No antibiotics were ad-
ded to the growth experiment cultures to minimize noise in the microarray
samples (antibiotics were added to over night culture to ensure strain stabil-
ity). Cultivation was performed under static conditions in a Julabo SW-20C
type waterbath set to 30°C without agitation. Cultures were kept in sus-
pension by slow stirring at 300 rpm using 5mm magnets. Optical density
was measured at 600 nm (OD600)on a Shimadzu UV mini 1240 spectropho-
tometer.
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16.2 High-pressure liquid chromatography analysis
Sampling for high-pressure liquid chromatography (HPLC) analysis con-
sisted of about 1.5 mL of sample withdrawn from the growing cultures at
different OD600 values (approx. 0.1, 0.2, 0.3,...). The sample was imme-
diately filtered through a 0.22 µm filter and stored at -20°C until it was
analyzed. The concentrations of glucose, lactate, formate and acetate were
determined by HPLC equipment from Shimadzu Corporation, Kyoto, Ja-
pan, the system was controlled by the program class VP 5.0. Separation
was performed with a Bio-Rad HPX-87H heated to 30°C. A securityGuard
cartridge system (Phenomenex) with a Carbo-H cartridge (Phenomenex)
was used to protect the HPLC column. The mobile phase consisted of 5
mM H2SO4, with a flow rate of 0.5 mL/min and all products were detected
on the Shodex refractive index detector, RID-10A. [153]
16.3 RNA purification
Purification of RNA was performed using the QIAGEN RNAprotect™bac-
terial reagent (cat. no. 76506) and the QIAGEN RNeasy Mini Kit (cat.
no. 74104). Cells were treated with RNAprotect™before proceeding with
purification using the RNeasy Mini Kit. Two samples of 10 ml were taken
during the growth experiment at OD600≈0.5 and mixed with 20 ml RNApro-
tect™. Cells were harvested after 10 min incubation at room temperature
by centrifugation at 2400 g for 15 min. Pellets were stored at -80°C for later
purification of RNA.
RNA extraction protocol: To extract RNA the cell pellet was lysed
using mechanical disruption in a modified version of protocol 3 and purified
according to protocol 7 of RNAprotect™Bacteria Reagent Handbook. The
pellet was resuspended in 700 µL RLT and transferred to safelock tubes
containing 0.5 ml acid washed glass beads (106 microns acid washed and
finer (G-4649) from Sigma). The cells were then disrupted in FastPrep™-24
by three rounds of 4.0 m/s for 45 s with 2 min of rest on ice in between.
Afterwards samples were centrifuged at 15.000 g in 20 s, and the supernatant
was supplemented with 70% ethanol (1:1). The purifcation on column was
done according protocol 7 with final elution in RNAse free water.
RNA quantification and quality assessment: RNA was quantified
and its purity estimated using Tecan infinite m200 pro with a NanoQuant
plate™and Magellan 7 software. Absorbance at 260nm was utilized for quan-
tification using extinction coefficient  = 25 µL µg-1 cm-1 and Lambert-Beers
law A =  · c · l. For assessment of purity A260/A280 and A260/A230 were
measured. Further assessment of RNA degradation and general quality was
done with Agilent Bioanalyzer according to manufacturer’s protocol. RNA
Integrity Number (RIN) was inspected to evaluate the RNA quality.
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16.4 DNA microarray analysis
Microarray handling: The Microarray analysis was handled by DTU Mul-
tiassay Core (DMAC), using an Agilent chip with all known and putative
genes of L. lactis MG1363. Each gene was tested with five different probes,
but occasionally less than five probes per gene existed. RNA was labeled
with one color, yielding one signal from each microarray chip.
Software analysis: The software used to analyse the transcriptomic data
was the statistical software package R and the Bioconductor suite of avail-
able packages [157] (in particular the packages limma [173], oligo[155] and
affy). A complete overview of the commands used can be found in appendix
F.
16.5 Carbon labeling experiments
Carbon flux analysis was performed using two different combinations of
labeled sugar: 1) 100% 13C-1 glucose and 2) 80% 13C-6 glucose (fully
labeled) combined with 20% regular glucose. Both O/N cultures and growth
experiments were prepared using these combinations. Two samples of 3 ml
were harvested from exponentially growing cells at OD600≈0.4. Medium
was removed by centrifugation (2500 g, 10 min), the pellet was washed with
2 ml of 0.9% NaCl, centrifuged again (7000 g, 2 min) and the cell pellet
stored at -80°C for later processing. When all samples were ready the pel-
lets were resuspended in 150 µl 6M HCl and the samples were then placed
at 105°C for 24 hours and subsequently dried in a heating block (placed in
a fume hood) at 85°C until black/brown. After drying, the samples were
shipped to Dr.-Ing. Lars M. Blank, Department of Biochemical and Chem-
ical Engineering TU Dortmund, Germany, for further analysis.
16.6 Sampling for metabolite analysis
Sampling for metabolite analysis was carried out as previously described in
section 8.2.
16.7 Correlation of cell density to cell mass
Correlation of cell density to cell mass was done as previously described in
section 8.3
16.8 Calculations




The following section contains the results from the two levels of analysis
performed on the BK strains expressing ATPase activity. The underlying
idea was to integrate data from both metabolome measurements and tran-
scriptome level analysis into an overall framework.
17.1 Physiological characterization of strains with
varying degrees of ATPase activity
To make sure that the results from these experiments correlate with the
previous findings an initial comparison of the physiological data obtained
in the growth experiments was done. The growth rates for each of the four
strains from the experiments with sampling for transcriptome and meta-
bolome samples respectively can be seen in table 17.1. The original values
reported by Koebmann et al. are listed as well.
Strain
Metabolomic Transcriptomic Koebmann et
samples samples al. 2002 % of REF
µ [h-1] µ [h-1] µ [h-1] Met. Trans. Koeb.
BK1010 0.81± 0.01 0.83± 0.01 0.74 100 100 100
BK1506 0.75± 0.01 0.81± 0.03 0.67 93 97 92
BK1503 0.68± 0.01 0.70± 0.01 0.58 83 84 79
BK1502 0.59± 0.01 0.51 72 69
Table 17.1: Growth rates from the experiments used to sample for transcriptomic
and metabolomic analysis. Metabolomic and transcriptomic samples in quadrup-
licates except BK1502 which was done in triplicate, Koebmann et al. 2002 taken
from [164].
Even though the specific growth rates differ slightly there is a good correla-
tion with the results observed by Koebmann et al. previously when looking
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at perturbation levels (% of REF). The slightly faster growth rates could be
caused by the difference in medium composition (SA vs SAL medium). No-
tice also that the level of perturbation is less than 10% and 20% for BK1506
and BK1503 respectively.
17.2 Metabolomic profiling of strains expressing
various degrees of ATPase activity
By looking at the concentrations of internal metabolites clues to the mechan-
isms that govern glycolytic flux control can possibly be uncovered. Samples
were taken as described in materials and methods section 16.6 in order to
analyze the levels of internal metabolites. The results from the analysis
can be seen below. Quadruplicate samples were analyzed for the strains:
BK1010, BK1506 and BK1503 while triplicate samples were analyzed for
BK1502. For each replicate two different samples were taken: one sample
and one cell free reference. A summary of the measured metabolite concen-
trations can be seen in table 17.2 and a plot is found in figure 17.1.
Strain G6P F6P F16BP DHAP GAP PEP PYR RIB5P
Metabolite concentrations in µM. Samples in triplicate/quadruplicate.
BK1010 7.26± 0.85 0.56± 0.29 16.92± 4.31 3.66± 1.08 3.19± 3.04 1.12± 0.42 2.28± 2.16 0.42± 0.34
BK1506 8.04± 2.22 1.03± 0.18 19.24± 2.41 3.06± 0.15 1.86± 1.04 1.13± 0.21 2.04± 6.79 0.34± 0.15
BK1503 6.45± 2.93 1.26± 0.53 16.19± 3.89 2.69± 0.38 0.41± 2.25 0.97± 0.14 2.78± 7.11 0.15± 0.06
BK1502 7.93± 2.17 1.11± 0.10 17.59± 1.54 2.53± 0.18 0.35± 0.34 1.07± 0.15 -3.54± 4.71 0.32± 0.12
Strain RI/XY5P SEDO7 AMP ADP ATP NAD NADP
BK1010 1.04± 0.21 0.00± 0.00 0.19± 0.03 0.94± 0.06 0.01± 0.01 4.07± 0.68 0.31± 0.11
BK1506 1.25± 0.28 0.00± 0.00 0.24± 0.03 1.03± 0.12 0.11± 0.15 2.87± 0.38 0.24± 0.18
BK1503 1.37± 0.02 0.00± 0.00 0.33± 0.10 1.26± 0.10 0.06± 0.11 2.88± 0.91 0.22± 0.06
BK1502 1.30± 0.11 0.00± 0.00 0.47± 0.06 1.56± 0.20 0.00± 0.00 2.46± 0.44 0.00± 0.01
Table 17.2: Overview of selected internal metabolite concentrations measured
in the samples taken from mid. exponential growth phase of BK1010, BK1506,
BK1503 and BK1502. G6P - Glucose-6-phosphate, F6P - Fructose-6-phosphate,
F16BP - Fructose-1,6-biphosphate, DHAP - Dihydroxyacetonephosphate, GAP -
Glyceraldehyde-3-phosphate, PEP - Phosphoenolpyruvate, PYR - Pyruvate, RIB5P
- Ribose-5-phosphate, RI/XY5P - Ribulose-5-phosphate and xylulose-5-phosphate,
SEDO7 - Sedoheptulose-7-phosphate, AMP - Adenosine monophosphate, ADP -
Adenosine diphosphate, ATP - Adenosine triphosphate, NAD - Nicotineamide ad-
enine dinucleotide, NADP - Nicotineamide adenine dinucleotide phosphate.
As evident from table 17.2 and figure 17.1 there was a lot of noise in the data
set, making any conclusions from the data difficult. One of the significant
results are the levels of ADP and AMP. There is a significant difference





















BK1010 BK1506 BK1503 BK1502
Figure 17.1: Plot of internal metabolite concentrations in samples from mid.
exponential growth from ATPase overexpressing strains: BK1010 (REF, dark
blue), BK1506 (LOW, blue), BK1503 (MED, turqoise) and BK1502 (HIGH,
green). G6P - Glucose-6-phosphate, F6P - Fructose-6-phosphate, F16BP - Fructose-
1,6-biphosphate, DHAP - Dihydroxyacetonephosphate, GAP - Glyceraldehyde-
3-phosphate, PEP - Phosphoenolpyruvate, PYR - Pyruvate, RIB5P - Ribose-5-
phosphate, RI/XY5P - Ribulose-5-phosphate and xylulose-5-phosphate, SEDO7 -
Sedoheptulose-7-phosphate, AMP - Adenosine monophosphate, ADP - Adenosine
diphosphate, ATP - Adenosine triphosphate, NAD - Nicotineamide adenine dinuc-
leotide, NADP - Nicotineamide adenine dinucleotide phosphate.
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This correlation between the ATPase activity level and the increase in con-
centrations of ADP and AMP indicates that the system to perturb the ATP
level works. When hydrolyzing ATP the expected result would be a lowered
ATP level and increased levels of AMP and ADP. This would appear to
hold true for all four strains and there is a significant difference between the
reference strain BK1010 and the more perturbed ATPase expressing strains
BK1503 and BK1502. Unfortunately there is no information on the level
of ATP. The other main observations are the level of fructose-6-phosphate
(F6P) which is significantly higher in the perturbed strains and the level of
NAD which is lowered in the perturbed strains.
17.3 Analysis of transcriptome levels in strains ex-
pressing ATPase activity reveals starvation
like response to pertubation of ATP level
To keep the pleiotropic effects of perturbing a key energy cofactor such as
ATP to a minimum, strains with low ATPase activity were chosen. For that
reason only the strains BK1010 (ref), BK 1506 (low) and BK1503 (medium)
were included in the growth experiments meant for transcriptome analysis.
Initially twelve samples were harvested, four replicates from each strain.
These were subsequently analyzed in two rounds (chip 1 and 2). Unfortu-
nately it was not possible to compare all twelve samples together because
of batch variations in the handling and processing of the chips. As a result
the main analysis focused on chip 1 from which BK1010 and BK1506 were
analyzed in duplicate while BK1503 was analyzed in triplicate. An overview
of the entire workflow is shown in figure 17.2. The organization of the res-
ults follows the pipeline outlined in figure figure 17.2 and includes a section
on each step prior to the differential gene expression analysis. A graphical
summary of the results can be found in figure 17.5.
17.3.1 Data quality check and normalization
The first step in the analysis of expression data is an inspection of the ob-
tained data from the image of the chip. One typically looks for spatial
anomalies (rings or shadows) or other non-homogeneous patterns and arti-
facts. These issues can sometimes be corrected by normalization but may be
to severe to improve. Figures from intensity plots and the raw chip images
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Figure 17.2: A schematic overview of the workflow in the analysis of microarray
samples from the ATPase perturbed strains, BK1010, BK1506 and BK1503. To
the left are the samples analyzed in each round and to the right a short flowchart
describing the steps involved in the data analysis.
The visual inspection of chip 1 and 2 raw images reveals artifacts
and clear differences between them
A visual inspection of the chip 1 image (supplementary material, section S.1,
page 2) shows that sample 1 has what looks like a very faint ring pattern in
the middle of the array. This is very faint and can hopefully be compensated
for by the spatial distribution of the probes. Also sample 3 looks slightly
darker than the other samples. This may affect the quality of the data
but can perhaps also be compensated for by normalization if the biological
information is retained.
Looking at the image of chip 2 (supplementary material, section S.1, page
3) the samples look nicely uniform. The intensity of sample 4 looks slightly
below the rest but this should be compensated during normalization. What
is also evident is a clear example of something affecting quality of sample
7 of the microarray (row 2 sample 3 from the left). One would not expect
that gene expression levels in a sample would naturally form a ring shaped
pattern (of course depending on the sample being analyzed). This was not a
sample from this project but it illustrates that events during the preparation
and handling of the microarray can affect the quality of the expression data
quite considerably.
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Singular value decomposition analysis shows clear signs of batch
effects between arrays
Since the transcriptomic data has been generated by two different arrays
one would not be surprised to find additional noise added by the separate
runs. When including the data set from chip 2 into the analysis, robustness
of the data actually went down (i.e. became less significant). More noise
than signal was added by inclusion of the additional replicates. A heatmap
(figure 17.3) of all the samples provided a clue to why this might be the
case. As shown in the singular value decomposition (SVD) analysis, the
most significant component appears to be the chip number. The samples
clearly segregate into two groups based on the chip number. This makes an
analysis of all samples together more complicated as the chip specific noise
has to be removed. So far this has not been accomplished and no further
investigations were made on the entire data set of 12 samples. Instead the
analysis focused on chip 1 instead.
Singular Value Decomposition
The components
BK1503 S12 CHIP 2
BK1506 S08 CHIP 2
BK1506 S07 CHIP 2
BK1010 S04 CHIP 2
BK1010 S03 CHIP 2
BK1010 S01 CHIP 2
BK1503 S11 CHIP 1
BK1503 S10 CHIP 1
BK1503 S09 CHIP 1
BK1506 S06 CHIP 1
BK1506 S05 CHIP 1
BK1010 S03 CHIP 1
BK1010 S02 CHIP 1
BK1010 S01 CHIP 1
Figure 17.3: A heatmap based on SVD for all the samples. The samples clearly
fall into two groups based on chip number.
Sample 3 on chip 1 is discarded based on intensity distribution
As was seen in the analysis of the raw image files, sample 3 (BK1010) on
chip 1 looked darker than the other two samples from BK1010. By plotting
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the intensity distribution for all the samples of chip 1 after normalization
(figure 17.4) it was clear that sample 3 deviated from the remaining two.

















BK1010 1 Chip 1
BK1010 2 Chip 1
BK1010 3 Chip 1
BK1506 5 Chip 1
BK1506 6 Chip 1
BK1503 9 Chip 1
BK1503 10 Chip 1
BK1503 11 Chip 1
Figure 17.4: A plot of intensity data for each of the eight samples on the first chip
after normalization. Sample 3 (yellow) has very different profile compared to the
rest which indicates the darker appearance on the image file could not be corrected
by normalization.
In order to see how different sample 3 was from the rest, a SVD analysis
was made to visualize the variance captured by the different components.
The analysis tries to capture the contribution of the different components
to the variance in the samples. A plot of the results can be seen in the
supplementary material (section S.1 page 11 and 12). Based on the intens-
ity distribution plot, the heatmap and the plot of the SVD, sample 3 was
omitted from the dataset for the analysis.
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Estimation of false detection rate for BK1506 and BK1503 as an
indicator for robustness of the data set
A t-test supplies a single p-value for each gene when two groups of samples
are compared. The p-value signifies the probability that the difference would
occur by random and the lower a p-value, the more confident is the hypo-
thesis that the two values actually do differ in expression under the as-
sumption that the p-values follow a normal distribution. When comparing
large sets of expression data, the many tests performed will mean that some
will be significant by chance. This can be avoided either by adjusting the
p-values (Bonferroni) or by estimating the false detection rate (FDR).
A way to visualize the false detection rate is done by plotting a volcano
plot in which samples are grouped together in random groups and the p-
value is plotted against the log2 fold change (FC). This is best achieved when
there is a balanced (even) set of samples from each group, but can also be
done on an unbalanced set of samples such as the one in this study. For
the data obtained from chip 1 the uneven number of samples in the BK1503
group (three compared to two in BK1010 and BK1506) means the random
permutations will be biased by the inclusion of an additional sample from
the BK1503 group.
Nevertheless one can still construct a volcano plot from these pseudo-
balanced permutations. The plots can be seen in the suppplementary ma-
terial (section S. 1, page 9 and 10). The volcano plots indicate that p-values
above a threshold of 0.0024 (BK1506) and 0.0016 (BK1503) could be false
positives. This is not a true FDR but can give a measure of the FDR to keep
in mind when viewing the results of differential gene expression analysis.
17.3.2 Normalization and averaging of probe data using ro-
bust multi-array averaging
The final step before performing an analysis of differential gene expression
is the averaging of probe level data into one value for each gene. Most have
4–6 probes but many such as the pseudo genes have just one. For identical
probes in different locations on the array, all are included in the analysis
and duplicate probes are treated as being unique. Pseudo genes and other
genes with less than 4 probes have not been included in the analysis.
The data set was normalized between arrays using a quantile algorithm
such that all samples follow an average density distribution, after which the
probe level data was averaged into a single value for each gene using Robust
Multi-array Averaging (RMA) [159].
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17.3.3 Transcriptome level analysis of Lactococcus lactis strains
displaying varying degrees of ATPase activity
There are several ways of looking at a transcriptomic data set such as the
one currently under investigation. Typically a list of the most differen-
tially expressed genes will the first thing one looks at. This would show
which genes were most affected by the differential conditions tested. This
experiment was designed to deliberately minimize the perturbation effect of
ATPase activity on the cells to minimize any pleiotropic effects that might
otherwise affect the results. This also has the effect that the difference in
response between the mutants and the wild type becomes less pronounced
than if we had used the BK1502 strain with a very high ATPase activity. So
just looking at the lists of top regulated genes may not be the best approach.
Rather a more pattern oriented approach that is looking at the response of
whole pathways or families of genes instead of just looking at the top up-
or down regulated genes might be more interesting. Since both approaches
have their strengths results from both are presented in the following section.
The most heavilly up- and downregulated genes indicate signs of
stress in BK1503 but not in BK1506
The two mutant strains BK1506 and BK1503 had different levels of ATPase
activity and hence also different perturbation levels. BK1506 had the low-
est perturbation ranking at less than 10% (growth rate) and BK1503 was
perturbed at around 16-17% (growth rate). Lists with the 50 most up and
downregulated genes can be viewed in table 17.3 and table 17.4 for BK1506
and in table 17.5 and 17.6 for BK1503.
Upregulated genes show the ATPase system to be working in both
strains A convenient control that the ATPase system is working is the
appearance of the atpAGD genes among the top ranked upregulated genes in
both BK1506 and BK1503. The response by BK1503 is interestingly showing
signs of stress response by the presence of sodA (superoxide dismutase)
and uspA ( universal stress protein A) among the top upregulated genes.
These are not among the top upregulated genes in BK1506. Even though
BK1503 is the more perturbed strain the level of perturbation may already
be sufficient to induce pleiotropic effects at this level. Components involved
in glucose transport are also present in the most upregulated genes in both
strains, namely celB for BK1506 and ptcA and ptcB for BK1503, all part of
the cellobiose PTS. Finally the presence of a global regulatory gene (codY )
among the top regulated genes in BK1503 would suggest a global response
to perturbation in ATP levels.
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Gene/locus LogFC p-value Annotation
llmg_1460 1.66 1.8E-06 putative di/TRI-peptide transport ATP-binding protein
atpG 1.36 4.8E-07 F0F1 ATP synthase subunit gamma 
celB 1.34 6.3E-06 cellobiose-specific PTS system IIC component 
atpD 1.27 1.5E-06 F0F1 ATP synthase subunit beta 
atpA 1.24 2.0E-06 F0F1 ATP synthase subunit alpha 
llmg_0258 1.22 1.2E-05 hypothetical protein
llmg_1458 1.21 4.7E-04 putative di/TRI-peptide transport system permease protein
llmg_0186 1.19 8.9E-06 hypothetical protein
llmg_1166 1.09 5.7E-03 putative endoglucanase 
llmg_1457 1.06 6.3E-03 putative di/TRI-peptide transport ATP-binding protein
llmg_1165 1.00 2.1E-02 hypothetical protein
llmg_1459 0.99 2.7E-05 putative di/TRI-peptide transport system permease protein
llmg_1619 0.99 4.7E-04 hypothetical protein
llmg_1167 0.96 5.7E-03 putative endoglucanase 
tagG 0.96 6.9E-04 teichoic acid ABC transporter permease protein
llmg_1824 0.95 4.6E-03 hypothetical protein
ps124 0.94 3.0E-04 hypothetical protein
dppC 0.92 3.7E-05 dipeptide transport system permease protein DppC
ps453 0.92 4.3E-04 phage tail component
uxuT 0.92 4.1E-02 Na-galactoside symporter
llmg_1164 0.91 3.3E-02 hypothetical protein
llmg_1127 0.90 8.8E-03 cell wall surface anchor family protein
llmg_1620 0.89 9.7E-05 hypothetical protein
llmg_1461 0.89 8.1E-05 putative di/TRI-peptide binding protein precursor
lplC 0.88 3.5E-02 sugar ABC transporter permease
llmg_0470 0.88 3.3E-03 hypothetical protein
maa 0.87 1.2E-03 maltose O-acetyltransferase 
llmg_0921 0.86 1.6E-03 putative secreted protein
llmg_1128 0.86 1.2E-02 hypothetical protein
ulaA, sgaT 0.85 3.9E-03 PTS system ascorbate-specific transporter subunit IIC
leuC 0.84 2.5E-02 isopropylmalate isomerase large subunit 
ps454 0.84 2.1E-03 hypothetical protein
llmg_0487 0.83 3.7E-04 putative trehalose/maltose hydrolase
llmg_0489 0.82 8.4E-04 sugar transport system permease protein
llmg_0922 0.81 2.4E-03 putative secreted protein
llmg_1618 0.81 1.7E-03 hypothetical protein
llmg_1393 0.81 5.3E-02 hypothetical protein
hadL 0.80 5.7E-04 cryptic haloacid dehalogenase 1 
llmg_1283 0.79 7.7E-02 hypothetical protein
ps515 0.78 2.8E-03 phage protein by Glimmer/Critica
llmg_0479 0.77 6.5E-03 hypothetical protein
galP 0.76 7.1E-02 galactose permease
ps514 0.76 4.6E-04 phage protein by Glimmer/Critica
dppD 0.76 2.6E-04 dipeptide transport ATP-binding protein DppD
polC 0.76 1.1E-04 DNA polymerase III PolC 
ps457 0.75 5.1E-03 serine/threonine-rich protein precursor
ps511 0.75 3.2E-04 hypothetical protein
aguA 0.74 8.3E-04 AguA protein 
llmg_0963 0.73 8.7E-03 PTS system, IIC component
llmg_2513 0.73 2.8E-03 putative transport protein
ps517 0.73 5.2E-04 putative DNA primase 
BK1506 - Top 50 upregulated genes
Table 17.3: The 50 most differentially upregulated genes in BK1506 (p=0.01).
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Gene/locus LogFC p-value Annotation
pbuO -0.73 1.5E-04 xanthine/uracil/vitamin C permease
tig -0.70 3.1E-04 trigger factor 
llmg_1359 -0.67 2.3E-03 hypothetical protein
llmg_1230 -0.66 1.4E-03 hypothetical protein
pstA -0.65 5.1E-03 phosphate transporter ATP-binding protein 
dfrA -0.64 1.3E-03 DfrA protein 
tmk -0.64 5.7E-03 thymidylate kinase 
uvrC -0.64 1.5E-03 excinuclease ABC subunit C
nagA -0.64 2.9E-02 NagA protein 
llmg_0760 -0.64 7.9E-03 putative transglycosylase
grpE -0.63 7.7E-04 heat shock protein GrpE
llmg_1366 -0.63 2.1E-03 hypothetical protein
llmg_2395 -0.63 3.1E-03 hypothetical protein
murA2 -0.63 7.7E-04 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
llmg_1252 -0.62 1.1E-02 hypothetical protein
llmg_1347 -0.62 1.8E-03 hypothetical protein
llmg_0873 -0.61 1.1E-03 putative (di)nucleoside polyphosphate hydrolase 
llmg_1362 -0.61 1.3E-02 hypothetical protein
llmg_1348 -0.61 5.6E-03 hypothetical protein
pyrF -0.60 1.8E-03 orotidine 5'-phosphate decarboxylase 
llmg_1645 -0.60 3.2E-03 general stress protein GSP13
llmg_1360 -0.59 5.8E-03 hypothetical protein
llmg_0218 -0.59 6.5E-03 putative glycosyl transferase 
llmg_1475 -0.59 7.7E-03 hypothetical protein
mutS -0.59 2.0E-03 DNA mismatch repair protein MutS
llmg_0599 -0.59 2.2E-03 hypothetical protein
dtpT -0.59 6.2E-03 di-/tripeptide transporter
ps205 -0.57 1.4E-02 cI-like repressor
purQ -0.57 3.6E-03 phosphoribosylformylglycinamidine synthase I 
glyQ -0.57 2.3E-02 glycyl-tRNA synthetase subunit alpha 
llmg_1115 -0.57 6.5E-03 XpaC-like protein
llmg_1708 -0.56 3.7E-03 putative glycosyltransferase
llmg_1026 -0.56 8.5E-03 putative methyltransferase
ps303 -0.55 1.1E-03 hypothetical protein
bmpA -0.55 7.1E-03 basic membrane protein A
llmg_1550 -0.54 1.2E-03 hypothetical protein
ftsL -0.54 2.3E-03 cell division protein
ps203 -0.54 2.4E-02 hypothetical protein
fabH -0.54 1.2E-02 3-oxoacyl-(acyl carrier protein) synthase III 
recX -0.53 2.8E-02 recombination regulator RecX
atpH -0.53 1.4E-02 F0F1 ATP synthase subunit delta 
nusB -0.53 1.1E-02 transcription termination protein NusB
llmg_0315 -0.53 4.7E-03 phosphonate ABC transporter permease
llmg_2426 -0.52 5.3E-02 hypothetical protein
potD -0.51 6.8E-03
spermidine/putrescine ABC transporter substrate-binding 
protein
def -0.51 4.5E-03 peptide deformylase 
deoD -0.51 1.2E-02 purine nucleoside phosphorylase 
ldh -0.51 1.5E-02 L-lactate dehydrogenase 
dnaB -0.51 3.5E-03
chromosome replication initiation / membrane attachment 
protein 
pgmA -0.51 4.9E-03 alpha-phosphoglucomutase
rpmD -0.51 2.6E-02 50S ribosomal protein L30
BK1506 - Top 50 downregulated genes
Table 17.4: The 50 most differentially downregulated genes in BK1506 (p=0.01).
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Gene/locus LogFC p-value Annotation
sodA 1.40 1.1E-05 SodA protein 
atpG 1.38 1.9E-07 F0F1 ATP synthase subunit gamma 
mtsA 1.22 6.3E-07 manganese ABC transporter substrate binding protein
atpA 1.11 2.4E-06 F0F1 ATP synthase subunit alpha 
mtsC 1.09 2.3E-06 manganese transport system membrane protein
atpD 1.08 2.9E-06 F0F1 ATP synthase subunit beta 
dnaN 1.05 2.5E-06 DNA polymerase III subunit beta 
llmg_0165 1.04 2.7E-06 hypothetical protein
ptcA 1.00 1.1E-04 cellobiose-specific PTS system IIA component 
pgmA 1.00 1.9E-05 alpha-phosphoglucomutase
llmg_0601 0.99 7.7E-05 putative secreted protein
pmi 0.98 4.0E-05 mannose-6-phosphate isomerase 
yfiA 0.97 6.2E-06 putative sigma 54 modulation protein
llmg_2145 0.97 2.5E-04 hypothetical protein
msrA 0.95 6.9E-04 MsrA protein 
llmg_1203 0.95 2.1E-05 ABC transporter ABC binding and permease protein
rex 0.92 7.3E-05 redox-sensing transcriptional repressor REX
llmg_0602 0.92 8.0E-05 hypothetical protein
thyA 0.92 7.2E-06 thymidylate synthase 
llmg_0585 0.92 7.5E-05 hypothetical protein
llmg_1135 0.90 8.0E-05 hypothetical protein
vacB2 0.89 1.1E-04 putative exoribonuclease R 
mtsB 0.87 1.7E-04 manganese ABC transporter ATP binding protein
era, bex, rbaA,  0.86 1.0E-03 GTP-binding protein Era
hslB 0.86 6.6E-05 HU-like DNA-binding protein
uspA 0.85 2.3E-04 universal stress protein A
codY 0.84 1.5E-04 transcriptional repressor CodY
llmg_0146 0.84 3.0E-05 aryl-alcohol dehydrogenase
llmg_1214 0.84 1.9E-04 hypothetical protein
llmg_2146 0.83 2.0E-04 hypothetical protein
ptcB 0.83 1.1E-03 cellobiose-specific PTS system IIB component 
llmg_0600 0.83 3.2E-05 glycosyl transferase
ppiA 0.82 1.5E-05 peptidyl-prolyl cis-trans isomerase, cyclophilin-type 
llmg_0152 0.80 8.9E-05 hypothetical protein
msmK 0.80 1.8E-04 multiple sugar-binding transport ATP-binding protein
llmg_2323 0.80 3.4E-05 hypothetical protein
nagD 0.80 3.4E-05 putative N-acetylglucosamine catabolic protein
llmg_0184 0.80 5.7E-05 putative lactoylglutathione lyase 
llmg_0726 0.80 2.4E-03 hypothetical protein
llmg_1667 0.79 1.5E-04 glycosyltransferase
llmg_0242 0.79 8.6E-04 hypothetical protein
aroF 0.79 1.5E-04 phospho-2-dehydro-3-deoxyheptonate aldolase 
llmg_2212 0.79 3.6E-05 hypothetical protein
llmg_0584 0.78 1.7E-04 hypothetical protein
llmg_1918 0.78 2.3E-04 hypothetical protein
ps302 0.78 2.9E-05 hypothetical protein
ps303 0.78 4.2E-05 hypothetical protein
rpsD 0.78 1.6E-04 30S ribosomal protein S4
pepC 0.77 1.5E-04 PepC protein 
llmg_1299 0.77 1.7E-03 hypothetical protein
llmg_0599 0.77 1.6E-04 hypothetical protein
BK1503 - Top 50 upregulated genes
Table 17.5: The 50 most differentially upregulated genes in BK1503 (p=0.01).
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purL -1.10 1.8E-04 phosphoribosylformylglycinamidine synthase II 
atpH -1.09 5.7E-05 F0F1 ATP synthase subunit delta 
pyk -1.09 1.3E-05 pyruvate kinase 
llmg_1794 -1.08 8.8E-06 hypothetical protein
fabZ -1.07 5.2E-05 (3R)-hydroxymyristoyl-ACP dehydratase 
pyrDB -1.07 1.1E-04 dihydroorotate dehydrogenase 1B 
accB -1.05 8.0E-05 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
fabF -1.05 3.4E-05 3-oxoacyl-[acyl-carrier-protein] synthase II 
rpsJ -1.01 6.0E-04 30S ribosomal protein S10
atpF -1.01 1.5E-04 F0F1 ATP synthase subunit B 
rpsE -1.01 2.6E-05 30S ribosomal protein S5
pyrP -1.00 3.7E-05 uracil permease (uracil transporter)
llmg_1780 -1.00 1.1E-05 hypothetical protein
carB -1.00 4.6E-05 carbamoyl phosphate synthase large subunit 
llmg_0872 -0.98 3.1E-05 putative (di)nucleoside polyphosphate hydrolase 
glmS -0.98 1.4E-05 glucosamine--fructose-6-phosphate aminotransferase 
llmg_1793 -0.96 3.2E-05 hypothetical protein
rplM -0.96 5.3E-04 50S ribosomal protein L13
rpsG -0.95 2.0E-04 30S ribosomal protein S7
rplR -0.94 9.7E-05 50S ribosomal protein L18
atpE -0.94 6.0E-05 F0F1 ATP synthase subunit C
glnQ -0.94 1.3E-04 glutamine ABC transporter ATP-binding protein
atpB -0.94 8.4E-05 F0F1 ATP synthase subunit A 
rpoB -0.92 3.6E-04 DNA-directed RNA polymerase subunit beta 
fabG -0.92 2.6E-04 3-ketoacyl-(acyl-carrier-protein) reductase 
purF -0.90 7.9E-04 amidophosphoribosyltransferase 
telB -0.90 1.0E-05 putative tellurium resistance protein
llmg_0208 -0.89 1.0E-04 hypothetical protein
glnP -0.89 3.7E-05 glutamine ABC transporter permease and substrate binding protein 
llmg_1007 -0.89 8.0E-05 hypothetical protein
rmlB -0.88 7.4E-05 dTDP-glucose 4,6-dehydratase 
nusA -0.88 3.1E-05 transcription elongation factor NusA
rpsB -0.88 1.4E-05 30S ribosomal protein S2
metK -0.87 1.4E-04 S-adenosylmethionine synthetase 
rpsS -0.87 7.1E-05 30S ribosomal protein S19
rplF -0.86 4.1E-05 50S ribosomal protein L6
priA -0.85 1.3E-04 primosome assembly protein PriA
guaA -0.85 1.1E-04 GMP synthase 
nupC -0.84 3.8E-04 purine/cytidine ABC transporter permease protein
rplV -0.84 1.9E-04 50S ribosomal protein L22
purQ -0.84 1.3E-04 phosphoribosylformylglycinamidine synthase I 
pstD -0.84 1.2E-03 phosphate transport system permease protein PstD
nupA -0.84 7.2E-05 purine/cytidine ABC transporter ATP-binding protein
rpoC -0.84 1.0E-03 DNA-directed RNA polymerase subunit beta' 
llmg_1353 -0.83 1.3E-04 putative tellurite resistance protein
rpoA -0.82 5.2E-05 DNA-directed RNA polymerase subunit alpha 
llmg_0376 -0.82 1.9E-04 amino acid permease
nupB -0.82 3.7E-04 purine/cytidine ABC transporter permease protein
phnC -0.81 1.6E-04 phosphonates import ATP-binding protein PhnC
rpmD -0.81 1.1E-03 50S ribosomal protein L30
BK1503 - Top 50 downregulated genes
Table 17.6: The 50 most differentially downregulated genes in BK1503 (p=0.01).
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Key glycolytic genes present among the most downregulated genes
Among the most downregulated genes we find genes associated with the AT-
Pase complex such as atpH (both) and atpE (BK1503), perhaps indicative
of a response to the overproduction of the remaining components. Interest-
ingly both lactate dehydrogenase ldh in BK1506 and pyruvate kinase pyk, a
key glycolytic enzyme, are among the most downregulated in both strains.
A final curious observation is the gene pgmA, involved in connecting the
leloir pathway and glycolysis [168] (conversion of glucose-1-phosphate to
glucose-6-phosphate), which is upregulated in BK1503 but downregulated
in BK1506.
17.3.4 Mapping the response of strains expressing varying
degrees of ATPase activity to metabolic pathways re-
veals a global picture of the transcriptomic response
The 50 most up and down regulated genes in both BK1506 and BK1503
confirmed that the ATPase system was active. It also revealed that two key
glycolytic genes were among the most heavily down regulated in both strains.
To further compare and contrast the response by BK1506 and BK1503 tables
were generated based on the response of particular metabolic pathways such
as glycolysis.
Tables were generated such that all the genes of a particular pathway
(based on information from Kyoto Encyclopedia of Genes and Genomes -
KEGG) were listed and the response of BK1506 and BK1503 as compared to
the reference BK1010 was listed in two adjacent columns together with the
p-values. The foldchange response of the individual genes were color coded
green (upregulation) and red (downregulation) with a gradient representing
the severity of the response. The scale of the gradient was adjusted to the
extremes of the response in the current data set so that bright red indicates
the most downregulated, bright green indicates the most upregulated and
white (no color) is the center indicating no change.
The values were further processed by using a p-value cutoff of 0.10 (10%)
which is high. Traditionally either a p-value cutoff (1% or 5%) or a fold-
change cutoff is used to assist in data analysis. Our selected p-value cutoff
is higher than normal since for foldchanges in the range of 1.5 times up or
downregulation, statistical significance would be harder to achieve than for
greater spans of regulation (the more extreme the foldchange the higher the
likelyhood of a significant p-value). Since the experimental setup was delib-
erately designed to minimize perturbations more extreme foldchanges were
automatically less likely.
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LogFC p. Value logFC P.value
glk -0.25 7.0E-02 -0.57 4.9E-04 glucokinase 
pgi 0.54 4.0E-03 glucose-6-phosphate isomerase 
pfk -0.26 6.1E-02 -0.56 6.9E-04 6-phosphofructokinase 
pyk -0.27 9.4E-02 -1.09 1.3E-05 pyruvate kinase 
ldh -0.51 1.5E-02 -0.45 1.8E-02 L-lactate dehydrogenase 
fbp 0.60 7.9E-03 0.65 2.8E-03 fructose-bisphosphatase 
fbaA -0.36 1.2E-02 -0.46 1.8E-03 fructose-bisphosphate aldolase 
tpiA -0.68 9.7E-04 triosephosphate isomerase 
gapB glyceraldehyde 3-phosphate dehydrogenase 
gapA 0.22 8.5E-02 glyceraldehyde 3-phosphate dehydrogenase 
pgk -0.35 5.5E-02 phosphoglycerate kinase 
llmg_1894 phosphoglycerate mutase family protein
gpmA -0.30 5.5E-02 -0.67 4.0E-04 phosphoglyceromutase 
gpmB -0.51 9.1E-04 phosphoglycerate mutase 
gpmC 0.25 6.4E-02 -0.56 5.3E-04 phosphoglycerate mutase 
eno -0.28 8.0E-02 phosphopyruvate hydratase 
pdhA -0.51 1.1E-02 pyruvate dehydrogenase E1 component alpha subunit 
pdhB -0.36 9.6E-02 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.35 9.8E-02 pyruvate dehydrogenase complex E2 component 
pdhD dihydrolipoamide dehydrogenase 
ldhX 0.45 1.6E-02 L-lactate dehydrogenase 
ldhB L-lactate dehydrogenase 
adhE 0.52 6.7E-02 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP alcohol dehydrogenase 
llmg_0955 alcohol dehydrogenase 
fadD -0.26 7.1E-02 long-chain acyl-CoA synthetase 
galM 0.57 6.2E-02 aldose 1-epimerase 
bglA2 6-phospho-beta-glucosidase 
arb 0.61 4.1E-04 6-phospho-beta-glucosidase 
celA 6-phospho-beta-glucosidase 
Glycolysis
Gene/locus BK1506 BK1503 Annotation
Table 17.7: Comparison of the expression level changes for the genes involved in
glycolysis, between BK1506 and BK1503. Green colour indicates increased expres-
sion, red colour decreased. A colour gradient indicates the relative foldchange, i.e.
stronger colour means bigger foldchange. Empty spots indicate original values had
a p-value below the cuttoff (0.10).
A complete overview of all the data can be viewed in the supplementary
material (chip 1) and in the appendix (chip 2). Tables from chip 1 are
included in supplementary material section S.2 while tables from chip 2
(appendix E, section E.1) and merged tables, contrasting the results from
both analysis side by side with 0.10 cutoff applied, (appendix E, section
E.2) are included in the appendix. In the following section a selection of the
tables generated from chip 1 will be presented.
The response of glycolytic genes and genes involved in pyruvate
metabolism to expression of varying degrees of ATPase activity
The response of genes connected to glycolysis can be seen in table 17.7. The
response is mostly downregulation as witnessed by pyruvate kinase (pyk),
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fructose-bisphosphate aldolase (fbaA), triosephosphate isomerase (tpiA) and
phosphoglyceromutase (gpmA/B/C) which is evident for both strains with
the most pronounced effect in BK1503. Genes with noteworthy upregulation
is fructose-bisphosphatase (fbp) and glucose-6-phosphate isomerase (pgi)
Although not a glycolytic gene lactate dehydrogenase (ldh and ldhX)
has also been included in this table. Interestingly ldh is downlregulated
while the alternative lactate dehydrogenase ldhX is upregulated.
LogFC p. Value logFC P.value
ptsI -0.37 2.1E-02 phosphoenolpyruvate-protein phosphotransferase 
ptsH 0.24 7.5E-02 phosphocarrier protein HPr
ptsK -0.25 1.0E-01 0.32 3.0E-02 HPr kinase/phosphorylase 
hprT 0.30 6.4E-02 HprT protein 
llmg_1426 sucrose-specific PTS system IIBC component 
bglP PTS system, beta-glucosides specific enzyme IIABC 
llmg_0453 sucrose-specific PTS enzyme IIABC
llmg_0454 -0.25 6.3E-02 beta-glucoside-specific PTS system IIABC component
ptcA 1.00 1.1E-04 cellobiose-specific PTS system IIA component 
ptcB 0.83 1.1E-03 cellobiose-specific PTS system IIB component 
llmg_1244 0.40 7.3E-02 hypothetical protein
ptcC 0.59 1.5E-02 cellobiose-specific PTS system IIC component 
celB 1.34 6.3E-06 0.33 3.8E-02 cellobiose-specific PTS system IIC component 
mtlF PTS system, mannitol-specific IIA component 
mtlA PTS system, mannitol-specific IIBC component 
ptnAB -0.78 1.6E-04 PTS system, mannose-specific IIAB components 
ptnC -0.65 6.3E-04 mannose-specific PTS system component IIC 
ptnD -0.49 1.8E-03 mannose-specific PTS system component IID
llmg_0866 0.42 1.0E-02
PTS system, unknown pentitol phosphotransferase enzyme IIB 
component 
ulaA, sgaT 0.85 3.9E-03 PTS system ascorbate-specific transporter subunit IIC
fruA 0.37 4.7E-02 PTS system, fructose specific IIBC components 
glcU putative glucose uptake protein GlcU
Phosphotransferase system (PTS) and glucose uptake
Gene/locus BK1506 BK1503 Annotation
Table 17.8: Comparison of the expression level changes for the genes involved in
the PTS, between BK1506 and BK1503. Green colour indicates increased expres-
sion, red colour decreased. A colour gradient indicates the relative foldchange, i.e.
stronger colour means bigger foldchange. Empty spots indicate original values had
a p-value below the cuttoff (0.10).
The response of genes involved in transport processes to varying
degrees of ATPase activity The genes associated with the PTS system
and ABC transporters can be seen in table 17.8 and table 17.9. The response
by the PTS system for glucose transport indicates a shift from PTSMan to
PTSCel. The two systems have similar capacity but differ in their affinity
with PTSMan being a high affinity system and PTSCel (in combination with
the permease glcU ) being a low affinity system with a preference for β-
glucose [10]. For the ABC transporters two interesting observations can
be made. There appears to be a high degree of upregulation in BK1506
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of dipeptide transport which seem to be missing in BK1503. Secondly a
very strong downregulation of phosphate transport is present in BK1503
and is also somewhat evident in BK1506. Whether the downregulation of
phosphate transport is a response to ATPase activity or whther it is a general
response, is an interesting question.
Regulatory responses to expression of varying degrees of ATPase
activity The responses of genes under CodY regulation or CcpA mediated
carbon catabolite repression (CCR) or carbon catabolite activation (CCA)
can be found in table 17.10 and table 17.11. CodY (codY ) was among the
highest upregulated genes in BK1503. Being a transcriptional repressor the
trend of downregulation as seen in table 17.10 seems to support this.
The response of genes under CcpA regulation seem to indicate relief of
CCR as most of the genes under repression are upregulated. Also notably
one of the most prominent targets of CcpA the las operon (LDH, PFK
and PYK) which is under CCA is downregulated. The effect is again most
prominent in BK1503 but also discernable in BK1506. This suggests a global
response to ATPase expression in accordance with the previous observations
of decrease in general metabolic capacity.
The transcription level response of strains expressing ATPase activ-
ity resembles a starvation response
The key examples of metabolic pathway maps from the transcription level
analysis presented show that the response to a perturbation in ATP level is
a downregulation of glycolysis. This response is counter intuitive to what
might be expected from a perturbation of the energy level in the cell, since
glycolysis is the main pathway for generating energy in Lactococcus lactis.
The same trend is seen for other central metabolic pathways such as the
pentose phosphate pathway, the TCA cycle and pyruvate metabolism and
fatty acid metabolism (supplementary material S.2, page 18, 19, 20 and 28).
There is an indication of a dose effect as the pattern is usually more pro-
nounced in BK1503 (the strain with higher expression of ATPase activity)
compared to BK1506. Also among the other anabolic pathways such as
purine metabolism, pyrimidine metabolism and fatty acid metabolism there
seems to be more downregulation in BK1503. This is in contrast to the
response which can be seen for transporters and arginine metabolism where
the effect appears to be upregulation in BK1506 which unfortunately cannot
be verified in BK1503.
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LogFC p. Value logFC P.value
potD -0.51 6.8E-03 0.47 7.1E-03 spermidine/putrescine ABC transporter substrate-binding protein
potC spermidine/putrescine ABC transporter permease
potB spermidine/putrescine ABC transporter permease
potA -0.28 4.3E-02 spermidine/putrescine ABC transporter ATP-binding protein
busAB -0.28 9.6E-02 0.30 5.1E-02 glycine betaine-binding periplasmic protein precursor
busAA -0.35 1.1E-02 glycine betaine/proline ABC transporter 
choS 0.35 7.8E-02 choline ABC transporter permease and substrate binding protein
choQ -0.33 1.5E-02 choline ABC transporter ATP binding protein 
malE maltose ABC transporter substrate binding protein
malF 0.72 4.2E-02 maltose transport system permease protein MalF
malG maltose ABC transporter permease protein MalG
msmK 0.80 1.8E-04 multiple sugar-binding transport ATP-binding protein
rbsB ribose ABC transporter substrate binding protein RbsB
rbsC ribose transport system permease protein RbsC
rbsD ribose ABC transporter permease protein RbsD
rbsD D-ribose pyranase
pstE -0.48 4.3E-03 -0.54 1.1E-03 phosphate transport substrate binding protein PstE
pstF -0.45 4.4E-03 phosphate transport substrate binding protein PstF
pstD -0.84 1.2E-03 phosphate transport system permease protein PstD
pstC -0.76 6.0E-04 phosphate transport system permease protein PstC
pstA -0.65 5.1E-03 -0.62 3.9E-03 phosphate transporter ATP-binding protein 
pstB -0.69 6.3E-04 phosphate transporter ATP-binding protein 
phnD -0.33 4.5E-02 -0.32 3.5E-02 phosphonate ABC transporter, phosphonate-binding protein PhnD
phnB -0.79 1.1E-04 phosphonate transport system permease protein PhnB
llmg_0315 -0.53 4.7E-03 -0.78 1.7E-04 phosphonate ABC transporter permease
phnC -0.81 1.6E-04 phosphonates import ATP-binding protein PhnC
plpA D-methionine-binding lipoprotein PlpA precursor
plpB D-methionine-binding lipoprotein PlpB precursor
plpC -0.28 3.5E-02 D-methionine-binding lipoprotein PlpC precursor
plpD -0.25 3.9E-02 D-methionine-binding lipoprotein PlpD precursor
llmg_0342 0.44 6.7E-03 -0.22 8.5E-02 amino acid ABC transporter permease protein
llmg_0341 0.44 5.9E-03 -0.24 6.1E-02 amino acid ABC transporter ATP binding protein
dppA dipeptide-binding protein precursor
dppB 0.48 7.6E-03 dipeptide transport system permease protein DppB
dppC 0.92 3.7E-05 dipeptide transport system permease protein DppC
dppD 0.76 2.6E-04 -0.23 9.1E-02 dipeptide transport ATP-binding protein DppD
dppF 0.60 2.0E-03 dipeptide transport ATP-binding protein DppF
fhuD ferrichrome ABC transporter substrate binding protein
fhuB ferrichrome ABC transporter permease protein
fhuG ferrichrome ABC transporter permease protein
llmg_1281 putative ABC transporter ATP-binding protein
fhuC ferrichrome ABC transporter FhuC
zitS 0.48 5.2E-03 zinc ABC transporter substrate binding protein
zitP 0.61 3.1E-02 zinc ABC transporter permease protein
zitQ 0.29 7.6E-02 zinc ABC transporter ATP binding protein
cbiQ 0.50 1.7E-02 putative cobalt ABC transporter permease protein
cbiQ2 -0.57 2.4E-03 putative cobalt ABC transporter permease protein
cbiO 0.39 2.2E-02 putative cobalt ABC transporter ATP-binding protein
cbiO -0.40 2.5E-02 cobalt transporter ATP-binding subunit
cbiO -0.55 8.8E-04 cobalt transporter ATP-binding subunit
llmg_1552 0.38 2.3E-02 putative ABC type transport system permease protein
drrB daunorubicin resistance transmembrane protein
llmg_0262 0.58 1.9E-03 0.25 7.2E-02 ABC transporter permease protein
llmg_1553 putative ABC transporter ATP-binding protein
drrA daunorubicin resistance ABC transporter ATP-binding subunit
tagG 0.96 6.9E-04 0.39 5.7E-02 teichoic acid ABC transporter permease protein
tagH 0.51 1.1E-02 teichoic acid export ATP-binding protein TagH 
ftsX -0.30 4.2E-02 cell division protein FtsX-like protein
ftsE -0.40 4.6E-02 cell division ATP-binding protein
llmg_1202 -0.24 9.2E-02 0.45 3.7E-03 ABC transporter ABC binding and permease protein
cydD cytochrome d ABC transporter ATP binding and permease protein
cydC cytochrome d ABC transporter ATP binding and permease protein
llmg_0989 ABC transporter ATP binding and permease protein
ABC transporters
Gene/locus BK1506 BK1503 Annotation
Table 17.9: Comparison of the expression level changes for the genes involved
in the ABC transporters, between BK1506 and BK1503. Green colour indicates
increased expression, red colour decreased. A colour gradient indicates the relative
foldchange, i.e. stronger colour means bigger foldchange. Empty spots indicate
original values had a p-value below the cuttoff (0.10).
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LogFC p. Value logFC P.value
dppA  dipeptide-binding protein precursor
dppB 0.48 8.1E-03  dipeptide transport system permease protein DppB
dppC 0.92 4.9E-05  dipeptide transport system permease protein DppC
dppD 0.76 3.2E-04 -0.23 8.8E-02  dipeptide transport ATP-binding protein DppD
dppF 0.60 2.3E-03  dipeptide transport ATP-binding protein DppF
gltD -0.22 9.4E-02  glutamate synthase subunit beta 
gltB -0.77 3.1E-03  glutamate synthase, large subunit 
lysA  LysA protein 
ilvD -0.61 8.9E-02  dihydroxy-acid dehydratase 
ilvB -0.57 8.9E-02  acetolactate synthase catalytic subunit 
ilvN -0.64 5.3E-02  acetolactate synthase 3 regulatory subunit 
ilvC -0.64 2.5E-02  ketol-acid reductoisomerase 
ilvA -0.56 6.2E-03  threonine dehydratase 
aldB -0.39 1.8E-02 -0.34 2.4E-02  AldB protein 
hisC  histidinol-phosphate aminotransferase 
hisZ  ATP phosphoribosyltransferase regulatory subunit 
hisG  ATP phosphoribosyltransferase catalytic subunit 
hisD  HisD protein 
hisB  imidazoleglycerol-phosphate dehydratase 




hisF  imidazole glycerol phosphate synthase subunit HisF 
hisI
 bifunctional phosphoribosyl-AMP cyclohydrolase/phos-phoribosyl-ATP 
pyrophosphatase protein 
hisK  histidinol-phosphatase 
ctrA -0.44 3.0E-03  putative amino-acid transporter
oppD -0.73 1.7E-04  oligopeptide transport ATP-binding protein OppD
oppF -0.63 2.8E-04  oligopeptide transport ATP-binding protein OppF
oppB -0.38 1.4E-02  peptide transport system permease protein OppB
oppC -0.40 7.9E-03  oligopeptide transport system permease protein OppC
oppA  oligopeptide-binding protein OppA precursor
pepO  endopeptidase O 
asnB -0.29 3.1E-02  asparagine synthetase B 
gltA  citrate synthase 
citB  aconitate hydratase 
icD  isocitrate dehydrogenase 
serC  phosphoserine aminotransferase 
serA -0.31 4.9E-02 -0.64 6.0E-04  D-3-phosphoglycerate dehydrogenase 
serB -0.49 8.5E-03  SerB protein 
ArcD1  arginine/ornithine antiporter
ArcC1  carbamate kinase 
ArcC2  carbamate kinase 
amtB -0.45 6.8E-03  ammonium transporter AmtB
dapB  dihydrodipicolinate reductase 
FtsW1  cell division protein ftsW1
Genes under codY regulation
Gene/locus BK1506 BK1503 Annotation
Table 17.10: Comparison of the expression level changes for genes regulated by
CodY, between BK1506 and BK1503. Green colour indicates increased expres-
sion, red colour decreased. A colour gradient indicates the relative foldchange, i.e.
stronger colour means bigger foldchange. Empty spots indicate original values had
a p-value below the cuttoff (0.10). Genes adapted from [158].
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LogFC p. Value logFC P.value Effect
galP 0.76 8.5E-02 Rep  galactose permease
galM 0.57 7.3E-02 Rep aldose 1-epimerase 
galK Rep galactokinase 
galT Rep galactose-1-phosphate uridylyltransferase 
galE -0.32 5.7E-02 0.33 3.8E-02 Rep GalE protein 
mtlA Rep PTS system, mannitol-specific IIBC component 
mtlR Rep transcriptional regulator mtl operon MtlR
mtlF 0.23 9.6E-02 Rep PTS system, mannitol-specific IIA component 
mtlD Rep mannitol-1-phosphate 5-dehydrogenase 
llmg_0453 Rep sucrose-specific PTS enzyme IIABC
llmg_0454 -0.25 6.0E-02 Rep beta-glucoside-specific PTS system IIABC component
trePP -0.21 5.3E-02 Rep putative trehalose/maltose hydrolase 
pgmB 0.36 1.2E-02 Rep beta-phosphoglucomutase 
llmg_0431 0.41 2.0E-02 Rep putative acyl carrier protein phosphodiesterase 2 
llmg_0432 Rep transcription regulator
ptcB 0.83 1.6E-03 Rep cellobiose-specific PTS system IIB component 
ptcA 1.00 1.8E-04 Rep cellobiose-specific PTS system IIA component 
llmg_0439 0.38 1.7E-02 Rep LacI family transcription regulator
ptcC 0.59 1.8E-02 Rep cellobiose-specific PTS system IIC component 
bglA Rep 6-phospho-beta-glucosidase 
arcA 0.63 7.2E-02 Rep arginine deiminase 
arcB Rep ornithine carbamoyltransferase 
arcD1 Rep arginine/ornithine antiporter
arcC1 Rep carbamate kinase 
arcC2 Rep carbamate kinase 
pfk -0.26 5.7E-02 -0.56 7.3E-04 Act 6-phosphofructokinase 
pyk -0.27 9.4E-02 -1.09 2.1E-05 Act pyruvate kinase 
ldh -0.51 1.8E-02 -0.45 2.1E-02 Act L-lactate dehydrogenase 
pgiA 0.54 4.7E-03 Act glucose-6-phosphate isomerase 
fruA 0.37 5.0E-02 Act PTS system, fructose specific IIBC components 
fruC -0.39 8.4E-03 Act tagatose-6-phosphate kinase 
fruR Act lactose transport regulator
Genes under ccpA regulation
Gene/locus BK1506 BK1503 Annotation
Table 17.11: Comparison of the expression level changes for genes regulated by
CcpA, between BK1506 and BK1503. Green colour indicates increased expres-
sion, red colour decreased. A colour gradient indicates the relative foldchange, i.e.
stronger colour means bigger foldchange. Empty spots indicate original values had
a p-value below the cuttoff (0.10). The grey sectioning indicates genes which share
regulation, indicated in the effect column.
In conclusion the metabolic pattern has indications of a starvation like re-
ponse to ATPase activity denoted by a downregulation of central metabolism
(notably key glycolytic enzymes such as phosphofructokinase, phosphogly-
ceromutase, triosephosphate isomerase and pyruvate kinase) and lactate de-
hydrogenase. In addition anabolic pathways such as fatty acid metabolism
and purine/pyrimidine metabolism are also downregulated in combination
with a shift towards the use of alternative substrates, illustrated by up-
regulation of peptide transporters, upregulation of fbp as a gluconeogenic
respons, and the relief of carbon catabolite repression regulated by ccpA. A
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LEGEND: glk – glucokinase, llmg_2499 – glucose-6-phosphate 1-dehydrogenase, llmg_2431 – 6-phosphogluconolactonase, gntZ/gnd – 6-
phosphogluconate dehydrogenase,  pgi – glucose-6-phosphate isomerase, tkt – transketolase, rpe/rpe2 – ribulose-phosphate 3-epimerase, 
rpiA/rpiB – ribose-5-phosphate isomerase, prsA/prsB – ribose-phosphate pyrophosphokinase, fbp – fructose-bisphosphatase, pfk – 
phosphofructokinase, fbaA – fructose-bisphosphate aldolase, tpiA – triosephosphate isomerase, gapB/gapA – glyceraldehyde 3-phosphate 
dehydrogenase, pgk – phosphoglycerate kinase, gpmA/gpmB/gpmC – phosphoglycerate mutase, eno – phosphopyruvate hydratase 
(enolase), pyk – pyruvate kinase, ldh/ldhB/ldhX – lactate dehydrogenase, als – acetolactate synthase, aldC/aldB – acetolactate 
decarboxylase, dar – acetoin( diacetyl) reductase, butA – acetoin reductase, butB – 2,3-butanediol dehydrogenase, pfl – pyruvate formate 
lyase, pdhA/pdhB/pdhC/pdhD – pyruvate dehydrogenase, adhE – bifunctional acetaldehyde-CoA/alcohol dehydrogenase, adhA – alcohol 
dehydrogenase, eutD – phosphotransacetylase, ackA/ackA2 – acetate kinase, fadD – acetyl-CoA synthetase, llmg_0870/glpF2/glpF3 –  
glycerol uptake facilitator, llmg_0945 – putative glycerol dehydrogenase,  dhaM/dhaK – dihydroxyacetone kinase, glpK – glycerol kinase, 
gpsA/glpD – glycerol-3-phosphate dehydrogenase. 
Figure 17.5: A schematic overview of the effects from ATPase expression on the
central metabolism of Lactococcus lactis. Green - upregulation, Red - downregula-
tion and Grey - no information. A colour gradient indicates the relative foldchange,




The aim of the experiments described was to get a deeper insight into the
response of Lactococcus lactis to various degrees of ATPase activity. The
approach was to combine data from a metabolomic analysis with data from
a transcriptomic analysis to characterize the response of two selected strains
with only slight perturbations to their metabolism.
18.1 Metabolomic profiling of strains expressing
ATPase activity confirms the ATPase system
as working but reveals the need for further
optimization
The previous study by Koebmann et al. [165] measured selected metabol-
ites and it was noted, that the concentration of glucose-6-phosphate almost
doubles from reference to BK1502, being 16mM in the reference and 32mM
in BK1502 while fructose-1,6-bisphosphate drops around 20%. This effect
could most likely be explained by the shift in glucose transport as described
in the transcriptional investigations. There is no sign of the pattern in this
data set generated in this work.
From a study by Solem et al. [176] the concentrations of DHAP was
reported to be approximately 7mM, the concentration of G6P was 15mM
and the concentration of FBP (F16BP) was 50mM, in the wild type L. lactis
IL1403. This pattern of four times the concentration of F16BP compared
to G6P corresponds better with the data in the present study.
What does seem to fit nicely with the strains examined are the measure-
ments of ADP and AMP. There seems to be a correlation of AMP and ADP
concentrations, ranging from low in reference to high in BK1502 which fits
the increase in ATPase expression. In contrast, the levels of NAD are lower
in response to the higher ATPase expression. This could be taken as an in-
direct measure that NADH levels are rising, since growth rates are lowered
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and biomass is more reduced than glucose (degree of reduction: biomass =
4.2, glucose = 4 [161]). It would be very interesting to repeat this analysis
with the optimizations already outlined in the discussion of the results from
screening of Lactococcus lactis for glycerol utilization.
18.2 Transcriptome profiling of strains expressing
varying degrees of ATPase activity indicates
a starvation like response to perturbations in
energy level
When comparing the response of the strains perturbed by ATPase activ-
ity, the general trend seems to be repression of anabolic pathways such as
glycolysis, fatty acid metabolism, purine metabolism and pyrimidine meta-
bolism. This response is complemented by activation of both fbp (fructose-
1,6-bisphosphatase) and pgi (glucose-6-phosphate isomerase), indicating a
response in the pentose phosphate pathway and gluconeogenesis. Further
there are indications of a shift in glucose transport and signs of relieved
catabolite repression possibly connected to the transcription factor CodY
(codY ) and CCR/CCA via CcpA.
18.2.1 Proper handling and processing of microarrays plays
a vital role in further data analysis
The original experimental design was anchored on analysis of four replicates
of each strain. This number of samples were more than could be handled
on a single chip which meant that the samples had to be distributed among
two separate microarray chips.
Even without the added complexity of batch effects between the chips the
signal from the (intentionally) slight perturbations in the experiment were
already at risk of being drowned out by noise introduced in the handling
preparation. The actual handling and running of the chips was done over a
period of several months and one cannot exclude degradation of the samples
in that time period.
Future investigations should take care to minimize the handling effects
experienced during this analysis by distributing samples evenly across the
purification step and the microarray chips, in order to ensure even distribu-
tion of the noise across replicates. Also it is advantageous to ensure an even
amount of samples for the FDR analysis and complete the arrays within as
short a period as possible.
Alternatively a more advanced bioinformatic pre-processing will be able
to extract the noise introduced by the batch effect and provide an effective
means of combatting these, allowing all samples to be compared. Several
attempts have been made so far to combat the issue of batch variation such
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as Frozen robust multiarray analysis (fRMA) [170] and an empirical Bayes
approach [180]. Future application of such advances in bioinformatics might
prove helpful in further analysis of such samples.
18.2.2 Implications of the observations made in the tran-
scriptome level analysis of strains expressing varying
degrees of ATPase activity
The following section contains a general discussion about the observed re-
sponses of both BK1506 and BK1503 as a whole.
Activity of global regulators such as transcription factors and
CcpA suggest a systemic response to ATPase activity
The effect on transcription factors could indicate a global response similar to
relief of catabolite repression. Unfortunately there is no significant informa-
tion on CcpA (ccpA, but the genes regulated by CcpA respond in a fashion
that indicates downregulation of ccpA. MalR (malR) is crucial for maltose
transport (despite being named as a repressor) [154] and ArgR (argR) is
involved in arginine metabolism but is believed to have other targets on the
genome (ARC boxes) [167].
The are indications of upregulation of the transcriptional regulator CodY.
CodY functions as a repressor for many genes in the chromosome. CodY
is associated with starvation response, biofilm formation, sporulation and
virulence in pathogenic organisms. CodY interacts with GTP (sensing of
energy level) and branched-chain amino acids (BCAA) (sensing of nutrients)
which is thought to increase binding affinity to DNA. A lowered level of GTP
or BCAA’s is connected with the transition to stationary phase and causes
CodY to detach from the target sites thereby relieving repression [178].
The response of genes in glycolysis and other anabolic pathways
suggest a lowered metabolic state which might present a bottle-
neck for glycolytic flux
Looking at the central metabolism, the downregulation of glycolysis could
explain the phenomenon that glycolytic flux does not increase with increased
ATPase activity as seen in E. coli. A downregulation of the main energy
producing pathway in anaerobic/static growth of Lactococcus lactis as a
response to a perturbation of the energy level in the cell could also indicate
that the signal from the lowered ATP/ADP ratio is not directed specifically
to energy homeostasis, but interpreted more as a general starvation response.
This triggers a change in metabolism towards slower growth and re-
lieves catabolite repression which in turn affects maltose transport, dipeptide
transport and causes a the shift in glucose transport, with the downregula-
tion of the PTSMan system (ptnAB, ptnC and ptnD) in BK1503 and upreg-
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ulation of the PTSCel system (ptcA, ptcB and ptcC). The two systems have
the same transport capacity but their affinity is very different. PTSMan has
much higher affinity (Km of 13µM) compared to the PTSCel system (Km of
≈9mM) [10]. The shift from high affinity to a lower affinity system would
indicate a starvation response since the uptake of glucose is done at the
expense of PEP, which acts as an energy reserve during starvation [169].
The heavy downregulation of phosphate transport is intriguing. It could
be connected to the hydrolysis of ATP or be a general response similar to
glycolysis other major anabolic pathways which appear to be turned down.
More anabolic pathways exhibit a response similar to glycolysis
The trend observed for the genes in glycolysis is repeated in several other
anabolic pathways. In amino sugar metabolism glmS which acts on fructose-
6-phosphate (and glucosamine-6-phosphate) is heavily downregulated. In
fatty acid metabolism the genes accB, accC and accD, which are involved
in conversion of Acetyl-Coa to Malonyl-CoA (a precursor for fatty acid syn-
thesis), are also heavily downregulated. In pyruvate metabolism pycA,
which is involved in the conversion of pyruvate to oxaloacetate is down-
regulated (OAA is a precursor to aspartate, which in turn can be used in
pyrimidine metabolism or as a nitrogen donor for purine metabolism) [181].
ATPase activity as a stimulus for glycerol utilization works - on a
transcriptional level In glycerolipid metabolism it seems that the initial
idea of using ATP hydrolysis to stimulate a metabolic response favorable to
glycerol utilization, worked on a transcriptional level to some extent. The
anaerobic branch had a partial upregulation, with dihydroxyacetone kinase
being upregulated but had a downregulation of glycerol dehydrogenase. The
aerobic branch saw upregulation of glycerol kinase and a shift of glycerol-3-
phosphate dehydrogenase from gpsA to glpD. The shift might be caused by
the cofactor utilization, which in the case of gpsA is NADPH and for glpD
is NADH.
The downregulation of glycolysis and other anabolic pathways
combined with the shift in glucose transport might provide part of
the answer to why glycolytic flux does not increase as a response
to ATP hydrolysis
The two main effects of hydrolyzing ATP is an increased Pi level and a
lowered energy state (ATP/ADP level). Recently Levering et al. invest-
igated the phosphate metabolism of Lactococcus lactis and Streptococcus
pyogenes, where they found that during starvation, most phosphate resides
in the phosphoenolpyruvate pool (≈20mM) and as inorganic Pi (45mM).
Whereas during glycolysis it shifts towards fructose-1,6-bisphosphate (50mM)
and ATP (8mM) [169].
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Could the increased Pi level be sufficient to elicit the observed
response to ATPase activity? The strains used in these experiments
were deliberately chosen to have slight perturbations. The difference in
concentrations of the phosphate pool components between starvation and
glycolysis are significant. Although the differences in concentration are big,
the transition has been reported to be gradual with a concentration of Pi at
25-30mM at glucose depletion rising to 40-45mM over a period of time [172,
171]. This raises the question whether the effects of hydrolyzing ATP could
increase the Pi level sufficiently to simulate the conditions of poorer growth?
Since even the slight perturbation of BK1506 is enough to induce a re-
sponse to ATPase activity it suggests that only a limited signal is needed.
The study by Levering et al. also found a strong connection between ex-
tracellular phosphate concentration and the intracellular level of fructose-
1,6-bisphosphate (which is connected to regulation of pyruvate kinase and
lactate dehydrogenase). This relationship adds a further level of complex-
ity to the system implicating transport of phosphate in the control of flux
through glycolysis and should be considered in future studies.
The indications of a profound metabolic shift as a response to ATPase
activity, as presented here, might be part of the explanation for why the
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The background for this project was to investigate the suitability of lactic
acid bacteria as production organisms for the production of biofuels and bio-
chemicals. Specifically the goal was to adapt the model organism Lactococcus
lactis to convert crude glycerol, generated as a byproduct from biodiesel pro-
duction, to value-added fuels or chemicals. Work was divided between four
main areas, life cycle assessment of the GLYFINERY project, screening of
Lactococcus lactis spp. for glycerol utilization, engineering of glycerol meta-
bolism in L. lactis and finally an investigation into perturbation of energy
metabolism in L. lactis.
Life cycle assessment - work package 7
The overall outcome of work package 7 is the integrated assessment of the
processes developed in the GLYFINERY project. The integrated assessment
evaluates the processes according to environmental, economic and technolo-
gical factors. This serves as guideline to future decision makers. For example
one could envision a process of great economic value but with terrible en-
vironmental effects. Two reports outlining the technological aspects of the
glycerol conversion processes and which further served as a basis for the
economical and the environmental assessments, can be seen in appendix A.
The main conclusions from these reports show several of the processes under
investigation, particularly the processes investigating butanol and 1,3-PDO
production, as interesting from an economic perspective. Although further
work is needed to improve yields and reduce downstream purification costs
for truly competitive processes.
Screening of Lactococcus lactis spp. for glycerol
utilization
Initially an attempt was made to use directed evolution to stimulate gly-
cerol assimilation. The experiment was discontinued after 2 weeks of serial
transfers, during which time, no change in the phenotype, i.e. ability to
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utilize glycerol, was observed. It was concluded that a more drastic select-
ive environment was perhaps necessary to stimulate this phenotype in the
strain. The main challenge in applying this approach is most likely that no
glycerol assimilation was apparent initially. It is perhaps better suited for
further adaptation of strains already metabolizing glycerol. Furthermore the
successful application of directed evolution to the challenge of glycerol as-
similation, would only be possible if a fairly simple set of mutational events
were enough to trigger the change, which is probably not the case for this
setting.
The beneficial effect on glycerol inhibition when utilizing tre-
halose as a substrate might be connected to the properties of
trehalose itself
Many different combinations of strains and conditions were tested for the
ability to stimulate glycerol assimilation, but none showed convincing signs
of achieving this goal. There were however indications of a beneficial effect
to glycerol supplementation, when cultivating strains in defined medium
supplemented with the disaccharide trehalose. When cultivating the strain
L. lactis IL1403 over night, cultures exhibited higher optical density under
aerobic conditions than cultures without added glycerol. Growth experi-
ments revealed that the growth rate of the two cultures were similar, with
the growth rate of the glycerol supplemented culture being approx. 84% of
the culture without glycerol.
Since this observation was only seen under aerobic conditions, the reason
for the improvement could be related to the activation of systems for pro-
tection against oxidative stress. One of these is an NADH oxidase, noxE,
which might have have influenced redox issues. Trehalose has been implic-
ated in numerous cellular functions in connection with stress, among which
is protection against oxidative stress, so the explanation could also simply
be the combination of glycerol and trehalose simply protects the cells better
in the aerobic environment. Further investigations are needed to determine
if this observation is in fact connected to glycerol metabolization.
Supplementation of glycerol in cultivations with xylose as a
substrate has a detrimental effect on growth rate
Besides the possible beneficial effects of glycerol supplementation in cultures
growing on trehalose, a detrimental effect of glycerol supplementation was
observed when cultivating L. lactis in defined medium with xylose as the
substrate. This was initially observed in over night cultures and was later
confirmed by growth experiments. The effect was mainly found in connection
with xylose and cultivations with other substrates, such as galactose or
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ribose, did show the same degree of inhibition when subjected to glycerol
supplementation.
The detrimental effect of glycerol persists in many different types
of growth media and under both anaerobic and respiratory cultiv-
ation
One can observe a significant detrimental effect on growth rate in L. lactis
NCDO2118 cultures growing growing on xylose, when supplemented with
glycerol. The level of inhibition varies with the medium composition and
the initial observations in BLL medium recorded a reduction of growth rate
for cultures supplemented with 0.5% glycerol, to approx. 20% of the level
found in cultivations without glycerol.
Samples from cultures cultivated in defined medium supplemented with
xylose and with or without the addition of glycerol, were sent for analysis
of internal metabolite concentrations, but the quality of the data was not
sufficient to provide additional information about the effect.
From a series of growth experiments it was determined that the effect
is most likely connected to xylose metabolism and its metabolism through
the pentose phosphate pathway/phosphoketolase pathway, but the actual
mechanism remains unknown. The pentose phosphate pathway is implicated
through xylose as a substrate and from experiments in which nucleosides
were added to the cultivation medium, which improved both growth rate
and biomass yield although not completely to the level of the reference
cultures (growth rate of approx. 70% of reference).
Cultivation in complex medium showed a similar reduction as in SAL
medium. Since many of the components for cell biomass are present in this
medium, this indicates that the problem might be connected to a bottleneck
in energy metabolism. This is also supported by the reduction of glycerol
inhibition when switching from BLL to SAL medium, since BLL medium
has fewer amino acids added thus requiring a larger energy input for growth.
The mechanism for glycerol inhibition remains elusive A suggested
mechanism for the inhibitory effect of glycerol under anaerobic conditions
was the inhibition of pyruvate formate-lyase by high levels of triosephos-
phates. Since DHAP is the metabolite connecting glycerol to glycolysis, any
assimilation would naturally cause the levels to rise. A further indication of
this was seen in external metabolite measurements, in which the metabolite
formate was absent in samples from glycerol supplemented cultures.
Under respiration permissive conditions the redox level (NADH/NAD+),
affecting glycerol-3-phosphate dehydrogenase and the pyruvate dehydro-
genase complex might be the cause of effect. Glycerol is more reduced than
glucose leading to a higher redox level. This is contradicted by the fact that
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under respiration permissive conditions the cell should be able to channel
excess redox to respiration and thereby solve the issue.
The curious persistence of inhibition under both anaerobic and respir-
atory conditions might indicate that there are several components to the
inhibitory mechanism. The improvement of growth rate in SA medium
compared to SAL would point in the direction of the metabolite acetate,
since sodium acetate is omitted in SAL medium. Acetate can be metabol-
ized to acetyl-CoA which is the common product of both PFL and PDH.
Furhermore xylose metabolized via the phosphoketolase pathway is conver-
ted to GAP and acetyl phosphate. Any inhibition of flux from glycolysis
(GAP) to acetyl-CoA would require a redirection of flux away from acetate
production thereby producing less ATP for growth. The precise components
and their contributions still remain to be investigated further in subsequent
studies.
Engineering of glycerol metabolism in Lactococcus
lactis
Several different constructs were initiated to help alleviate some of the pos-
sible difficulties of glycerol metabolization. In a response to the initial ana-
lysis, strains featuring overexpression of glycerol kinase were constructed
and characterized. Unfortunately, the constructs could not be verified, as
glycerol kinase activity was not detected under experimental conditions.
This could possibly be caused by native regulatory issues interfering with
the system. More work need to be done if this strategy is to be pursued in
future studies.
Introduction of a recombinant pathway for glycerol metabol-
ization as an alternative route to the possibly non-funtional
endogenous pathway
As a response to the possibility that the genetic components already present
in Lactococcus lactis may not be fully functional, an alterntive route for
glycerol dissimilation was devised.
The system consisted of three genes, glycerol dehydrogenase (dhaD) from
Citrobacter freundii, dihydroxyacetone kinase (dhaK) also from Citrobacter
freundii and a glycerol facilitator (glpF) from Esherichia coli. The genes
were cloned into an artificial operon structure with glpF in front of dhaD and
dhaK. Gene expression was modulated with a synthetic promoter library,
to ensure a suitable level of expression could be found without knowing the
exact level required, in advance.
Several different combinations of the operon were transformed into Lacto-
coccus lactis. This included integrative and plasmid versions, constructed
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by either traditional or USER cloning, as full operons or as combinations of
either dhaD and dhaK together or separate. Despite this no strains were
verified as having a functional operon, and none have been found that meta-
bolized glycerol.
Further work is needed to determine if the operon could be used to in-
troduce glycerol dissimilation into L. lactis. Since this is an artificial operon
many of the problems could stem from flawed design or unforeseen issues.
The ribosomal binding sites were taken from glycolytic genes, which for the
glycerol facilitator (being a membrane protein) might not have been the best
choice. The idea of introducing the required machinery under a known con-
trol is still valid and many other options exist for the different components.
Introduction of NADH oxidase activity alone is not enough
to allow growth on glycerol by Lactococcus lactis
An initial analysis predicted that growth on glycerol might give rise to issues
with redox balance for L. lactis. To provide a solution to that issue strains
overexpressing NADH oxidase activity were constructed. The two water
forming NADH oxidases, noxE (L. lactis) and nox (S. pneumoniae) were
used to construct libraries of strains with NADH oxidase activity.
Selected strains were characterized and displayed varying degrees of
NADH oxidase activity in the lower range. The strains were cultivated in
defined medium supplemented with glycerol as the sole carbon and energy
source, but did not grow. This indicated that a redox problem was not the
only issue preventing the strains from metabolizing glycerol. The next step
would be to combine these libraries with the glycerol operon or other con-
structs. This combined effort might provide the basis for growth on glycerol.
Alternatively strains with higher levels of NADH oxidase activity might be
constructed and tested, to assess whether that it is simply a higher level of
NADH oxidase activity which is necessary to stimulate glycerol assimilation
by L. lactis.
Several challenges remain for glycerol assimilation by Lacto-
coccus lactis
The most pressing question is the functional characterization of the existing
metabolic pathway for glycerol assimilation. In particular glycerol transport
into the cell, which was assumed to be functional, may be non-functional or
perhaps not have sufficient capacity to be able to sustain growth on glycerol.
Several glycerol facilitators have been annotated, but their individual
contribution remains unknown. Furthermore a major intrinsic protein (MIP),
a group which can be subdivided into aquaporins, glycerol facilitators and
aquaglyceroporins, from L. lactis was shown to be permeable to glycerol in
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the same manner as glpF from E. coli. A more systematic characterization
of the endogenous components would therefore benefit further studies.
Transcriptomic analysis of perturbations of energy metabol-
ism in Lactococcus lactis shows a starvation like response to
varied degrees of ATPase activity.
The transcriptomic analysis of Lactococcus lactis strains with overexpression
of ATPase activity revealed that the effect of hydrolyzing ATP, and thus
lowering the energy state of the cell (ATP/ADP ratio), was a downregulation
of glycolysis and anabolic pathways in general. This might indicate that
the perturbation triggers a more general starvation response, signaling a
metabolic shift to prepare the cell for slower growth on a broader range
of substrates. Pi released from hydrolysis of ATP is already connected to
regulation of pyruvate kinase and lactate dehydrogenase. This regulation
appears to be mediated by HPr and CcpA regulation of central carbon
metabolism. These results provide some interesting clues to direct further
work on elucidating the control of glycolysis in Lactococcus lactis.
Metabolomic profiling of the four strains BK1010, BK1506, BK1503 and
BK1502 did unfortunately not reveal any novel clues to the control of gly-
colysis. There was a lack of signal in the data prepared from analysis of
the samples, which was most likely caused by a lack of sufficient biomass.
It would be very interesting to repeat this analysis on samples with more
biomass present, to get a better understanding of the metabolic response
caused by perturbing the energy metabolism of Lactococcus lactis.
Outlook
The task of making Lactococcus lactis grow on glycerol as sole carbon and
energy source still remains to be completed. It will most likely require the
combined efforts on all of the three areas investigated, to accomplish this
task. It was from the beginning the foundation of the project, that the
results from one part of the project, would be combined with results from
others.
Strains with the synthetic glycerol assimilation operon would addition-
ally be outfitted with a library of NADH oxidase activity and would even-
tually be cultivated under the most stimulating of conditions. Further work
would involve more rigorous investigations into each area to ascertain why
the constructs did not work, and perhaps devise novel approaches to con-
structing these strains.
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The results from the transcriptome analysis needs further ex-
perimental validation
There are several avenues which can be investigated further. The validation
by experimental work and the further analysis of the results from the tran-
scriptome level analysis by metabolite measurements or enzymatic assays
of key regulated enzymes would be very interesting. The ultimate goal of
determining control of glycolytic flux in Lactococcus lactis and ultimately
increasing it, still remains to be accomplished.
Perhaps the indications gathered from the transcriptome analysis can
be used as a starting point for future investigations into counter acting the
downregulation of the cental metabolic pathways in response to a drain in
energy level. An obvious candidate for further studies is the regulation of
central metabolism by HPr and CcpA.
More light might be shed on the inhibitory effect of glycerol
in combination with xylose by further metabolomic investig-
ations
The glycerol inhibition phenomenon also merits further study. Initially just
a coincidental observation, some effort has been put into characterizing the
phenomenon, but the observations made in this thesis are far from exhaust-
ive. A suitable approach for further investigations could be similar to the one
from the work described here, consisting of growth experiments, transcrip-
tome analysis and metabolome analysis, repeating the internal metabolite
measurements.
Engineering of glycerol metabolism in Lactococcus lactis re-
quires a more robust characterization of the existing compon-
ents
Finally the goal of engineering glycerol metabolism of Lactococcus lactis
by modulation of redox cofactor levels or the introduction of a synthetic
pathway for glycerol assimilation, is still ongoing.
The initial attempts at cloning an artificial operon containing all the
necessary genes for glycerol assimilation met with adversity, prompting a
step back and re-evaluation of this approach. Perhaps the design principles
should be modified before attempting again. This might entail a more com-
plete characterization of the existing enzymatic machinery and introduction
of genes from E. coli which has been shown to work previously.Especially
the role of glycerol transport needs to be clarified since this step is crucial
to further assimilation.
The modulation of cofactor levels, in particular the modulation of NADH
level was achieved. However the activities and range of the library was
limited and should be expanded upon in further work.
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BK1010 2 Chip 1
BK1010 3 Chip 1
BK1506 5 Chip 1
BK1506 6 Chip 1
BK1503 9 Chip 1
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BK1010 3 Chip 1
BK1506 5 Chip 1
BK1506 6 Chip 1
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BK1010 1 Chip 2010 3 Chip 21010 4 Chip 2
BK1506 7 Chip 2
BK1506 8 Chip 2
BK1503 12 Chip 2
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SUPPLEMENTARY MATERIAL
S.2 – Results from the differential gene 






This section contains all the results from the 
analysis of differential gene expression from 











logFC p-value logFC p-value
adaA -0.31 3.5E-02 0.01 9.3E-01
AraC family transcriptional regulator, regulatory protein of 
adaptative response / methylphosphotriester-DNA alkyltransferase 
methyltransferase [EC:2.1.1.-] 
fruR -0.05 7.2E-01 0.10 4.7E-01
lactose transport regulator, DeoR family transcriptional regulator, 
fructose operon transcriptional repressor
malR -0.16 1.8E-01 0.55 4.2E-04 maltose operon transcriptional repressor
ccpA -0.10 5.3E-01 0.01 9.2E-01 catabolite control protein A
rbsR -0.01 9.6E-01 -0.15 2.3E-01 ribose operon repressor
llmg_0956 -0.14 5.9E-01 0.45 7.4E-02 LacI family transcription regulator
treR -0.31 3.5E-02 -0.47 2.5E-03 trehalose operon transcriptional repressor
rgrB 0.04 7.4E-01 0.57 6.2E-04 GntR family transcriptional regulator
rmaG -0.46 4.4E-02 -0.47 2.8E-02 MarR family transcriptional regulator
glnR 0.11 4.6E-01 -0.27 6.4E-02 glutamine synthetase repressor
fur -0.45 4.5E-03 0.07 5.7E-01 ferric uptake regulation protein
flpB 0.14 3.8E-01 -0.03 8.6E-01 transcriptional regulator FNR like protein B
flpA -0.01 9.7E-01 -0.02 8.9E-01 FNR like protein A
llmg_1224 -0.08 5.5E-01 0.42 6.6E-03 transcriptional regulator
llmg_0709 -0.25 2.2E-01 0.10 5.9E-01 PadR-like family transcriptional regulator
llmg_2339 0.09 4.8E-01 0.09 4.5E-01 transcriptional regulator
arsR 0.23 1.8E-01 0.07 6.6E-01 regulator of arsenical resistance
birA1 -0.23 9.3E-02 -0.04 7.1E-01
biotin--[acetyl-CoA-carboxylase] ligase and biotin operon repressor 
(EC:6.3.4.15)
birA2 -0.01 9.5E-01 0.20 8.1E-02
acetyl-CoA carboxylase ligase / biotin operon repressor bifunctional 
protein (EC:6.3.4.
codY 0.01 9.7E-01 0.84 1.5E-04 transcriptional repressor CodY
ps602 0.31 4.4E-02 0.53 1.5E-03 hypothetical protein
mtlR -0.03 8.6E-01 -0.10 4.7E-01 transcriptional regulator mtl operon MtlR
ahrC -0.22 1.7E-01 -0.08 5.9E-01 arginine transcriptional regulator
argR 0.05 6.8E-01 0.34 8.0E-03 arginine repressor
cspE -0.12 4.8E-01 0.41 1.9E-02 cold shock-like protein CspE
cspD2 0.06 6.7E-01 0.30 5.2E-02 cold shock-like protein cspD2
cspB -0.23 3.0E-01 0.02 9.0E-01 cold shock-like protein CspB
hrcA -0.45 1.7E-02 0.34 4.0E-02 heat-inducible transcription repressor
tenA -0.19 2.0E-01 -0.10 4.3E-01 transcriptional activator TenA
ctsR 0.18 1.6E-01 0.17 1.4E-01 transcriptional regulator CtsR
parA 0.43 9.8E-02 -0.11 6.2E-01 chromosome partitioning protein ParA
pyrR -0.18 2.3E-01 -0.63 7.9E-04
bifunctional pyrimidine regulatory protein PyrR uracil 
phosphoribosyltransferase
nrdR -0.30 4.1E-02 -0.39 8.3E-03 transcriptional regulator NrdR
purR -0.40 4.1E-02 0.57 4.5E-03 pur operon repressor
comX -0.39 5.7E-02 -0.11 5.1E-01 competence regulator ComX
rpoD -0.31 1.2E-01 0.09 6.2E-01 RNA polymerase sigma factor RpoD




LogFC p. Value logFC P.value
glk -0.25 7.0E-02 -0.57 4.9E-04 glucokinase 
pgi -0.16 3.5E-01 0.54 4.0E-03 glucose-6-phosphate isomerase 
pfk -0.26 6.1E-02 -0.56 6.9E-04 6-phosphofructokinase 
pyk -0.27 9.4E-02 -1.09 1.3E-05 pyruvate kinase 
ldh -0.51 1.5E-02 -0.45 1.8E-02 L-lactate dehydrogenase 
fbp 0.60 7.9E-03 0.65 2.8E-03 fructose-bisphosphatase 
fbaA -0.36 1.2E-02 -0.46 1.8E-03 fructose-bisphosphate aldolase 
tpiA -0.24 1.6E-01 -0.68 9.7E-04 triosephosphate isomerase 
gapB -0.07 5.2E-01 0.03 7.8E-01 glyceraldehyde 3-phosphate dehydrogenase 
gapA 0.22 8.5E-02 -0.08 4.5E-01 glyceraldehyde 3-phosphate dehydrogenase 
pgk -0.35 5.5E-02 -0.12 4.3E-01 phosphoglycerate kinase 
llmg_1894 0.06 6.6E-01 -0.01 9.1E-01 phosphoglycerate mutase family protein
gpmA -0.30 5.5E-02 -0.67 4.0E-04 phosphoglyceromutase 
gpmB -0.04 7.5E-01 -0.51 9.1E-04 phosphoglycerate mutase 
gpmC 0.25 6.4E-02 -0.56 5.3E-04 phosphoglycerate mutase 
eno -0.28 8.0E-02 -0.17 2.2E-01 phosphopyruvate hydratase 
pdhA 0.01 9.7E-01 -0.51 1.1E-02 pyruvate dehydrogenase E1 component alpha subunit 
pdhB 0.27 2.4E-01 -0.36 9.6E-02 pyruvate dehydrogenase E1 component beta subunit 
pdhC 0.14 5.0E-01 -0.35 9.8E-02 pyruvate dehydrogenase complex E2 component 
pdhD 0.02 9.2E-01 -0.20 3.4E-01 dihydrolipoamide dehydrogenase 
ldhX -0.18 3.1E-01 0.45 1.6E-02 L-lactate dehydrogenase 
ldhB 0.17 2.3E-01 0.10 4.5E-01 L-lactate dehydrogenase 
adhE 0.52 6.7E-02 -0.10 6.8E-01 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP 0.16 3.0E-01 -0.24 1.1E-01 alcohol dehydrogenase 
llmg_0955 -0.12 6.2E-01 0.04 8.4E-01 alcohol dehydrogenase 
fadD -0.26 7.1E-02 -0.12 3.2E-01 long-chain acyl-CoA synthetase 
galM 0.57 6.2E-02 0.24 3.4E-01 aldose 1-epimerase 
bglA2 0.24 1.1E-01 0.07 5.7E-01 6-phospho-beta-glucosidase 
arb -0.07 5.9E-01 0.61 4.1E-04 6-phospho-beta-glucosidase 
celA 0.25 1.1E-01 -0.02 9.1E-01 6-phospho-beta-glucosidase 




LogFC p. Value logFC P.value
gltA -0.02 8.6E-01 -0.13 2.8E-01 citrate synthase 
citB -0.10 4.4E-01 -0.13 2.5E-01 aconitate hydratase 
icd -0.09 4.6E-01 -0.01 9.5E-01 isocitrate dehydrogenase 
pdhD 0.02 9.2E-01 -0.20 3.4E-01 dihydrolipoamide dehydrogenase 
frdC -0.29 5.8E-02 -0.28 4.2E-02 fumarate reductase flavoprotein subunit 




pyruvate dehydrogenase E1 component alpha subunit 
pdhB 0.27 2.4E-01 -0.36 9.6E-02 pyruvate dehydrogenase E1 component beta subunit 
pdhC 0.14 5.0E-01 -0.35 9.8E-02 pyruvate dehydrogenase complex E2 component 




LogFC p. Value logFC P.value
pgi -0.16 3.5E-01 0.54 4.0E-03 glucose-6-phosphate isomerase 
llmg_2499 0.04 8.5E-01 -0.38 4.4E-02 glucose-6-phosphate 1-dehydrogenase 
llmg_2431 0.10 4.1E-01 -0.06 5.7E-01 hypothetical protein
gntZ 0.29 3.3E-02 -0.12 2.9E-01 6-phosphogluconate dehydrogenase-like protein 
gnd -0.19 1.4E-01 -0.50 1.0E-03 6-phosphogluconate dehydrogenase 
rpe -0.16 2.9E-01 -0.60 1.3E-03 ribulose-phosphate 3-epimerase 
rpe2 0.08 6.3E-01 0.24 1.2E-01 ribulose-phosphate 3-epimerase 
tkt -0.02 8.9E-01 -0.54 1.2E-03 transketolase 
rpiA -0.26 9.8E-02 0.47 5.9E-03 ribose-5-phosphate isomerase A 
rpiB -0.14 3.0E-01 0.08 5.3E-01 ribose-5-phosphate isomerase B 
deoC -0.03 8.0E-01 -0.58 4.5E-04 deoxyribose-phosphate aldolase 
rbsK 0.07 6.1E-01 0.08 5.1E-01 ribokinase 
deoB -0.25 7.1E-02 -0.76 6.4E-05 phosphopentomutase 
prsB -0.32 3.6E-02 -0.26 6.1E-02 ribose-phosphate pyrophosphokinase 
prsA -0.16 3.6E-01 0.06 7.0E-01 ribose-phosphate pyrophosphokinase 
kdgA 0.55 2.7E-02 -0.06 7.5E-01
keto-hydroxyglutarate-aldolase/keto-deoxy-
phosphogluconate aldolase 
gntK 0.03 8.2E-01 -0.26 8.3E-02 gluconate kinase 
fbaA -0.36 1.2E-02 -0.46 1.8E-03 fructose-bisphosphate aldolase 
fbp 0.60 7.9E-03 0.65 2.8E-03 fructose-bisphosphatase 
pfk -0.26 6.1E-02 -0.56 6.9E-04 6-phosphofructokinase 




LogFC p. Value logFC P.value
fadD -0.26 7.1E-02 -0.12 3.2E-01 long-chain acyl-CoA synthetase 
pdhA 0.01 9.7E-01 -0.51 1.1E-02 pyruvate dehydrogenase E1 component alpha subunit 
pdhB 0.27 2.4E-01 -0.36 9.6E-02 pyruvate dehydrogenase E1 component beta subunit 
pdhC 0.14 5.0E-01 -0.35 9.8E-02 pyruvate dehydrogenase complex E2 component 
pdhD 0.02 9.2E-01 -0.20 3.4E-01 dihydrolipoamide dehydrogenase 
pfl 0.03 8.4E-01 0.19 1.5E-01 formate acetyltransferase 
adhE 0.52 6.7E-02 -0.10 6.8E-01 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
ackA2 -0.33 5.7E-02 -0.35 2.9E-02 acetate kinase 
ackA1 0.30 7.5E-02 -0.04 7.8E-01 AckA1 protein 
eutD -0.25 6.9E-02 -0.23 6.4E-02 phosphotransacetylase 
pyk -0.27 9.4E-02 -1.09 1.3E-05 pyruvate kinase 
accA -0.22 1.2E-01 -0.01 9.5E-01 AccA protein 
accB -0.23 2.2E-01 -1.05 8.0E-05 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
accC -0.26 5.7E-02 -0.71 9.2E-05 acetyl-CoA carboxylase biotin carboxylase subunit 
accD -0.14 2.4E-01 -0.28 2.6E-02 acetyl-CoA carboxylase subunit beta 
llmg_0568 -0.04 8.1E-01 -0.27 9.8E-02 acylphosphatase 
poxL 0.24 2.0E-01 -0.11 4.9E-01 pyruvate oxidase 
ldhX -0.18 3.1E-01 0.45 1.6E-02 L-lactate dehydrogenase 
ldhB 0.17 2.3E-01 0.10 4.5E-01 L-lactate dehydrogenase 
ldh -0.51 1.5E-02 -0.45 1.8E-02 L-lactate dehydrogenase 
llmg_0184 0.07 5.9E-01 0.80 5.7E-05 putative lactoylglutathione lyase 
mleS 0.03 8.7E-01 -0.17 2.9E-01 malate dehydrogenase 
pycA -0.36 4.8E-02 -0.60 2.3E-03 pyruvate carboxylase 
thiL -0.19 2.2E-01 0.10 5.0E-01 ThiL protein 




LogFC p. Value logFC P.value
chiC 0.08 5.8E-01 -0.16 2.3E-01 acidic endochitinase precursor 
nagZ 0.07 5.9E-01 -0.02 8.8E-01 putative beta-N-acetylglucosaminidase 
murQ, yfeU 0.31 5.1E-02 -0.08 5.5E-01 N-acetylmuramic acid-6-phosphate etherase
glmU -0.30 4.6E-02 -0.56 1.0E-03 bifunctional N-acetylglucosamine-1-phosphate 
uridyltransferase/glucosamine-1-phosphate acetyltransferase 
llmg_1317 -0.38 4.8E-02 0.49 9.4E-03 N-acetylmannosamine-6-phosphate 2-epimerase 
murA2 -0.63 7.7E-04 -0.35 1.6E-02 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
murA1 -0.02 9.0E-01 0.00 9.8E-01 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
murB 0.02 8.8E-01 -0.02 8.9E-01 UDP-N-acetylenolpyruvoylglucosamine reductase 
glmM -0.12 3.8E-01 0.13 3.0E-01 phosphoglucosamine mutase 
nagA -0.64 2.9E-02 -0.45 7.7E-02 NagA protein 
scrK 0.53 1.1E-03 -0.22 6.6E-02 fructokinase 
nagB -0.23 1.5E-01 0.40 1.2E-02 glucosamine-6-phosphate isomerase 
glmS -0.37 2.0E-02 -0.98 1.4E-05 glucosamine--fructose-6-phosphate aminotransferase 
llmg_1608 0.35 1.7E-01 -0.09 7.0E-01 putative glycosyl hydrolases 
llmg_1320 -0.12 4.5E-01 -0.16 2.8E-01 putative xylan beta-1,4-xylosidase 
glk -0.25 7.0E-02 -0.57 4.9E-04 glucokinase 
pgi -0.16 3.5E-01 0.54 4.0E-03 glucose-6-phosphate isomerase 
galU -0.14 4.5E-01 0.19 2.7E-01 UDP--glucose-1-phosphate uridylyltransferase 
galT 0.16 3.6E-01 0.02 9.0E-01 galactose-1-phosphate uridylyltransferase 
ugd -0.01 9.7E-01 -0.09 5.1E-01 UDP-glucose 6-dehydrogenase 
galK 0.25 2.0E-01 0.06 7.1E-01 galactokinase 
galE -0.32 5.6E-02 0.33 3.7E-02 GalE protein 
llmg_2003 0.09 5.7E-01 0.23 1.2E-01 UDP-glucose 4-epimerase 
llmg_0247 0.65 8.5E-03 0.06 7.5E-01 putative UDP-glucose 4-epimerase 
ptnAB -0.20 2.0E-01 -0.78 1.6E-04 PTS system, mannose-specific IIAB components 
ptnC -0.03 8.6E-01 -0.65 6.3E-04 mannose-specific PTS system component IIC 
ptnD -0.18 1.9E-01 -0.49 1.8E-03 mannose-specific PTS system component IID
pmi -0.05 7.2E-01 0.98 4.0E-05 mannose-6-phosphate isomerase 
glgD 0.17 3.6E-01 0.07 6.8E-01 glucose-1-phosphate adenylyltransferase 
glgC 0.31 1.6E-01 0.11 5.5E-01 glucose-1-phosphate adenylyltransferase 
Gene/locus BK1506 BK1503 Annotation
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LogFC p. Value logFC P.value
ptsI -0.11 4.9E-01 -0.37 2.1E-02 phosphoenolpyruvate-protein phosphotransferase 
ptsH 0.04 7.5E-01 0.24 7.5E-02 phosphocarrier protein HPr
ptsK -0.25 1.0E-01 0.32 3.0E-02 HPr kinase/phosphorylase 
hprT -0.26 1.4E-01 0.30 6.4E-02 HprT protein 
llmg_1426 0.22 1.0E-01 -0.15 2.1E-01 sucrose-specific PTS system IIBC component 
bglP 0.17 3.5E-01 0.01 9.3E-01 PTS system, beta-glucosides specific enzyme IIABC 
llmg_0453 0.07 5.7E-01 -0.01 9.6E-01 sucrose-specific PTS enzyme IIABC
llmg_0454 0.23 1.1E-01 -0.25 6.3E-02 beta-glucoside-specific PTS system IIABC component
ptcA -0.10 5.7E-01 1.00 1.1E-04 cellobiose-specific PTS system IIA component 
ptcB 0.15 4.7E-01 0.83 1.1E-03 cellobiose-specific PTS system IIB component 
llmg_1244 0.40 7.3E-02 0.32 1.1E-01 hypothetical protein
ptcC 0.59 1.5E-02 -0.06 7.5E-01 cellobiose-specific PTS system IIC component 
celB 1.34 6.3E-06 0.33 3.8E-02 cellobiose-specific PTS system IIC component 
mtlF 0.23 1.0E-01 0.02 8.8E-01 PTS system, mannitol-specific IIA component 
mtlA 0.23 1.4E-01 -0.15 2.9E-01 PTS system, mannitol-specific IIBC component 
ptnAB -0.20 2.0E-01 -0.78 1.6E-04 PTS system, mannose-specific IIAB components 
ptnC -0.03 8.6E-01 -0.65 6.3E-04 mannose-specific PTS system component IIC 
ptnD -0.18 1.9E-01 -0.49 1.8E-03 mannose-specific PTS system component IID
llmg_0866 0.42 1.0E-02 0.15 2.4E-01
PTS system, unknown pentitol phosphotransferase enzyme IIB 
component 
ulaA, sgaT 0.85 3.9E-03 0.12 5.7E-01 PTS system ascorbate-specific transporter subunit IIC
fruA 0.37 4.7E-02 -0.19 2.4E-01 PTS system, fructose specific IIBC components 
glcU -0.19 2.0E-01 0.06 6.1E-01 putative glucose uptake protein GlcU
Gene/locus BK1506 BK1503 Annotation
Phosphotransferase system (PTS) and glucose uptake
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LogFC p. Value logFC P.value
nudH -0.05 6.8E-01 -0.17 1.8E-01 dinucleoside polyphosphate hydrolase 
eno -0.28 8.0E-02 -0.17 2.2E-01 phosphopyruvate hydratase 
pnpA -0.12 4.8E-01 -0.56 4.1E-03 polynucleotide phosphorylase/polyadenylase 
vacB1 0.10 6.6E-01 -0.49 3.0E-02 putative exoribonuclease R 
vacB2 -0.21 2.0E-01 0.89 1.1E-04 putative exoribonuclease R 
rheA -0.09 7.1E-01 0.06 7.9E-01 ATP-dependent RNA helicase
recQ -0.01 9.4E-01 -0.38 1.5E-02 ATP-dependent DNA helicase RecQ 
llmg_0302 0.21 2.8E-01 -0.60 5.4E-03 putative Zn-dependent hydrolase
dnaK -0.25 1.1E-01 -0.19 1.9E-01 molecular chaperone DnaK
groEL -0.14 2.6E-01 -0.31 1.5E-02 chaperonin GroEL




LogFC p. Value logFC P.value
potD -0.51 6.8E-03 0.47 7.1E-03 spermidine/putrescine ABC transporter substrate-binding protein
potC -0.09 5.8E-01 -0.03 8.4E-01 spermidine/putrescine ABC transporter permease
potB -0.01 9.5E-01 -0.11 3.9E-01 spermidine/putrescine ABC transporter permease
potA -0.28 4.3E-02 -0.17 1.5E-01 spermidine/putrescine ABC transporter ATP-binding protein
busAB -0.28 9.6E-02 0.30 5.1E-02 glycine betaine-binding periplasmic protein precursor
busAA -0.10 4.1E-01 -0.35 1.1E-02 glycine betaine/proline ABC transporter 
choS -0.17 4.1E-01 0.35 7.8E-02 choline ABC transporter permease and substrate binding protein
choQ -0.01 9.2E-01 -0.33 1.5E-02 choline ABC transporter ATP binding protein 
malE -0.09 5.0E-01 -0.16 1.8E-01 maltose ABC transporter substrate binding protein
malF 0.72 4.2E-02 0.14 6.3E-01 maltose transport system permease protein MalF
malG 0.61 1.2E-01 0.36 2.9E-01 maltose ABC transporter permease protein MalG
msmK -0.01 9.6E-01 0.80 1.8E-04 multiple sugar-binding transport ATP-binding protein
rbsB 0.09 5.9E-01 0.00 1.0E+00 ribose ABC transporter substrate binding protein RbsB
rbsC -0.02 9.2E-01 -0.08 6.8E-01 ribose transport system permease protein RbsC
rbsD 0.24 1.7E-01 -0.04 7.9E-01 ribose ABC transporter permease protein RbsD
rbsD 0.06 6.7E-01 -0.02 8.8E-01 D-ribose pyranase
pstE -0.48 4.3E-03 -0.54 1.1E-03 phosphate transport substrate binding protein PstE
pstF -0.01 9.7E-01 -0.45 4.4E-03 phosphate transport substrate binding protein PstF
pstD 0.15 4.7E-01 -0.84 1.2E-03 phosphate transport system permease protein PstD
pstC 0.17 3.4E-01 -0.76 6.0E-04 phosphate transport system permease protein PstC
pstA -0.65 5.1E-03 -0.62 3.9E-03 phosphate transporter ATP-binding protein 
pstB -0.16 3.2E-01 -0.69 6.3E-04 phosphate transporter ATP-binding protein 
phnD -0.33 4.5E-02 -0.32 3.5E-02 phosphonate ABC transporter, phosphonate-binding protein PhnD
phnB -0.22 1.4E-01 -0.79 1.1E-04 phosphonate transport system permease protein PhnB
llmg_0315 -0.53 4.7E-03 -0.78 1.7E-04 phosphonate ABC transporter permease
phnC -0.10 5.1E-01 -0.81 1.6E-04 phosphonates import ATP-binding protein PhnC
plpA -0.09 5.1E-01 -0.05 7.0E-01 D-methionine-binding lipoprotein PlpA precursor
plpB -0.19 1.8E-01 -0.13 3.0E-01 D-methionine-binding lipoprotein PlpB precursor
plpC 0.11 4.0E-01 -0.28 3.5E-02 D-methionine-binding lipoprotein PlpC precursor
plpD -0.03 8.1E-01 -0.25 3.9E-02 D-methionine-binding lipoprotein PlpD precursor
llmg_0342 0.44 6.7E-03 -0.22 8.5E-02 amino acid ABC transporter permease protein
llmg_0341 0.44 5.9E-03 -0.24 6.1E-02 amino acid ABC transporter ATP binding protein
dppA 0.14 2.8E-01 -0.16 1.8E-01 dipeptide-binding protein precursor
dppB 0.48 7.6E-03 -0.14 3.2E-01 dipeptide transport system permease protein DppB
dppC 0.92 3.7E-05 0.01 9.2E-01 dipeptide transport system permease protein DppC
dppD 0.76 2.6E-04 -0.23 9.1E-02 dipeptide transport ATP-binding protein DppD
dppF 0.60 2.0E-03 -0.18 1.9E-01 dipeptide transport ATP-binding protein DppF
fhuD 0.05 7.3E-01 -0.05 7.1E-01 ferrichrome ABC transporter substrate binding protein
fhuB 0.43 1.6E-01 -0.06 8.1E-01 ferrichrome ABC transporter permease protein
fhuG 0.25 2.1E-01 0.09 6.0E-01 ferrichrome ABC transporter permease protein
llmg_1281 0.24 4.5E-01 -0.14 6.3E-01 putative ABC transporter ATP-binding protein
fhuC 0.28 2.4E-01 -0.02 9.2E-01 ferrichrome ABC transporter FhuC
zitS 0.11 4.8E-01 0.48 5.2E-03 zinc ABC transporter substrate binding protein
zitP 0.61 3.1E-02 0.34 1.6E-01 zinc ABC transporter permease protein
zitQ 0.28 1.2E-01 0.29 7.6E-02 zinc ABC transporter ATP binding protein
cbiQ 0.50 1.7E-02 0.15 3.6E-01 putative cobalt ABC transporter permease protein
cbiQ2 -0.25 1.3E-01 -0.57 2.4E-03 putative cobalt ABC transporter permease protein
cbiO 0.39 2.2E-02 -0.01 9.4E-01 putative cobalt ABC transporter ATP-binding protein
cbiO -0.40 2.5E-02 -0.19 1.9E-01 cobalt transporter ATP-binding subunit
cbiO 0.04 7.3E-01 -0.55 8.8E-04 cobalt transporter ATP-binding subunit
llmg_1552 0.13 4.0E-01 0.38 2.3E-02 putative ABC type transport system permease protein
drrB -0.39 1.5E-01 -0.21 3.9E-01 daunorubicin resistance transmembrane protein
llmg_0262 0.58 1.9E-03 0.25 7.2E-02 ABC transporter permease protein
llmg_1553 0.25 2.3E-01 0.04 8.4E-01 putative ABC transporter ATP-binding protein
drrA 0.18 3.3E-01 0.03 8.4E-01 daunorubicin resistance ABC transporter ATP-binding subunit
tagG 0.96 6.9E-04 0.39 5.7E-02 teichoic acid ABC transporter permease protein
tagH 0.51 1.1E-02 0.11 4.7E-01 teichoic acid export ATP-binding protein TagH 
ftsX -0.24 1.2E-01 -0.30 4.2E-02 cell division protein FtsX-like protein
ftsE -0.40 4.6E-02 -0.09 6.1E-01 cell division ATP-binding protein
llmg_1202 -0.24 9.2E-02 0.45 3.7E-03 ABC transporter ABC binding and permease protein
cydD -0.08 6.3E-01 -0.09 5.3E-01 cytochrome d ABC transporter ATP binding and permease protein
cydC -0.08 5.2E-01 -0.08 4.8E-01 cytochrome d ABC transporter ATP binding and permease protein
llmg_0989 0.09 4.6E-01 -0.03 7.6E-01 ABC transporter ATP binding and permease protein




LogFC p. Value logFC P.value
apl 0.30 1.9E-01 0.24 2.4E-01 alkaline phosphatase 
pstE -0.48 4.3E-03 -0.54 1.1E-03 phosphate transport substrate binding protein PstE
pstF -0.01 9.7E-01 -0.45 4.4E-03 phosphate transport substrate binding protein PstF
kinC -0.15 3.0E-01 -0.13 3.3E-01 sensor histidine kinase 
llrC -0.17 2.8E-01 -0.03 8.5E-01 two-component system regulator
llmg_0458 -0.19 1.7E-01 0.15 2.3E-01 hypothetical protein 
dnaA -0.36 3.7E-02 0.63 1.2E-03 chromosomal replication initiation protein
mleS 0.03 8.7E-01 -0.17 2.9E-01 malate dehydrogenase 
comX -0.39 5.7E-02 -0.11 5.1E-01 competence regulator ComX
frdC -0.29 5.8E-02 -0.28 4.2E-02 fumarate reductase flavoprotein subunit 
llmg_0018 0.09 5.3E-01 0.30 3.5E-02 beta-lactamase A 
kinD -0.14 2.4E-01 -0.27 3.1E-02 sensor protein kinase KinD 
glnB -0.30 4.0E-02 -0.33 1.9E-02 nitrogen regulatory protein P-II
glnA -0.16 3.0E-01 -0.61 1.3E-03 GlnA protein 
thiL -0.19 2.2E-01 0.10 5.0E-01 ThiL protein 
cydA -0.07 6.2E-01 -0.27 4.7E-02 cytochrome bd-I ubiquinol oxidase subunit I 
cydB 0.03 8.1E-01 0.07 5.3E-01 cytochrome d ubiquinol oxidase, subunit II 




LogFC p. Value logFC P.value
dppA 0.14 2.7E-01 -0.16 1.7E-01  dipeptide-binding protein precursor
dppB 0.48 8.1E-03 0.00 3.1E-01  dipeptide transport system permease protein DppB
dppC 0.92 4.9E-05 0.01 9.1E-01  dipeptide transport system permease protein DppC
dppD 0.76 3.2E-04 -0.23 8.8E-02  dipeptide transport ATP-binding protein DppD
dppF 0.60 2.3E-03 -0.18 1.9E-01  dipeptide transport ATP-binding protein DppF
gltD -0.02 8.7E-01 -0.22 9.4E-02  glutamate synthase subunit beta 
gltB -0.07 7.4E-01 -0.77 3.1E-03  glutamate synthase, large subunit 
lysA -0.13 3.1E-01 -0.19 1.3E-01  LysA protein 
ilvD -0.12 7.4E-01 -0.61 8.9E-02  dihydroxy-acid dehydratase 
ilvB -0.16 6.4E-01 -0.57 8.9E-02  acetolactate synthase catalytic subunit 
ilvN -0.36 2.8E-01 -0.64 5.3E-02  acetolactate synthase 3 regulatory subunit 
ilvC -0.17 5.3E-01 -0.64 2.5E-02  ketol-acid reductoisomerase 
ilvA -0.29 1.3E-01 -0.56 6.2E-03  threonine dehydratase 
aldB -0.39 1.8E-02 -0.34 2.4E-02  AldB protein 
hisC -0.06 7.8E-01 0.28 1.9E-01  histidinol-phosphate aminotransferase 
hisZ 0.15 6.6E-01 0.07 8.1E-01  ATP phosphoribosyltransferase regulatory subunit 
hisG 0.08 7.0E-01 -0.28 1.5E-01  ATP phosphoribosyltransferase catalytic subunit 
hisD 0.08 5.7E-01 -0.05 7.0E-01  HisD protein 
hisB 0.09 5.1E-01 0.04 7.6E-01  imidazoleglycerol-phosphate dehydratase 
hisH -0.08 5.3E-01 -0.03 8.2E-01  imidazole glycerol phosphate synthase subunit HisH 
hisA -0.01 9.7E-01 0.00 5.9E-01
 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)-methylideneamino] imidazole-
4-carboxamide isomerase 
hisF -0.19 1.4E-01 -0.04 7.4E-01  imidazole glycerol phosphate synthase subunit HisF 
hisI 0.03 8.1E-01 0.10 4.5E-01
 bifunctional phosphoribosyl-AMP cyclohydrolase/phos-phoribosyl-ATP 
pyrophosphatase protein 
hisK 0.05 7.4E-01 0.17 1.9E-01  histidinol-phosphatase 
ctrA -0.14 2.8E-01 -0.44 3.0E-03  putative amino-acid transporter
oppD -0.07 6.1E-01 -0.73 1.7E-04  oligopeptide transport ATP-binding protein OppD
oppF -0.09 4.7E-01 -0.63 2.8E-04  oligopeptide transport ATP-binding protein OppF
oppB 0.11 4.5E-01 -0.38 1.4E-02  peptide transport system permease protein OppB
oppC 0.01 9.1E-01 -0.40 7.9E-03  oligopeptide transport system permease protein OppC
oppA -0.07 5.9E-01 0.17 1.9E-01  oligopeptide-binding protein OppA precursor
pepO 0.02 8.8E-01 -0.05 6.7E-01  endopeptidase O 
asnB -0.21 1.2E-01 -0.29 3.1E-02  asparagine synthetase B 
gltA -0.02 8.5E-01 -0.13 2.7E-01  citrate synthase 
citB -0.10 4.3E-01 -0.13 2.4E-01  aconitate hydratase 
icD -0.09 4.4E-01 -0.01 9.5E-01  isocitrate dehydrogenase 
serC -0.08 5.3E-01 -0.14 2.4E-01  phosphoserine aminotransferase 
serA -0.31 4.9E-02 -0.64 6.0E-04  D-3-phosphoglycerate dehydrogenase 
serB -0.27 1.3E-01 -0.49 8.5E-03  SerB protein 
ArcD1 0.50 1.5E-01 -0.12 6.8E-01  arginine/ornithine antiporter
ArcC1 0.28 3.4E-01 -0.15 5.6E-01  carbamate kinase 
ArcC2 0.25 2.8E-01 -0.07 7.3E-01  carbamate kinase 
amtB -0.16 2.8E-01 -0.45 6.8E-03  ammonium transporter AmtB
dapB -0.02 8.7E-01 -0.20 1.5E-01  dihydrodipicolinate reductase 
FtsW1 -0.30 1.6E-01 -0.01 9.5E-01  cell division protein ftsW1
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LogFC p. Value logFC P.value Effect
galP 0.76 8.5E-02 0.08 8.3E-01 Rep  galactose permease
galM 0.57 7.3E-02 0.24 3.6E-01 Rep aldose 1-epimerase 
galK 0.25 2.1E-01 0.06 7.1E-01 Rep galactokinase 
galT 0.16 3.7E-01 0.02 9.0E-01 Rep galactose-1-phosphate uridylyltransferase 
galE -0.32 5.7E-02 0.33 3.8E-02 Rep GalE protein 
mtlA 0.23 1.4E-01 -0.15 2.9E-01 Rep PTS system, mannitol-specific IIBC component 
mtlR -0.03 8.6E-01 -0.10 4.6E-01 Rep transcriptional regulator mtl operon MtlR
mtlF 0.23 9.6E-02 0.02 8.7E-01 Rep PTS system, mannitol-specific IIA component 
mtlD 0.21 1.0E-01 0.01 9.4E-01 Rep mannitol-1-phosphate 5-dehydrogenase 
llmg_0453 0.07 5.5E-01 -0.01 9.6E-01 Rep sucrose-specific PTS enzyme IIABC
llmg_0454 0.23 1.1E-01 -0.25 6.0E-02 Rep beta-glucoside-specific PTS system IIABC component
trePP -0.16 1.6E-01 -0.21 5.3E-02 Rep putative trehalose/maltose hydrolase 
pgmB 0.15 2.7E-01 0.36 1.2E-02 Rep beta-phosphoglucomutase 
llmg_0431 0.41 2.0E-02 0.02 8.7E-01 Rep putative acyl carrier protein phosphodiesterase 2 
llmg_0432 0.15 2.3E-01 0.08 4.9E-01 Rep transcription regulator
ptcB 0.15 4.8E-01 0.83 1.6E-03 Rep cellobiose-specific PTS system IIB component 
ptcA -0.10 5.7E-01 1.00 1.8E-04 Rep cellobiose-specific PTS system IIA component 
llmg_0439 0.22 1.5E-01 0.38 1.7E-02 Rep LacI family transcription regulator
ptcC 0.59 1.8E-02 -0.06 7.5E-01 Rep cellobiose-specific PTS system IIC component 
bglA 0.25 1.1E-01 -0.02 9.1E-01 Rep 6-phospho-beta-glucosidase 
arcA 0.63 7.2E-02 0.02 9.4E-01 Rep arginine deiminase 
arcB 0.43 1.3E-01 -0.06 8.2E-01 Rep ornithine carbamoyltransferase 
arcD1 0.50 1.5E-01 -0.12 6.8E-01 Rep arginine/ornithine antiporter
arcC1 0.28 3.4E-01 -0.15 5.6E-01 Rep carbamate kinase 
arcC2 0.25 2.8E-01 -0.07 7.3E-01 Rep carbamate kinase 
pfk -0.26 5.7E-02 -0.56 7.3E-04 Act 6-phosphofructokinase 
pyk -0.27 9.4E-02 -1.09 2.1E-05 Act pyruvate kinase 
ldh -0.51 1.8E-02 -0.45 2.1E-02 Act L-lactate dehydrogenase 
pgiA -0.16 3.5E-01 0.54 4.7E-03 Act glucose-6-phosphate isomerase 
fruA 0.37 5.0E-02 -0.19 2.4E-01 Act PTS system, fructose specific IIBC components 
fruC -0.18 1.9E-01 -0.39 8.4E-03 Act tagatose-6-phosphate kinase 
fruR -0.05 7.2E-01 0.10 4.7E-01 Act lactose transport regulator
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LogFC p. Value logFC P.value
accA -0.22 1.2E-01 -0.01 9.5E-01 AccA protein 
accB -0.23 2.2E-01 -1.05 8.0E-05 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
accC -0.26 5.7E-02 -0.71 9.2E-05 acetyl-CoA carboxylase biotin carboxylase subunit 
accD -0.14 2.4E-01 -0.28 2.6E-02 acetyl-CoA carboxylase subunit beta 
fabD -0.21 2.2E-01 -0.76 5.6E-04 malonyl CoA-acyl carrier protein transacylase 
fabF -0.23 1.8E-01 -1.05 3.4E-05 3-oxoacyl-[acyl-carrier-protein] synthase II 
fabH -0.54 1.2E-02 -0.51 9.9E-03 3-oxoacyl-(acyl carrier protein) synthase III 
fabG -0.33 9.6E-02 -0.92 2.6E-04 3-ketoacyl-(acyl-carrier-protein) reductase 
fabG -0.38 9.0E-02 -0.58 1.1E-02 3-ketoacyl-(acyl-carrier-protein) reductase 
fabZ -0.26 1.6E-01 -1.07 5.2E-05 (3R)-hydroxymyristoyl-ACP dehydratase 
llmg_0538 -0.30 7.2E-02 0.66 8.0E-04 (3R)-hydroxymyristoyl-(acyl-carrier-protein) dehydratase 
fabI -0.24 1.2E-01 -0.22 1.1E-01 enoyl-(acyl carrier protein) reductase 
llmg_1415 -0.14 2.7E-01 0.58 5.4E-04 hypothetical protein
thiL -0.19 2.2E-01 0.10 5.0E-01 ThiL protein 
llmg_1965 0.27 1.5E-01 -0.02 9.1E-01 putative AMP-binding enzyme 
adhE 0.52 6.7E-02 -0.10 6.8E-01 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP 0.16 3.0E-01 -0.24 1.1E-01 alcohol dehydrogenase 
llmg_0955 -0.12 6.2E-01 0.04 8.4E-01 alcohol dehydrogenase 
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llmg_0870 0.07 6.5E-01 -0.30 5.3E-02 transporter
glpF2 0.67 6.6E-04 -0.10 4.6E-01 glycerol uptake facilitator
glpF3 -0.15 2.5E-01 0.45 3.5E-03 putative glycerol uptake facilitator protein
dhaK 0.35 4.4E-02 0.11 4.5E-01 DhaKLM operon coactivator DhaQ 
dhaM 0.57 2.8E-03 -0.04 7.4E-01 dihydroxyacetone kinase DhaM 
glpK 0.52 2.0E-02 -0.24 1.9E-01 glycerol kinase 
plsX 0.16 3.0E-01 -0.21 1.5E-01 putative glycerol-3-phosphate acyltransferase PlsX
llmg_1540 -0.17 3.7E-01 0.05 7.8E-01 putative glycerol-3-phosphate acyltransferase PlsY
llmg_0119 -0.18 2.0E-01 -0.18 1.6E-01 putative acyltransferase 
dgkA -0.34 4.4E-02 0.38 1.8E-02 DgkA protein 
llmg_2421 -0.01 9.2E-01 0.17 1.9E-01 hypothetical protein
glpD 0.44 2.9E-02 -0.18 2.8E-01 GlpD protein 
gpsA -0.18 3.4E-01 -0.59 4.9E-03 NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 
llmg_0945 -0.12 3.2E-01 -0.49 1.0E-03 putative glycerol dehydrogenase 
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llmg_2075 -0.30 2.8E-02 -0.70 8.2E-05 ADP-ribose pyrophosphatase 
deoB -0.25 7.1E-02 -0.76 6.4E-05 phosphopentomutase 
prsB -0.32 3.6E-02 -0.26 6.1E-02 ribose-phosphate pyrophosphokinase 
prsA -0.16 3.6E-01 0.06 7.0E-01 ribose-phosphate pyrophosphokinase 
purF -0.25 2.6E-01 -0.90 7.9E-04 amidophosphoribosyltransferase 
purD -0.50 7.0E-03 -0.69 4.9E-04 phosphoribosylamine--glycine ligase 
purN -0.19 2.2E-01 0.09 5.2E-01 phosphoribosylglycinamide formyltransferase 
purS -0.21 9.8E-02 -0.12 3.0E-01 phosphoribosylformylglycinamidine synthetase PurS
purQ -0.57 3.6E-03 -0.84 1.3E-04 phosphoribosylformylglycinamidine synthase I 
purL -0.37 1.0E-01 -1.10 1.8E-04 phosphoribosylformylglycinamidine synthase II 
purM -0.32 3.8E-02 -0.39 9.1E-03 phosphoribosylaminoimidazole synthetase 
purK -0.31 7.8E-02 -0.02 9.0E-01 phosphoribosylaminoimidazole carboxylase ATPase subunit 
purE -0.06 6.9E-01 -0.59 1.4E-03 phosphoribosylaminoimidazole carboxylase catalytic subunit 
purC -0.19 1.3E-01 0.11 3.1E-01 phosphoribosylaminoimidazole-succinocarboxamide synthase 
purB -0.27 9.0E-02 0.33 3.5E-02 adenylosuccinate lyase 
purH -0.43 3.3E-02 -1.15 2.9E-05
bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 
apt -0.11 4.7E-01 0.19 2.0E-01 adenine phosphoribosyltransferase 
nucA -0.29 2.4E-01 0.22 3.3E-01 5'-nucleotidase 
llmg_0192 0.18 2.3E-01 -0.09 5.1E-01 5'-nucleotidase precursor 
deoD -0.51 1.2E-02 0.64 1.8E-03 purine nucleoside phosphorylase 
hprT -0.26 1.4E-01 0.30 6.4E-02 HprT protein 
hpt -0.02 9.1E-01 0.29 7.9E-02 hypoxanthine phosphoribosyltransferase 
guaB -0.35 7.8E-02 -0.77 8.6E-04 inosine 5'-monophosphate dehydrogenase 
llmg_1188 -0.21 1.0E-01 -0.62 1.7E-04 hypothetical protein
xpt -0.42 9.6E-03 -0.44 4.2E-03 xanthine phosphoribosyltransferase 
guaA -0.20 1.9E-01 -0.85 1.1E-04 GMP synthase 
guaC -0.36 1.9E-02 -0.12 3.4E-01 guanosine 5'-monophosphate oxidoreductase 
gmk 0.03 8.5E-01 0.22 1.2E-01 guanylate kinase 
pyk -0.27 9.4E-02 -1.09 1.3E-05 pyruvate kinase 
nrdE -0.14 2.9E-01 -0.20 1.1E-01 ribonucleotide-diphosphate reductase subunit alpha 
nrdF -0.41 2.6E-02 -0.08 5.8E-01 ribonucleotide-diphosphate reductase subunit beta 
llmg_0281 0.11 3.6E-01 -0.21 8.3E-02 anaerobic ribonucleoside triphosphate reductase 
rpoA -0.21 1.4E-01 -0.82 5.2E-05 DNA-directed RNA polymerase subunit alpha 
rpoB -0.05 7.8E-01 -0.92 3.6E-04 DNA-directed RNA polymerase subunit beta 
rpoC -0.14 4.9E-01 -0.84 1.0E-03 DNA-directed RNA polymerase subunit beta' 
rpoE -0.26 6.2E-02 0.14 2.4E-01 DNA-directed RNA polymerase subunit delta 
rpoZ -0.37 2.8E-02 -0.01 9.1E-01 DNA-directed RNA polymerase subunit omega 
polA 0.28 6.7E-02 0.11 4.2E-01 DNA polymerase I 
dnaE 0.08 5.4E-01 0.22 8.6E-02 DNA polymerase III DnaE 
polC 0.76 1.1E-04 -0.05 6.4E-01 DNA polymerase III PolC 
dnaN -0.08 5.0E-01 1.05 2.5E-06 DNA polymerase III subunit beta 
dnaX 0.19 1.7E-01 -0.44 4.4E-03 DNA polymerase III subunits gamma and tau 
holA -0.39 2.9E-02 -0.16 2.7E-01 DNA polymerase III subunit delta 
holB -0.24 9.0E-02 -0.29 3.2E-02 DNA polymerase III subunit delta' 
dnaQ -0.14 3.3E-01 0.21 1.2E-01 DNA polymerase III, epsilon chain 
relA -0.21 1.4E-01 0.04 7.7E-01 GTP pyrophosphokinase 
llmg_0382 0.15 3.7E-01 -0.07 6.3E-01 putative GTP pyrophosphokinase 
purA -0.20 1.4E-01 -0.28 3.7E-02 adenylosuccinate synthetase 
add -0.32 3.7E-02 0.23 8.3E-02 adenosine deaminase 
cpdC -0.32 2.1E-02 -0.39 4.2E-03 2',3'-cyclic-nucleotide 2'-phosphodiesterase 
adk -0.06 6.7E-01 0.54 2.4E-03 adenylate kinase 
pnpA -0.12 4.8E-01 -0.56 4.1E-03 polynucleotide phosphorylase/polyadenylase 
arcC2 0.25 2.7E-01 -0.07 7.2E-01 carbamate kinase 
arcC1 0.28 3.3E-01 -0.15 5.4E-01 carbamate kinase 




LogFC p. Value logFC P.value
carB -0.33 6.3E-02 -1.00 4.6E-05 carbamoyl phosphate synthase large subunit 
carA -0.12 4.7E-01 -0.71 6.7E-04 carbamoyl phosphate synthase small subunit 
pyrB -0.07 5.8E-01 -0.77 6.8E-05 aspartate carbamoyltransferase catalytic subunit 
pyrC -0.33 4.4E-02 -0.55 2.0E-03 dihydroorotase 
pyrDA -0.38 5.4E-02 0.23 1.8E-01 dihydroorotate dehydrogenase 1A 
pyrDB 0.05 7.9E-01 -1.07 1.1E-04 dihydroorotate dehydrogenase 1B 
pyrE -0.33 2.0E-02 -0.48 1.3E-03 orotate phosphoribosyltransferase 
pyrF -0.60 1.8E-03 -0.70 3.4E-04 orotidine 5'-phosphate decarboxylase 
cmk -0.33 3.9E-02 0.13 3.4E-01 cytidylate kinase 
pyrH -0.16 2.0E-01 -0.19 1.1E-01 uridylate kinase 
pnpA -0.12 4.8E-01 -0.56 4.1E-03 polynucleotide phosphorylase/polyadenylase 
llmg_1188 -0.21 1.0E-01 -0.62 1.7E-04 hypothetical protein
pyrG 0.05 7.1E-01 -0.31 2.8E-02 CTP synthetase 
rpoA -0.21 1.4E-01 -0.82 5.2E-05 DNA-directed RNA polymerase subunit alpha 
rpoB -0.05 7.8E-01 -0.92 3.6E-04 DNA-directed RNA polymerase subunit beta 
rpoC -0.14 4.9E-01 -0.84 1.0E-03 DNA-directed RNA polymerase subunit beta' 
rpoE -0.26 6.2E-02 0.14 2.4E-01 DNA-directed RNA polymerase subunit delta 
rpoZ -0.37 2.8E-02 -0.01 9.1E-01 DNA-directed RNA polymerase subunit omega 
polA 0.28 6.7E-02 0.11 4.2E-01 DNA polymerase I 
dnaE 0.08 5.4E-01 0.22 8.6E-02 DNA polymerase III DnaE 
polC 0.76 1.1E-04 -0.05 6.4E-01 DNA polymerase III PolC 
dnaN -0.08 5.0E-01 1.05 2.5E-06 DNA polymerase III subunit beta 
dnaX 0.19 1.7E-01 -0.44 4.4E-03 DNA polymerase III subunits gamma and tau 
holA -0.39 2.9E-02 -0.16 2.7E-01 DNA polymerase III subunit delta 
holB -0.24 9.0E-02 -0.29 3.2E-02 DNA polymerase III subunit delta' 
dnaQ -0.14 3.3E-01 0.21 1.2E-01 DNA polymerase III, epsilon chain 
udk -0.20 9.8E-02 0.59 2.1E-04 uridine kinase 
nucA -0.29 2.4E-01 0.22 3.3E-01 5'-nucleotidase 
llmg_0192 0.18 2.3E-01 -0.09 5.1E-01 5'-nucleotidase precursor 
udp -0.45 3.6E-03 -0.30 1.9E-02 uridine phosphorylase 
upp -0.27 7.1E-02 0.34 2.0E-02 uracil phosphoribosyltransferase 
pyrR -0.18 2.3E-01 -0.63 7.9E-04
bifunctional pyrimidine regulatory protein PyrR uracil 
phosphoribosyltransferase 
pdp -0.18 1.8E-01 -0.58 4.6E-04 pyrimidine-nucleoside phosphorylase 
trxB1 -0.19 1.5E-01 0.21 8.2E-02 TrxB1 protein 
trxB2 -0.05 7.1E-01 0.21 1.3E-01 TrxB2 protein 
llmg_0281 0.11 3.6E-01 -0.21 8.3E-02 anaerobic ribonucleoside triphosphate reductase 
nrdE -0.14 2.9E-01 -0.20 1.1E-01 ribonucleotide-diphosphate reductase subunit alpha 
nrdF -0.41 2.6E-02 -0.08 5.8E-01 ribonucleotide-diphosphate reductase subunit beta 
ps428 -0.26 8.6E-02 -0.11 3.9E-01 deoxyuridine 5'-triphosphate nucleotidohydrolase 
ps325 -0.06 6.9E-01 0.04 7.3E-01 deoxyuridine 5'-triphosphate nucleotidohydrolase 
dut 0.23 1.5E-01 -0.04 7.8E-01 deoxyuridine 5'-triphosphate nucleotidohydrolase 
thyA 0.04 7.3E-01 0.92 7.2E-06 thymidylate synthase 
cdd -0.05 7.0E-01 -0.43 4.2E-03 Cdd protein 
deoD -0.51 1.2E-02 0.64 1.8E-03 purine nucleoside phosphorylase 
llmg_1416 0.30 1.5E-01 0.33 8.9E-02 hypothetical protein
ntd 0.11 4.0E-01 -0.13 3.2E-01 nucleoside deoxyribosyltransferase 
tdk -0.24 1.4E-01 0.07 6.0E-01 thymidine kinase 
tmk -0.64 5.7E-03 -0.32 8.1E-02 thymidylate kinase 
cpdC -0.32 2.1E-02 -0.39 4.2E-03 2',3'-cyclic-nucleotide 2'-phosphodiesterase 




LogFC p. Value logFC P.value
speG 0.18 2.6E-01 0.25 9.6E-02 spermidine acetyltransferase 
llmg_0177 0.30 2.4E-01 -0.06 7.7E-01 amidase
proC -0.39 1.7E-02 -0.37 1.5E-02 pyrroline-5-carboxylate reductase 
ocd -0.09 5.9E-01 0.01 9.6E-01 ornithine cyclodeaminase, mu-crystallin-like protein
proB -0.17 1.6E-01 -0.47 1.1E-03 gamma-glutamyl kinase 
proA -0.11 4.1E-01 -0.04 7.2E-01 gamma-glutamyl phosphate reductase 
kdgA 0.55 2.7E-02 -0.06 7.5E-01
keto-hydroxyglutarate-aldolase/keto-deoxy-
phosphogluconate aldolase 
arcB 0.43 1.2E-01 -0.06 8.1E-01 ornithine carbamoyltransferase 
argF 0.16 4.8E-01 -0.27 2.0E-01 ornithine carbamoyltransferase 
argG -0.08 6.2E-01 -0.41 1.7E-02 argininosuccinate synthase 
argH -0.10 4.9E-01 -0.19 1.7E-01 argininosuccinate lyase 
arcA 0.63 6.1E-02 0.02 9.4E-01 arginine deiminase 
glnA -0.16 3.0E-01 -0.61 1.3E-03 GlnA protein 
arcC2 0.25 2.7E-01 -0.07 7.2E-01 carbamate kinase 
arcC1 0.28 3.3E-01 -0.15 5.4E-01 carbamate kinase 
argJ 0.11 5.1E-01 -0.29 8.4E-02
bifunctional ornithine acetyltransferase/N-acetylglutamate 
synthase protein 
argB 0.29 2.7E-01 -0.25 3.0E-01 acetylglutamate kinase 
argC 0.14 3.6E-01 -0.12 3.9E-01 N-acetyl-gamma-glutamyl-phosphate reductase 
argD 0.59 8.6E-02 -0.21 4.7E-01 acetylornithine aminotransferase 
argE -0.23 1.4E-01 -0.45 6.9E-03 acetylornithine deacetylase 
Gene/locus BK1506 BK1503 Annotation
Arginine and proline metabolism
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LogFC p. Value logFC P.value
dfrA -0.64 1.3E-03 0.28 6.2E-02 DfrA protein 
fhs -0.27 5.1E-02 0.16 1.8E-01 formate--tetrahydrofolate ligase 




glyA -0.25 9.8E-02 -0.33 2.6E-02 serine hydroxymethyltransferase 
purN -0.19 2.2E-01 0.09 5.2E-01 phosphoribosylglycinamide formyltransferase 
purH -0.43 3.3E-02 -1.15 2.9E-05 bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 
fmt -0.20 1.2E-01 -0.52 9.0E-04 methionyl-tRNA formyltransferase 
thyA 0.04 7.3E-01 0.92 7.2E-06 thymidylate synthase 
metF -0.07 5.9E-01 -0.10 3.9E-01 5,10-methylenetetrahydrofolate reductase
llmg_0181 0.23 1.0E-01 0.15 2.2E-01 5-formyltetrahydrofolate cyclo-ligase family protein 
thiD1 0.41 6.6E-02 -0.09 6.1E-01 phosphomethylpyrimidine kinase 
nifS -0.27 1.3E-01 -0.17 2.7E-01 putative iron-sulfur cofactor synthesis protein 
nifZ -0.50 4.9E-03 0.47 4.2E-03 pyridoxal-phosphate dependent aminotransferase 
llmg_1972 0.09 6.4E-01 -0.61 6.4E-03 hypothetical protein
thiI 0.19 3.0E-01 -0.40 2.7E-02 thiamine biosynthesis protein ThiI
thiM 0.00 9.7E-01 -0.11 3.7E-01 hydroxyethylthiazole kinase 
thiE -0.24 8.2E-02 -0.08 5.1E-01 thiamine-phosphate pyrophosphorylase 
thiN -0.02 9.1E-01 0.16 2.4E-01 thiamin pyrophosphokinase 
tenA -0.19 2.0E-01 -0.10 4.3E-01 transcriptional activator TenA
ribA 0.24 1.1E-01 0.02 8.5E-01 riboflavin biosynthesis protein RibA 
ribD 0.15 2.2E-01 0.02 8.4E-01 riboflavin biosynthesis protein RibD 
ribH 0.08 5.8E-01 -0.02 8.6E-01 6,7-dimethyl-8-ribityllumazine synthase 
ribB 0.40 8.3E-03 0.15 2.1E-01 riboflavin synthase subunit alpha 
ribC, ribF -0.12 4.1E-01 0.51 3.0E-03 bifunctional riboflavin kinase/FMN adenylyltransferase 
thiD2 -0.09 6.2E-01 0.00 1.0E+00 phosphomethylpyrimidine kinase 
serC -0.08 5.4E-01 -0.14 2.5E-01 phosphoserine aminotransferase 
thrC -0.33 3.4E-02 -0.45 4.4E-03 threonine synthase 
pncB -0.34 3.5E-02 -0.38 1.4E-02 nicotinate phosphoribosyltransferase 
deoD -0.51 1.2E-02 0.64 1.8E-03 purine nucleoside phosphorylase 
nucA -0.29 2.4E-01 0.22 3.3E-01 5'-nucleotidase 
llmg_0192 0.18 2.3E-01 -0.09 5.1E-01 5'-nucleotidase precursor 
nadD -0.38 1.8E-02 -0.38 1.2E-02 nicotinic acid mononucleotide adenylyltransferase 
nadD1 0.00 9.8E-01 -0.25 1.9E-01 nicotinate-nucleotide adenylyltransferase 
nadE -0.19 2.1E-01 0.14 2.8E-01 NAD synthetase 
ppnK 0.08 6.9E-01 -0.22 2.4E-01 inorganic polyphosphate/ATP-NAD kinase 
als -0.13 5.1E-01 -0.35 6.9E-02 acetolactate synthase 
ilvB -0.16 6.2E-01 -0.57 7.6E-02 acetolactate synthase catalytic subunit 
ilvH -0.36 2.6E-01 -0.64 4.3E-02 acetolactate synthase 3 regulatory subunit 
ilvC -0.17 5.1E-01 -0.64 2.0E-02 ketol-acid reductoisomerase 
ilvD -0.12 7.3E-01 -0.61 7.5E-02 dihydroxy-acid dehydratase 
panE -0.13 4.3E-01 0.72 6.9E-04 2-dehydropantoate 2-reductase 
coaA -0.40 2.4E-02 0.37 2.3E-02 pantothenate kinase 
dfpB -0.11 4.0E-01 -0.38 7.6E-03 phosphopantothenate--cysteine ligase 
dfpA 0.14 4.2E-01 -0.45 1.4E-02 phosphopantothenoylcysteine decarboxylase 
coaD -0.03 8.6E-01 0.14 3.6E-01 phosphopantetheine adenylyltransferase 
coaE 0.07 5.5E-01 0.19 9.1E-02 dephospho-CoA kinase 
acpS -0.19 1.8E-01 -0.48 2.7E-03 4'-phosphopantetheinyl transferase 
ilvE -0.19 2.7E-01 0.04 8.1E-01 branched-chain amino acid aminotransferase 
birA2 -0.01 9.5E-01 0.20 8.1E-02 acetyl-CoA carboxylase ligase / biotin operon repressor 
birA1 -0.23 9.3E-02 -0.04 7.1E-01
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1. Introduction, goal and scope 
 
According to the EU directive 2009/28/EC of 23 April 2009, all member countries shall ensure by 2020 that 
the share of energy from renewable sources in transport is at least 10 % of the total fuel consumption. For 
achieving this goal an increased production of biodiesel from biomass plays an important role. In biodiesel 
production, glycerol is derived as by-product. Due to an increased biodiesel production in recent years high 
amounts of glycerol entered the market. This development led to a saturation of the glycerol market over 
the last years with prices for crude glycerol falling considerably. 
The objective of the GLYFINERY project is to search for alternative uses for glycerol. Thereby, sustainable 
usage pathways for glycerol shall be determined and the biodiesel production as a whole shall be 
optimized. This is achieved by designing biorefinery production schemes for the production of biofuels, bio-
energy and green chemicals from glycerol. Accompanying, the objective of WP7 is to assess the economic 
and ecological sustainability of biodiesel production and glycerol processing and to derive optimisation 
potentials. 
There are two core questions for which the assessments in WP 7 will provide answers: 
1. From an ecological and economic point of view, what is the best way to use glycerol resulting from 
biodiesel production? 
2. How do the different usage pathways for glycerol from biodiesel production affect the economic 
and ecological performance of biodiesel production as a whole? 
To address the core questions, the following issues will be assessed: 
• What are the advantages and disadvantages of innovative glycerol usage pathways in 
comparison to the currently existing pathways? 
• What is the best use of the products derived from glycerol processing? 
• How does the production of green energy from glycerol compare to the material usage or the 
usage in chemical industries? 
• What is the influence of different usage pathways for the by-products on the overall results and 
which usage shall be preferred? 
• What is the relative importance of various life cycle steps on the overall results and which 
optimisation potentials can be identified? 
 
This paper was prepared as a fulfilment of work task 7.1: Technological assessment as part of work package 
7: Integrated assessment. The paper describes the technological aspects of glycerol production and 
processing and defines the life cycles and system boundaries. The definitions and settings will be used in 
the following tasks, especially for the ecological (WT 7.2) and economic (WT 7.3) assessment.  
Each conversion process is dealt with in a separate section and the main focus of the report is the single 
process systems i. e. conversion of glycerol to a single product such as the conversion of glycerol to ethanol. 
No multi-product scenarios have been considered so far. 
1
2. Background 
2.1 Biodiesel: A source of crude glycerol 
 
The focus of the GLYFINERY project is the conversion of glycerol to other useful compounds. The biggest 
source of glycerol is associated with the increasing production of biodiesel. In biodiesel production the 
main byproduct is glycerol (glycerin, glycerine, 1,2,3-Propanetriol, 1,2,3-Trihydroxypropane). When 
producing biodiesel approx. 10 % of the reaction volume in a given biodiesel production process ends up as 
glycerol. When considering that biodiesel production in Europe has increased to an annual production of 
around 5.7 million tonnes in 2007 the amount of glycerol which could be utilized from this production alone 
would be in the order of 570,000 ton (1). An overview of a typical biodiesel production process can be seen 
in Figure 1 below.  
 
Figure 1: Schematic overview of a standard biodiesel production process. Two main products are produced in this process are 
biodiesel and glycerol.  
 
2.2 Production of biodiesel 
 
The basic process of producing biodiesel is a chemical transesterification reaction converting triglycerides 
into fatty acid alkyl monoesters (FAAM) in the presence of a catalyst. An overview of the reaction can be 
seen in Figure 2. 
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As shown in Figure 2 the transesterification reaction requires three moles of alcohol to convert 1 mole of 
triglyceride which yields three moles of fatty acid alkyl esters and one mole of glycerol. Even though the 
stochiometric demand is three moles of alcohol higher ratios (6:1 or higher) are generally used in practice 
to ensure complete reaction (2; 3; 4; 5). 
When setting up a biodiesel production process there are a several different parameters to take into 
account: the feedstock to use, choice of catalyst and type of alcohol. In principle any oleaginous material 
can be used as feedstock for a biodiesel process. Most biodiesel production comes from virgin vegetable oil 
of crops such as rape seed, sunflower or soy bean. Other feedstocks include nonedible oils (jatropha, 
pongamia), waste cooking oils or animal fats. However these feedstocks can have higher levels of free fatty 
acids (FFA) and water which leads to problems with saponification during biodiesel production with an 
alkali catalyst.  
The choice of alcohol to use is mainly an economic concern. Branched chain alcohols may improve the cold 
flow properties of biodiesel produced from very saturated sources but generally no difference in yield can 
be observed from various types of alcohols. Since methanol is often the cheapest alcohol available and can 
be obtained in a very anhydrous formulation it is often the alcohol of choice (6; 7). 
There are three major types of catalysts used for biodiesel production: acid catalysts (HCl, H2SO4, etc.), 
alkali catalysts (NaOH, KOH, etc.) and enzymatic catalysts (lipase). Other catalytic schemes have been 
proposed such as reaction with super critical methanol or using heterogeneous catalysts such as ZrO2 or 
ZnO. The only catalysts used on an industrial scale are the acid and alkali catalysts. The predominant 
catalyst is the alkali catalyst which is preferably selected on the basis that is has high yield, fast reaction 
time and is also cheap. The main drawback of alkali catalysis is the risk of saponification in feedstocks 
containing high levels of FFA’s and water. Acid catalyst have higher tolerances for FFA’s and water but 
require higher alcohol to oil ratios and have slower reaction times. Enzymatic catalysts have moderate 
reaction conditions and do not require the same amount of excess alcohol ratios that the chemical catalysts 
do. Furthermore the use of enzymatic catalysts also eases downstream processing and product recovery. 
Figure 2: Stoichiometry of transesterification reaction. In this example the R1-R3 groups represent fatty acid radicals and 
methanol is used as alcohol. The reaction takes place in the presence of a catalyst (not shown) yielding fatty acid methyl ester 
(FAME).  
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The main inhibitory factor in their widespread use is cost (7; 4; 5; 2). An overview of catalytic strategies can 
be seen in Table 1. 
Alkali catalyst Acid catalyst Enzymatic catalyst 
+ Fast 
+ High conversion ratios 
 
÷ Energy intensive 
÷ Difficult glycerol recovery 
÷ Process susceptible to 
interference by FFA’s and 
water 
÷ Soap formation 
+ One step process 
+ Tolerates high levels of 
FFA’s and water 
 
÷ Energy intensive 
÷ Higher alcohol/oil ratio 
required 
 
+ No soap formation 
+ Moderate reaction 
conditions 
+ Low alcohol to oil/ratio 
+ Easy product recovery 
 
÷ Very expensive  
Table 1: Overview of the different catalytic strategies employed for biodiesel production. 
On a commercial scale the most prevalent process is alkali catalyzed transesterification with methanol as 
alkyl receptor. To reduce the risk of saponificaion from FFA and water content in the oil feedstock a 
common strategy is to first employ an acid catalyzed transesterificarion step to remove FFA’s and water 
followed by alkali catalyzed transesterification (2). 
 
 
2.3 Composition of biodiesel and crude glycerol 
 
Since biodiesel production is a simple chemical transesterification reaction the composition of biodiesel is 
closely related to the composition of the feedstock used. The most suitable feedstocks for biodiesel 
production are: almond, olive, corn, rapeseed and high oleic sunflower oils (certified according to standard 
UNE-EN 14214) (8).  This direct relationship also means that biodiesel produced from animal fats or other 
saturated sources often have difficulty in achieving desired cold flow properties although this can be partly 
remedied by the right choice of alcohol.   
When considering the nature of crude glycerol produced from different feedstocks, the composition of the 
crude glycerol obtained after transesterification only has an indirect relation to the choice of feedstock. It is 
the feedstock which dictates the most appropriate choice of catalyst which then imposes a set of 
characteristics on the crude glycerol obtained after transesterifcation. These characteristics together with 
the extent of postproduction purification of the crude glycerol, determines the final characteristics of the 
commercially available glycerol feedstock. Generally the composition of available glycerol will be different 
from different producers of biodiesel and depend on the process used (9). Therefore product limits will 
need to be defined for the contents of various components in the feedstock in order to be compatible with 
the GLYFINERY process or pre-treatment of feedstock should be considered. As an example the 
composition of glycerol feedstock obtained from GLYFINERY partner MEROCO can be seen in Table 2.  
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Parameters Unit Value Limit 
Glycerol % wt. 82.4 min. 82,0 
Water % wt. 9.7 max. 10 
Methanol % wt. 0.01 max. 0.5 
Ash % wt. 6.4 max. 7.0 
Table 2: Composition of crude glycerol feedstock obtained from GLYFINERY partner MEROCO. Data taken from a certificate of 
quality obtained directly from MEROCO.  
 
Most glycerol feedstock falls within the range of 60-90% glycerol w/w with varying amounts of the other 
components (water, methanol and salts) (10; 11; 9).
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3. GLYFINERY scenarios 
 
In the following chapters, the GLYFINERY scenarios are described. The description follows the life cycle of 
glycerol production and processing until the use of the main products and by-products. First, general 
specifications and settings are defined in chapter 3.1. In chapter 3.2, the systems of biodiesel and glycerol 
production as well as the raw materials for biodiesel production are described. Subsequently, the scenarios 
for glycerol processing to innovative products are presented in chapter 3.3. The description covers the 
reference use of glycerol (i. e. the use of glycerol that would be realized without the innovative pathways), 
the use of the main products with the conventional products that are replaced, the plant design as well as 
the use of by-products. These scenarios are summarized in a table in chapter 3.4. The respective flow charts 
can be found in chapter 4.   
 
3.1 General specifications, definitions and settings 
 
For the ecological and economic analysis of the GLYFINERY scenarios, general definitions and settings are 
necessary. They are used in both analyses and guarantee their consistency. The general definitions and 
settings are described and explained below. Definitions and settings specific for either the economic or the 
ecological assessment will be described and explained within the reports of these tasks (reports for WT 7.2 
and WT 7.3, respectively).  
 
• Technical reference (pilot or mature): The project aims at comparing glycerol processing 
technologies, i. e.  future innovative technologies with existing (conventional) pathways. 
Therefore, mature technologies are used as basis for the ecological and economic assessment. 
• Time frame: The analysed technologies are currently in development and not yet existent. First 
pilot plants might be available in 2015. As the objective of this project is to compare mature 
technologies (see ‘Technical reference’), 2020 is set as reference year.  
In addition, by 2020 10 % renewable fuels in transport will be mandatory within the European 
Union.  
• Functional unit: The questions to be answered result in different functional units. As the main 
objective of the GLYFINERY project is to optimize glycerol processing, the benefit from using 1 
tonne of crude glycerol is set as functional unit.  
With regard to the second question – the optimization of biodiesel production as a whole with 
an optimal use of glycerol playing an important role – the benefit from using the output of the 
biodiesel production is used as functional unit, i.e. all results are related to 1 tonne biodiesel. 
• Geographical coverage: Europe is the main producer of biodiesel in the world and therewith of 
glycerol. As glycerol is traded world wide and as critical amounts of glycerol are needed for a 
successful implementation of innovative technologies, Europe as a whole (and not a specific 
country within Europe) is set as geographical reference. This implies the use of EU27 average 
values for prices, yields, power mixes, etc.  
Sensitivity analyses will show the dependency of single productions steps from certain factors. 
These factors might differ between European countries, like wages, power mix etc. Therefore, if 
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it becomes evident that the country specific conditions have significant influence on the results, 
for the geographical coverage single countries may be chosen to show the dependencies.  In 
the ecological assessment, this might be the case for the power mix in energy production from 
biogas. Here, the power mix will be varied based on different countries, e. g. France (with a 
great share of nuclear power), Sweden (with a great share of renewable energy carriers) and 
Poland (with a great share of fossil energy carriers). In the economic analysis, labour costs 
might play an important role. Here, a Western European country with high labour costs (e. g. 





3.2 Glycerol production 
 
Glycerol is derived as by-product in biodiesel production. In order to answer the core questions described 
in chapter 1, two different systems need to be assessed. They are presented below, followed by the 
description of raw materials which are used in biodiesel production.   
 
3.2.1. Systems to be studied 
 
In chapter 1, two core objectives have been defined: the optimization of glycerol processing and use in 
innovative pathways as well as the optimization of the biodiesel production as a whole. To analyse both 
issues, two different systems are regarded: 
1. Glycerol processing 
The analysis starts with crude glycerol as it leaves the biodiesel plant (80 % purity). Transports (for 
centralized systems), processing as well as the use of main and by-products are examined. The aim 
is to deliver a detailed analysis of glycerol processing and usage as well as to identify best possible 
use options. Based on these analyses, optimization potentials are derived.   






























Figure 3: Life cycle of glycerol processing. 
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2. Biodiesel production as a whole 
The whole life cycle of biodiesel production is examined, i.e. the production of oil crops, their 
processing to biodiesel as well as the processing and usage of all by-products including glycerol. 
Besides different pathways for glycerol usage other parameters are varied as well, e. g. the raw 
materials. This analysis aims at depicting the impact of different glycerol usage pathways on the 
whole biodiesel production and at optimizing the biodiesel production from an economic and 
ecological point of view. 






























































Figure 4: Life cycle of biodiesel production. 
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3.2.2. Raw materials  
 
Biodiesel can be produced from different oil crops as well as from waste cooking oil and waste animal fats. 
The feedstock used for biodiesel production influences different factors that are relevant for the economic 
and ecological assessments, such as the yields of the main product and the by-products as well as the type 
and amount of ancillary products needed. In contrast, the feedstock has no relevant impact on the glycerol 
properties and its processing. Therefore, the variation of feedstock is made only within the analysis of the 
whole biodiesel system (biodiesel production combined with glycerol processing) and not for the analysis of 
glycerol processing and usage options.   
For analysing the influence of the feedstock on the whole biodiesel system, the following feedstocks are 
regarded: 
• Rape seed oil from Europe 
• Soybean oil imported from Brazil 
• Palm oil imported from South East Asia 
The baseline scenario is the production of biodiesel from rape seed oil. Regarding one single oil crop serves 
the purpose to point out the impacts of different processing steps as well as of different glycerol usage 
pathways.  
In reality, however, biodiesel producers use a mixture of different vegetable oils, mostly rape seed oil, 
soybean oil and palm oil. Therefore these mixtures are assessed as well. To fulfill the European biodiesel 
standard DIN EN 14214, the proportions need to be as follows:  
1. 70 % rapeseed oil and 30 % soybean oil or 
2. 70 % rapeseed, 20 % soybean oil, 10 % palm oil 
It has to be noted that the cultivation of soybeans and oil palm may cause land use changes that might 
massively affect the results of the ecological assessment. 
Besides the usage of oil crops, the processing of waste cooking oil and waste animal fats is an option 
increasingly put into praxis. However, the potential of these feedstocks in Europe is low. The amount of 
waste oils available for biodiesel production within Europe is estimated as 85 000 tonnes. Since the amount 
of glycerol produced is only 10 % of the produced biodiesel, the amount of glycerol from waste oils would 
be too small to justify innovative processing as described within this project. Therefore, waste oils are not 
included in the GLYFINERY scenarios. 
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3.3 Glycerol processing  
 
The GLYFINERY project has several products under investigation to determine the potential for adding value 




• Biogas  
In the following chapters (chapter 3.3.2 to 3.3.5), these four pathways are described in detail. In chapter 
3.3.6 the use of the by-products derived in ethanol, butanol and 1,3-PDO production is described, followed 
by a summary of all scenarios in chapter 3.4.  
However, first a reference system needs to be defined for the glycerol use, i. e. the use that would be 
realized without the innovative pathways defined in this project. This reference use is presented in chapter 
3.3.1.  
 
3.3.1. Reference system for glycerol use 
 
The reference system describes in which way glycerol from biodiesel production would be used if the 
innovative usage pathways described within the GLYFINERY project were not realized, i. e. the conventional 
usage pathway for the reference year 2020. The innovative usage pathways are compared to the 
conventional uses in order to identify respective advantages and disadvantages. 
The glycerol market is divided into two sections: a market for crude glycerol with about 80 % purity (crude 
glycerol as accrued in the biodiesel plants) and a market for refined glycerol with above 99.5 % purity. 
During biodiesel production, first crude glycerol is produced which has to be purified and refined at 
relatively high efforts. Due to an increased production of biodiesel, the quantity of crude glycerol 
worldwide rose remarkably in recent years. In 2008, 12.24 million tonnes of biodiesel have been produced 
which is equivalent to 1.224 million tonnes of crude glycerol. Compared to that, the world market for 
refined glycerol was estimated at only 900 000 tonnes in 2005 (16).  
Although the capacities for glycerol refining are rising due to the construction of new plants, this increase is 
much slower than the increase in crude glycerol production. Even a further extension in refining facilities 
would not be able to absorb all crude glycerol entering the market. One of the main reasons for the slow 
growth is the high variation in amounts and prices of crude glycerol due to political uncertainties with 
regard to biodiesel subsidies. These uncertainties lead to a great reluctance towards investments. One 
consequence of the glycerol glut is a massive decline in prices. In September 2009, the price for crude 
glycerol was only 100 € / tonne, while the price for refined glycerol was about 300 € / tonne (17). While 
large biodiesel producers increasingly refine the glycerol themselves, small producers give it away for free 
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or even have to pay for its disposal. Regarding the current decrease in prices, the price for the energetic use 
is commonly seen as the minimum value to which the price might decline.  
To cover the whole range of future possible glycerol usage pathways, two different reference systems are 
analyzed: 
1. The direct use for energy defines the minimum value for the use of excess crude glycerol. 
Glycerol is used at 80 % purity without further refining. The following scenarios are analysed: 
a. Provision of energy to biodiesel plant replacing the average electricity and heat mix 
b. External use of energy replacing the average electricity and heat mix 
c. External use of energy replacing the average electricity mix 
d. External use of energy replacing the average heat mix 
In the environmental assessment, replaced power and heat mixes are known to have a 
significant influence on the results. Therefore, these mixes will be varied based on different 
countries, e.g. France (with a large share of nuclear power), Sweden (with a large share of 
renewable energy carriers) and Poland (with a large share of fossil energy carriers).  
2. However, part of the crude glycerol will enter the markets due to an increase in refining 
capacities. To integrate these usage pathways and to define an upper limit for the glycerol 
value range, its material use is analyzed as second reference system. Precisely, the direct usage 
as a component of chemicals, pharmaceutical and cosmetic products is analyzed. The analysis 
includes the expenditures for crude glycerol refining to above 99.5 % purity. 






































3.3.2. Glycerol to ethanol 
 
Current situation 
Ethanol is currently produced in two different pathways: synthetic ethanol from ethylene (which is 
produced from crude oil; see Figure 6) and ethanol from the fermentation of renewable resources (cereals, 
sugar crops, lignocellulose). 95 % of the currently produced ethanol is derived from fermentation and only 
5 % synthetically. Ethanol is used for beverages, in the chemical industry and as fuel. In 2005, the world 
wide uses were distributed as follows: 12 % of the whole ethanol production were used for beverages, 16 % 
in the chemical industry, and 72 % as fuel. Most of the synthetic ethanol is used in the industrial pathway 




Figure 6: Flowchart depicting the synthesis of ethanol from fossil crude oil.  
 
Use and replaced conventional products (reference products)  
Within the GLYFINERY project, the following pathways for the ethanol from glycerol fermentation are 
analysed: 
• Usage in the chemical industry as a substitute for ethanol from fossil sources (crude oil  
naphtha  ethylene  ethanol) 
• Usage as fuel as a substitute for fossil gasoline 
Even though only a small amount of ethanol is used in the chemical industry, this ethanol is of high 
importance as a solvent. Moreover, the biggest producers of synthetic ethanol are located in Europe (19). 
Ethanol from glycerol substitutes ethanol from fossil resources, i. e. synthetic ethanol produced with 
ethylene or rather naphtha as raw material. 
Most of the ethanol produced today is used as fuel. As is the case for all ethanol from biomass, ethanol 
from glycerol substitutes fossil gasoline. Already with today’s amounts of glycerol, a considerable amount 
of bioethanol could be produced. If all glycerol from the European wide biodiesel production (around 8 
million tonnes; 19) would be used for ethanol production, 720 000 tonnes ethanol could be produced, 
which equals about one third of the current production of 2.2 million tonnes in Europe (20). 
In the medium or long term, the biofuels produced in Europe will stabilize on a certain level (due to 
politically determined conditions). The production of ethanol from glycerol is independent from this 
development. Therefore, ethanol from glycerol is not in direct competition with bio-ethanol from other 
biomass sources; i. e. glycerol most likely will not replace other biomass feedstocks for fuel ethanol 
production. These other sources thus are not analyzed as reference products within this project.  
Ethanol from glycerol fermentation could also be used to replace methanol in MTBE in order to produce 
ETBE. In Europe, ethanol in ETBE usually is produced from biomass. Here, the same line of argument can be 
used as above: since glycerol production is independent from the development of the biofuel market, 
ethanol from glycerol production does not compete with bio-ethanol from other biomass sources. 
Therefore, it is not regarded as reference product.   
Another option is practiced in the USA. Here, the use of MTBE is forbidden and thus ETBE is used as 
additive by default. In this case, bio-ethanol from glycerol fermentation would replace conventionally 




Use of by-products 
During ethanol production from glycerol, different by-products are derived. These are – depending on the 
environmental conditions – hydrogen and carbon dioxide or formic acid. While carbon dioxide is emitted to 
the atmosphere, hydrogen or formic acid remains in the fermentation broth. The fermentation broth can at 
least be used for biogas production without by-product extraction (see chapter 3.3.6 By-product use for 
biogas production). 
Alternatively, use options with a higher value might be realisable. This has to be clarified in the course of 
this project. If such alternative use options turn out to be realisable, the use of the processed by-product 
will be compared to a respective conventional equivalent product: 
• Formation of hydrogen and carbon dioxide: hydrogen from glycerol processing substitutes 
hydrogen from fossil natural gas whilst carbon dioxide is released to the atmosphere 
• Formation of formic acid: formic acid from glycerol processing replaces formic acid from fossil 
natural gas (via methanol)  
 
Plant design 
Ethanol from glycerol fermentation can only be produced in large centralized plants. An average biodiesel 
plant produces about 10 000 tonnes of glycerol, yielding in about 3 500 tonnes of ethanol. Existing ethanol 
plants in Europe have capacities between 50 000 tonnes and 2 000 000 tonnes. Even to meet the lower 
limit, glycerol from at least 14 biodiesel plants is needed. The glycerol with 80 % purity is transported by 
lorry to the ethanol processing plant. This procedure is shown in Figure 7. Considering the biodiesel and 
glycerol fermentation plant sizes and the average distribution of biodiesel plants in Europe, the average 









Figure 7: Scheme of the centralized ethanol production from locally produced glycerol   
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3.3.3. Glycerol to butanol 
 
Current situation 
Butanol mostly is used in chemical industries. It is an important platform chemical and can be used as a 
solvent for surface coatings such as varnishes or in the plastics and textile industry.  
Almost all butanol used today is synthesized from fossil sources. This can be done in a variety of ways but 
the most prevalent is propylene (propene) hydroformylation (oxo synthesis) from fossil propylene (12).  A 
schematic overview of the process can be seen in Figure 8.  
Petroleum ButanolPropylene
 
Figure 8: Flowchart depicting the synthesis of butanol from fossil crude oil. 
 
Use and replaced conventional products (reference products)  
Theoretically, the production of bio-butanol has the potential to substitute conventional butanol in all 
aspects of its use. Furthermore, if the production costs can be kept low enough this would open up new 
venues for the use of butanol. Within the GLYFINERY project the following pathway for butanol from 
glycerol fermentation is analyzed:  
• Usage of butanol in chemical industries as substitute for butanol from fossil sources (crude oil 
 naphtha  propylene butanol) 
The usage of butanol from glycerol processing as transport fuel is theoretically possible but not realistic. 
The amount of butanol that can be produced in Europe by glycerol processing is very small. Even if all 
glycerol from European biodiesel production was used for butanol production, only 160 000 tonnes of 
butanol could be produced at the best. Compared to that, the total ethanol production in Europe is about 
2.2 million tonnes, which again is only a small part of the total biofuel production. The infrastructure 
adaptations in the petroleum industries or, alternatively, technical adaptations in the vehicle motors are 
not viable from an economic point of view for these small amounts of butanol.  
 
Use of by-products 
During butanol production from glycerol, different by-products are derived. Depending on the conditions, 
carbon dioxide, water, hydrogen, acetone, ethanol and 1,3-PDO can be obtained. Carbon dioxide is 
released to the atmosphere while the other by-products remain part of the fermentation broth which at 
least can be used for biogas production (see chapter 3.3.6 By-product use for biogas production).  
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If it turns out in the course of the project that other by-products are more likely and that other value-
adding uses for these by-products are possible, the use of the processed by-product will be compared to a 
respective conventional equivalent product:  
• hydrogen from glycerol processing substitutes hydrogen from natural gas 
• ethanol from glycerol processing substitutes ethanol from crude oil processing (via ethylene) 
• acetone from glycerol processing substitutes acetone from crude oil (via benzene and 
propylene) 
• 1.3-PDO from glycerol processing substitutes PDO from crude oil (via ethylene) 
However, these options still need to be examined in the course of the project. 
 
Plant design 
The butanol recovery in glycerol fermentation is only 20 % on average. An average biodiesel plant with an 
annual production of 100 000 tonnes of biodiesel produces 2 000 tonnes of butanol at the best. For this 
reason, only larger centralized butanol plants are economically viable. As for ethanol production, crude 
glycerol with 80 % purity is transported to a central facility for fermentation and separation of butanol. In 
Europe, a realistic size for a butanol processing facility may be around 10 000 tonnes / yr (21). Thus, around 
five biodiesel plants are needed to supply one central butanol processing unit, resulting in an average 





























3.3.4. Glycerol to 1,3-propanediol (PDO) 
 
Current situation 
1,3-propanediol or trimethylene glycol (1,3-PDO) is a chemical mostly used in polymeric applications for the 
production of textiles or biodegradable plastics. Nowadays, one of the main field of applications for 1,3-
PDO is  the production of polytrimethyleneterephthalate (PTT). This is a relatively new fiber which, in 
certain fields of applications, has superior characteristics compared to nylon and PET. For the PTT market – 
and thus for 1,3-PDO – a strong growth is predicted.   
The production of 1,3-PDO stems mostly from petrochemical sources although some biological production 
has been implemented. The latter is applied since 2006 by DuPont that produces PDO from corn starch 
fermentation (capacity: 45 000 tonnes /yr). The chemical production of PDO starts with acrolein or ethylene 
but only has a yield of around 45 %. A schematic overview can be seen in Figure 10. This complex synthesis 
resulting in relatively high costs process has limited the use of PDO (13; 14). Out of both processes, 
currently only the production with ethylene as raw material is realized. The main producer is Shell with a 
production capacity of 73 000 tonnes / yr.   
Petroleum 1,3-PDOAcrolein / Ethylene
 
Figure 10: Flowchart depicting the synthesis of 1,3-propanediol from fossil crude oil. 
 
 
Use and replaced conventional products (reference products)  
The GLYFINERY project covers the following usages of 1,3-PDO: 
• Usage in chemical industries as substitute for PDO from fossil sources (crude oil  naphtha  
ethylene  PDO) 
• Usage in chemical industries as substitute for PDO from corn starch fermentation 
Synthetic PDO is still the main input for chemical industries. However, the use of bio-based 1,3-PDO has the 
potential to increase the uses of the chemical if the production cost can be kept low enough. In view of low 
glycerol prices and rising crude oil prices the usage of glycerol for PDO production and as a substitute for 
ethylene is of rising attractiveness. With growing PTT markets, there are enough market capacities to 
absorb the bio-PDO from glycerol processing.  
Furthermore, 1,3-propanediol produced by the GLYFINERY process has the potential to also replace the 
recently developed process of producing 1,3-propanediol from sugar using first generation technology. 
Corn starch as a renewable resource is currently used only by one company (see above) which comes up 
with a considerable part of the world’s PDO production. If PDO production from glycerol is realized on 
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industrial scale, this would probably lead to the displacement of corn starch. For this reason, the 
substitution of corn starch by glycerol is analyzed as a second scenario.   
 
Use of by-products 
Also in PDO production from glycerol organic compounds are obtained as by-products. Depending on the 
bacteria used for fermentation and on the conditions, this can be only oxygen or additionally butyric acid, 
acetate and ethanol. Organic compounds formed during PDO synthesis can at least be used in a biogas 
plant for biogas production (see chapter 3.3.6 By-product use for biogas production), but alternative and 
more valuable usages may be identified in course of this project. In case such alternative pathways are 
found to be realisable, the organic compounds from glycerol processing are compared to respective 
equivalent products from fossil sources: 
• butyric acid from glycerol processing substituting butyric acid from petroleum processing (via 
butanol and propylene) 
• acetate from glycerol processing substituting acetate from natural gas (via methanol) 
• ethanol from glycerol processing substituting ethanol from crude oil processing (via ethylene) 
 
Plant design 
The PDO yield from glycerol processing is about 60 %. Thus, an average biodiesel plant with an annual 
production of 100 000 tonnes produces 6 000 tonnes PDO at the best. Even for the smaller currently 
running PDO plant (with a capacity of about 45 000 tonnes / yr), the glycerol of about 8 biodiesel plants is 
needed to supply one PDO plant. Therefore, PDO production – just as ethanol and butanol production – can 
only be realized in centralized facilities. The crude glycerol (with 80 % purity) produced in biodiesel plants is 







































Figure 11: Scheme of the centralized PDO production from locally produced glycerol  
 
 
3.3.5. Glycerol to biogas 
 
Biogas production in the GLYFINERY system 
Besides the above described use pathways of glycerol, it also can be directly fermented in a biogas plant.  
For this purpose, no refining of the crude glycerol is necessary, i.e. it can be directly used at 80% purity.  
Two options are regarded for the biogas production:  
• Mono-fermentation of glycerol  
• Use of glycerol as co-substrate 
The first option has been discussed controversially at the progress meeting in Bratislava (8 / 9 April 2010). 
Experiments on glycerol mono-fermentation have shown that this is difficult to realize. However, research 
on this subject is ongoing. Therefore, this option will be kept for the time being and further information will 
be collected in the course of the project.   
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The use of glycerol as co-substrate is the more common use option. The addition of glycerol can increase 
the biogas yields of the different substrates considerably. In order to cover the whole bandwidth of glycerol 
co-fermentation, two options are assessed:  
• Co-fermentation with manure (from cattle and pig) 
• Co-fermentation with corn 
To both substrates, 6 % glycerol (by weight) is added, an amount being still favourable to the anaerobic 
digestion (22; 23; 24; 25; 26). The addition of glycerol changes the performance of biogas plants. In 
particular compared to corn silage, much higher biogas yields per tonne of feedstock are achieved. In fact, a 
share of 6 wt-% of glycerol leads to a share of 23 % in energy output for corn silage and of 69 % for manure 
co-fermentation. Therefore, it is most likely that on the long term glycerol will be co-fermented in newly 
established or restructured biogas plants which have been designed for a feedstock mix with higher energy 
yield. As a result, no conventional feedstock is going to be replaced by glycerol.  
  
Use and replaced conventional products (reference products)  
The biogas obtained from glycerol fermentation can be used in different ways. The following options are 
assessed:  
1. The biogas is used for process energy generation in the biodiesel plant and replaces 
conventional energy sources.  
2. The biogas is used to produce power and heat which is exported and replaces conventional 
power and heat.  
3. The biogas is further processed into biomethane and  
a) used as chemical replacing natural gas 
b) used as transport fuel replacing conventional gasoline and natural gas, respectively, 
c) used for heat and power production which replaces conventional heat and power.  
In option 1, glycerol is processed with mono-fermentation within the biodiesel plant. In options 2 and 3, 
both co- and mono-fermentation are assessed.  
In environmental assessments, replaced power and heat mixes are known to have a significant influence on 
the results. Therefore, these mixes will be varied in all three use options based on different countries, e. g. 
France (with a large share of nuclear power), Sweden (with a large share of renewable energy carriers) and 
Poland (with a large share of fossil energy carriers).  
 
Use of by-products 
In biogas production, digestate is obtained as a by-product. The digestate can be applied on fields replacing 
mineral fertiliser. However, since glycerol digestate has low nutrient contents, the application to 
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agricultural land might not be feasible from an economic point of view. In this case its treatment in a 
sewage plant might be an alternative option. This still needs to be clarified in the course of the project.  
Plant design for mono-fermentation of glycerol 
The amount of glycerol produced in an average biodiesel plant is enough to feed a 2 MWel biogas plant. 
Therefore, glycerol is fermented directly at the biodiesel plant (referred to as ‘local’ use) and no 
transportation is necessary. No processing (i.e. refining) of the glycerol is needed for its fermentation.  
The processing of biogas into biomethane1
The principle of local biogas / biomethane production is shown in 
 is economically viable only for larger plants. For example, in 
Germany, the plants need a capacity of at least about 2-2.5 MW (equivalent electrical power). Since in an 
average biodiesel plant enough glycerol is derived for feeding such big plants, biogas can be processed 























Figure 12: Local biogas / biomethan production in biodiesel plants (mono-fermentation). 
As crude glycerol contains hardly no mineral nutrients (except for some potassium), nutrient 
supplementation is needed for mono-fermentation which has to be taken into account for the 
environmental and the economic analysis.  
Plant design for co-fermentation of glycerol 
In co-fermentation, only 6% of glycerol (by weight) is added as co-substrate. Since in an average biodiesel 
plant, high amounts of glycerol are obtained, the glycerol has to be distributed among several biogas plants 
(here referred to as ‘decentralized’ option). Based on an average biogas plant capacity of 0.5 MW, about   
2-5 plants (depending on plant design) are needed to co-ferment 6% glycerol with manure, and about 15 
plants to co-ferment 6% glycerol with corn silage. Based on the current distribution of biogas plants in 
Europe, the average transport distance is about 5-70 km (depending on co-ferment type and region).  
1 Biogas which is concentrated via a biogas upgrader to the same standards as fossil natural gas 
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The processing of biogas into biomethane is economically viable only for big plants of at least about 2-
2.5 MW (equivalent electrical power; see above). Three of such big biogas plants are needed to co-ferment 
the glycerol production of one biodiesel plant. Assuming that every 12th biogas plant is a 2.5 MW plant, the 
average transport distance is about 15-50 km. 


































3.3.6. By-product use for biogas production 
Biomass 
During the processing of glycerol into ethanol, butanol and 1,3-PDO, different by-products are derived. 
They are contained in the fermentation broth as (solid) distillation residue (see chapters 3.3.2, 3.3.3, 3.3.4). 
Furthermore, liquid residues from glycerol filters are obtained in the production of each of the three 
products. Both types of residues can be used as a feedstock for biogas production providing part of the 
process energy required for glycerol processing. The biogas use option is assessed as the basic scenario as 
long as the extraction of by-products from the fermentation broth is not proved to be feasible.   
This means that the fermentation broth as well as filter residues obtained during the production of ethanol, 
butanol and 1,3-PDO are used in biogas plants which are directly attached to the glycerol processing 
facilities. The biogas is used for the production of process energy which is used for glycerol processing and 
replaces fossil energy carriers. In case surplus power is produced it is exported to the grid replacing 
conventionally produced electricity.  
The feasibility of biogas production among others depends on the amount of biogas that can be produced, 
i.e. on the amount of by-products that is obtained during glycerol processing. This is subject to further 
research in WP 4. Depending on the outcomes of this work-package, other options of residual treatment 
might be taken into consideration, e. g. the disposal in a sewage plant.  
For the solid use fraction the use as animal feed has been suggested as an alternative use option beside the 
fermentation in a biogas plant. However, the amount of residue is expected to be too small to justify its 
collection, processing and use as animal feed. If there is no livestock farming adjacent to the glycerol plant, 
the residues would have to be concentrated (i.e. dried) to make them transportable and storable, which 
would result in extra costs. 
 
Biogas digestate 
If the residues are fermented, digestate is obtained as a by-product. For the time being, its use as fertilizer 
replacing mineral fertilizer is assessed. It has to be noted that in case GMO are used for glycerol processing, 
the use of the digestate as fertilizer needs to be clarified.  
However, it might turn out that the digestate has low nutrient contents meaning that an application to 
agricultural land would not be feasible from an economic point of view. In this case its treatment in a 
sewage plant might be an alternative option. This needs to be clarified in the course of the project. 
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3.4 Summary: GLYFINERY scenarios 
 
Table 3 summarizes the main GLYFINERY scenarios including the use of the main product, the plant design 
(local / decentralized) as well as the reference products. The last column depicts the number allocated to 
each scenario. For a better orientation, these numbers are also displayed in the flow charts in chapter 4.  
Table 3: Summary of main GLYFINERY scenarios 
Main product Centralized / 
decentralized 




Fossil ethanol via ethylene 
(crude oil) 
1 a 
Transport fuel Gasoline 1 b 
Butanol Centralized Chemical 
Fossil butanol via propylene 
(crude oil) 
2 
1,3-PDO Centralized Chemical 
Fossil 1,3-PDO via ethylene 
(crude oil) 
3 a 






Process energy for 
biodiesel production  
Conventional heat / electricity 
4 a I  




Conventional heat / electricity 
4 b I 
Biomethane as transport 
fuel 
Gasoline 
4 b II 
Biomethane as transport 
fuel  / chemical 
Natural gas 
4 b III 
Biogas – Co-
fermentation 
Decentralized3 Export of heat/electricity   Conventional heat / electricity 4 c I 
Decentralized4 
Biomethane for 
heat/electricity production  
Conventional heat / electricity  
4 d I  
Biomethane as transport 
fuel 
Gasoline 
4 d II  
Biomethane as transport 
fuel / chemical 
Natural gas 
4 d III  
2 i.e. biogas / biomethane production directly at biodiesel plant  
3 i.e. transportation of crude glycerol from biodiesel plant to decentralised plants for biogas / biomethane production  
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4. GLYFINERY scenarios: Qualitative flowcharts  
 
This section contains the qualitative flowcharts for each of the pathways under investigation which has 
been described in the previous chapters. For each main product (ethanol, butanol, 1,3-PDO, biogas) two 
flowcharts are shown: to the first one illustrates the various process steps within that particular pathway 
including all inputs and outputs. The second one deals with the glycerol processing as black box and focuses 
on the outputs and the respective conventional products they replace (reference products).   
 
4.1 Glycerol to ethanol 
 
The flowchart for the production of ethanol can be seen in Figure 14. The purification method is simple 
distillation. The purification of ethanol by liquid/liquid extraction or solid phase extraction (as specified in 
WT 5.2 and WT 5.6) was not investigated. Hence the purification is done by simple distillation. 
























1 needs to be clarified
Process energy
Figure 14: Detailed flowchart depicting the glycerol processing to ethanol. 
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Figure 15 shows all products derived in ethanol production from glycerol fermentation and the respective 
reference products.  The numbers in the flow charts indicate the scenario. An overview on all scenarios can 


















heat / powerHeat / power
1a
1b





Figure 15: Flowchart depicting all products from ethanol production including all reference products. 
27
4.2 Glycerol to butanol  
 
The flowchart for the production of butanol can be seen in Figure 16. The process has two main products: 
butanol and 1,3-propanediol. Since there is no main product, the purification will depend on the cost and 
profitability of each component in the mix. Any residual products are left in the residual fermentation broth 










































Figure 16: Detailed flowchart depicting the glycerol processing to butanol. 
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Figure 17 shows all products derived in butanol production from glycerol fermentation and the respective 
reference products. The numbers depicted in the flow charts indicate the scenario. An overview on all 
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Figure 17: Flowchart depicting all products from butanol production including all reference products.
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4.3 Glycerol to 1,3-propanediol  
 
The flowchart for the production of 1,3-propanediol can be seen in Figure 18. As was determined in WP 5 
the most promising purification method for 1,3-propanediol is continuous direct liquid/liquid extraction. As 
in the other processes the remaining products and residual glycerol and nutrients are left in the residual 



































1 needs to be clarified
Process energy
 
Figure 18: Detailed flowchart depicting the glycerol processing to 1,3-PDO. 
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Figure 19 shows all products derived in PDO production from glycerol fermentation and the respective 
reference products. The numbers depicted in the flow charts indicate the scenario. An overview on all 


































4.4 Glycerol to biogas  
 
The flowchart for the direct production of biogas from glycerol is shown in Figure 20. The biogas is either 













Figure 20: Detailed flowchart depicting the glycerol processing to biogas and biomethane.   
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Figure 21 shows all products derived in biogas production from glycerol fermentation and the respective 
reference products. The numbers depicted in the flow charts indicate the scenario. An overview on all 
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This section contains an updated version of the 
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4 b II, 4 d II
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Escherichia coli EH05  Batch  20.7 0.22 Durnin et al., 2009
Klebsiella pneumoniae 
GEM167/pBR‐pdc‐adh 
Fed‐batch 25.0 0.78 Oh et al., 2011














  Phase II 27.5 0.18  



























































































































































































































































































































Clostridium diolis  glycerol  85 g/l  chemical mutagenesis 
and genome shuffling 
[9] 
































































Based on the pilot experiment data, the total time and fermentation volume was estimated for 1 ton of 
glycerol (Table 9). 
Table 9: Fermentation parameters pr. ton of glycerol, based on experimental data.  
Parameter Value 
Glycerol  1000 kg 
Final 1,3-PDO production 560 kg 
Total volume of fermentation media 10 000 liters 
Fermenter A 500 liters 
Fermenter B 10 000 liters  
The total time of fermentation  14-20 days 
 
After the second fermentation in fermenter B, the biomass was separated by pilot scale continuous flow 
centrifugation (14.000 rpm) with a feed rate of 300 ml/h. Clear supernatant was used for the 1,3-PDO 
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Results from the initial screening for 
glycerol utilization. 
 
B.1 – Baseline screening of growth on various 
substrates for selected Lactococcus lactis 
strains 
 








B.1 - Baseline screening of growth on various 






This section contains the results from the 
baseline screening of growth on various sugars 
by Lactococcus lactis strains MG1363, 



























MG1363 (max ON OD600, duplicates+triplicates)
0% std. Dev. 0.05% Std. Dev. 0.10% Std. Dev. 0.20% Std. Dev. 0.30% Std. Dev. 0.40% Std. Dev.
0.050 0.009 0.252 0.004 0.430 0.031 0.838 0.057 1.29 0.10 1.55 0.07
0.088 0.012 0.445 0.000 0.794 0.006 1.490 0.020 2.28 0.28 2.63 0.12
0.003 0.001 #N/A #N/A 0.390 0.021 0.547 0.066 1.17 0.03 1.42 0.02
0.028 0.001 0.232 0.010 0.579 0.012 1.457 0.098 1.98 0.17 2.13 0.06
0.014 0.000 0.236 0.001 0.495 0.008 0.899 0.023 1.28 0.03 1.27 0.06
0.029 0.003 0.395 0.016 0.875 0.035 1.633 0.023 1.53 0.06 1.48 0.01
0.000 0.000 0.231 0.000 0.448 0.017 0.805 0.016 1.11 0.01 1.15 0.00
0.023 0.001 0.391 0.014 0.853 0.015 1.710 0.044 1.91 0.09 1.83 0.00
SAL + Galactose + Hem
SAL + Maltose




SAL + Glucose + Hem
SAL + Fructose
SAL + Fructose + Hem
0.50% Std. Dev. 0.60% Std. Dev. 0.75% Std. Dev. 1.00% Std. Dev. 1.50% Std. Dev. 2.00% Std. Dev.
1.58 0.03 1.60 0.00 1.58 0.02 1.61 0.00 1.55 0.02 1.57 0.02
2.99 0.10 3.37 0.39 3.41 0.42 3.34 0.40 3.54 0.14 3.67 0.08
1.48 0.04 1.58 0.02 1.60 0.02 1.61 0.05 1.63 0.01 1.63 0.01
1.91 0.10 2.02 0.07 2.04 0.07 2.59 0.22 2.72 0.14 2.63 0.12
1.22 0.01 1.19 0.00 1.18 0.01 1.14 0.00 1.15 0.00 1.12 0.01
1.46 0.11 1.38 0.06 2.46 0.18 3.09 0.09 3.00 0.22 2.85 0.04
1.17 0.02 1.18 0.02 1.16 0.01 1.18 0.02 1.20 0.00 1.23 0.01
2.02 0.12 2.07 0.33 1.93 0.04 4.27 0.07 4.27 0.27 3.98 0.49
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0% std. Dev. 0.05% Std. Dev. 0.10% Std. Dev. 0.20% Std. Dev. 0.30% Std. Dev. 0.40% Std. Dev.
0.003 0.002 0.190 0.002 0.330 0.002 0.610 0.008 0.95 0.02 1.03 0.01
0.030 0.001 0.237 0.003 0.440 0.000 0.873 0.006 1.35 0.04 2.08 0.30
0.010 0.002 0.070 0.020 0.070 0.003 0.130 0.020 0.72 0.06 0.92 0.01
0.026 0.002 0.258 0.006 0.505 0.016 0.897 0.051 1.22 0.10 1.84 0.14
0.006 0.001 0.241 0.001 0.435 0.003 0.829 0.064 1.10 0.11 1.03 0.02
0.012 0.001 0.443 0.005 0.776 0.017 1.310 0.040 1.83 0.15 2.14 0.11
0.012 0.001 0.204 0.005 0.403 0.005 0.770 0.030 0.95 0.01 1.00 0.03
0.026 0.003 0.441 0.019 0.804 0.014 1.350 0.110 1.77 0.17 1.92 0.09
0.002 0.001 0.158 0.000 0.346 0.000 0.727 0.009 0.85 0.02 0.89 0.01




SAL + Glucose + Hem
SAL + Fructose
SAL + Fructose + Hem
SAL + Galactose + Hem
SAL + Maltose
SAL + Maltose+ Hem
SAL + Xylose
SAL + Xylose + Hem
0.50% Std. Dev. 0.60% Std. Dev. 0.75% Std. Dev. 1.00% Std. Dev. 1.50% Std. Dev. 2.00% Std. Dev.
1.03 0.01 1.02 0.01 1.02 0.01 1.01 0.00 1.01 0.02 1.01 0.00
2.34 0.03 2.33 0.18 2.32 0.39 2.18 0.00 1.97 0.28 1.87 0.03
0.94 0.04 1.05 0.07 1.11 0.01 1.05 0.01 1.03 0.01 1.05 0.00
2.16 0.00 2.20 0.05 2.14 0.00 2.31 0.00 2.47 0.08 2.65 0.10
1.02 0.01 1.02 0.01 0.96 0.03 0.94 0.06 0.92 0.02 0.88 0.01
2.06 0.08 2.22 0.05 2.35 0.10 2.39 0.15 2.46 0.10 2.43 0.12
1.00 0.00 1.02 0.02 1.03 0.01 1.05 0.02 1.04 0.01 1.08 0.06
2.06 0.30 2.25 0.59 2.09 0.18 2.82 0.01 2.79 0.06 2.98 0.28
0.89 0.00 0.92 0.01 0.98 0.02 0.97 0.06 0.99 0.00 1.05 0.03
1.57 0.02 1.58 0.09 1.56 0.04 1.63 0.03 1.63 0.05 1.59 0.06
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0% std. Dev. 0.05% Std. Dev. 0.10% Std. Dev. 0.20% Std. Dev. 0.30% Std. Dev. 0.40% Std. Dev.
0.003 0.001 0.237 0.003 0.396 0.011 0.552 0.000 1.02 0.02 #N/A #N/A
0.010 0.001 0.312 0.005 0.597 0.012 1.027 0.012 1.48 0.02 1.92 0.03
0.006 0.000 0.048 0.013 0.064 0.030 0.088 0.032 0.43 0.02 0.45 0.01
0.009 0.002 0.252 0.000 0.459 0.005 0.790 0.044 1.26 0.11 1.78 0.08
0.005 0.001 0.250 0.005 0.449 0.002 0.845 0.027 1.07 0.03 1.10 0.01
0.002 0.001 0.369 0.016 0.760 0.010 1.507 0.032 1.83 0.01 2.26 0.02
0.014 0.006 0.225 0.004 0.390 0.000 0.782 0.048 0.94 0.04 0.96 0.02
0.009 0.000 0.443 0.013 0.797 0.025 1.345 0.078 1.72 0.08 2.11 0.08
0.013 0.001 0.225 0.009 0.371 0.002 0.680 0.087 0.88 0.03 0.92 0.05




SAL + Glucose + Hem
SAL + Fructose
SAL + Fructose + Hem
SAL + Galactose + Hem
SAL + Maltose
SAL + Maltose + Hem
SAL + Xylose
SAL + Xylose + Hem
0.50% Std. Dev. 0.60% Std. Dev. 0.75% Std. Dev. 1.00% Std. Dev. 1.50% Std. Dev. 2.00% Std. Dev.
1.12 0.06 1.09 0.02 1.09 0.02 1.11 0.07 1.05 0.02 1.03 0.01
2.06 0.17 2.02 0.07 2.01 0.04 1.97 0.02 1.96 0.02 #N/A #N/A
0.48 0.01 0.50 0.01 0.55 0.00 0.58 0.04 0.54 0.03 0.55 0.03
1.84 0.07 1.90 0.04 1.84 0.02 1.92 0.06 1.95 0.05 2.01 0.04
1.09 0.01 1.08 0.01 1.07 0.01 1.10 0.03 1.09 0.02 1.09 0.01
2.52 0.08 2.52 0.01 2.53 0.07 2.56 0.02 2.59 0.01 2.58 0.04
0.96 0.03 0.96 0.03 0.95 0.01 0.97 0.00 0.94 0.03 0.94 0.02
2.37 0.01 2.43 0.00 2.49 0.08 2.65 0.14 2.87 0.07 2.89 0.20
0.97 0.02 0.93 0.02 1.02 0.07 1.04 0.04 1.04 0.03 1.05 0.04
1.65 0.05 1.59 0.01 1.63 0.03 1.60 0.06 1.75 0.16 1.74 0.11
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B.2 – Results from glycerol utilization screening 






This section contains the results from the 
screening of selected Lactococcus lactis spp. 
for utilization of glycerol in medium 













Medium 1: SAL + 0.2% glucose + 0-1% glycerol 
Medium 2:  SAL + 0.2% glucose + 0-1% glycerol 








% glycerol Optical density [600nm] 
1.1A 0.00 0.78 0.64 0.55 0.52 0.52 0.51 
1.2A 0.05 0.67 0.59 0.54 0.57 0.44 0.51 
1.3A 0.10 0.66 0.65 0.51 0.49 0.35 0.46 
1.4A 0.20 0.86 0.59 0.50 0.62 0.39 0.52 
1.5A 0.30 0.65 0.54 0.49 0.53 0.37 0.46 
1.6A 0.40 0.70 0.59 0.46 0.52 0.56 0.46 
1.7A 0.50 0.52 0.50 0.46 0.55 0.60 0.42 
1.8A 0.60 0.64 0.50 0.51 0.57 0.54 0.49 
1.9A 0.70 0.76 0.51 0.44 0.56 0.42 0.42 
1.10A 0.80 0.76 0.42 0.62 0.60 0.55 0.43 
1.11A 0.90 0.73 0.53 0.55 0.55 0.53 0.44 
1.12A 1.00 0.60 0.59 0.58 0.56 0.42 0.50 
 
300312 catalase 








% glycerol Optical density [600nm] 
2.1A 0.00 0.48 0.32 0,19 0.28 0.22 0.22 
2.2A 0.05 0.43 0.35 0,23 0.24 0.21 0.25 
2.3A 0.10 0.44 0.33 0,24 0.34 0.23 0.00 
2.4A 0.20 0.37 0.31 0,23 0.39 0.27 0.31 
2.5A 0.30 0.37 0.31 0,33 0.45 0.31 0.38 
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2.6A 0.40 0.54 0.31 0.29 0.46 0.30 0.26 
2.7A 0.50 0.54 0.35 0.32 0.48 0.33 0.24 
2.8A 0.60 0.41 0.30 0.31 0.51 0.38 0.26 
2.9A 0.70 0.56 0.28 0.28 0.43 0.40 0.31 
2.10A 0.80 0.63 0.44 0.27 0.50 0.46 0.29 
2.11A 0.90 0.47 0.38 0.23 0.38 0.39 0.27 
2.12A 1.00 0.58 0.42 0.27 0.49 0.38 0.33 
 
300312 catalase 








% glycerol Optical density [600nm] 
3.1A 0.00 1.00 0.92 0.82 1.27 0.73 0.54 
3.2A 0.05 0.00 0.24 0.42 x 0.56 0.44 
3.3A 0.10 1.03 0.71 0.87 1.46 0.76 0.68 
3.4A 0.20 0.82 0.49 0.48 1.20 0.72 0.52 
3.5A 0.30 1.01 0.66 0.65 1.19 0.87 0.55 
3.6A 0.40 0.92 0.72 0.51 0.93 0.83 0.50 
3.7A 0.50 0.20 0.71 0.51 1.26 0.64 0.66 
3.8A 0.60 0.95 0.73 0.51 1.01 0.95 0.60 
3.9A 0.70 0.95 0.81 0.40 1.13 0.82 0.63 
3.10A 0.80 0.90 0.64 0.51 1.25 0.79 0.62 
3.11A 0.90 0.76 0.65 0.48 1.03 0.71 0.59 
3.12A 1.00 0.85 0.71 0.47 1.07 0.83 0.63 
 
300312 catalase 







Data from cultivation of Lactococcus lactis NCDO2118 and MG1363 in SAL 
medium supplemented with 0.2% glucose and with or without 0.2% glycerol. 
Strains were cultivated at 28°C under respiration permissive conditions  













Results from the screening of Lactococcus 





This section contains the results from screening 
of selected Lactococcus lactis strains MG1363, 









NCDO2118, 30°C, ON, anaerob 
SAL + 0.5% sugar 
SAL + 0.5% sugar + 0.5% glycerol 
Tube Medium Dilut. OD600 meas. OD600 calc. Average 
OD600 
SD 
19 SAL + Fructose 10 x 0.039 0.390 0.44 0.050 
20 SAL + Fructose 10 x 0.044 0.440    
21 SAL + Fructose 10 x 0.049 0.490    
22 SAL + Fructose + 
Glycerol 
10 x 0.049 0.490 0.49 0.015 
23 SAL + Fructose + 
Glycerol 
10 x 0.051 0.510    
24 SAL + Fructose + 
Glycerol 
10 x 0.048 0.480    
25 SAL + Xylose 10 x 0.084 0.840 0.87 0.029 
26 SAL + Xylose 4 x 0.224 0.896    
27 SAL + Xylose 4 x 0.220 0.880    
28 SAL + Xylose + 
Glycerol 
4 x 0.147 0.588 0.54 0.046 
29 SAL + Xylose + 
Glycerol 
4 x 0.130 0.520    
30 SAL + Xylose + 
Glycerol 














MG1363, 30°C, ON, respiratory 
SAL + 1% sugar 
Tube Medium dilut.  OD600 
meas. 
OD600 calc. Average 
OD600 
SD pH 
1 SAL + HEM(5γ) 1 x 0.003 0.003 0.002 0.001 7 
2 SAL + HEM(5γ) 1 x 0.001 0.001   7 
3 SAL + HEM(5γ) 1 x 0.001 0.001   7 
4 SAL + HEM(5γ) + Glucose 
(1%) 
13 x 0.152 1.976 2.12 0.22 6 
5 SAL + HEM(5γ) + Glucose 
(1%) 
13 x 0.155 2.015   6 
6 SAL + HEM(5γ) + Glucose 
(1%) 
13 x 0.183 2.379   6 
7 SAL + HEM(5γ) + Fructose 
(1%) 
13 x 0.192 2.496 2.53 0.03 5 
8 SAL + HEM(5γ) + Fructose 
(1%) 
13 x 0.194 2.522   5 
9 SAL + HEM(5γ) + Fructose 
(1%) 
13 x 0.197 2.561   5 
10 SAL + HEM(5γ) + Xylose 
(1%) 
1 x 0.028 0.028 0.021 0.007 7 
11 SAL + HEM(5γ) + Xylose 
(1%) 
1 x 0.022 0.022   7 
12 SAL + HEM(5γ) + Xylose 
(1%) 
1 x 0.014 0.014   7 
13 SAL + HEM(5γ) + 
Galactose (1%) 
13 x 0.146 1.898 1.89 0.01 5 
14 SAL + HEM(5γ) + 
Galactose (1%) 
13 x 0.145 1.885   5 
15 SAL + HEM(5γ) + 
Galactose (1%) 










 KF147, 30°C, ON, respiratory 
SAL + 1% sugar 
Tube Medium dilut.  OD600 
meas. 
OD600 calc. Average 
OD600 
SD pH 
1 SAL + HEM(5γ) 1 x 0.015 0.015 0.018 0.00
4 
7 
2 SAL + HEM(5γ) 1 x 0.017 0.017   7 
3 SAL + HEM(5γ) 1 x 0.022 0.022   7 
4 SAL + HEM(5γ) + Glucose 
(1%) 
10 x 0.146 1.460 1.44 0.03 4 
5 SAL + HEM(5γ) + Glucose 
(1%) 
10 x 0.145 1.450   4 
6 SAL + HEM(5γ) + Glucose 
(1%) 
10 x 0.140 1.400   4 
7 SAL + HEM(5γ) + Fructose 
(1%) 
10 x 0.155 1.550 1.55 0.02 4 
8 SAL + HEM(5γ) + Fructose 
(1%) 
10 x 0.154 1.540   4 
9 SAL + HEM(5γ) + Fructose 
(1%) 
10 x 0.157 1.570   4 
10 SAL + HEM(5γ) + Xylose 
(1%) 
10 x 0.112 1.120 1.11 0.09 6 
11 SAL + HEM(5γ) + Xylose 
(1%) 
10 x 0.120 1.200   6 
12 SAL + HEM(5γ) + Xylose 
(1%) 
10 x 0.102 1.020   6 
13 SAL + HEM(5γ) + 
Galactose (1%) 
10 x 0.216 2.160 2.30 0.27 5 
14 SAL + HEM(5γ) + 
Galactose (1%) 
10 x 0.261 2.610   5 
15 SAL + HEM(5γ) + 
Galactose (1%) 










 NCDO2118, 30°C, ON, respiratory 
SAL + 1% sugar 
Tube Medium dilut.  OD600 
meas. 
OD600 calc. Average 
OD600 
SD pH 
1 SAL + HEM(10γ) 1 x 0.002 0.002 0.006 0.003 7 
2 SAL + HEM(10γ) 1 x 0.007 0.007   7 
3 SAL + HEM(10γ) 1 x 0.008 0.008   7 
4 SAL + HEM(10γ) + Glucose 
(1%) 
10 x 0.182 1.820 1.82 0.05 4 
5 SAL + HEM(10γ) + Glucose 
(1%) 
10 x 0.187 1.870   4 
6 SAL + HEM(10γ) + Glucose 
(1%) 
10 x 0.177 1.770   4 
7 SAL + HEM(10γ) + 
Fructose (1%) 
10 x 0.106 1.060 1.10 0.04 5 
8 SAL + HEM(10γ) + 
Fructose (1%) 
10 x 0.111 1.110   4 
9 SAL + HEM(10γ) + 
Fructose (1%) 
10 x 0.113 1.130   4 
10 SAL + HEM(10γ) + Xylose 
(1%) 
10 x 0.022 0.220 0.293 0.067 7 
11 SAL + HEM(10γ) + Xylose 
(1%) 
10 x 0.035 0.350   7 
12 SAL + HEM(10γ) + Xylose 
(1%) 
10 x 0.031 0.310   7 
13 SAL + HEM(10γ) + 
Galactose (1%) 
10 x 0.045 0.450 1.37 0.54 7 
14 SAL + HEM(10γ) + 
Galactose (1%) 
10 x 0.125 1.250   6 
15 SAL + HEM(10γ) + 
Galactose (1%) 
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MG1363, KF147, NCDO2118, 30°C, ON, anaerobic 
SAL + 0.1% sugar 
SAL + 0.1% sugar + 1% glycerol   
Strain Tub
e 







MG1363 1 SAL + Fructose 5 x 0.075 0.38 0.38 0.02 
 1  1 x 0.344 0.34 0.35 0.01 
MG1363 2 SAL + Fructose 5 x 0.074 0.37 0.37 0.02 
 2  1 x 0.345 0.35   
MG1363 3 SAL + Fructose 5 x 0.080 0.40   
 3  1 x 0.369 0.37   
MG1363 4 SAL + Fructose + 
Glycerol 
5 x 0.063 0.32 0.32 0.03 
 4  1 x 0.296 0.30 0.30 0.02 
MG1363 5 SAL + Fructose + 
Glycerol 
5 x 0.069 0.35 0.31 0.02 
 5  1 x 0.326 0.33   
MG1363 6 SAL + Fructose + 
Glycerol 
5 x 0.058 0.29   
 6  1 x 0.279 0.28   
KF147 7 SAL + Fructose 5 x 0.031 0.16 0.14 0.02 
 7  1 x 0.143 0.14 0.13 0.02 
KF147 8 SAL + Fructose 5 x 0.025 0.13 0.13 0.02 
 8  1 x 0.109 0.11   
KF147 9 SAL + Fructose 5 x 0.029 0.15   
 9  1 x 0.125 0.13   
KF147 10 SAL + Fructose + 
Glycerol 
5 x 0.031 0.16 0.16 0.02 
 10  1 x 0.134 0.13 0.14 0.02 
KF147 11 SAL + Fructose + 
Glycerol 
5 x 0.030 0.15 0.15 0.02 
 11  1 x 0.128 0.13   
KF147 12 SAL + Fructose + 
Glycerol 
5 x 0.037 0.19   
 12  1 x 0.167 0.17   
KF147 13 SAL + Xylose 5 x 0.032 0.16 0.15 0.01 
 13  1 x 0.158 0.16 0.15 0.01 
KF147 14 SAL + Xylose 5 x 0.029 0.15 0.15 0.01 
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 14  1 x 0.137 0.14   
KF147 15 SAL + Xylose 5 x 0.028 0.14   
 15  1 x 0.140 0.14   
KF147 16 SAL + Xylose + Glycerol 5 x 0.016 0.08 0.09 0.01 
 16  1 x 0.067 0.07 0.07 0.01 
KF147 17 SAL + Xylose + Glycerol 5 x 0.017 0.09 0.08 0.01 
 17  1 x 0.067 0.07   
KF147 18 SAL + Xylose + Glycerol 5 x 0.019 0.10   
 18  1 x 0.082 0.08   
NCDO2118 19 SAL + Fructose 5 x 0.014 0.070 0.07 0.00 
 19  1 x 0.046 0.046 0.04 0.01 
NCDO2118 20 SAL + Fructose 5 x 0.013 0.065 0.05 0.02 
 20  1 x 0.036 0.036   
NCDO2118 21 SAL + Fructose 5 x 0.014 0.070   
 21  1 x 0.037 0.037   
NCDO2118 22 SAL + Fructose + 
Glycerol 
5 x 0.016 0.080 0.09 0.02 
 22  1 x 0.062 0.062 0.06 0.01 
NCDO2118 23 SAL + Fructose + 
Glycerol 
5 x 0.022 0.110 0.08 0.02 
 23  1 x 0.072 0.072   
NCDO2118 24 SAL + Fructose + 
Glycerol 
5 x 0.015 0.075   
 24  1 x 0.053 0.053   
NCDO2118 25 SAL + Xylose 5 x 0.020 0.100 0.15 0.05 
 25  1 x 0.092 0.092 0.15 0.06 
NCDO2118 26 SAL + Xylose 5 x 0.030 0.150 0.15 0.05 
 26  1 x 0.154 0.154   
NCDO2118 27 SAL + Xylose 5 x 0.041 0.205   
 27  1 x 0.208 0.208   
NCDO2118 28 SAL + Xylose + Glycerol 5 x 0.020 0.100 0.11 0.02 
 28  1 x 0.084 0.084 0.09 0.01 
NCDO2118 29 SAL + Xylose + Glycerol 5 x 0.019 0.095 0.10 0.01 
 29  1 x 0.085 0.085   
NCDO2118 30 SAL + Xylose + Glycerol 5 x 0.025 0.125    









MG1363, KF147, NCDO2118, 30°C, ON, Respiratory 
BLL + 0.5% sugar 
BLL + 0.5% sugar + 1% glycerol  









MG1363 31 BLL + HEM + Fructose 5 x 0.075 0.38 0.31 0.06 
MG1363 32 BLL + HEM + Fructose 5 x 0.053 0.27   
MG1363 33 BLL + HEM + Fructose 5 x 0.056 0.28   
MG1363 34 BLL + HEM + Fructose + 
Glycerol 
2 x 0.115 0.23 0.18 0.05 
MG1363 35 BLL + HEM + Fructose + 
Glycerol 
1 x 0.155 0.16   
MG1363 36 BLL + HEM + Fructose + 
Glycerol 
1 x 0.141 0.14   
KF147 37 BLL + HEM + Fructose 2 x 0.144 0.29 0.28 0.04 
KF147 38 BLL + HEM + Fructose 2 x 0.158 0.32   
KF147 39 BLL + HEM + Fructose 2 x 0.118 0.24   
KF147 40 BLL + HEM + Fructose + 
Glycerol 
2 x 0.107 0.21 0.25 0.14 
KF147 41 BLL + HEM + Fructose + 
Glycerol 
2 x 0.199 0.40   
KF147 42 BLL + HEM + Fructose + 
Glycerol 
2 x 0.064 0.13   
KF147 43 BLL + HEM + Xylose 1 x 0.138 0.14 0.09 0.04 
KF147 44 BLL + HEM + Xylose 1 x 0.062 0.06   
KF147 45 BLL + HEM + Xylose 1 x 0.070 0.07   
KF147 46 BLL + HEM + Xylose + 
Glycerol 
1 x 0.067 0.07 0.06 0.02 
KF147 47 BLL + HEM + Xylose + 
Glycerol 
1 x 0.048 0.05   
KF147 48 BLL + HEM + Xylose + 
Glycerol 
1 x 0.079 0.08   
NCDO2118 49 BLL + HEM + Fructose 2 x 0.180 0.360 0.37 0.01 
NCDO2118 50 BLL + HEM + Fructose 2 x 0.179 0.358   
NCDO2118 51 BLL + HEM + Fructose 2 x 0.189 0.378   
NCDO2118 52 BLL + HEM + Fructose + 
Glycerol 
2 x 0.182 0.364 0.37 0.01 
NCDO2118 53 BLL + HEM + Fructose + 
Glycerol 
2 x 0.182 0.364   
NCDO2118 54 BLL + HEM + Fructose + 
Glycerol 
2 x 0.189 0.378   
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NCDO2118 55 BLL + HEM + Xylose 2 x 0.024 0.048 0.07 0.03 
NCDO2118 56 BLL + HEM + Xylose 2 x 0.027 0.054   
NCDO2118 57 BLL + HEM + Xylose 2 x 0.048 0.096   
NCDO2118 58 BLL + HEM + Xylose + 
Glycerol 
1 x 0.031 0.031 0.05 0.02 
NCDO2118 59 BLL + HEM + Xylose + 
Glycerol 
1 x 0.059 0.059   
NCDO2118 60 BLL + HEM + Xylose + 
Glycerol 
1 x 0.059 0.059    
 
Series Max OD SD 
MG1363 - Fructose 0.31 0.06 
MG1363 - Fructose + Glycerol 0.18 0.05 
KF147 - Fructose 0.28 0.04 
KF147 - Fructose + Glycerol 0.25 0.14 
KF147 - Xylose 0.09 0.04 
KF147 - Xylose + Glycerol 0.06 0.02 
NCDO2118 - Fructose 0.37 0.01 
NCDO2118 - Fructose + 
Glycerol 
0.37 0.01 
NCDO2118 - Xylose 0.07 0.03

























Results from growth experiments with the 
sugars glucose and maltose with or 





This section contains the results from growth 
experiments with glucose and maltose with or 
without glycerol supplementation. 
 
Growth 02: Glucose + glycerol 
Growth 03: Glucose 
Growth 04: Maltose 
                  Maltose + glycerol 
 
Experiment: Growth 02 – glucose and 
glycerol. 
Contain.  Strain  Alias  Medium 
Kolbe 5: AH 64 MG1363 SAL + 0,1% glucose + 1% glycerol + 5 µg/mL Hemin 
Kolbe 6: AH 64  MG1363 SAL + 0,1% glucose + 1% glycerol + 5 µg/mL Hemin 
Kolbe 7: AH 64 MG1363 SAL + 0,1% glucose + 1% glycerol + 5 µg/mL Hemin 
Kolbe 8: AH 64 MG1363 SAL + 0,1% glucose + 1% glycerol + 5 µg/mL Hemin 
 
Kolbe Laktat [mM] 
Kolbe 5 5,73 
Kolbe 6 5,75 
Kolbe 7 5,63 






0,00 100,00 200,00 300,00 400,00 500,00 600,00 700,00 800,00 900,00 1000,00
Kolbe 5 - MG1363 - 53.32 min.
Kolbe 6 - MG1363 - 54.15 min.
Kolbe 7 - MG1363 - 53.73 min.
Kolbe 8 - MG1363 - 55.45 min.
Aver. Td SD Td Aver. µ SD µ 
54,16 0,92 0,77 0,01 
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   mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G02 
K5P0 
0 5.01 n.a. 146.01 n.a. n.a. n.a. 
G02 
K5P1 
0.101 4.27 0.85 147.90 n.a. n.a. n.a. 
G02 
K5P2 
0.165 3.73 1.47 147.10 n.a. n.a. n.a. 
G02 
K5P3 
0.212 3.29 1.98 147.33 n.a. n.a. n.a. 
G02 
K5P4 
0.309 2.41 2.83 142.24 n.a. n.a. n.a. 
G02 
K5P5 
0.440 1.35 4.13 146.96 n.a. n.a. n.a. 
G02 
K5P6 
0.590 0.30 5.12 143.98 n.a. n.a. n.a. 
G02 
K5P7 
0.644 n.a. 5.65 148.92 n.a. n.a. n.a. 
G02 
K5P8 























































Optical Density [600nm] 
MG1363 - Glucose + glycerol - 1 
Glucose Lactate Glycerol 
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   mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G02 
K6P0 
0 5.08 n.a. 145.95 n.a. n.a. n.a. 
G02 
K6P1 
0.087 3.87 0.39 131.07 n.a. n.a. n.a. 
G02 
K6P2 
0.140 3.83 0.97 145.67 n.a. n.a. n.a. 
G02 
K6P3 
0.180 3.45 1.58 143.45 n.a. n.a. n.a. 
G02 
K6P4 
0.257 2.81 2.47 147.25 n.a. n.a. n.a. 
G02 
K6P5 
0.370 1.89 3.55 149.89 n.a. n.a. n.a. 
G02 
K6P6 
0.485 0.93 4.62 147.78 n.a. n.a. n.a. 
G02 
K6P7 
0.624 n.a. 4.66 123.66 n.a. n.a. n.a. 
G02 
K6P8 























































Optical Density [600nm] 
MG1363 - Glucose + glycerol - 2 
Glucose Lactate Glycerol 
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   mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G02 
K7P0 
0 5.03 n.a. 145.75 n.a. n.a. n.a. 
G02 
K7P1 
0.094 4.23 0.77 147.42 n.a. n.a. n.a. 
G02 
K7P2 
0.152 3.82 1.41 147.53 n.a. n.a. n.a. 
G02 
K7P3 
0.198 3.36 1.92 147.77 n.a. n.a. n.a. 
G02 
K7P4 
0.291 2.66 2.72 147.58 n.a. n.a. n.a. 
G02 
K7P5 
0.390 1.54 4.01 147.55 n.a. n.a. n.a. 
G02 
K7P6 
0.543 0.52 5.14 147.84 n.a. n.a. n.a. 
G02 
K7P7 
0.624 n.a. 5.84 148.51 n.a. n.a. n.a. 
G02 
K7P8 























































Optical Density [600nm] 
MG1363 - Glucose + glycerol - 3 
Glucose Lactate Glycerol 
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   mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G02 
K8P0 
0 4.71 n.a. 135.66 n.a. n.a. n.a. 
G02 
K8P1 
0.136 3.61 0.99 135.25 n.a. n.a. n.a. 
G02 
K8P2 
0.215 3.19 1.98 147.12 n.a. n.a. n.a. 
G02 
K8P3 
0.276 2.66 2.79 147.07 n.a. n.a. n.a. 
G02 
K8P4 
0.399 1.61 3.62 147.65 n.a. n.a. n.a. 
G02 
K8P5 
0.560 0.21 5.59 147.07 n.a. 1.26 n.a. 
G02 
K8P6 
0.587 n.a. 5.92 148.89 n.a. 1.07 n.a. 
G02 
K8P7 
0.575 n.a. 5.69 148.72 n.a. 0.96 n.a. 
G02 
K8P8 























































Optical Density [600nm] 
MG1363 - Glucose + glycerol - 4 
Glucose Lactate Glycerol 
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Experiment: Growth 03 – glucose without 
glycerol. 
Contain.  Strain  Alias  Medium 
Kolbe 1: AH 64 MG1363 SAL + 0,1% glucose + 5 µg/mL Hemin 
Kolbe 2: AH 64  MG1363 SAL + 0,1% glucose + 5 µg/mL Hemin 
Kolbe 3: AH 64 MG1363 SAL + 0,1% glucose + 5 µg/mL Hemin 
Kolbe 4: AH 64 MG1363 SAL + 0,1% glucose + 5 µg/mL Hemin 
  
Aver. Td SD Td Aver. µ SD µ 




















  mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G03 
K1P0 
0 5.25 n.a. n.a. n.a. n.a. n.a. 
G03 
K1P1 
0.084 4.63 0.64 n.a. n.a. n.a. n.a. 
G03 
K1P2 
0.109 4.20 0.88 n.a. n.a. n.a. n.a. 
G03 
K1P3 
0.142 4.15 1.30 n.a. n.a. n.a. n.a. 
G03 
K1P4 
0.190 3.68 1.81 n.a. n.a. n.a. n.a. 
G03 
K1P5 
0.248 3.15 2.45 n.a. n.a. n.a. n.a. 
G03 
K1P6 
0.364 2.22 3.51 n.a. n.a. n.a. n.a. 
G03 
K1P7 
0.420 1.54 4.24 n.a. n.a. n.a. n.a. 
G03 
K1P8 
0.522 0.85 5.03 n.a. n.a. n.a. n.a. 
G03 
K1P9 






y = -8.2057x + 5.2139 


























Optical Density [600nm] 
MG1363 - 1 
Glucose Lactate Linear (Glucose) 
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  mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G03 
K2P0 
0 5.20 n.a. 145.95 n.a. n.a. n.a. 
G03 
K2P1 
0.102 4.45 0.80 131.07 n.a. n.a. n.a. 
G03 
K2P2 
0.133 4.12 1.16 145.67 n.a. n.a. n.a. 
G03 
K2P3 
0.171 3.89 1.69 143.45 n.a. n.a. n.a. 
G03 
K2P4 
0.230 3.39 2.36 147.25 n.a. 0.2213 n.a. 
G03 
K2P5 
0.302 2.75 3.15 149.89 n.a. 0.6903 n.a. 
G03 
K2P6 
0.436 1.59 4.52 147.78 n.a. 1.0496 n.a. 
G03 
K2P7 
0.536 0.78 5.40 123.66 n.a. 1.242 n.a. 
G03 
K2P8 
0.645 n.a. 6.25 147.16 n.a. n.a. n.a. 
G03 
K2P9 






y = -8.0305x + 5.2077 


























Optical Density [600nm] 
MG1363 - 2 
Glucose Lactate Linear (Glucose) 
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  mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G03 
K3P0 
0 5.25 n.a. n.a. n.a. n.a. n.a. 
G03 
K3P1 
0.065 4.78 0.53 n.a. n.a. n.a. n.a. 
G03 
K3P2 
0.084 4.65 0.75 n.a. n.a. n.a. n.a. 
G03 
K3P3 
0.109 4.44 0.99 n.a. n.a. n.a. n.a. 
G03 
K3P4 
0.143 4.09 1.45 n.a. n.a. n.a. n.a. 
G03 
K3P5 
0.186 3.75 1.95 n.a. n.a. n.a. n.a. 
G03 
K3P6 
0.262 3.06 2.81 n.a. n.a. 0.294 n.a. 
G03 
K3P7 
0.320 2.58 3.38 n.a. n.a. 0.7929 n.a. 
G03 
K3P8 
0.382 2.05 4.00 n.a. n.a. 0.9502 n.a. 
G03 
K3P9 






y = -8.5842x + 5.3282 
























Optical Density [600nm] 
MG1363 - 3 
Glucose Lactate Linear (Glucose) 
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  mM mM mM mM mM mM 
Sample OD600 Glucose Lactate Glycerol Formate Acetate Ethanol 
G03 
K4P0 
0 5.28 n.a. n.a. n.a. n.a. n.a. 
G03 
K4P1 
0.081 4.62 0.68 n.a. n.a. n.a. n.a. 
G03 
K4P2 
0.105 4.41 0.99 n.a. n.a. n.a. n.a. 
G03 
K4P3 
0.138 4.16 1.35 n.a. n.a. n.a. n.a. 
G03 
K4P4 
0.185 3.76 1.89 n.a. n.a. n.a. n.a. 
G03 
K4P5 
0.248 3.28 2.52 n.a. n.a. 0.1929 n.a. 
G03 
K4P6 
0.348 2.31 3.68 n.a. n.a. 0.7652 n.a. 
G03 
K4P7 
0.424 1.66 4.39 n.a. n.a. 1.1512 n.a. 
G03 
K4P8 
0.543 0.97 5.15 n.a. n.a. 1.1444 n.a. 
G03 
K4P9 






y = -8.0552x + 5.2464 


























Optical Density [600nm] 
MG1363 - 4 
Glucose Lactate Linear (Glucose) 
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Experiment: Growth 04 – maltose with and 
without glycerol. 
Contain. Strain Alias Genetics Medium 
Kolbe 1: AH 64 MG 1363 WT SAL + 0,1% maltose + 5 µg/mL hemin 
Kolbe 2: AH 64 MG 1363 WT SAL + 0,1% maltose + 5 µg/mL hemin 
Kolbe 3: AH 64 MG 1363 WT SAL + 0,1% maltose + 5 µg/mL hemin 
Kolbe 4: AH 64 MG 1363 WT SAL + 0,1% maltose + 5 µg/mL hemin 
Kolbe 5: AH 64 MG 1363 WT SAL + 0,1% maltose + 1% glycerol + 5 µg/mL hemin 
Kolbe 6: AH 64 MG 1363 WT SAL + 0,1% maltose + 1% glycerol + 5 µg/mL hemin 
Kolbe 7: AH 64 MG 1363 WT SAL + 0,1% maltose + 1% glycerol + 5 µg/mL hemin 





















   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K1P0 
0 2.9685 n.a. n.a. n.a. n.a. n.a. 
G04 
K1P1 
0.103 2.6954 0.6535 n.a. n.a. 0.6723 n.a. 
G04 
K1P2 
0.144 2.5373 0.9509 n.a. n.a. 1.1425 n.a. 
G04 
K1P3 
0.191 2.2027 1.3636 n.a. n.a. 1.5563 n.a. 
G04 
K1P4 
0.255 1.7819 1.7783 n.a. n.a. 2.3001 n.a. 
G04 
K1P5 
0.367 1.2826 2.4677 n.a. n.a. 3.3815 n.a. 
G04 
K1P6 
0.471 0.8049 3.1198 n.a. n.a. 4.4085 n.a. 
G04 
K1P7 
0.639 0.3465 3.2984 n.a. n.a. 5.664 n.a. 
G04 
K1P8 






























Optical Density [600nm] 




   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K2P0 
0 2.945 n.a. n.a. n.a. n.a. n.a. 
G04 
K2P1 
0.083 2.7892 0.4908 n.a. n.a. 0.5876 n.a. 
G04 
K2P2 
0.110 2.6398 0.7332 n.a. n.a. 0.846 n.a. 
G04 
K2P3 
0.141 2.4308 0.9093 n.a. n.a. 1.0819 n.a. 
G04 
K2P4 
0.188 2.1561 1.4104 n.a. n.a. 1.8593 n.a. 
G04 
K2P5 
0.273 1.7463 1.9143 n.a. n.a. 2.5423 n.a. 
G04 
K2P6 
0.341 1.3718 2.3912 n.a. n.a. 3.3137 n.a. 
G04 
K2P7 
0.458 0.8694 2.971 n.a. n.a. 4.2283 n.a. 
G04 
K2P8 
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   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K3P0 
0 2.9443 n.a. n.a. n.a. n.a. n.a. 
G04 
K3P1 
0.105 2.7236 0.6631 n.a. n.a. 0.5929 n.a. 
G04 
K3P2 
0.143 2.5198 0.908 n.a. n.a. 1.1385 n.a. 
G04 
K3P3 
0.197 2.2348 1.3555 n.a. n.a. 1.7684 n.a. 
G04 
K3P4 
0.264 1.7963 1.8018 n.a. n.a. 2.466 n.a. 
G04 
K3P5 
0.379 1.2661 2.5066 n.a. n.a. 3.5127 n.a. 
G04 
K3P6 
0.491 0.7657 3.1351 n.a. n.a. 4.5463 n.a. 
G04 
K3P7 
0.661 0.3107 3.2592 n.a. n.a. 5.7534 n.a. 
G04 
K3P8 
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   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K4P0 
0 2.9184 n.a. n.a. n.a. n.a. n.a. 
G04 
K4P1 
0.104 2.6174 0.653 n.a. n.a. 0.7601 n.a. 
G04 
K4P2 
0.148 2.4514 0.9355 n.a. n.a. 1.2065 n.a. 
G04 
K4P3 
0.204 2.0218 1.2563 n.a. n.a. 1.6115 n.a. 
G04 
K4P4 
0.270 1.7654 1.8069 n.a. n.a. 2.4548 n.a. 
G04 
K4P5 
0.393 1.2219 2.4837 n.a. n.a. 3.5321 n.a. 
G04 
K4P6 
0.523 0.6926 3.0079 n.a. n.a. 4.4451 n.a. 
G04 
K4P7 
0.703 0.2818 3.2262 n.a. n.a. 5.8639 n.a. 
G04 
K4P8 
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   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K5P0 
0 2.8054 n.a. 140.1603 n.a. n.a. n.a. 
G04 
K5P1 
0.082 2.6081 0.1447 140.7857 n.a. n.a. n.a. 
G04 
K5P2 
0.116 2.4774 0.3351 142.0676 n.a. 0.5208 n.a. 
G04 
K5P3 
0.145 2.1695 0.5069 136.8945 n.a. 1.1843 n.a. 
G04 
K5P4 
0.194 1.9591 0.7321 140.264 n.a. 1.7064 n.a. 
G04 
K5P5 
0.286 1.5963 0.999 141.6949 n.a. 2.4831 n.a. 
G04 
K5P6 
0.354 1.1682 1.3124 134.6202 n.a. 3.3886 n.a. 
G04 
K5P7 
0.458 0.758 1.7493 141.6658 n.a. 4.5161 n.a. 
G04 
K5P8 
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MG1363 - Maltose + glycerol - 1 
Maltose Lactate Glycerol 
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   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K6P0 
0 2.7457 n.a. 138.2757 n.a. n.a. n.a. 
G04 
K6P1 
0.088 2.5745 0.2238 140.314 n.a. n.a. n.a. 
G04 
K6P2 
0.115 2.4176 0.3393 140.5768 n.a. 0.6361 n.a. 
G04 
K6P3 
0.142 2.2003 0.4411 142.1424 n.a. 1.3765 n.a. 
G04 
K6P4 
0.198 1.8967 0.6322 140.4135 n.a. 1.9242 n.a. 
G04 
K6P5 
0.298 1.4819 1.1338 142.6165 n.a. 2.9611 n.a. 
G04 
K6P6 
0.368 1.0614 1.4604 139.4777 n.a. 3.7193 n.a. 
G04 
K6P7 
0.492 0.5741 1.7847 139.5443 n.a. 4.7446 n.a. 
G04 
K6P8 
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MG1363 - Glucose + glycerol - 2 
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   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K7P0 
0 2.7629 n.a. 138.8586 n.a. n.a. n.a. 
G04 
K7P1 
0.087 2.5484 0.1905 138.2967 n.a. n.a. n.a. 
G04 
K7P2 
0.123 2.3947 0.342 138.0249 n.a. 1.0095 n.a. 
G04 
K7P3 
0.164 2.1342 0.4746 137.7373 n.a. 1.3369 n.a. 
G04 
K7P4 
0.223 1.8651 0.6088 139.721 n.a. 2.1488 n.a. 
G04 
K7P5 
0.318 1.4203 1.0653 141.2958 n.a. 3.0866 n.a. 
G04 
K7P6 
0.408 1.005 2.309 142.5051 n.a. 4.054 n.a. 
G04 
K7P7 
0.556 0.5227 2.7002 143.5436 n.a. 5.1805 n.a. 
G04 
K7P8 























































Optical Density [600nm] 
MG1363 - Glucose + glycerol - 3 
Maltose Lactate Glycerol 
APPENDIX D
Page 18
   mM mM mM mM mM mM 
Sample OD600 Maltose Lactate Glycerol Formate Acetate Ethanol 
G04 
K8P0 
0 2.79 n.a. 140.90 n.a. n.a. n.a. 
G04 
K8P1 
0.125 2.45 0.30 140.99 n.a. 0.84 n.a. 
G04 
K8P2 
0.182 2.18 0.40 141.98 n.a. 1.47 n.a. 
G04 
K8P3 
0.256 1.76 0.59 139.90 n.a. 2.12 n.a. 
G04 
K8P4 
0.369 1.20 2.06 141.28 n.a. 3.49 n.a. 
G04 
K8P5 
0.569 0.51 2.73 143.70 n.a. 5.07 n.a. 
G04 
K8P6 
0.692 0.16 1.69 139.17 n.a. 5.98 n.a. 
G04 
K8P7 
0.743 n.a. n.a. n.a. n.a. n.a. n.a. 
G04 
K8P8 
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Quality control data and results from 
microarray analysis of chip 1 and 2 
 
 
E.1 – Results from the differential gene 
expression analysis of chip 2. 
E.2 – Merged tables of the differential gene 








E.1 – Results from the differential gene 






This section contains all the results from the 
analysis of differential gene expression from 
chip 2 (together with the results from chip 1) 










logFC p-value logFC p-value
adaA -0.24 1.7E-02 -0.11 2.9E-01
AraC family transcriptional regulator, regulatory protein of 
adaptative response / methylphosphotriester-DNA alkyltransferase 
methyltransferase [EC:2.1.1.-] 
fruR 0.04 7.2E-01 0.34 3.6E-02
lactose transport regulator, DeoR family transcriptional regulator, 
fructose operon transcriptional repressor
malR -0.17 5.4E-02 -0.09 3.6E-01 maltose operon transcriptional repressor
ccpA -0.10 3.8E-01 -0.23 1.3E-01 catabolite control protein A
rbsR 0.07 5.2E-01 -0.19 1.9E-01 ribose operon repressor
llmg_0956 -0.05 4.7E-01 0.15 8.4E-02 LacI family transcription regulator
treR 0.15 7.1E-02 0.16 1.1E-01 trehalose operon transcriptional repressor
rgrB -0.12 1.1E-01 0.22 3.0E-02 GntR family transcriptional regulator
rmaG -0.20 1.8E-02 -0.28 1.2E-02 MarR family transcriptional regulator
glnR 0.02 7.7E-01 -0.04 6.1E-01 glutamine synthetase repressor
fur -0.35 1.9E-02 -0.02 9.0E-01 ferric uptake regulation protein
flpB 0.07 3.7E-01 0.05 5.4E-01 transcriptional regulator FNR like protein B
flpA -0.44 2.5E-03 -0.54 2.8E-03 FNR like protein A
llmg_1224 -0.43 1.6E-03 -0.61 9.0E-04 transcriptional regulator
llmg_0709 -0.44 4.8E-04 -0.42 2.3E-03 PadR-like family transcriptional regulator
llmg_2339 -0.20 1.2E-01 -0.35 5.1E-02 transcriptional regulator
arsR -0.06 5.1E-01 -0.28 3.7E-02 regulator of arsenical resistance
birA1 -0.32 5.6E-03 -0.33 1.4E-02
biotin--[acetyl-CoA-carboxylase] ligase and biotin operon repressor 
(EC:6.3.4.15)
birA2 0.04 6.0E-01 0.18 7.9E-02
acetyl-CoA carboxylase ligase / biotin operon repressor bifunctional 
protein (EC:6.3.4.
codY -0.07 2.1E-01 -0.01 8.4E-01 transcriptional repressor CodY
ps602 -0.02 8.0E-01 -0.01 8.8E-01 hypothetical protein
mtlR 0.36 1.5E-03 0.15 1.2E-01 transcriptional regulator mtl operon MtlR
ahrC 0.12 1.4E-01 0.19 7.6E-02 arginine transcriptional regulator
argR 0.35 4.5E-03 0.75 2.6E-04 arginine repressor
cspE 0.04 6.7E-01 0.12 3.4E-01 cold shock-like protein CspE
cspD2 0.13 4.5E-01 0.15 5.0E-01 cold shock-like protein cspD2
cspB -0.15 5.9E-01 -0.39 2.8E-01 cold shock-like protein CspB
hrcA -0.09 5.7E-01 0.09 6.4E-01 heat-inducible transcription repressor
tenA -0.23 7.1E-03 -0.27 1.1E-02 transcriptional activator TenA
ctsR 0.09 1.4E-01 0.17 4.5E-02 transcriptional regulator CtsR
parA -0.06 4.1E-01 -0.17 7.9E-02 chromosome partitioning protein ParA
pyrR -0.03 6.8E-01 0.03 6.7E-01
bifunctional pyrimidine regulatory protein PyrR uracil 
phosphoribosyltransferase
nrdR 0.10 1.3E-01 0.14 1.2E-01 transcriptional regulator NrdR
purR -0.17 2.1E-02 -0.22 2.3E-02 pur operon repressor
comX -0.05 6.5E-01 -0.10 4.8E-01 competence regulator ComX
rpoD -0.15 5.2E-02 -0.26 1.6E-02 RNA polymerase sigma factor RpoD
ptsH 0.01 8.74E-01 -0.10 2.19E-01 phosphocarrier protein HPr
Trancsription factors
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LogFC p. Value logFC P.value
glk 0.03 6.8E-01 0.02 8.5E-01 glucokinase 
pgi -0.02 8.0E-01 -0.10 2.3E-01 glucose-6-phosphate isomerase 
pfk 0.01 9.1E-01 -0.11 1.7E-01 6-phosphofructokinase 
pyk -0.04 5.6E-01 -0.10 2.8E-01 pyruvate kinase 
ldh -0.05 4.2E-01 -0.62 1.1E-04 L-lactate dehydrogenase 
fbp 0.19 7.1E-02 0.39 1.3E-02 fructose-bisphosphatase 
fbaA 0.04 4.8E-01 0.04 5.7E-01 fructose-bisphosphate aldolase 
tpiA -0.33 9.0E-03 -0.64 9.8E-04 triosephosphate isomerase 
gapB -0.04 5.6E-01 -0.10 2.8E-01 glyceraldehyde 3-phosphate dehydrogenase 
gapA -0.28 1.0E-02 -0.21 7.7E-02 glyceraldehyde 3-phosphate dehydrogenase 
pgk -0.06 3.2E-01 -0.07 3.2E-01 phosphoglycerate kinase 
llmg_1894 0.19 7.0E-02 0.07 5.6E-01 phosphoglycerate mutase family protein
gpmA -0.09 2.1E-01 -0.05 5.5E-01 phosphoglyceromutase 
gpmB 0.22 3.3E-02 0.28 3.3E-02 phosphoglycerate mutase 
gpmC 0.26 1.5E-02 0.13 2.4E-01 phosphoglycerate mutase 
eno 0.05 4.1E-01 -0.07 4.2E-01 phosphopyruvate hydratase 
pdhA 0.07 2.6E-01 0.08 2.9E-01 pyruvate dehydrogenase E1 component alpha subunit 
pdhB 0.03 6.7E-01 -0.08 3.2E-01 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.02 7.1E-01 0.07 4.1E-01 pyruvate dehydrogenase complex E2 component 
pdhD 0.12 1.7E-01 0.12 2.6E-01 dihydrolipoamide dehydrogenase 
ldhX -0.17 2.4E-02 -0.34 3.2E-03 L-lactate dehydrogenase 
ldhB 0.08 3.1E-01 0.15 1.7E-01 L-lactate dehydrogenase 
adhE 0.49 6.0E-02 0.64 5.5E-02 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP 0.20 1.5E-01 0.30 1.0E-01 alcohol dehydrogenase 
llmg_0955 0.11 1.7E-01 0.06 5.6E-01 alcohol dehydrogenase 
fadD -0.10 4.1E-01 -0.06 6.9E-01 long-chain acyl-CoA synthetase 
galM 0.13 1.7E-01 0.28 3.7E-02 aldose 1-epimerase 
bglA2 0.17 2.2E-02 0.23 1.6E-02 6-phospho-beta-glucosidase 
arb 0.12 4.6E-01 0.35 1.1E-01 6-phospho-beta-glucosidase 
celA 0.28 2.3E-03 0.34 3.1E-03 6-phospho-beta-glucosidase 
Glycolysis
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gltA 0.26 2.2E-02 0.33 2.1E-02 citrate synthase 
citB 0.15 1.5E-01 0.40 1.2E-02 aconitate hydratase 
icd 0.25 3.6E-03 0.41 1.0E-03 isocitrate dehydrogenase 
pdhD 0.12 1.7E-01 0.12 2.6E-01 dihydrolipoamide dehydrogenase 
frdC -0.09 4.4E-01 -0.07 6.1E-01 fumarate reductase flavoprotein subunit 




pyruvate dehydrogenase E1 component alpha subunit 
pdhB 0.03 6.7E-01 -0.08 3.2E-01 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.02 7.1E-01 0.07 4.1E-01 pyruvate dehydrogenase complex E2 component 
TCA cycle
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pgi -0.02 8.0E-01 -0.10 2.3E-01 glucose-6-phosphate isomerase 
llmg_2499 0.07 3.1E-01 0.11 2.4E-01 glucose-6-phosphate 1-dehydrogenase 
llmg_2431 0.30 9.5E-03 0.53 1.7E-03 hypothetical protein
gntZ -0.02 7.9E-01 0.03 7.2E-01 6-phosphogluconate dehydrogenase-like protein 
gnd -0.02 8.3E-01 -0.21 5.1E-02 6-phosphogluconate dehydrogenase 
rpe 0.15 9.4E-02 0.22 7.0E-02 ribulose-phosphate 3-epimerase 
rpe2 -0.17 3.1E-02 -0.20 4.3E-02 ribulose-phosphate 3-epimerase 
tkt 0.11 2.3E-01 0.11 3.2E-01 transketolase 
rpiA -0.25 3.9E-02 -0.38 2.1E-02 ribose-5-phosphate isomerase A 
rpiB -0.11 3.1E-01 -0.13 3.3E-01 ribose-5-phosphate isomerase B 
deoC 0.05 4.7E-01 -0.02 7.9E-01 deoxyribose-phosphate aldolase 
rbsK 0.17 6.8E-02 0.03 7.9E-01 ribokinase 
deoB 0.01 9.0E-01 0.01 8.6E-01 phosphopentomutase 
prsB -0.22 8.1E-03 -0.30 5.5E-03 ribose-phosphate pyrophosphokinase 
prsA -0.03 6.3E-01 0.05 5.5E-01 ribose-phosphate pyrophosphokinase 
kdgA 0.22 8.4E-03 0.40 1.3E-03
keto-hydroxyglutarate-aldolase/keto-deoxy-
phosphogluconate aldolase 
gntK 0.13 7.5E-02 0.05 5.6E-01 gluconate kinase 
fbaA 0.04 4.8E-01 0.04 5.7E-01 fructose-bisphosphate aldolase 
fbp 0.19 7.1E-02 0.39 1.3E-02 fructose-bisphosphatase 
pfk 0.01 9.1E-01 -0.11 1.7E-01 6-phosphofructokinase 
Pentose phosphate pathway
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LogFC p. Value logFC P.value
fadD -0.10 4.1E-01 -0.06 6.9E-01 long-chain acyl-CoA synthetase 
pdhA 0.07 2.6E-01 0.08 2.9E-01 pyruvate dehydrogenase E1 component alpha subunit 
pdhB 0.03 6.7E-01 -0.08 3.2E-01 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.02 7.1E-01 0.07 4.1E-01 pyruvate dehydrogenase complex E2 component 
pdhD 0.12 1.7E-01 0.12 2.6E-01 dihydrolipoamide dehydrogenase 
pfl 0.05 4.4E-01 0.04 6.2E-01 formate acetyltransferase 
adhE 0.49 6.0E-02 0.64 5.5E-02 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
ackA2 0.15 2.8E-01 0.23 2.0E-01 acetate kinase 
ackA1 -0.09 4.4E-01 0.03 8.5E-01 AckA1 protein 
eutD -0.47 1.4E-02 -0.61 1.2E-02 phosphotransacetylase 
pyk -0.04 5.6E-01 -0.10 2.8E-01 pyruvate kinase 
accA -0.05 5.5E-01 -0.10 3.2E-01 AccA protein 
accB 0.02 7.2E-01 -0.10 2.1E-01 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
accC 0.05 4.8E-01 0.05 5.1E-01 acetyl-CoA carboxylase biotin carboxylase subunit 
accD 0.03 6.1E-01 0.06 4.2E-01 acetyl-CoA carboxylase subunit beta 
llmg_0568 0.39 5.5E-04 0.45 9.3E-04 acylphosphatase 
poxL 0.19 6.2E-02 0.12 2.8E-01 pyruvate oxidase 
ldhX -0.17 2.4E-02 -0.34 3.2E-03 L-lactate dehydrogenase 
ldhB 0.08 3.1E-01 0.15 1.7E-01 L-lactate dehydrogenase 
ldh -0.05 4.2E-01 -0.62 1.1E-04 L-lactate dehydrogenase 
llmg_0184 -0.21 1.6E-01 -0.14 4.3E-01 putative lactoylglutathione lyase 
mleS -0.13 1.2E-01 -0.26 2.9E-02 malate dehydrogenase 
pycA -0.06 3.6E-01 -0.25 1.3E-02 pyruvate carboxylase 
thiL -0.34 2.2E-03 -0.28 1.6E-02 ThiL protein 
Pyruvate metabolism
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LogFC p. Value logFC P.value
chiC 0.43 2.5E-03 0.50 3.8E-03 acidic endochitinase precursor 
nagZ 0.04 6.7E-01 -0.01 9.6E-01 putative beta-N-acetylglucosaminidase 
murQ, yfeU 0.15 5.8E-02 -0.10 2.6E-01 N-acetylmuramic acid-6-phosphate etherase
glmU 0.20 7.6E-02 0.27 6.1E-02 bifunctional N-acetylglucosamine-1-phosphate 
uridyltransferase/glucosamine-1-phosphate acetyltransferase 
llmg_1317 -0.04 8.3E-01 0.17 4.5E-01 N-acetylmannosamine-6-phosphate 2-epimerase 
murA2 -0.14 2.2E-01 -0.12 3.8E-01 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
murA1 -0.22 8.0E-03 -0.27 1.0E-02 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
murB 0.01 8.8E-01 0.02 8.0E-01 UDP-N-acetylenolpyruvoylglucosamine reductase 
glmM -0.30 1.2E-03 -0.32 3.1E-03 phosphoglucosamine mutase 
nagA -0.25 1.9E-02 -0.21 8.1E-02 NagA protein 
scrK 0.40 1.1E-03 0.68 2.1E-04 fructokinase 
nagB -0.33 7.9E-04 -0.44 5.8E-04 glucosamine-6-phosphate isomerase 
glmS -0.07 3.0E-01 -0.23 1.9E-02 glucosamine--fructose-6-phosphate aminotransferase 
llmg_1608 0.20 4.5E-02 0.50 2.4E-03 putative glycosyl hydrolases 
llmg_1320 -0.14 7.7E-02 -0.26 2.0E-02 putative xylan beta-1,4-xylosidase 
glk 0.03 6.8E-01 0.02 8.5E-01 glucokinase 
pgi -0.02 8.0E-01 -0.10 2.3E-01 glucose-6-phosphate isomerase 
galU -0.01 8.8E-01 0.04 5.8E-01 UDP--glucose-1-phosphate uridylyltransferase 
galT 0.23 4.7E-02 0.56 2.8E-03 galactose-1-phosphate uridylyltransferase 
ugd 0.00 9.5E-01 -0.13 2.0E-01 UDP-glucose 6-dehydrogenase 
galK 0.06 3.3E-01 0.32 3.4E-03 galactokinase 
galE -0.17 5.1E-02 -0.36 5.1E-03 GalE protein 
llmg_2003 -0.11 2.6E-01 -0.39 1.1E-02 UDP-glucose 4-epimerase 
llmg_0247 0.15 2.2E-01 0.10 4.8E-01 putative UDP-glucose 4-epimerase 
ptnAB 0.02 7.7E-01 -0.10 1.9E-01 PTS system, mannose-specific IIAB components 
ptnC 0.02 7.2E-01 -0.10 2.1E-01 mannose-specific PTS system component IIC 
ptnD -0.02 7.1E-01 0.06 4.5E-01 mannose-specific PTS system component IID
pmi 0.02 7.8E-01 0.40 1.8E-03 mannose-6-phosphate isomerase 
glgD 0.01 9.3E-01 0.29 1.2E-02 glucose-1-phosphate adenylyltransferase 
glgC 0.24 8.1E-03 0.28 1.3E-02 glucose-1-phosphate adenylyltransferase 
Amino sugar and nucleotide sugar metabolism
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ptsI 0.02 7.3E-01 0.02 7.8E-01 phosphoenolpyruvate-protein phosphotransferase 
ptsH 0.01 8.7E-01 -0.10 2.2E-01 phosphocarrier protein HPr
ptsK -0.02 8.2E-01 -0.03 7.7E-01 HPr kinase/phosphorylase 
hprT -0.08 2.2E-01 0.08 3.5E-01 HprT protein 
llmg_1426 0.07 5.4E-01 0.09 5.3E-01 sucrose-specific PTS system IIBC component 
bglP 0.46 7.0E-03 0.42 3.1E-02 PTS system, beta-glucosides specific enzyme IIABC 
llmg_0453 0.03 6.2E-01 0.03 7.5E-01 sucrose-specific PTS enzyme IIABC
llmg_0454 0.02 7.4E-01 0.05 5.5E-01 beta-glucoside-specific PTS system IIABC component
ptcA 0.35 7.9E-02 0.55 3.6E-02 cellobiose-specific PTS system IIA component 
ptcB 0.31 5.9E-02 0.43 4.2E-02 cellobiose-specific PTS system IIB component 
llmg_1244 0.16 3.4E-02 0.35 3.0E-03 hypothetical protein
ptcC 0.45 9.8E-04 0.47 2.8E-03 cellobiose-specific PTS system IIC component 
celB 0.33 1.0E-02 0.44 7.6E-03 cellobiose-specific PTS system IIC component 
mtlF 0.25 1.4E-02 0.04 6.8E-01 PTS system, mannitol-specific IIA component 
mtlA 0.53 2.6E-03 0.73 1.7E-03 PTS system, mannitol-specific IIBC component 
ptnAB 0.02 7.7E-01 -0.10 1.9E-01 PTS system, mannose-specific IIAB components 
ptnC 0.02 7.2E-01 -0.10 2.1E-01 mannose-specific PTS system component IIC 
ptnD -0.02 7.1E-01 0.06 4.5E-01 mannose-specific PTS system component IID
llmg_0866 0.02 9.0E-01 -0.01 9.4E-01
PTS system, unknown pentitol phosphotransferase enzyme IIB 
component 
ulaA, sgaT 0.39 4.3E-04 0.63 9.5E-05 PTS system ascorbate-specific transporter subunit IIC
fruA 0.23 7.8E-02 0.41 2.4E-02 PTS system, fructose specific IIBC components 
glcU 0.05 4.5E-01 -0.15 1.1E-01 putative glucose uptake protein GlcU
Phosphotransferase system (PTS) and glucose uptake
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nudH -0.08 4.4E-01 -0.18 1.9E-01 dinucleoside polyphosphate hydrolase 
eno 0.05 4.1E-01 -0.07 4.2E-01 phosphopyruvate hydratase 
pnpA -0.01 9.4E-01 -0.10 4.4E-01 polynucleotide phosphorylase/polyadenylase 
vacB1 -0.08 3.3E-01 -0.15 1.5E-01 putative exoribonuclease R 
vacB2 -0.40 4.4E-03 -0.53 3.7E-03 putative exoribonuclease R 
rheA -0.09 2.3E-01 -0.26 2.3E-02 ATP-dependent RNA helicase
recQ 0.02 7.4E-01 0.04 6.7E-01 ATP-dependent DNA helicase RecQ 
llmg_0302 0.05 4.7E-01 0.12 2.0E-01 putative Zn-dependent hydrolase
dnaK 0.02 7.5E-01 -0.08 3.2E-01 molecular chaperone DnaK
groEL 0.08 6.4E-01 0.08 7.2E-01 chaperonin GroEL
RNA degradation
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potD -0.01 8.7E-01 -0.18 5.3E-02 spermidine/putrescine ABC transporter substrate-binding protein
potC 0.07 3.0E-01 0.16 8.5E-02 spermidine/putrescine ABC transporter permease
potB 0.17 3.4E-02 -0.02 7.6E-01 spermidine/putrescine ABC transporter permease
potA 0.21 3.3E-02 0.29 2.4E-02 spermidine/putrescine ABC transporter ATP-binding protein
busAB 0.03 7.2E-01 0.02 8.5E-01 glycine betaine-binding periplasmic protein precursor
busAA 0.09 3.4E-01 0.04 7.3E-01 glycine betaine/proline ABC transporter 
choS 0.19 4.8E-02 0.55 1.1E-03 choline ABC transporter permease and substrate binding protein
choQ 0.13 5.7E-02 0.38 1.7E-03 choline ABC transporter ATP binding protein 
malE -0.03 8.7E-01 -0.07 7.3E-01 maltose ABC transporter substrate binding protein
malF 0.22 3.1E-02 0.23 5.8E-02 maltose transport system permease protein MalF
malG 0.15 1.6E-01 0.48 5.8E-03 maltose ABC transporter permease protein MalG
msmK 0.31 8.7E-02 0.67 1.3E-02 multiple sugar-binding transport ATP-binding protein
rbsB 0.12 9.9E-02 -0.12 1.9E-01 ribose ABC transporter substrate binding protein RbsB
rbsC 0.13 1.2E-01 0.15 1.5E-01 ribose transport system permease protein RbsC
rbsD 0.23 2.3E-02 0.11 3.1E-01 ribose ABC transporter permease protein RbsD
rbsD 0.16 5.7E-02 0.07 4.2E-01 D-ribose pyranase
pstE 0.07 4.4E-01 -0.07 5.3E-01 phosphate transport substrate binding protein PstE
pstF 0.31 1.6E-02 0.57 2.9E-03 phosphate transport substrate binding protein PstF
pstD 0.24 1.7E-02 0.16 1.6E-01 phosphate transport system permease protein PstD
pstC 0.27 5.6E-03 0.20 4.9E-02 phosphate transport system permease protein PstC
pstA -0.04 5.1E-01 -0.20 3.9E-02 phosphate transporter ATP-binding protein 
pstB 0.15 3.2E-02 0.21 2.4E-02 phosphate transporter ATP-binding protein 
phnD -0.14 6.8E-02 -0.09 3.1E-01 phosphonate ABC transporter, phosphonate-binding protein PhnD
phnB 0.01 8.8E-01 -0.18 1.3E-01 phosphonate transport system permease protein PhnB
llmg_0315 0.08 5.4E-01 -0.03 8.4E-01 phosphonate ABC transporter permease
phnC -0.06 4.0E-01 -0.28 1.2E-02 phosphonates import ATP-binding protein PhnC
plpA 0.10 3.0E-01 0.16 2.0E-01 D-methionine-binding lipoprotein PlpA precursor
plpB 0.03 7.3E-01 0.10 3.5E-01 D-methionine-binding lipoprotein PlpB precursor
plpC 0.11 1.6E-01 0.14 1.5E-01 D-methionine-binding lipoprotein PlpC precursor
plpD -0.01 8.7E-01 -0.01 9.0E-01 D-methionine-binding lipoprotein PlpD precursor
llmg_0342 0.17 3.0E-02 0.14 1.3E-01 amino acid ABC transporter permease protein
llmg_0341 0.20 3.4E-02 0.21 6.2E-02 amino acid ABC transporter ATP binding protein
dppA 0.04 6.1E-01 -0.06 5.0E-01 dipeptide-binding protein precursor
dppB 0.08 2.8E-01 0.06 5.3E-01 dipeptide transport system permease protein DppB
dppC 0.08 1.9E-01 0.13 1.3E-01 dipeptide transport system permease protein DppC
dppD 0.16 4.1E-02 0.10 2.4E-01 dipeptide transport ATP-binding protein DppD
dppF -0.02 7.9E-01 -0.10 2.8E-01 dipeptide transport ATP-binding protein DppF
fhuD -0.21 7.4E-02 -0.38 2.1E-02 ferrichrome ABC transporter substrate binding protein
fhuB 0.16 4.6E-02 0.15 1.1E-01 ferrichrome ABC transporter permease protein
fhuG 0.02 8.3E-01 -0.07 6.3E-01 ferrichrome ABC transporter permease protein
llmg_1281 0.05 5.8E-01 -0.27 6.3E-02 putative ABC transporter ATP-binding protein
fhuC -0.02 7.6E-01 0.08 3.8E-01 ferrichrome ABC transporter FhuC
zitS 0.30 2.3E-03 -0.14 1.3E-01 zinc ABC transporter substrate binding protein
zitP 0.42 4.9E-03 0.07 6.0E-01 zinc ABC transporter permease protein
zitQ 0.47 2.0E-03 0.15 2.6E-01 zinc ABC transporter ATP binding protein
cbiQ 0.05 5.9E-01 0.01 9.3E-01 putative cobalt ABC transporter permease protein
cbiQ2 0.13 1.4E-01 0.07 4.7E-01 putative cobalt ABC transporter permease protein
cbiO 0.05 5.2E-01 0.12 2.5E-01 putative cobalt ABC transporter ATP-binding protein
cbiO -0.04 5.9E-01 0.01 9.5E-01 cobalt transporter ATP-binding subunit
cbiO 0.22 1.7E-02 0.23 3.6E-02 cobalt transporter ATP-binding subunit
llmg_1552 -0.03 8.3E-01 0.10 5.8E-01 putative ABC type transport system permease protein
drrB 0.47 4.7E-04 0.58 5.6E-04 daunorubicin resistance transmembrane protein
llmg_0262 0.09 3.8E-01 0.36 2.7E-02 ABC transporter permease protein
llmg_1553 0.10 1.7E-01 0.31 7.8E-03 putative ABC transporter ATP-binding protein
drrA 0.32 1.4E-02 0.39 1.7E-02 daunorubicin resistance ABC transporter ATP-binding subunit
tagG 0.14 1.4E-01 -0.02 8.5E-01 teichoic acid ABC transporter permease protein
tagH 0.16 8.0E-02 -0.14 2.0E-01 teichoic acid export ATP-binding protein TagH 
ftsX -0.11 1.8E-01 -0.25 3.4E-02 cell division protein FtsX-like protein
ftsE -0.06 3.3E-01 -0.06 4.8E-01 cell division ATP-binding protein
llmg_1202 0.02 7.6E-01 0.13 1.3E-01 ABC transporter ABC binding and permease protein
cydD 0.10 2.1E-01 0.06 5.4E-01 cytochrome d ABC transporter ATP binding and permease protein
cydC 0.21 2.6E-02 0.11 2.7E-01 cytochrome d ABC transporter ATP binding and permease protein
llmg_0989 0.06 5.3E-01 0.10 3.6E-01 ABC transporter ATP binding and permease protein
ABC transporters
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apl -0.16 1.5E-01 -0.25 1.0E-01 alkaline phosphatase 
pstE 0.07 4.4E-01 -0.07 5.3E-01 phosphate transport substrate binding protein PstE
pstF 0.31 1.6E-02 0.57 2.9E-03 phosphate transport substrate binding protein PstF
kinC 0.00 9.6E-01 0.04 6.4E-01 sensor histidine kinase 
llrC -0.08 2.1E-01 0.02 7.9E-01 two-component system regulator
llmg_0458 -0.17 2.7E-01 -0.17 3.7E-01 hypothetical protein 
dnaA 0.05 5.3E-01 0.08 3.7E-01 chromosomal replication initiation protein
mleS -0.13 1.2E-01 -0.26 2.9E-02 malate dehydrogenase 
comX -0.05 6.5E-01 -0.10 4.8E-01 competence regulator ComX
frdC -0.09 4.4E-01 -0.07 6.1E-01 fumarate reductase flavoprotein subunit 
llmg_0018 0.11 2.1E-01 0.13 2.2E-01 beta-lactamase A 
kinD -0.02 7.1E-01 0.14 1.3E-01 sensor protein kinase KinD 
glnB -0.53 1.7E-03 -0.79 6.9E-04 nitrogen regulatory protein P-II
glnA 0.01 9.2E-01 -0.10 2.1E-01 GlnA protein 
thiL -0.34 2.2E-03 -0.28 1.6E-02 ThiL protein 
cydA 0.04 5.6E-01 0.14 9.7E-02 cytochrome bd-I ubiquinol oxidase subunit I 
cydB 0.10 2.7E-01 0.01 9.2E-01 cytochrome d ubiquinol oxidase, subunit II 
Two-component system
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dppA 0.04 6.1E-01 -0.06 5.0E-01 dipeptide-binding protein precursor
dppB 0.08 2.8E-01 0.06 5.3E-01 dipeptide transport system permease protein DppB
dppC 0.08 1.9E-01 0.13 1.3E-01 dipeptide transport system permease protein DppC
dppD 0.16 4.1E-02 0.10 2.4E-01 dipeptide transport ATP-binding protein DppD
dppF -0.02 7.9E-01 -0.10 2.8E-01 dipeptide transport ATP-binding protein DppF
gltD 0.11 1.2E-01 0.06 4.2E-01 glutamate synthase subunit beta 
gltB 0.15 4.9E-02 0.12 1.7E-01 glutamate synthase, large subunit 
lysA -0.08 2.4E-01 -0.22 3.2E-02 LysA protein 
ilvD 0.19 6.8E-02 0.14 2.5E-01 dihydroxy-acid dehydratase 
ilvB 0.24 3.1E-02 0.22 8.6E-02 acetolactate synthase catalytic subunit 
ilvH 0.29 3.4E-02 0.17 2.7E-01 acetolactate synthase 3 regulatory subunit 
ilvC 0.31 1.8E-02 0.21 1.4E-01 ketol-acid reductoisomerase 
ilvA 0.26 3.9E-02 -0.04 7.5E-01 threonine dehydratase 
aldB 0.01 8.9E-01 -0.11 2.4E-01 AldB protein 
hisC -0.02 7.9E-01 0.18 5.7E-02 histidinol-phosphate aminotransferase 
hisZ 0.27 3.2E-03 0.52 3.0E-04 ATP phosphoribosyltransferase regulatory subunit 
hisG 0.26 2.9E-02 0.47 5.9E-03 ATP phosphoribosyltransferase catalytic subunit 
hisD 0.22 3.3E-02 0.58 1.1E-03 HisD protein 
hisB 0.14 1.1E-01 0.45 2.4E-03 imidazoleglycerol-phosphate dehydratase 
hisH 0.17 1.0E-01 0.27 4.9E-02 imidazole glycerol phosphate synthase subunit HisH 
hisA 0.19 6.4E-02 0.42 7.3E-03
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-
carboxamide isomerase 
hisF 0.25 7.7E-02 0.47 1.7E-02 imidazole glycerol phosphate synthase subunit HisF 
hisI 0.36 2.4E-02 0.72 3.0E-03
bifunctional phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-ATP 
pyrophosphatase protein 
hisK 0.25 3.8E-02 0.60 2.0E-03 histidinol-phosphatase 
ctrA 0.02 6.6E-01 0.06 4.4E-01 putative amino-acid transporter
oppD -0.01 8.7E-01 -0.04 6.0E-01 oligopeptide transport ATP-binding protein OppD
oppF 0.02 7.3E-01 -0.10 2.2E-01 oligopeptide transport ATP-binding protein OppF
oppB -0.01 9.0E-01 0.06 5.4E-01 peptide transport system permease protein OppB
oppC -0.04 5.2E-01 0.02 8.2E-01 oligopeptide transport system permease protein OppC
oppA -0.04 5.2E-01 0.02 8.2E-01 oligopeptide-binding protein OppA precursor
pepO -0.01 8.4E-01 -0.05 5.2E-01 endopeptidase O 
asnB -0.08 2.8E-01 -0.02 8.3E-01 asparagine synthetase B 
gltA 0.26 2.2E-02 0.33 2.1E-02 citrate synthase 
citB 0.15 1.5E-01 0.40 1.2E-02 aconitate hydratase 
icd 0.25 3.6E-03 0.41 1.0E-03 isocitrate dehydrogenase 
serC 0.09 2.2E-01 0.18 8.3E-02 phosphoserine aminotransferase 
serA 0.18 3.1E-02 0.24 2.5E-02 D-3-phosphoglycerate dehydrogenase 
serB 0.12 1.8E-01 0.04 6.8E-01 SerB protein 
arcD1 0.34 5.4E-03 0.21 9.5E-02 arginine/ornithine antiporter
arcC1 0.31 4.3E-03 0.29 1.7E-02 carbamate kinase 
arcC2 0.07 4.0E-01 -0.10 3.6E-01 carbamate kinase 
amtB -0.35 2.9E-02 -0.55 1.2E-02 ammonium transporter AmtB
dapB 0.25 7.0E-03 0.30 8.7E-03 dihydrodipicolinate reductase 
ftsW1 -0.01 8.9E-01 -0.01 9.2E-01 cell division protein ftsW1
Genes under codY regulation
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galP 0.34 9.5E-03 0.49 4.8E-03 Rep  galactose permease
galM 0.13 1.7E-01 0.28 3.7E-02 Rep aldose 1-epimerase 
galK 0.06 3.3E-01 0.32 3.4E-03 Rep galactokinase 
galT 0.23 4.7E-02 0.56 2.8E-03 Rep galactose-1-phosphate uridylyltransferase 
galE -0.17 5.1E-02 -0.36 5.1E-03 Rep GalE protein 
mtlA 0.53 2.6E-03 0.73 1.7E-03 Rep PTS system, mannitol-specific IIBC component 
mtlR 0.36 1.5E-03 0.15 1.2E-01 Rep transcriptional regulator mtl operon MtlR
mtlF 0.25 1.4E-02 0.04 6.8E-01 Rep PTS system, mannitol-specific IIA component 
mtlD 0.22 9.9E-02 0.27 1.1E-01 Rep mannitol-1-phosphate 5-dehydrogenase 
llmg_0453 0.03 6.2E-01 0.03 7.5E-01 Rep sucrose-specific PTS enzyme IIABC
llmg_0454 0.02 7.4E-01 0.05 5.5E-01 Rep beta-glucoside-specific PTS system IIABC component
trePP -0.03 6.2E-01 -0.01 8.7E-01 Rep putative trehalose/maltose hydrolase 
pgmB 0.07 3.6E-01 0.13 2.0E-01 Rep beta-phosphoglucomutase 
llmg_0431 0.30 3.3E-03 0.16 1.0E-01 Rep putative acyl carrier protein phosphodiesterase 2 
llmg_0432 0.04 5.3E-01 0.02 8.1E-01 Rep transcription regulator
ptcB 0.31 5.9E-02 0.43 4.2E-02 Rep cellobiose-specific PTS system IIB component 
ptcA 0.35 7.9E-02 0.55 3.6E-02 Rep cellobiose-specific PTS system IIA component 
llmg_0439 0.26 1.5E-01 0.34 1.4E-01 Rep LacI family transcription regulator
ptcC 0.45 9.8E-04 0.47 2.8E-03 Rep cellobiose-specific PTS system IIC component 
bglA2 0.17 2.2E-02 0.23 1.6E-02 Rep 6-phospho-beta-glucosidase 
arcA 0.18 7.5E-02 0.27 4.3E-02 Rep arginine deiminase 
arcB 0.28 2.0E-02 0.10 4.2E-01 Rep ornithine carbamoyltransferase 
arcD1 0.34 5.4E-03 0.21 9.5E-02 Rep arginine/ornithine antiporter
arcC1 0.31 4.3E-03 0.29 1.7E-02 Rep carbamate kinase 
arcC2 0.07 4.0E-01 -0.10 3.6E-01 Rep carbamate kinase 
pfk 0.01 9.1E-01 -0.11 1.7E-01 Act 6-phosphofructokinase 
pyk -0.04 5.6E-01 -0.10 2.8E-01 Act pyruvate kinase 
ldh -0.05 4.2E-01 -0.62 1.1E-04 Act L-lactate dehydrogenase 
pgi -0.02 8.0E-01 -0.10 2.3E-01 Act glucose-6-phosphate isomerase 
fruA 0.23 7.8E-02 0.41 2.4E-02 Act PTS system, fructose specific IIBC components 
fruC 0.20 7.9E-02 0.44 1.0E-02 Act tagatose-6-phosphate kinase 
fruR 0.04 7.2E-01 0.34 3.6E-02 Act lactose transport regulator
Genes under ccpA regulation
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accA -0.05 5.5E-01 -0.10 3.2E-01 AccA protein 
accB 0.02 7.2E-01 -0.10 2.1E-01 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
accC 0.05 4.8E-01 0.05 5.1E-01 acetyl-CoA carboxylase biotin carboxylase subunit 
accD 0.03 6.1E-01 0.06 4.2E-01 acetyl-CoA carboxylase subunit beta 
fabD -0.03 6.7E-01 -0.06 4.8E-01 malonyl CoA-acyl carrier protein transacylase 
fabF -0.04 5.5E-01 0.05 5.2E-01 3-oxoacyl-[acyl-carrier-protein] synthase II 
fabH 0.00 9.9E-01 -0.07 4.1E-01 3-oxoacyl-(acyl carrier protein) synthase III 
fabG 0.03 6.6E-01 -0.09 2.6E-01 3-ketoacyl-(acyl-carrier-protein) reductase 
fabG -0.08 4.2E-01 -0.02 8.5E-01 3-ketoacyl-(acyl-carrier-protein) reductase 
fabZ -0.02 7.9E-01 -0.10 2.3E-01 (3R)-hydroxymyristoyl-ACP dehydratase 
llmg_0538 -0.12 7.6E-02 -0.07 3.6E-01 (3R)-hydroxymyristoyl-(acyl-carrier-protein) dehydratase 
fabI -0.16 3.5E-02 -0.10 2.5E-01 enoyl-(acyl carrier protein) reductase 
llmg_1415 -0.16 6.2E-02 0.05 5.7E-01 hypothetical protein
thiL -0.34 2.2E-03 -0.28 1.6E-02 ThiL protein 
llmg_1965 0.06 5.9E-01 -0.09 5.1E-01 putative AMP-binding enzyme 
adhE 0.49 6.0E-02 0.64 5.5E-02 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP 0.20 1.5E-01 0.30 1.0E-01 alcohol dehydrogenase 
llmg_0955 0.11 1.7E-01 0.06 5.6E-01 alcohol dehydrogenase 
Fatty acid biosynthesis and fatty acid metabolism
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llmg_0870 -0.26 2.8E-02 -0.48 5.5E-03 transporter
glpF2 0.54 7.6E-05 0.60 1.6E-04 glycerol uptake facilitator
glpF3 -0.22 1.8E-02 -0.60 4.1E-04 putative glycerol uptake facilitator protein
dhaK -0.25 1.4E-02 -0.25 3.3E-02 DhaKLM operon coactivator DhaQ 
dhaM 0.07 2.8E-01 0.20 2.7E-02 dihydroxyacetone kinase DhaM 
glpK 0.20 9.8E-03 0.15 6.4E-02 glycerol kinase 
plsX -0.17 2.3E-02 -0.24 1.7E-02 putative glycerol-3-phosphate acyltransferase PlsX
llmg_1540 -0.17 1.2E-01 -0.40 1.5E-02 putative glycerol-3-phosphate acyltransferase PlsY
llmg_0119 -0.40 5.2E-04 -0.64 1.2E-04 putative acyltransferase 
dgkA 0.03 5.7E-01 0.19 3.5E-02 DgkA protein 
llmg_2421 -0.19 1.8E-02 -0.21 3.2E-02 hypothetical protein
glpD 0.25 6.3E-03 -0.02 8.4E-01 GlpD protein 
gpsA -0.03 6.1E-01 -0.11 2.2E-01
NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 
llmg_0945 0.05 4.8E-01 0.08 3.9E-01 putative glycerol dehydrogenase 
Glycerolipid and glycerol metabolism 
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llmg_2075 0.08 3.8E-01 -0.18 1.3E-01 ADP-ribose pyrophosphatase 
deoB 0.01 9.0E-01 0.01 8.6E-01 phosphopentomutase 
prsB -0.22 8.1E-03 -0.30 5.5E-03 ribose-phosphate pyrophosphokinase 
prsA -0.03 6.3E-01 0.05 5.5E-01 ribose-phosphate pyrophosphokinase 
purF -0.01 9.0E-01 0.06 5.4E-01 amidophosphoribosyltransferase 
purD -0.03 6.9E-01 0.05 5.6E-01 phosphoribosylamine--glycine ligase 
purN -0.40 6.1E-03 -0.58 3.1E-03 phosphoribosylglycinamide formyltransferase 
purS 0.02 7.2E-01 -0.10 2.1E-01 phosphoribosylformylglycinamidine synthetase PurS
purQ -0.04 5.6E-01 0.06 5.1E-01 phosphoribosylformylglycinamidine synthase I 
purL 0.00 1.0E+00 -0.05 4.7E-01 phosphoribosylformylglycinamidine synthase II 
purM -0.04 5.8E-01 -0.17 7.5E-02 phosphoribosylaminoimidazole synthetase 
purK -0.01 8.3E-01 0.04 6.2E-01 phosphoribosylaminoimidazole carboxylase ATPase subunit 
purE -0.02 7.6E-01 -0.10 2.4E-01 phosphoribosylaminoimidazole carboxylase catalytic subunit 
purC -0.05 4.2E-01 0.03 6.7E-01 phosphoribosylaminoimidazole-succinocarboxamide synthase 
purB -0.09 1.6E-01 -0.08 2.7E-01 adenylosuccinate lyase 
purH -0.07 2.9E-01 -0.08 3.2E-01
bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 
apt -0.12 8.3E-02 -0.36 2.5E-03 adenine phosphoribosyltransferase 
nucA -0.28 1.5E-02 -0.12 3.2E-01 5'-nucleotidase 
llmg_0192 0.03 6.1E-01 0.28 8.9E-03 5'-nucleotidase precursor 
deoD -0.10 3.3E-01 -0.15 2.5E-01 purine nucleoside phosphorylase 
hprT -0.08 2.2E-01 0.08 3.5E-01 HprT protein 
hpt 0.09 2.3E-01 0.02 8.4E-01 hypoxanthine phosphoribosyltransferase 
guaB -0.19 2.7E-02 -0.32 7.5E-03 inosine 5'-monophosphate dehydrogenase 
llmg_1188 0.13 2.0E-01 0.03 7.8E-01 hypothetical protein
xpt -0.08 2.5E-01 -0.25 2.2E-02 xanthine phosphoribosyltransferase 
guaA -0.23 1.1E-01 -0.32 8.6E-02 GMP synthase 
guaC -0.47 1.9E-03 -0.61 1.7E-03 guanosine 5'-monophosphate oxidoreductase 
gmk -0.03 6.1E-01 0.08 2.7E-01 guanylate kinase 
pyk -0.04 5.6E-01 -0.10 2.8E-01 pyruvate kinase 
nrdE -0.03 6.1E-01 -0.08 3.7E-01 ribonucleotide-diphosphate reductase subunit alpha 
nrdF 0.12 4.6E-01 0.10 6.0E-01 ribonucleotide-diphosphate reductase subunit beta 
llmg_0281 -0.24 5.5E-03 -0.32 4.0E-03 anaerobic ribonucleoside triphosphate reductase 
rpoA 0.06 3.9E-01 0.06 4.8E-01 DNA-directed RNA polymerase subunit alpha 
rpoB 0.01 9.1E-01 -0.01 9.2E-01 DNA-directed RNA polymerase subunit beta 
rpoC -0.03 6.2E-01 0.06 5.2E-01 DNA-directed RNA polymerase subunit beta' 
rpoE -0.15 2.0E-01 -0.16 3.0E-01 DNA-directed RNA polymerase subunit delta 
rpoZ 0.13 1.6E-01 -0.08 4.6E-01 DNA-directed RNA polymerase subunit omega 
polA -0.04 5.7E-01 -0.09 3.1E-01 DNA polymerase I 
dnaE -0.11 7.7E-02 -0.04 5.6E-01 DNA polymerase III DnaE 
polC -0.04 7.0E-01 -0.13 3.2E-01 DNA polymerase III PolC 
dnaN 0.06 4.8E-01 0.09 4.6E-01 DNA polymerase III subunit beta 
dnaX 0.09 2.5E-01 -0.03 7.8E-01 DNA polymerase III subunits gamma and tau 
holA -0.06 4.2E-01 -0.09 3.2E-01 DNA polymerase III subunit delta 
holB -0.06 5.4E-01 0.09 4.5E-01 DNA polymerase III subunit delta' 
dnaQ -0.25 4.9E-03 -0.21 3.2E-02 DNA polymerase III, epsilon chain 
relA 0.00 9.6E-01 -0.06 4.3E-01 GTP pyrophosphokinase 
llmg_0382 0.13 1.4E-01 0.19 9.3E-02 putative GTP pyrophosphokinase 
purA -0.01 8.6E-01 -0.10 2.2E-01 adenylosuccinate synthetase 
add -0.27 1.7E-02 -0.60 1.0E-03 adenosine deaminase 
cpdC -0.26 4.5E-03 -0.50 4.7E-04 2',3'-cyclic-nucleotide 2'-phosphodiesterase 
adk -0.09 3.5E-01 0.33 2.3E-02 adenylate kinase 
pnpA -0.01 9.4E-01 -0.10 4.4E-01 polynucleotide phosphorylase/polyadenylase 
arcC2 0.07 4.0E-01 -0.10 3.6E-01 carbamate kinase 
arcC1 0.31 4.3E-03 0.29 1.7E-02 carbamate kinase 
Purine metabolism
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carB -0.01 8.5E-01 -0.07 3.7E-01 carbamoyl phosphate synthase large subunit 
carA 0.00 9.9E-01 0.00 9.9E-01 carbamoyl phosphate synthase small subunit 
pyrB 0.06 3.7E-01 -0.06 4.3E-01 aspartate carbamoyltransferase catalytic subunit 
pyrC -0.03 6.7E-01 -0.07 3.5E-01 dihydroorotase 
pyrDA -0.39 1.1E-02 -0.53 8.5E-03 dihydroorotate dehydrogenase 1A 
pyrDB 0.01 8.5E-01 -0.10 2.0E-01 dihydroorotate dehydrogenase 1B 
pyrE 0.01 9.1E-01 0.09 2.7E-01 orotate phosphoribosyltransferase 
pyrF -0.27 1.2E-02 -0.53 1.3E-03 orotidine 5'-phosphate decarboxylase 
cmk -0.13 1.1E-01 0.14 1.5E-01 cytidylate kinase 
pyrH -0.01 8.3E-01 0.07 4.0E-01 uridylate kinase 
pnpA -0.01 9.4E-01 -0.10 4.4E-01 polynucleotide phosphorylase/polyadenylase 
llmg_1188 0.13 2.0E-01 0.03 7.8E-01 hypothetical protein
pyrG -0.03 6.0E-01 0.00 9.9E-01 CTP synthetase 
rpoA 0.06 3.9E-01 0.06 4.8E-01 DNA-directed RNA polymerase subunit alpha 
rpoB 0.01 9.1E-01 -0.01 9.2E-01 DNA-directed RNA polymerase subunit beta 
rpoC -0.03 6.2E-01 0.06 5.2E-01 DNA-directed RNA polymerase subunit beta' 
rpoE -0.15 2.0E-01 -0.16 3.0E-01 DNA-directed RNA polymerase subunit delta 
rpoZ 0.13 1.6E-01 -0.08 4.6E-01 DNA-directed RNA polymerase subunit omega 
polA -0.04 5.7E-01 -0.09 3.1E-01 DNA polymerase I 
dnaE -0.11 7.7E-02 -0.04 5.6E-01 DNA polymerase III DnaE 
polC -0.04 7.0E-01 -0.13 3.2E-01 DNA polymerase III PolC 
dnaN 0.06 4.8E-01 0.09 4.6E-01 DNA polymerase III subunit beta 
dnaX 0.09 2.5E-01 -0.03 7.8E-01 DNA polymerase III subunits gamma and tau 
holA -0.06 4.2E-01 -0.09 3.2E-01 DNA polymerase III subunit delta 
holB -0.06 5.4E-01 0.09 4.5E-01 DNA polymerase III subunit delta' 
dnaQ -0.25 4.9E-03 -0.21 3.2E-02 DNA polymerase III, epsilon chain 
udk -0.52 4.9E-04 -0.37 1.0E-02 uridine kinase 
nucA -0.28 1.5E-02 -0.12 3.2E-01 5'-nucleotidase 
llmg_0192 0.03 6.1E-01 0.28 8.9E-03 5'-nucleotidase precursor 
udp 0.05 5.3E-01 0.15 1.7E-01 uridine phosphorylase 
upp -0.30 7.2E-03 -0.49 2.2E-03 uracil phosphoribosyltransferase 
pyrR -0.03 6.8E-01 0.03 6.7E-01
bifunctional pyrimidine regulatory protein PyrR uracil 
phosphoribosyltransferase 
pdp 0.16 4.7E-02 0.26 1.6E-02 pyrimidine-nucleoside phosphorylase 
trxB1 -0.21 4.0E-02 -0.07 5.4E-01 TrxB1 protein 
trxB2 -0.27 7.9E-03 -0.31 1.2E-02 TrxB2 protein 
llmg_0281 -0.24 5.5E-03 -0.32 4.0E-03 anaerobic ribonucleoside triphosphate reductase 
nrdE -0.03 6.1E-01 -0.08 3.7E-01 ribonucleotide-diphosphate reductase subunit alpha 
nrdF 0.12 4.6E-01 0.10 6.0E-01 ribonucleotide-diphosphate reductase subunit beta 
ps428 0.25 3.0E-02 0.27 5.8E-02 deoxyuridine 5'-triphosphate nucleotidohydrolase 
ps325 0.14 5.4E-02 0.20 4.1E-02 deoxyuridine 5'-triphosphate nucleotidohydrolase 
dut -0.07 4.1E-01 -0.10 3.6E-01 deoxyuridine 5'-triphosphate nucleotidohydrolase 
thyA -0.47 5.0E-04 -0.38 5.4E-03 thymidylate synthase 
cdd -0.03 6.9E-01 0.00 9.9E-01 Cdd protein 
deoD -0.10 3.3E-01 -0.15 2.5E-01 purine nucleoside phosphorylase 
llmg_1416 -0.27 3.2E-02 -0.24 1.0E-01 hypothetical protein
ntd 0.17 3.2E-02 0.07 4.1E-01 nucleoside deoxyribosyltransferase 
tdk 0.03 6.4E-01 -0.05 5.7E-01 thymidine kinase 
tmk -0.13 1.6E-01 -0.22 7.1E-02 thymidylate kinase 
cpdC -0.26 4.5E-03 -0.50 4.7E-04 2',3'-cyclic-nucleotide 2'-phosphodiesterase 
Pyrimidine metabolism
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LogFC p. Value logFC P.value
speG -0.13 6.6E-02 0.07 3.5E-01 spermidine acetyltransferase 
llmg_0177 0.28 5.7E-03 0.40 2.9E-03 amidase
proC -0.18 5.3E-02 -0.23 5.0E-02 pyrroline-5-carboxylate reductase 
ocd -0.34 1.5E-03 -0.46 1.0E-03
ornithine cyclodeaminase, mu-crystallin-like protein 
proB -0.13 9.5E-02 -0.28 1.3E-02 gamma-glutamyl kinase 
proA -0.15 7.4E-02 -0.26 2.3E-02 gamma-glutamyl phosphate reductase 
kdgA 0.22 8.4E-03 0.40 1.3E-03
keto-hydroxyglutarate-aldolase/keto-deoxy-
phosphogluconate aldolase 
arcB 0.28 2.0E-02 0.10 4.2E-01 ornithine carbamoyltransferase 
argF -0.53 7.8E-05 -0.67 7.5E-05 ornithine carbamoyltransferase 
argG 0.17 6.2E-02 0.30 1.8E-02 argininosuccinate synthase 
argH 0.00 9.7E-01 -0.07 3.4E-01 argininosuccinate lyase 
arcA 0.18 7.5E-02 0.27 4.3E-02 arginine deiminase 
glnA 0.01 9.2E-01 -0.10 2.1E-01 GlnA protein 
arcC2 0.07 4.0E-01 -0.10 3.6E-01 carbamate kinase 
arcC1 0.31 4.3E-03 0.29 1.7E-02 carbamate kinase 
argJ -0.17 1.1E-01 -0.24 7.0E-02
bifunctional ornithine acetyltransferase/N-acetylglutamate 
synthase protein 
argB -0.34 2.4E-03 -0.23 4.0E-02 acetylglutamate kinase 
argC -0.39 8.9E-04 -0.47 1.2E-03 N-acetyl-gamma-glutamyl-phosphate reductase 
argD -0.10 2.7E-01 0.05 6.4E-01 acetylornithine aminotransferase 
argE -0.10 2.5E-01 -0.18 1.0E-01 acetylornithine deacetylase 
Arginine and proline metabolism
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dfrA -0.14 4.7E-02 -0.02 8.4E-01 DfrA protein 
fhs -0.12 1.8E-01 -0.04 6.7E-01 formate--tetrahydrofolate ligase 




glyA -0.13 6.6E-02 -0.25 1.5E-02 serine hydroxymethyltransferase 
purN -0.40 6.1E-03 -0.58 3.1E-03 phosphoribosylglycinamide formyltransferase 
purH -0.07 2.9E-01 -0.08 3.2E-01 bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 
fmt 0.12 1.5E-01 0.00 9.7E-01 methionyl-tRNA formyltransferase 
thyA -0.47 5.0E-04 -0.38 5.4E-03 thymidylate synthase 
metF -0.24 6.4E-02 -0.34 4.3E-02 5,10-methylenetetrahydrofolate reductase
llmg_0181 0.00 9.8E-01 -0.06 5.6E-01 5-formyltetrahydrofolate cyclo-ligase family protein 
thiD1 0.11 1.9E-01 0.05 6.3E-01 phosphomethylpyrimidine kinase 
nifS -0.02 7.6E-01 0.19 4.6E-02 putative iron-sulfur cofactor synthesis protein 
nifZ -0.33 1.8E-03 -0.48 9.5E-04 pyridoxal-phosphate dependent aminotransferase 
llmg_1972 0.12 9.4E-02 0.04 5.9E-01 hypothetical protein
thiI -0.46 6.3E-04 -0.42 3.7E-03 thiamine biosynthesis protein ThiI
thiM -0.10 1.9E-01 -0.03 7.0E-01 hydroxyethylthiazole kinase 
thiE -0.04 4.8E-01 -0.02 8.3E-01 thiamine-phosphate pyrophosphorylase 
thiN -0.07 3.5E-01 0.10 3.2E-01 thiamin pyrophosphokinase 
tenA -0.23 7.1E-03 -0.27 1.1E-02 transcriptional activator TenA
ribA -0.03 6.5E-01 0.00 9.6E-01 riboflavin biosynthesis protein RibA 
ribD -0.10 1.6E-01 -0.12 1.9E-01 riboflavin biosynthesis protein RibD 
ribH 0.12 1.5E-01 0.27 2.0E-02 6,7-dimethyl-8-ribityllumazine synthase 
ribB -0.01 8.2E-01 0.00 9.7E-01 riboflavin synthase subunit alpha 
ribC, ribF -0.11 2.3E-01 -0.01 9.6E-01 bifunctional riboflavin kinase/FMN adenylyltransferase 
thiD2 0.03 7.8E-01 -0.10 4.9E-01 phosphomethylpyrimidine kinase 
serC 0.09 2.2E-01 0.18 8.3E-02 phosphoserine aminotransferase 
thrC 0.06 3.7E-01 -0.01 8.6E-01 threonine synthase 
pncB 0.06 3.5E-01 0.00 9.9E-01 nicotinate phosphoribosyltransferase 
deoD -0.10 3.3E-01 -0.15 2.5E-01 purine nucleoside phosphorylase 
nucA -0.28 1.5E-02 -0.12 3.2E-01 5'-nucleotidase 
llmg_0192 0.03 6.1E-01 0.28 8.9E-03 5'-nucleotidase precursor 
nadD -0.16 1.8E-01 -0.12 3.8E-01 nicotinic acid mononucleotide adenylyltransferase 
nadD1 0.22 2.1E-02 0.28 2.0E-02 nicotinate-nucleotide adenylyltransferase 
nadE 0.10 1.2E-01 0.11 1.8E-01 NAD synthetase 
ppnK -0.09 1.3E-01 -0.04 5.5E-01 inorganic polyphosphate/ATP-NAD kinase 
als -0.25 1.5E-02 -0.43 3.7E-03 acetolactate synthase 
ilvB 0.24 3.1E-02 0.22 8.6E-02 acetolactate synthase catalytic subunit 
ilvH 0.29 3.4E-02 0.17 2.7E-01 acetolactate synthase 3 regulatory subunit 
ilvC 0.31 1.8E-02 0.21 1.4E-01 ketol-acid reductoisomerase 
ilvD 0.19 6.8E-02 0.14 2.5E-01 dihydroxy-acid dehydratase 
panE -0.42 1.2E-03 -0.14 1.8E-01 2-dehydropantoate 2-reductase 
coaA -0.19 4.5E-02 -0.13 2.2E-01 pantothenate kinase 
dfpB -0.05 4.5E-01 0.06 5.3E-01 phosphopantothenate--cysteine ligase 
dfpA 0.03 6.2E-01 0.12 2.1E-01 phosphopantothenoylcysteine decarboxylase 
coaD -0.07 4.8E-01 -0.09 4.3E-01 phosphopantetheine adenylyltransferase 
coaE -0.09 2.9E-01 -0.10 3.3E-01 dephospho-CoA kinase 
acpS -0.03 6.5E-01 -0.06 4.9E-01 4'-phosphopantetheinyl transferase 
ilvE -0.36 3.7E-03 -0.55 1.4E-03 branched-chain amino acid aminotransferase 
birA2 0.04 6.0E-01 0.18 7.9E-02
acetyl-CoA carboxylase ligase / biotin operon repressor 
bifunctional protein 
birA1 -0.32 5.6E-03 -0.33 1.4E-02





Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Biotin metabolism
Vitamin and cofactor metabolism
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E.2 – Merged tables of the differential gene 






This section contains the complete collection of 
results from the analysis of differential gene 
expression from both chip 1 and chip 2 (sorted 










BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
adaA -0.31 -0.24 AraC family transcriptional regulator, regulatory protein 
fruR 0.34 lactose transport regulator, fructose operon transcriptional repressor
malR 0.55 -0.17 maltose operon transcriptional repressor
ccpA catabolite control protein A
rbsR ribose operon repressor
llmg_0956 0.45 0.15 LacI family transcription regulator
treR -0.31 -0.47 0.15 trehalose operon transcriptional repressor
rgrB 0.57 0.22 GntR family transcriptional regulator
rmaG -0.46 -0.47 -0.20 -0.28 MarR family transcriptional regulator
glnR -0.27 glutamine synthetase repressor
fur -0.45 -0.35 ferric uptake regulation protein
flpB transcriptional regulator FNR like protein B
flpA -0.44 -0.54 FNR like protein A
llmg_1224 0.42 -0.43 -0.61 transcriptional regulator
llmg_0709 -0.44 -0.42 PadR-like family transcriptional regulator
llmg_2339 -0.35 transcriptional regulator
arsR -0.28 regulator of arsenical resistance
birA1 -0.23 -0.32 -0.33 biotin--[acetyl-CoA-carboxylase] ligase and biotin operon repressor
birA2 0.20 0.18 acetyl-CoA carboxylase ligase / biotin operon repressor bifunctional protein
codY 0.84 transcriptional repressor CodY
ps602 0.31 0.53 hypothetical protein
mtlR 0.36 transcriptional regulator mtl operon MtlR
ahrC 0.19 arginine transcriptional regulator
argR 0.34 0.35 0.75 arginine repressor
cspE 0.41 cold shock-like protein CspE
cspD2 0.30 cold shock-like protein cspD2
cspB cold shock-like protein CspB
hrcA -0.45 0.34 heat-inducible transcription repressor
tenA -0.23 -0.27 transcriptional activator TenA
ctsR 0.17 transcriptional regulator CtsR
parA 0.43 -0.17 chromosome partitioning protein ParA
pyrR -0.63 bifunctional pyrimidine regulatory protein PyrR
nrdR -0.30 -0.39 transcriptional regulator NrdR
purR -0.40 0.57 -0.17 -0.22 pur operon repressor
comX -0.39 competence regulator ComX






BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
glk -0.25 -0.57 glucokinase 
pgi 0.54 glucose-6-phosphate isomerase 
pfk -0.26 -0.56 6-phosphofructokinase 
pyk -0.27 -1.09 pyruvate kinase 
ldh -0.51 -0.45 -0.62 L-lactate dehydrogenase 
fbp 0.60 0.65 0.19 0.39 fructose-bisphosphatase 
fbaA -0.36 -0.46 fructose-bisphosphate aldolase 
tpiA -0.68 -0.33 -0.64 triosephosphate isomerase 
gapB glyceraldehyde 3-phosphate dehydrogenase 
gapA 0.22 -0.28 -0.21 glyceraldehyde 3-phosphate dehydrogenase 
pgk -0.35 -0.07 phosphoglycerate kinase 
llmg_1894 0.19 phosphoglycerate mutase family protein
gpmA -0.30 -0.67 phosphoglyceromutase 
gpmB -0.51 0.22 0.28 phosphoglycerate mutase 
gpmC 0.25 -0.56 0.26 phosphoglycerate mutase 
eno -0.28 phosphopyruvate hydratase 
pdhA -0.51 pyruvate dehydrogenase E1 component alpha subunit 
pdhB -0.36 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.35 pyruvate dehydrogenase complex E2 component 
pdhD dihydrolipoamide dehydrogenase 
ldhX 0.45 -0.17 -0.34 L-lactate dehydrogenase 
ldhB L-lactate dehydrogenase 
adhE 0.52 0.49 0.64 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP 0.30 alcohol dehydrogenase 
llmg_0955 alcohol dehydrogenase 
fadD -0.26 long-chain acyl-CoA synthetase 
galM 0.57 0.28 aldose 1-epimerase 
bglA2 0.17 0.23 6-phospho-beta-glucosidase 
arb 0.61 6-phospho-beta-glucosidase 
celA 0.28 0.34 6-phospho-beta-glucosidase 
Glycolysis
Gene/locus Annotation
Chip 1 Chip 2
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BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
gltA 0.26 0.33 citrate synthase 
citB 0.40 aconitate hydratase 
icd 0.25 0.41 isocitrate dehydrogenase 
pdhD dihydrolipoamide dehydrogenase 
frdC -0.29 -0.28 fumarate reductase flavoprotein subunit 
pycA -0.36 -0.60 -0.25 pyruvate carboxylase 
pdhA -0.51 pyruvate dehydrogenase E1 component alpha subunit 
pdhB -0.36 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.35 pyruvate dehydrogenase complex E2 component 
TCA cycle
Gene/locus Annotation
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BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
pgi 0.54 glucose-6-phosphate isomerase 
llmg_2499 -0.38 glucose-6-phosphate 1-dehydrogenase 
llmg_2431 0.30 0.53 hypothetical protein
gntZ 0.29 6-phosphogluconate dehydrogenase-like protein 
gnd -0.50 -0.21 6-phosphogluconate dehydrogenase 
rpe -0.60 0.15 ribulose-phosphate 3-epimerase 
rpe2 -0.17 -0.20 ribulose-phosphate 3-epimerase 
tkt -0.54 transketolase 
rpiA -0.26 0.47 -0.25 -0.38 ribose-5-phosphate isomerase A 
rpiB ribose-5-phosphate isomerase B 
deoC -0.58 deoxyribose-phosphate aldolase 
rbsK 0.17 ribokinase 
deoB -0.25 -0.76 phosphopentomutase 
prsB -0.32 -0.26 -0.22 -0.30 ribose-phosphate pyrophosphokinase 
prsA ribose-phosphate pyrophosphokinase 
kdgA 0.55 0.22 0.40 keto-hydroxyglutarate-aldolase
gntK -0.26 0.13 gluconate kinase 
fbaA -0.36 -0.46 fructose-bisphosphate aldolase 
fbp 0.60 0.65 0.19 0.39 fructose-bisphosphatase 
pfk -0.26 -0.56 6-phosphofructokinase 
Pentose phosphate pathway
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logFC logFC logFC logFC
fadD -0.26 long-chain acyl-CoA synthetase 
pdhA -0.51 pyruvate dehydrogenase E1 component alpha subunit 
pdhB -0.36 pyruvate dehydrogenase E1 component beta subunit 
pdhC -0.35 pyruvate dehydrogenase complex E2 component 
pdhD dihydrolipoamide dehydrogenase 
pfl formate acetyltransferase 
adhE 0.52 0.49 0.64 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
ackA2 -0.33 -0.35 acetate kinase 
ackA1 0.30 AckA1 protein 
eutD -0.25 -0.23 -0.47 -0.61 phosphotransacetylase 
pyk -0.27 -1.09 pyruvate kinase 
accA AccA protein 
accB -1.05 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
accC -0.26 -0.71 acetyl-CoA carboxylase biotin carboxylase subunit 
accD -0.28 acetyl-CoA carboxylase subunit beta 
llmg_0568 -0.27 0.39 0.45 acylphosphatase 
poxL 0.19 pyruvate oxidase 
ldhX 0.45 -0.17 -0.34 L-lactate dehydrogenase 
ldhB L-lactate dehydrogenase 
ldh -0.51 -0.45 -0.62 L-lactate dehydrogenase 
llmg_0184 0.80 -0.14 putative lactoylglutathione lyase 
mleS -0.26 malate dehydrogenase 
pycA -0.36 -0.60 -0.25 pyruvate carboxylase 
thiL -0.34 -0.28 ThiL protein 
Pyruvate metabolism
Gene/locus Annotation
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logFC logFC logFC logFC
chiC 0.43 0.50 acidic endochitinase precursor 
nagZ putative beta-N-acetylglucosaminidase 
murQ, yfeU 0.31 0.15 N-acetylmuramic acid-6-phosphate etherase
glmU -0.30 -0.56 0.20 0.27 bifunctional N-acetylglucosamine-1-phosphate 
llmg_1317 -0.38 0.49 N-acetylmannosamine-6-phosphate 2-epimerase 
murA2 -0.63 -0.35 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
murA1 -0.22 -0.27 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
murB UDP-N-acetylenolpyruvoylglucosamine reductase 
glmM -0.30 -0.32 phosphoglucosamine mutase 
nagA -0.64 -0.45 -0.25 -0.21 NagA protein 
scrK 0.53 -0.22 0.40 0.68 fructokinase 
nagB 0.40 -0.33 -0.44 glucosamine-6-phosphate isomerase 
glmS -0.37 -0.98 -0.23 glucosamine--fructose-6-phosphate aminotransferase 
llmg_1608 0.20 0.50 putative glycosyl hydrolases 
llmg_1320 -0.14 -0.26 putative xylan beta-1,4-xylosidase 
glk -0.25 -0.57 glucokinase 
pgi 0.54 glucose-6-phosphate isomerase 
galU UDP--glucose-1-phosphate uridylyltransferase 
galT 0.23 0.56 galactose-1-phosphate uridylyltransferase 
ugd UDP-glucose 6-dehydrogenase 
galK 0.32 galactokinase 
galE -0.32 0.33 -0.17 -0.36 GalE protein 
llmg_2003 -0.39 UDP-glucose 4-epimerase 
llmg_0247 0.65 putative UDP-glucose 4-epimerase 
ptnAB -0.78 PTS system, mannose-specific IIAB components 
ptnC -0.65 mannose-specific PTS system component IIC 
ptnD -0.49 mannose-specific PTS system component IID
pmi 0.98 0.40 mannose-6-phosphate isomerase 
glgD 0.29 glucose-1-phosphate adenylyltransferase 
glgC 0.24 0.28 glucose-1-phosphate adenylyltransferase 
Amino sugar and nucleotide sugar metabolism
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Chip 1 Chip 2
Page 26
APPENDIX E
BK1506 BK1503 BK1506 BK1503
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ptsI -0.37 phosphoenolpyruvate-protein phosphotransferase 
ptsH 0.24 phosphocarrier protein HPr
ptsK -0.25 0.32 HPr kinase/phosphorylase 
hprT 0.30 HprT protein 
llmg_1426 sucrose-specific PTS system IIBC component 
bglP 0.46 0.42 PTS system, beta-glucosides specific enzyme IIABC 
llmg_0453 sucrose-specific PTS enzyme IIABC
llmg_0454 -0.25 beta-glucoside-specific PTS system IIABC component
ptcA 1.00 0.35 0.55 cellobiose-specific PTS system IIA component 
ptcB 0.83 0.31 0.43 cellobiose-specific PTS system IIB component 
llmg_1244 0.40 0.16 0.35 hypothetical protein
ptcC 0.59 0.45 0.47 cellobiose-specific PTS system IIC component 
celB 1.34 0.33 0.33 0.44 cellobiose-specific PTS system IIC component 
mtlF 0.25 PTS system, mannitol-specific IIA component 
mtlA 0.53 0.73 PTS system, mannitol-specific IIBC component 
ptnAB -0.78 PTS system, mannose-specific IIAB components 
ptnC -0.65 mannose-specific PTS system component IIC 
ptnD -0.49 mannose-specific PTS system component IID
llmg_0866 0.42 PTS system, enzyme IIB component 
ulaA, sgaT 0.85 0.39 0.63 PTS system ascorbate-specific transporter subunit IIC
fruA 0.37 0.23 0.41 PTS system, fructose specific IIBC components 
glcU putative glucose uptake protein GlcU
Phosphotransferase system (PTS) and glucose uptake
Gene/locus Annotation
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nudH dinucleoside polyphosphate hydrolase 
eno -0.28 phosphopyruvate hydratase 
pnpA -0.56 polynucleotide phosphorylase/polyadenylase 
vacB1 -0.49 putative exoribonuclease R 
vacB2 0.89 -0.40 -0.53 putative exoribonuclease R 
rheA -0.26 ATP-dependent RNA helicase
recQ -0.38 ATP-dependent DNA helicase RecQ 
llmg_0302 -0.60 putative Zn-dependent hydrolase
dnaK molecular chaperone DnaK
groEL -0.31 chaperonin GroEL
RNA degradation
Gene/locus Annotation
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logFC logFC logFC logFC
potD -0.51 0.47 -0.18 spermidine/putrescine ABC transporter substrate-binding protein
potC 0.16 spermidine/putrescine ABC transporter permease
potB 0.17 spermidine/putrescine ABC transporter permease
potA -0.28 0.21 0.29 spermidine/putrescine ABC transporter ATP-binding protein
busAB -0.28 0.30 glycine betaine-binding periplasmic protein precursor
busAA -0.35 glycine betaine/proline ABC transporter 
choS 0.35 0.19 0.55 choline ABC transporter permease and substrate binding protein
choQ -0.33 0.13 0.38 choline ABC transporter ATP binding protein 
malE maltose ABC transporter substrate binding protein
malF 0.72 0.22 0.23 maltose transport system permease protein MalF
malG 0.48 maltose ABC transporter permease protein MalG
msmK 0.80 0.31 0.67 multiple sugar-binding transport ATP-binding protein
rbsB 0.12 ribose ABC transporter substrate binding protein RbsB
rbsC ribose transport system permease protein RbsC
rbsD 0.23 ribose ABC transporter permease protein RbsD
rbsD 0.16 D-ribose pyranase
pstE -0.48 -0.54 phosphate transport substrate binding protein PstE
pstF -0.45 0.31 0.57 phosphate transport substrate binding protein PstF
pstD -0.84 0.24 phosphate transport system permease protein PstD
pstC -0.76 0.27 0.20 phosphate transport system permease protein PstC
pstA -0.65 -0.62 -0.20 phosphate transporter ATP-binding protein 
pstB -0.69 0.15 0.21 phosphate transporter ATP-binding protein 
phnD -0.33 -0.32 -0.14 phosphonate ABC transporter, phosphonate-binding protein PhnD
phnB -0.79 phosphonate transport system permease protein PhnB
llmg_0315 -0.53 -0.78 phosphonate ABC transporter permease
phnC -0.81 -0.28 phosphonates import ATP-binding protein PhnC
plpA D-methionine-binding lipoprotein PlpA precursor
plpB D-methionine-binding lipoprotein PlpB precursor
plpC -0.28 D-methionine-binding lipoprotein PlpC precursor
plpD -0.25 D-methionine-binding lipoprotein PlpD precursor
llmg_0342 0.44 -0.22 0.17 amino acid ABC transporter permease protein
llmg_0341 0.44 -0.24 0.20 0.21 amino acid ABC transporter ATP binding protein
dppA dipeptide-binding protein precursor
dppB 0.48 dipeptide transport system permease protein DppB
dppC 0.92 dipeptide transport system permease protein DppC
dppD 0.76 -0.23 0.16 dipeptide transport ATP-binding protein DppD
dppF 0.60 dipeptide transport ATP-binding protein DppF
fhuD -0.21 -0.38 ferrichrome ABC transporter substrate binding protein
fhuB 0.16 ferrichrome ABC transporter permease protein
fhuG ferrichrome ABC transporter permease protein
llmg_1281 -0.27 putative ABC transporter ATP-binding protein
fhuC ferrichrome ABC transporter FhuC
zitS 0.48 0.30 zinc ABC transporter substrate binding protein
zitP 0.61 0.42 zinc ABC transporter permease protein
zitQ 0.29 0.47 zinc ABC transporter ATP binding protein
cbiQ 0.50 putative cobalt ABC transporter permease protein
cbiQ2 -0.57 putative cobalt ABC transporter permease protein
cbiO 0.39 putative cobalt ABC transporter ATP-binding protein
cbiO -0.40 cobalt transporter ATP-binding subunit
cbiO -0.55 0.22 0.23 cobalt transporter ATP-binding subunit
llmg_1552 0.38 putative ABC type transport system permease protein
drrB 0.47 0.58 daunorubicin resistance transmembrane protein
llmg_0262 0.58 0.25 0.36 ABC transporter permease protein
llmg_1553 0.31 putative ABC transporter ATP-binding protein
drrA 0.32 0.39 daunorubicin resistance ABC transporter ATP-binding subunit
tagG 0.96 0.39 teichoic acid ABC transporter permease protein
tagH 0.51 0.16 teichoic acid export ATP-binding protein TagH 
ftsX -0.30 -0.25 cell division protein FtsX-like protein
ftsE -0.40 cell division ATP-binding protein
llmg_1202 -0.24 0.45 ABC transporter ABC binding and permease protein
cydD cytochrome d ABC transporter ATP binding and permease protein
cydC 0.21 cytochrome d ABC transporter ATP binding and permease protein
llmg_0989 ABC transporter ATP binding and permease protein
ABC transporters
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logFC logFC logFC logFC
apl -0.25 alkaline phosphatase 
pstE -0.48 -0.54 phosphate transport substrate binding protein PstE
pstF -0.45 0.31 0.57 phosphate transport substrate binding protein PstF
kinC sensor histidine kinase 
llrC two-component system regulator
llmg_0458 hypothetical protein 
dnaA -0.36 0.63 chromosomal replication initiation protein
mleS -0.26 malate dehydrogenase 
comX -0.39 competence regulator ComX
frdC -0.29 -0.28 fumarate reductase flavoprotein subunit 
llmg_0018 0.30 beta-lactamase A 
kinD -0.27 sensor protein kinase KinD 
glnB -0.30 -0.33 -0.53 -0.79 nitrogen regulatory protein P-II
glnA -0.61 GlnA protein 
thiL -0.34 -0.28 ThiL protein 
cydA -0.27 0.14 cytochrome bd-I ubiquinol oxidase subunit I 
cydB cytochrome d ubiquinol oxidase, subunit II 
Two-component system
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BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
dppA dipeptide-binding protein precursor
dppB 0.48 dipeptide transport system permease protein DppB
dppC 0.92 dipeptide transport system permease protein DppC
dppD 0.76 -0.23 0.16 dipeptide transport ATP-binding protein DppD
dppF 0.60 dipeptide transport ATP-binding protein DppF
gltD -0.22 glutamate synthase subunit beta 
gltB -0.77 0.15 glutamate synthase, large subunit 
lysA -0.22 LysA protein 
ilvD -0.61 0.19 dihydroxy-acid dehydratase 
ilvB -0.57 0.24 0.22 acetolactate synthase catalytic subunit 
ilvN -0.64 0.29 acetolactate synthase 3 regulatory subunit 
ilvC -0.64 0.31 ketol-acid reductoisomerase 
ilvA -0.56 0.26 threonine dehydratase 
aldB -0.39 -0.34 AldB protein 
hisC 0.18 histidinol-phosphate aminotransferase 
hisZ 0.27 0.52 ATP phosphoribosyltransferase regulatory subunit 
hisG 0.26 0.47 ATP phosphoribosyltransferase catalytic subunit 
hisD 0.22 0.58 HisD protein 
hisB 0.45 imidazoleglycerol-phosphate dehydratase 
hisH 0.27 imidazole glycerol phosphate synthase subunit HisH 
hisA 0.19 0.42 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)
hisF 0.25 0.47 imidazole glycerol phosphate synthase subunit HisF 
hisI 0.36 0.72 bifunctional phosphoribosyl-AMP cyclohydrolase/phosphoribosyl
hisK 0.25 0.60 histidinol-phosphatase 
ctrA -0.44 putative amino-acid transporter
oppD -0.73 oligopeptide transport ATP-binding protein OppD
oppF -0.63 oligopeptide transport ATP-binding protein OppF
oppB -0.38 peptide transport system permease protein OppB
oppC -0.40 oligopeptide transport system permease protein OppC
oppA oligopeptide-binding protein OppA precursor
pepO endopeptidase O 
asnB -0.29 asparagine synthetase B 
gltA 0.26 0.33 citrate synthase 
citB 0.40 aconitate hydratase 
icD 0.25 0.41 isocitrate dehydrogenase 
serC 0.18 phosphoserine aminotransferase 
serA -0.31 -0.64 0.18 0.24 D-3-phosphoglycerate dehydrogenase 
serB -0.49 SerB protein 
ArcD1 0.34 0.21 arginine/ornithine antiporter
ArcC1 0.31 0.29 carbamate kinase 
ArcC2 carbamate kinase 
amtB -0.45 -0.35 -0.55 ammonium transporter AmtB
dapB 0.25 0.30 dihydrodipicolinate reductase 
FtsW1 cell division protein ftsW1




BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC Effect
galP 0.76 0.34 0.49 Rep  galactose permease
galM 0.57 0.28 Rep aldose 1-epimerase 
galK 0.32 Rep galactokinase 
galT 0.23 0.56 Rep galactose-1-phosphate uridylyltransferase 
galE -0.32 0.33 -0.17 -0.36 Rep GalE protein 
mtlA 0.53 0.73 Rep PTS system, mannitol-specific IIBC component 
mtlR 0.36 Rep transcriptional regulator mtl operon MtlR
mtlF 0.23 0.25 Rep PTS system, mannitol-specific IIA component 
mtlD 0.22 Rep mannitol-1-phosphate 5-dehydrogenase 
llmg_0453 Rep sucrose-specific PTS enzyme IIABC
llmg_0454 -0.25 Rep beta-glucoside-specific PTS system IIABC component
trePP -0.21 Rep putative trehalose/maltose hydrolase 
pgmB 0.36 Rep beta-phosphoglucomutase 
llmg_0431 0.41 0.30 Rep putative acyl carrier protein phosphodiesterase 2 
llmg_0432 Rep transcription regulator
ptcB 0.83 0.31 0.43 Rep cellobiose-specific PTS system IIB component 
ptcA 1.00 0.35 0.55 Rep cellobiose-specific PTS system IIA component 
llmg_0439 0.38 Rep LacI family transcription regulator
ptcC 0.59 0.45 0.47 Rep cellobiose-specific PTS system IIC component 
bglA 0.17 0.23 Rep 6-phospho-beta-glucosidase 
arcA 0.63 0.18 0.27 Rep arginine deiminase 
arcB 0.28 Rep ornithine carbamoyltransferase 
arcD1 0.34 0.21 Rep arginine/ornithine antiporter
arcC1 0.31 0.29 Rep carbamate kinase 
arcC2 Rep carbamate kinase 
pfk -0.26 -0.56 Act 6-phosphofructokinase 
pyk -0.27 -1.09 Act pyruvate kinase 
ldh -0.51 -0.45 -0.62 Act L-lactate dehydrogenase 
pgiA 0.54 Act glucose-6-phosphate isomerase 
fruA 0.37 0.23 0.41 Act PTS system, fructose specific IIBC components 
fruC -0.39 0.20 0.44 Act tagatose-6-phosphate kinase 
fruR 0.34 Act lactose transport regulator
Genes under ccpA regulation
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logFC logFC logFC logFC
accA AccA protein 
accB -1.05 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit 
accC -0.26 -0.71 acetyl-CoA carboxylase biotin carboxylase subunit 
accD -0.28 acetyl-CoA carboxylase subunit beta 
fabD -0.76 malonyl CoA-acyl carrier protein transacylase 
fabF -1.05 3-oxoacyl-[acyl-carrier-protein] synthase II 
fabH -0.54 -0.51 3-oxoacyl-(acyl carrier protein) synthase III 
fabG -0.33 -0.92 3-ketoacyl-(acyl-carrier-protein) reductase 
fabG -0.38 -0.58 3-ketoacyl-(acyl-carrier-protein) reductase 
fabZ -1.07 (3R)-hydroxymyristoyl-ACP dehydratase 
llmg_0538 -0.30 0.66 -0.12 (3R)-hydroxymyristoyl-(acyl-carrier-protein) dehydratase 
fabI -0.16 enoyl-(acyl carrier protein) reductase 
llmg_1415 0.58 -0.16 hypothetical protein
thiL -0.34 -0.28 ThiL protein 
llmg_1965 putative AMP-binding enzyme 
adhE 0.52 0.49 0.64 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
adhA, adhP 0.30 alcohol dehydrogenase 
llmg_0955 alcohol dehydrogenase 
Fatty acid biosynthesis and fatty acid metabolism
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BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
llmg_0870 -0.30 -0.26 -0.48 transporter
glpF2 0.67 0.54 0.60 glycerol uptake facilitator
glpF3 0.45 -0.22 -0.60 putative glycerol uptake facilitator protein
dhaK 0.35 -0.25 -0.25 DhaKLM operon coactivator DhaQ 
dhaM 0.57 0.20 dihydroxyacetone kinase DhaM 
glpK 0.52 0.20 0.15 glycerol kinase 
plsX -0.17 -0.24 putative glycerol-3-phosphate acyltransferase PlsX
llmg_1540 -0.40 putative glycerol-3-phosphate acyltransferase PlsY
llmg_0119 -0.40 -0.64 putative acyltransferase 
dgkA -0.34 0.38 0.19 DgkA protein 
llmg_2421 -0.19 -0.21 hypothetical protein
glpD 0.44 0.25 GlpD protein 
gpsA -0.59 NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 
llmg_0945 -0.49 putative glycerol dehydrogenase 




BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
llmg_2075 -0.30 -0.70 ADP-ribose pyrophosphatase 
deoB -0.25 -0.76 phosphopentomutase 
prsB -0.32 -0.26 -0.22 -0.30 ribose-phosphate pyrophosphokinase 
prsA ribose-phosphate pyrophosphokinase 
purF -0.90 amidophosphoribosyltransferase 
purD -0.50 -0.69 phosphoribosylamine--glycine ligase 
purN -0.40 -0.58 phosphoribosylglycinamide formyltransferase 
purS -0.21 phosphoribosylformylglycinamidine synthetase PurS
purQ -0.57 -0.84 phosphoribosylformylglycinamidine synthase I 
purL -1.10 phosphoribosylformylglycinamidine synthase II 
purM -0.32 -0.39 -0.17 phosphoribosylaminoimidazole synthetase 
purK -0.31 phosphoribosylaminoimidazole carboxylase ATPase subunit 
purE -0.59 phosphoribosylaminoimidazole carboxylase catalytic subunit 
purC phosphoribosylaminoimidazole-succinocarboxamide synthase 
purB -0.27 0.33 adenylosuccinate lyase 
purH -0.43 -1.15 bifunctional phosphoribosylaminoimidazolecarboxamide….
apt -0.12 -0.36 adenine phosphoribosyltransferase 
nucA -0.28 5'-nucleotidase 
llmg_0192 0.28 5'-nucleotidase precursor 
deoD -0.51 0.64 purine nucleoside phosphorylase 
hprT 0.30 HprT protein 
hpt 0.29 hypoxanthine phosphoribosyltransferase 
guaB -0.35 -0.77 -0.19 -0.32 inosine 5'-monophosphate dehydrogenase 
llmg_1188 -0.62 hypothetical protein
xpt -0.42 -0.44 -0.25 xanthine phosphoribosyltransferase 
guaA -0.85 -0.32 GMP synthase 
guaC -0.36 -0.47 -0.61 guanosine 5'-monophosphate oxidoreductase 
gmk guanylate kinase 
pyk -0.27 -1.09 pyruvate kinase 
nrdE ribonucleotide-diphosphate reductase subunit alpha 
nrdF -0.41 ribonucleotide-diphosphate reductase subunit beta 
llmg_0281 -0.21 -0.24 -0.32 anaerobic ribonucleoside triphosphate reductase 
rpoA -0.82 DNA-directed RNA polymerase subunit alpha 
rpoB -0.92 DNA-directed RNA polymerase subunit beta 
rpoC -0.84 DNA-directed RNA polymerase subunit beta' 
rpoE -0.26 DNA-directed RNA polymerase subunit delta 
rpoZ -0.37 DNA-directed RNA polymerase subunit omega 
polA 0.28 DNA polymerase I 
dnaE 0.22 -0.11 DNA polymerase III DnaE 
polC 0.76 DNA polymerase III PolC 
dnaN 1.05 DNA polymerase III subunit beta 
dnaX -0.44 DNA polymerase III subunits gamma and tau 
holA -0.39 DNA polymerase III subunit delta 
holB -0.24 -0.29 DNA polymerase III subunit delta' 
dnaQ -0.25 -0.21 DNA polymerase III, epsilon chain 
relA GTP pyrophosphokinase 
llmg_0382 0.19 putative GTP pyrophosphokinase 
purA -0.28 adenylosuccinate synthetase 
add -0.32 0.23 -0.27 -0.60 adenosine deaminase 
cpdC -0.32 -0.39 -0.26 -0.50 2',3'-cyclic-nucleotide 2'-phosphodiesterase 
adk 0.54 0.33 adenylate kinase 
pnpA -0.56 polynucleotide phosphorylase/polyadenylase 
arcC2 carbamate kinase 
arcC1 0.31 0.29 carbamate kinase 
Purine metabolism
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BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
carB -0.33 -1.00 carbamoyl phosphate synthase large subunit 
carA -0.71 carbamoyl phosphate synthase small subunit 
pyrB -0.77 aspartate carbamoyltransferase catalytic subunit 
pyrC -0.33 -0.55 dihydroorotase 
pyrDA -0.38 -0.39 -0.53 dihydroorotate dehydrogenase 1A 
pyrDB -1.07 dihydroorotate dehydrogenase 1B 
pyrE -0.33 -0.48 orotate phosphoribosyltransferase 
pyrF -0.60 -0.70 -0.27 -0.53 orotidine 5'-phosphate decarboxylase 
cmk -0.33 -0.13 cytidylate kinase 
pyrH uridylate kinase 
pnpA -0.56 polynucleotide phosphorylase/polyadenylase 
llmg_1188 -0.62 hypothetical protein
pyrG -0.31 CTP synthetase 
rpoA -0.82 DNA-directed RNA polymerase subunit alpha 
rpoB -0.92 DNA-directed RNA polymerase subunit beta 
rpoC -0.84 DNA-directed RNA polymerase subunit beta' 
rpoE -0.26 DNA-directed RNA polymerase subunit delta 
rpoZ -0.37 DNA-directed RNA polymerase subunit omega 
polA 0.28 DNA polymerase I 
dnaE 0.22 -0.11 DNA polymerase III DnaE 
polC 0.76 DNA polymerase III PolC 
dnaN 1.05 DNA polymerase III subunit beta 
dnaX -0.44 DNA polymerase III subunits gamma and tau 
holA -0.39 DNA polymerase III subunit delta 
holB -0.24 -0.29 DNA polymerase III subunit delta' 
dnaQ -0.25 -0.21 DNA polymerase III, epsilon chain 
udk -0.20 0.59 -0.52 -0.37 uridine kinase 
nucA -0.28 5'-nucleotidase 
llmg_0192 0.28 5'-nucleotidase precursor 
udp -0.45 -0.30 uridine phosphorylase 
upp -0.27 0.34 -0.30 -0.49 uracil phosphoribosyltransferase 
pyrR -0.63 bifunctional pyrimidine regulatory protein PyrR …
pdp -0.58 0.16 0.26 pyrimidine-nucleoside phosphorylase 
trxB1 0.21 -0.21 TrxB1 protein 
trxB2 -0.27 -0.31 TrxB2 protein 
llmg_0281 -0.21 -0.24 -0.32 anaerobic ribonucleoside triphosphate reductase 
nrdE ribonucleotide-diphosphate reductase subunit alpha 
nrdF -0.41 ribonucleotide-diphosphate reductase subunit beta 
ps428 -0.26 0.25 0.27 deoxyuridine 5'-triphosphate nucleotidohydrolase 
ps325 0.14 0.20 deoxyuridine 5'-triphosphate nucleotidohydrolase 
dut deoxyuridine 5'-triphosphate nucleotidohydrolase 
thyA 0.92 -0.47 -0.38 thymidylate synthase 
cdd -0.43 Cdd protein 
deoD -0.51 0.64 purine nucleoside phosphorylase 
llmg_1416 0.33 -0.27 hypothetical protein
ntd 0.17 nucleoside deoxyribosyltransferase 
tdk thymidine kinase 
tmk -0.64 -0.32 -0.22 thymidylate kinase 





BK1506 BK1503 BK1506 BK1503
logFC logFC logFC logFC
speG 0.25 -0.13 spermidine acetyltransferase 
llmg_0177 0.28 0.40 amidase
proC -0.39 -0.37 -0.18 -0.23 pyrroline-5-carboxylate reductase 
ocd -0.34 -0.46 ornithine cyclodeaminase, mu-crystallin-like protein 
proB -0.47 -0.13 -0.28 gamma-glutamyl kinase 
proA -0.15 -0.26 gamma-glutamyl phosphate reductase 
kdgA 0.55 0.22 0.40 keto-hydroxyglutarate-aldolase…
arcB 0.28 ornithine carbamoyltransferase 
argF -0.53 -0.67 ornithine carbamoyltransferase 
argG -0.41 0.17 0.30 argininosuccinate synthase 
argH argininosuccinate lyase 
arcA 0.63 0.18 0.27 arginine deiminase 
glnA -0.61 GlnA protein 
arcC2 carbamate kinase 
arcC1 0.31 0.29 carbamate kinase 
argJ -0.29 -0.24 bifunctional ornithine acetyltransferase…
argB -0.34 -0.23 acetylglutamate kinase 
argC -0.39 -0.47 N-acetyl-gamma-glutamyl-phosphate reductase 
argD 0.59 acetylornithine aminotransferase 
argE -0.45 acetylornithine deacetylase 
Arginine and proline metabolism
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logFC logFC logFC logFC
dfrA -0.64 0.28 -0.14 DfrA protein 
fhs -0.27 formate--tetrahydrofolate ligase 
folD -0.36 -0.35 bifunctional 5,10-methylene-tetrahydrofolate dehydrogenase…
glyA -0.25 -0.33 -0.13 -0.25 serine hydroxymethyltransferase 
purN -0.40 -0.58 phosphoribosylglycinamide formyltransferase 
purH -0.43 -1.15 bifunctional phosphoribosylaminoimidazolecarboxamide…
fmt -0.52 methionyl-tRNA formyltransferase 
thyA 0.92 -0.47 -0.38 thymidylate synthase 
metF -0.24 -0.34 5,10-methylenetetrahydrofolate reductase
llmg_0181 0.23 5-formyltetrahydrofolate cyclo-ligase family protein 
thiD1 0.41 phosphomethylpyrimidine kinase 
nifS 0.19 putative iron-sulfur cofactor synthesis protein 
nifZ -0.50 0.47 -0.33 -0.48 pyridoxal-phosphate dependent aminotransferase 
llmg_1972 -0.61 0.12 hypothetical protein
thiI -0.40 -0.46 -0.42 thiamine biosynthesis protein ThiI
thiM hydroxyethylthiazole kinase 
thiE -0.24 thiamine-phosphate pyrophosphorylase 
thiN thiamin pyrophosphokinase 
tenA -0.23 -0.27 transcriptional activator TenA
ribA riboflavin biosynthesis protein RibA 
ribD riboflavin biosynthesis protein RibD 
ribH 0.27 6,7-dimethyl-8-ribityllumazine synthase 
ribB 0.40 riboflavin synthase subunit alpha 
ribC, ribF 0.51 bifunctional riboflavin kinase/FMN adenylyltransferase 
thiD2 phosphomethylpyrimidine kinase 
serC 0.18 phosphoserine aminotransferase 
thrC -0.33 -0.45 threonine synthase 
pncB -0.34 -0.38 nicotinate phosphoribosyltransferase 
deoD -0.51 0.64 purine nucleoside phosphorylase 
nucA -0.28 5'-nucleotidase 
llmg_0192 0.28 5'-nucleotidase precursor 
nadD -0.38 -0.38 nicotinic acid mononucleotide adenylyltransferase 
nadD1 0.22 0.28 nicotinate-nucleotide adenylyltransferase 
nadE NAD synthetase 
ppnK inorganic polyphosphate/ATP-NAD kinase 
als -0.35 -0.25 -0.43 acetolactate synthase 
ilvB -0.57 0.24 0.22 acetolactate synthase catalytic subunit 
ilvH -0.64 0.29 acetolactate synthase 3 regulatory subunit 
ilvC -0.64 0.31 ketol-acid reductoisomerase 
ilvD -0.61 0.19 dihydroxy-acid dehydratase 
panE 0.72 -0.42 2-dehydropantoate 2-reductase 
coaA -0.40 0.37 -0.19 pantothenate kinase 
dfpB -0.38 phosphopantothenate--cysteine ligase 
dfpA -0.45 phosphopantothenoylcysteine decarboxylase 
coaD phosphopantetheine adenylyltransferase 
coaE 0.19 dephospho-CoA kinase 
acpS -0.48 4'-phosphopantetheinyl transferase 
ilvE -0.36 -0.55 branched-chain amino acid aminotransferase 
birA2 0.20 0.18 acetyl-CoA carboxylase ligase / biotin operon repressor…
birA1 -0.23 -0.32 -0.33 biotin--[acetyl-CoA-carboxylase] ligase and biotin operon…
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Biotin metabolism
Vitamin and cofactor metabolism
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The script used to perform the analysis of 





This section contains the R-script used to 
perform the analysis in the statistical software 
package R. The analysis was performed by 
running a subset of the commands found 










# work in progress... 




# specify the a folder in relative of full path where plots are saved 
path <- 'Plots chip 1' 
#Set working directory, tell R where to find the samples 
setwd('C:/Users/achh/Documents/Projekter/02 - PhD projekt - GLYFINERY 
(open)/Microarray/02 - ATPase stammer - August-November 2011/Data analyse') 
# Read the targets file (filenames and conditions) 
targets <- readTargets("Samples.txt") 
# Array of the slide index numbers used internally in the program 
nArrays = length(targets$FileName) 
slideIndex = c(1:nArrays) 
# Initialization of sample names and colors for plotting of Densities. The color array 
should be tweaked   
sampleNames = paste(targets$Condition, targets$Sample, sep=" ") 
if(length(targets$Chip) == length(sampleNames)) sampleNames <- paste(sampleNames, " 
Chip ", targets$Chip, sep="") 
#sampleNames without "chip" 
sampleNamesNoChip = paste(targets$Condition, targets$Sample, sep=" ") 
b10 <- targets$Condition == "BK1010" 
b06 <- targets$Condition == "BK1506" 
b03 <- targets$Condition == "BK1503" 
colors <- c() 
colors[b10] =  hsv(seq(0, 0.15,    length.out = sum(b10)), seq(0.6, 1, length.out = 
sum(b10)),seq(0.7, 1, length.out = sum(b10)) ) # red hues to BK1010 
colors[b06] =  hsv(seq(0.25, 0.4,  length.out = sum(b06)), seq(0.6, 1, length.out = 
sum(b06)),seq(0.7, 1, length.out = sum(b06)) ) # green hues to BK1506 
colors[b03] =  hsv(seq(0.57, 0.72, length.out = sum(b03)), seq(0.6, 1, length.out = 
sum(b03)),seq(0.7, 1, length.out = sum(b03)) ) # blue hues to BK1506 
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# Read raw datafiles. Only G and Gb is used later. The red channels need to be filled 
with data of the same size for commands to work.  
RG <- read.maimages(targets, columns = list(G = "gMedianSignal", Gb = 
"gBGMedianSignal", R = "gProcessedSignal", Rb = "gIsPosAndSignif"), annotation = 
c("Row", "Col","FeatureNum", "ControlType","ProbeName")) 
# Subtract background - Background subtraction often introduce noise - Here only used 
in some plots 
RGBgCor <- limma::backgroundCorrect(RG, method="normexp", offset=1)  
# Paranoid me put zeroes into the background intensities 
RG$Gb = RG$Gb * 0 
RGBgCor$Gb = RG$Gb 
# Normalize data 
RG.norm <- RG 
RG.norm$G <- normalizeBetweenArrays(RG$G, method="quantile") 
RG.spline <- RG 
RG.spline$G <- normalize.qspline(RG.spline$G) 
# Extract loci from ProbeNames. Normal probes: "llmg_geneNumber_probeIndex", get their 
probeIndex stripped. In this way genes from the same locus can be identified. 
SpecialCases <- c("rRNA", "tRNA", "pseudo", "r60") # probenames which must be taken 
care of seperately. OBS! there is only one probe for each of "rRNA", "tRNA", "pseudo" 
genes. 
RG.norm$genes$locus <-sapply(strsplit(RG.norm$genes$ProbeName, "_"), function(V){ 
 if(length(V)==1){return(V)} 
 if(V[1]=="llmg" && sum(V[2] == SpecialCases)) {return(paste(V, 
collapse="_"))} 
 if(V[2] == "phage") {return(paste(V[1:length(V)-1], collapse= "_"))} 
 if(V[1] == "llmg") {return(paste(V[1],"_",V[2], sep=""))} 
 paste(V, collapse="_")} 
) 
# Find all non-control probes 
# Pseudo genes pilles fra da de kun har en enkelt probe...  
BV.nonC <- sapply(RG$genes$ProbeName, function(e){sum(RG$genes$ProbeName == e) <= 2}) 





# Make RMA (output in log2) 
Green = basicRMA(RG.norm$G[BV.nonC & BV.highCopy,], RG.norm$genes$locus[BV.nonC & 
BV.highCopy], normalize=FALSE, background = FALSE) 
G.norm <- normalize.qspline(Green) 
# G.norm <-  basicRMA(RG$G[BV.nonC & BV.highCopy,], RG.norm$genes$locus[BV.nonC & 
BV.highCopy], normalize=TRUE, background = FALSE) 
 
# Make MAList object for further processing 
reducedLoci = as.data.frame(rownames(Green)) 
colnames(reducedLoci) = "Locus" 
E.norm <- new("MAList", list(targets=RG.norm$targets, genes=reducedLoci, 
source=RG.norm$source, M=Green*0, A=G.norm)) 
E  <- new("MAList", list(targets=RG.norm$targets, genes=reducedLoci, 
source=RG.norm$source, M=Green*0, A=Green)) 
# Plot densities. First comes the red channels then the green. We have gProcessedSignal 
in the red channels 
plotDensities(E, singlechannels= c((nArrays + 1):(2 * nArrays)), groups = c( 
1:nArrays), col=colors ) 
legend(x = 6.0, y = 0.35, legend = sampleNamesNoChip, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, "/densities.after.RMA.pdf", sep="")) 
 
plotDensities(RG, singlechannels= c((nArrays + 1):(2 * nArrays)), groups = 
c(1:nArrays), col=colors ) 
legend(x = 1.3, y = 0.45, legend = sampleNames, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, "/densities.pdf", sep="")) 
 
plotDensities(RGBgCor, singlechannels= c((nArrays + 1):(2 * nArrays)), groups = 
c(1:nArrays), col=colors ) 
legend(x = 1.3, y = 0.45, legend = sampleNames, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, "/densitiesAfterBackgroundCorrection.pdf", 
sep="")) 
 
plotDensities(RG, singlechannels= c(1:nArrays), groups = c(1:nArrays), col=colors ) 
legend(x = 1.3, y = 0.45, legend = sampleNames, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, "/densitiesProcessedSig.pdf", sep="")) 
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 plotDensities(RG.norm, singlechannels= c((nArrays + 1):(2 * nArrays)), groups = c( 
1:nArrays), col=colors ) 
legend(x = 15.7, y = 0.33, legend = sampleNames, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, "/densities.after.norm.quantile.pdf", 
sep="")) 
 
plotDensities(RG.spline, singlechannels= c((nArrays + 1):(2 * nArrays)), groups = c( 
1:nArrays), col=colors ) 
legend(x = 15.7, y = 0.33, legend = sampleNames, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, "/densities.after.norm.qspline.pdf", 
sep="")) 
 
plotDensity(E.norm, singlechannels= c((nArrays + 1):(2 * nArrays)), groups = c( 
1:nArrays), col=colors  ) 
legend(x = 6, y = 0.33, legend = sampleNames, fill = colors, col = "black") 
dev.print( device = pdf, file = paste(path, 
"/densities.after.norm.RMA.norm.qspline.pdf", sep="")) 
 
# Make SVD 
SVD <- svd(G.norm - rowMeans(G.norm)) 
S <-  matrix(0 , ncol(G.norm), ncol(G.norm)) 
diag(S)<-SVD$d 
 
image( S%*%t(SVD$v), main="Singular Value Decomposition",  xlab = "The components", 
axes = FALSE) 
axis(side = 2, at = seq(0, 1, length.out = nArrays), labels = sampleNames, las =1, 
cex.axis = 0.4) 
lines(c(0,1),c((sum(b10)-0.5)/(nArrays-1),(sum(b10)-0.5)/(nArrays-1))) 
lines(c(0,1),c((sum(b10+b06)-0.5)/(nArrays-1),(sum(b10+b06)-0.5)/(nArrays-1))) 
dev.print( device = pdf, file = paste(path,"/SVD heatmap.pdf", sep = "")) 
 
#PCA lignende clustering 
plot(SVD$v[,1], SVD$v[,2], col = "white", main = "Singular Value Decomposition", 
 xlab = "First Component", ylab = "Second Component") 
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text(SVD$v[,1], SVD$v[,2], sampleNames, col = colors, cex = 0.7) 
dev.print( device = pdf, file = paste(path,"/SVD1-2.pdf", sep = "")) 
# Plot intensity vs. intensity 
# After RMA 
# plot(E$A[,1], E$A[,2], pch = 20, cex = 0.3, xlab = paste("Microarray ", 1), ylab = 
paste("Microarray ", 2)) 
# dev.print( device = pdf, file = paste(path,"/Slide ", 2, " Vs slide ", 1, ".pdf")) 
#  
# plot(E$A[,3], E$A[,4], pch = 20, cex = 0.3, xlab = "Microarray 4"   , ylab = 
"Microarray 5") 
# dev.print( device = pdf, file = paste(path",/Slide ", 5, " Vs slide ", 4, ".pdf")) 
# 
# for (i in 1:11) { 
#  for (j in (i+1):12) { 
#   plot(E$A[,j], E$A[,i], pch = 20, cex = 0.3, xlab = 
paste("Microarray ", j), ylab = paste("Microarray ", i)) 
#   dev.print( device = pdf, file = paste(path,"/sample ", i , " Vs 
sample ", j , " after RMA.pdf")) 
#  } 
# } 
 
#plot(log(RG$G[,4],2), log(RG$G[,5],2), pch = 20, cex = 0.3) 
# Setup analysis 
f <- factor(targets$Condition, levels = unique(targets$Condition)) 
design <- model.matrix(~0 + f) 
colnames(design) <- levels(f) 
fit <- lmFit(E$A, design) 
contrast.matrix <- makeContrasts("BK1506-BK1010", "BK1503-BK1010", levels=design) 
fit2 <- contrasts.fit(fit, contrast.matrix) 
fit2 <- eBayes(fit2) 
 
# export data 
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output <- topTable(fit2, adjust="BH", coef="BK1506-BK1010", genelist=E$genes, 
number=40000) 
write.table(output, file= paste(path, "/BK1506-BK1010.csv", sep = ""), 
sep="\t",row.name=FALSE, quote=FALSE) 
output <- topTable(fit2, adjust="BH", coef="BK1503-BK1010", genelist=E$genes, 
number=40000) 
write.table(output, file=paste(path, "/BK1503-BK1010.csv", sep = ""), sep="\t", 
row.name=FALSE, quote=FALSE) 
 
output <- topTable(fit2, adjust="BH", genelist=E$genes, number=40000) 
write.table(output, file=paste(path, "/all.csv", sep=""), sep="\t", row.name=FALSE, 
quote=FALSE) 
# Make volcanoplots 
# Volcano BK1506 vs BK1010 
# Permuted conditions 
#f <- factor(targets$Condition[c(1,4, 2,3, 5:7) ], levels = unique(targets$Condition)) 
permP <- c() 
iter <- 30 
for(i in 1:iter) { 
f <- factor(sample(targets$Condition), levels = unique(targets$Condition)) 
design <- model.matrix(~0 + f) 
colnames(design) <- levels(f) 
fitPerm <- lmFit(E$A, design) 
contrast.matrix <- makeContrasts("BK1506-BK1010", "BK1503-BK1010", levels=design) 
fitPerm2 <- contrasts.fit(fitPerm, contrast.matrix) 
fitPerm2 <- eBayes(fitPerm2) 
permP <- rbind(permP, fitPerm2$p.value) 
} 
pO <- sort(fit2$p.value[,1]) 
pP <- sort(permP[,1]) 
nO <- 1 
nP <- 1 
FDR <- vector(mode = "numeric", length = length(pO)) 
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while (nO <= length(pO)) { 
 while (pO[nO] > pP[nP] & nP <= length(pP)) {nP <- nP+1} 
 FDR[nO] <- (nP-1)/nO/iter 
 nO <- nO + 1 
} 
plot(FDR, main = "FDR BK1506", xlab = "significant genes", ylab = "False discovery 
rate", type = "p", col= "#00000030") 
dev.print( device = pdf, file = paste(path,"/FDR_BK1506.pdf", sep = "")) 
# p1 <- permP[order(permP[,1]),1] 
#  
# count <- c(1:length(fit2$p.value[,1])) 
#  
# porder1 <- fit2$p.value[order(fit2$p.value[,1]),1] 
#  
# y1 <- sapply(count,  function(n) {sum(p1 < porder1[n])/n})/iter 
#  
# plot(y1, main = "FDR BK1506", xlab = "significant genes", ylab = "False discovery 
rate", type = "l") 
# dev.print( device = pdf, file = paste(path,"/FDR_BK1506.pdf", sep = "")) 
# # y1 <- apply(count, function(n) {sum(p1 < 
fit2$p.value[order(fit2$p.value[,1]),1][n])/n}) 
pO <- sort(fit2$p.value[,2]) 
pP <- sort(fitPerm2$p.value[,2]) 
nO <- 1 
nP <- 1 
FDR <- vector(mode = "numeric", length = length(pO)) 
while (nO <= length(pO)) { 
 while (pO[nO] > pP[nP] & nP <= length(pP)) {nP <- nP+1} 
 FDR[nO] <- (nP-1)/nO/ncol(fmat) 
 nO <- nO + 1 
} 
plot(FDR, main = "FDR BK1503", xlab = "significant genes", ylab = "False discovery 
rate", type = "l") 
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dev.print( device = pdf, file = paste(path,"/FDR_BK1503.pdf", sep = "")) 
# p2 <- permP[order(permP[,2]),2] 
#  
# count <- c(1:length(fit2$p.value[,2])) 
#  
# porder2 <- fit2$p.value[order(fit2$p.value[,2]),2] 
#  
# y2 <- sapply(count,  function(n) {sum(p2 < porder2[n])/n})/iter 
#  
# plot(y2, main = "FDR BK1503", xlab = "significant genes", ylab = "False discovery 
rate", type = "l") 
# dev.print( device = pdf, file = paste(path,"/FDR_BK1503.pdf", sep = "")) 
############################################################################### 
# The volcanoplot - OBS! c(..) er datasæt specifikt!  
f <- factor(targets$Condition[c(1,4,6, 2,7, 3,5,8) ], levels = 
unique(targets$Condition)) 
design <- model.matrix(~0 + f) 
colnames(design) <- levels(f) 
fit <- lmFit(E$A, design) 
contrast.matrix <- makeContrasts("BK1506-BK1010", "BK1503-BK1010", levels=design) 
fitPerm2 <- contrasts.fit(fit, contrast.matrix) 
fitPerm2 <- eBayes(fitPerm2) 
plot(fit2$coefficients[,1],fit2$p.value[,1], log = "y", pch = 20, cex = 0.3, main = 
"Volcano Plot for BK1506", xlab = "logFC", ylab = "P value", xlim = c(-1.5, 1.5)) 
points(fitPerm2$coefficients[,1],fitPerm2$p.value[,1], pch = 20, cex = 0.3, col = 
"red") 
lowP = min(fitPerm2$p.value[,1]) 
lines(c(-2, 2), c(rep(lowP,2)), col = "red" ) 
text(1.4, lowP*1.25, paste("p = ", round(lowP,4)), cex = 0.7) 






 # Volcano BK1503 vs BK1010 
# Permuted conditions 
# The volcanoplot 
plot(fit2$coefficients[,2],fit2$p.value[,2], log = "y", pch = 20, cex = 0.3, main = 
"Volcano Plot for BK1503", xlab = "logFC", ylab = "P value", xlim = c(-1.5, 1.5)) 
points(fitPerm2$coefficients[,2],fitPerm2$p.value[,2], pch = 20, cex = 0.3, col = 
"red") 
lowP = min(fitPerm2$p.value[,2]) 
lines(c(-2, 2), c(rep(lowP,2)), col = "red" ) 
text(1.4, lowP*1.25, paste("p = ", round(lowP,4)), cex = 0.7) 
dev.print( device = pdf, file = paste(path, "/volcanoBK1503.pdf", sep="")) 
####################################################################################### 
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